,CUI1,CUI2,label
0,Peptide Receptor,"RXFP1 protein, human",0
1,Peptide Receptor,"Prokr2 protein, mouse",0
2,Peptide Receptor,"ATPase beta-subunit, rat",0
3,"Receptors, Thyrotropin-Releasing Hormone","TRH-R1 protein, mouse",0
4,"Receptors, Thyrotropin-Releasing Hormone","TRH-R2 protein, mouse",0
5,"Silver Compounds, Inorganic",AgBiS2,0
6,"Antibodies, Bispecific",Bi20 antibody,0
7,"Receptors, Odorant","Obp57d protein, Drosophila",0
8,"Receptors, Purinergic P2","P2Y10 protein, human",0
9,Arsenites,"2,3-dipalmitoyloxypropylarsonic acid",0
10,Haemophilus Vaccines,Hib-MenCY-TT vaccine,0
11,"Vaccines, Conjugate",Hib-MenCY-TT vaccine,0
12,Chloride Channels,"BSND protein, human",0
13,Chloride Channels,"CLIC protein, Drosophila",0
14,Chloride Channels,"TTYH3 protein, human",0
15,Interleukin Receptor,"interleukin-23 receptor, mouse",0
16,Interleukin Receptor,"interleukin-34 receptor, human",0
17,"Receptors, Cytoplasmic and Nuclear","Nhr-6 protein, C elegans",0
18,"Receptors, Cytoplasmic and Nuclear","C1orf85 protein, human",0
19,"Receptors, Cytoplasmic and Nuclear","VSR3 protein, Arabidopsis",0
20,"Receptors, Cytoplasmic and Nuclear","PEX5L protein, human",0
21,"Receptors, Cytoplasmic and Nuclear","ribosome receptor p180, human",0
22,Gelsolin,gelsolin (160-169),0
23,porin,"NanC protein, E coli",0
24,Mucin-1 Antigen,CAM 123-6 antigen,0
25,Mucin-1 Antigen,"MUC-X protein, human",0
26,Mucin-1 Antigen,"MUC-1 protein, human (950-958)",0
27,Homeodomain Proteins,"Phf6 protein, mouse",0
28,Homeodomain Proteins,"Prx1 protein, rat",0
29,Homeodomain Proteins,"RHOX5 protein, human",0
30,Homeodomain Proteins,"Cdx1b protein, zebrafish",0
31,Homeodomain Proteins,"NKX5-3 protein, human",0
32,ATP-Binding Cassette Transporters,"RDE-2 protein, C elegans",0
33,ATP-Binding Cassette Transporters,"PDR10 protein, S cerevisiae",0
34,ATP-Binding Cassette Transporters,"PDR15 protein, S cerevisiae",0
35,ATP-Binding Cassette Transporters,"LptF protein, E coli",0
36,ATP-Binding Cassette Transporters,"LptG protein, E coli",0
37,ras Proteins,"RBEL1 protein, human",0
38,ras Proteins,"Dexras1 protein, rat",0
39,ras Proteins,"Hras protein, rat",0
40,Glutamic Acid,copoly(aspartic acid-glutamic acid),0
41,Immunoconjugates,MLN2704 antibody,0
42,Cell Cycle Proteins,"Crif1 protein, mouse",0
43,Cell Cycle Proteins,"RbEST47 protein, mouse",0
44,Cell Cycle Proteins,"SRG8 protein, human",0
45,Cell Cycle Proteins,"HTP-3 protein, C elegans",0
46,Cell Cycle Proteins,"shugoshin protein, mouse",0
47,Cell Cycle Proteins,"Cdc6 protein, rat",0
48,Cell Cycle Proteins,"bora protein, human",0
49,Cell Cycle Proteins,"Inn1 protein, S cerevisiae",0
50,Cell Cycle Proteins,"Msa1 protein, S cerevisiae",0
51,Cell Cycle Proteins,"killen protein, human",0
52,Cell Cycle Proteins,"Spy1 protein, mouse",0
53,Cell Cycle Proteins,"Ecm11 protein, S cerevisiae",0
54,Cell Cycle Proteins,"WEE1 protein, Xenopus",0
55,Cell Cycle Proteins,"ETG1 protein, Arabidopsis",0
56,Cell Cycle Proteins,"Sugt1 protein, mouse",0
57,Cell Cycle Proteins,"Brd4 protein, zebrafish",0
58,"Adhesins, Bacterial","YadB protein, Yersinia pestis",0
59,"Adhesins, Bacterial","YadC protein, Yersinia pestis",0
60,"Adhesins, Escherichia coli","EhaA, Escherichia coli O157:H7",0
61,Molecular Chaperones,"POC4 protein, S cerevisiae",0
62,Molecular Chaperones,"IRC25 protein, S cerevisiae",0
63,Molecular Chaperones,"Unc45a protein, zebrafish",0
64,Molecular Chaperones,"unc-85 protein, C elegans",0
65,Molecular Chaperones,"ERdj5 protein, mouse",0
66,Chaperonin 10,early pregnancy factor,0
67,CD11 Antigens,"integrin alphaD, mouse",0
68,Macrolides,laulimalide,0
69,Macrolides,dolabelide A,0
70,Macrolides,dolabelide B,0
71,Macrolides,dolabelide D,0
72,Macrolides,dolabelide C,0
73,Macrolides,"14-ethyl-2,5,11-trimethyl-4,13,19,20-tetraoxa-tricyclo(14.2.1.1(7,10))eicosane-3,12-dione",0
74,Macrolides,chlorotonil A,0
75,Macrolides,spirastrellolide C,0
76,Macrolides,spirastrellolide G,0
77,Macrolides,salarin A,0
78,Macrolides,salarin B,0
79,Macrolides,tulearin,0
80,Macrolides,aspergillide A,0
81,Macrolides,aspergillide C,0
82,Macrolides,aspergillide B,0
83,Macrolides,2-hydroxytetracosanolide,0
84,Macrolides,phoxalone,0
85,Macrolides,exiguolide,0
86,Macrolides,trichodermatide A,0
87,Macrolides,Iriomoteolide-3a,0
88,Macrolides,22-epoxyberkeleydione,0
89,Macrolides,miniolutelide A,0
90,Macrolides,miniolutelide B,0
91,Macrolides,plakortenone,0
92,Macrolides,callipeltoside C,0
93,Macrolides,mirabilin (macrolide lactam),0
94,Macrolides,menisporopsin B,0
95,Macrolides,"10,11-dihydrodictyostatin",0
96,Macrolides,archazolide A,0
97,Macrolides,miyakolide,0
98,Macrolides,benzopyrenomycin,0
99,Macrolides,dihydroresorcylide,0
100,Macrolides,7-hydroxydihydroresorcylide,0
101,"Antigens, CD5","Cd5 protein, mouse",0
102,Insulin-Like Growth-Factor-Binding Proteins,"acid-labile subunit, Drosophila",0
103,Neural Cell Adhesion Molecules,"Nrxn1 protein, mouse",0
104,"Bridged Bicyclo Compounds, Heterocyclic","2',6'-dihydroxy-8'-(thymin-1-yl)-9'-oxabicyclo(4.3.0)nonane",0
105,"Bridged Bicyclo Compounds, Heterocyclic",2-oxo-5-azabicyclo(2.2.1)heptane,0
106,"Bridged Bicyclo Compounds, Heterocyclic",annuionone B,0
107,"Bridged Bicyclo Compounds, Heterocyclic",tanarifuranonol,0
108,"Bridged Bicyclo Compounds, Heterocyclic","spiro(4-benzyloxy-2,3-isopropylidenedioxy-1-oxa-cyclopentane-5,5'-(2-benzoylmethylene-1,3-diazacyclohexane))",0
109,"Bridged Bicyclo Compounds, Heterocyclic","6-(4-nitrophenyl)-2-phenyl-4,4-dipropyl-3,5-diazabicyclo(3.1.0)hex-2-ene",0
110,"Bridged Bicyclo Compounds, Heterocyclic","(3aS-(3aalpha,4beta,5beta,7beta,7aalpha))-4-(octahydro-5-hydroxy-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-iodobenzonitrile",0
111,"Bridged Bicyclo Compounds, Heterocyclic",polyrhacitide A,0
112,"Bridged Bicyclo Compounds, Heterocyclic",polyrhacitide B,0
113,"Bridged Bicyclo Compounds, Heterocyclic","3,7-dinitro-1,3,5,7-tetraazabicyclo(3,3,1)nonane",0
114,"Bridged Bicyclo Compounds, Heterocyclic",LYR 71,0
115,Stem Cell Factor,"KITL2 protein, mouse",0
116,Telomerase,"TERT protein, Arabidopsis",0
117,Nonheme Iron Proteins,"MEMO1 protein, human",0
118,GTP-Binding Proteins,"Ghalpha protein, rat",0
119,GTP-Binding Proteins,"GBP5 protein, human",0
120,GTP-Binding Proteins,"mAtNOS1 protein, human",0
121,"GTP-Binding Protein alpha Subunits, Gi-Go","GOA-1 protein, C elegans",0
122,NADPH Oxidase,"NCF2 protein, human",0
123,"Hemagglutinin Glycoproteins, Influenza Virus",influenza virus hemagglutinin peptide 2 (1-23),0
124,Resin Cements,G-Cem resin cement,0
125,Resin Cements,Rely-X,0
126,Resin Cements,clearfil esthetic cement,0
127,"Vaccines, DNA",pGJA-P VAX vaccine,0
128,Insect Proteins,"CYP6F1 protein, Culex pipiens pallens",0
129,Insect Proteins,"brasiliensin protein, Triatoma brasiliensis",0
130,Insect Proteins,"chymotrypsin inhibitor 13 protein, Bombyx mori",0
131,Cancer Vaccines,CHP-HER2 vaccine,0
132,Peptidylprolyl Isomerase,"PpiD protein, E coli",0
133,Protein Disulfide-Isomerases,"P4HB protein, human",0
134,Protein Disulfide-Isomerases,"P4hb protein, mouse",0
135,Protein Disulfide-Isomerases,"P4hb protein, rat",0
136,Protein Disulfide-Isomerases,"PDIA2 protein, human",0
137,Protein Disulfide-Isomerases,"PDIA4 protein, human",0
138,Protein Disulfide-Isomerases,"PDIA5 protein, human",0
139,Protein Disulfide-Isomerases,"Pdia6 protein, mouse",0
140,Protein Disulfide-Isomerases,"Pdia2 protein, mouse",0
141,Protein Disulfide-Isomerases,"Pdia4 protein, mouse",0
142,Protein Disulfide-Isomerases,"Pdia5 protein, mouse",0
143,Protein Disulfide-Isomerases,"dsbA protein, E coli",0
144,Protein Disulfide-Isomerases,"dsbC protein, E coli",0
145,CXCR4 Receptors,"CXCR4 protein, human",0
146,Carbon-Oxygen Ligases,"WaaL protein, Pseudomonas aeruginosa",0
147,Aldose-Ketose Isomerases,"5-methylthioribose 1-phosphate isomerase, Bacillus subtilis",0
148,Carbon-Oxygen Lyases,"phosphothreonine lyase, Salmonella enterica",0
149,Phosphorus-Oxygen Lyases,"diadenylate cyclase, Bacillus subtilis",0
150,Glutathione Disulfide,NOV 002,0
151,Archaeal Proteins,"CYP119 protein, Sulfolobus solfataricus",0
152,Diacylglycerol Kinase,"diacylglycerol kinase zeta, human",0
153,Diacylglycerol Kinase,"diacylglycerol kinase epsilon, human",0
154,aminoacyltransferase,"mprF protein, Staphylococcus aureus",0
155,Alkyl and Aryl Transferases,"DesVI protein, Streptomyces venezuelae",0
156,Gastrin releasing peptide,gastrin releasing peptide (14-27),0
157,Gastrin releasing peptide,"gastrin releasing peptide (18-27), Phe(25)-",0
158,Gastrin releasing peptide,gastrin releasing peptide (1-16),0
159,Ribosomal Protein S6 Kinase,"S6K1 protein, rat",0
160,Transposase,"HARBI1 protein, human",0
161,Polymethyl Methacrylate,versabond,0
162,Polymethyl Methacrylate,SmartSet GHV,0
163,Polymethyl Methacrylate,Palacos R+G,0
164,Benzyl Alcohol,Hyposen,0
165,Cyclin B,"CLB4 protein, S cerevisiae",0
166,Cyclin D1,"CCND1 protein, human",0
167,Cyclin D1,"Ccnd1 protein, mouse",0
168,Cyclin D1,"Ccnd1 protein, rat",0
169,Propanols,1-chloro-1-propanol,0
170,Hydrogels,Bulkamid,0
171,Peptide Nucleic Acids,aminoethylglycyl PNA,0
172,water channel,"NIP7;1 protein, Arabidopsis",0
173,RNA Helicase,"Mov10 protein, human",0
174,Interleukin-18,"EGF-IL-18 fusion protein, mouse",0
175,Poloxamer,pre-seed,0
176,Guanosine Triphosphate Phosphohydrolases,"dnd protein, Drosophila",0
177,Guanosine Triphosphate Phosphohydrolases,"RERG protein, human",0
178,Guanosine Triphosphate Phosphohydrolases,"PIKE protein, mouse",0
179,Guanosine Triphosphate Phosphohydrolases,"ATL2 protein, human",0
180,Guanosine Triphosphate Phosphohydrolases,"ATL3 protein, human",0
181,Guanosine Triphosphate Phosphohydrolases,"Guf1 protein, S cerevisiae",0
182,Guanosine Triphosphate Phosphohydrolases,"EMB2473 protein, Arabidopsis",0
183,Monomeric GTP-Binding Proteins,"GTR2 protein, S cerevisiae",0
184,Monomeric GTP-Binding Proteins,"Agap2 protein, rat",0
185,Monomeric GTP-Binding Proteins,"REM2 protein, human",0
186,Guanine Nucleotide Exchange Factors,"Epac-1 protein, rat",0
187,Guanine Nucleotide Exchange Factors,"PLEKHG6 protein, human",0
188,Guanine Nucleotide Exchange Factors,"PLEKHG2 protein, human",0
189,Guanine Nucleotide Exchange Factors,"Dock180 protein, mouse",0
190,Guanine Nucleotide Exchange Factors,"Get3 protein, S cerevisiae",0
191,Guanine Nucleotide Exchange Factors,"Gapex-5 protein, mouse",0
192,Guanine Nucleotide Exchange Factors,"Varp protein, human",0
193,Guanine Nucleotide Exchange Factors,"RANBP10 protein, human",0
194,ras Guanine Nucleotide Exchange Factors,"RasGRP3 protein, mouse",0
195,ras Guanine Nucleotide Exchange Factors,"RASEF protein, human",0
196,ras Guanine Nucleotide Exchange Factors,"Rasgrp2 protein, Xenopus",0
197,rap GTP-Binding Proteins,"RAP2A protein, Xenopus",0
198,GTPase-Activating Proteins,"TBC1D1 protein, human",0
199,GTPase-Activating Proteins,"Rga1 protein, S cerevisiae",0
200,GTPase-Activating Proteins,"Spa-1 protein, human",0
201,GTPase-Activating Proteins,"P-Rex2 protein, mouse",0
202,GTPase-Activating Proteins,"Rga4 protein, S pombe",0
203,GTPase-Activating Proteins,"OPHN1 protein, rat",0
204,GTPase-Activating Proteins,"srGAP1 protein, rat",0
205,GTPase-Activating Proteins,"srGAP2 protein, rat",0
206,GTPase-Activating Proteins,"SRGAP3 protein, rat",0
207,rab GTP-Binding Proteins,"Rab-35 protein, C elegans",0
208,rab GTP-Binding Proteins,"Rab8 protein, rat",0
209,RGS Proteins,"Rgs17 protein, rat",0
210,Glucuronides,achyranthoside G,0
211,Glucuronides,achyranthoside H,0
212,ADP-Ribosylation Factors,"cholix toxin, Vibrio cholerae",0
213,ADP-Ribosylation Factors,"Arl13b protein, human",0
214,rho GTP-Binding Proteins,"RhoA protein, mouse",0
215,L-Type Calcium Channels,"CACNA1S protein, mouse",0
216,rab1 GTP-Binding Proteins,"TBC1D20 protein, human",0
217,rab1 GTP-Binding Proteins,"Rab1B protein, human",0
218,Receptor Protein-Tyrosine Kinases,"Tyro3 protein, rat",0
219,N-type calcium channels,"CACNA1B protein, Xenopus",0
220,Conotoxin,"conomarphin, Conus marmoreus",0
221,Nerve Growth Factor,"LIP1 proNGF peptide, human",0
222,Nerve Growth Factor,"LIP2 proNGF peptide, human",0
223,Heterotrimeric GTP-Binding Proteins,"XLG2 protein, Arabidopsis",0
224,Heterotrimeric GTP-Binding Proteins,"XLG3 protein, Arabidopsis",0
225,beta-Defensins,"DEFB-109 peptide, human",0
226,beta-Defensins,"gallinacin-8 protein, chicken",0
227,beta-Defensins,"gallinacin-9 protein, chicken",0
228,beta-Defensins,"Defb14 protein, mouse",0
229,Antimicrobial Cationic Peptides,"cancrin, Rana cancrivora",0
230,Antimicrobial Cationic Peptides,"ocellatin 4 protein, Leptodactylus ocellatus",0
231,Antimicrobial Cationic Peptides,"dermadistinctin K, Phyllomedusa distincta",0
232,Antimicrobial Cationic Peptides,"ascaphin-8 peptide, Ascaphus truei",0
233,Antimicrobial Cationic Peptides,"arasin 1, Hyas araneus",0
234,Antimicrobial Cationic Peptides,(KIAGKIA)3 peptide,0
235,Antimicrobial Cationic Peptides,"Ltc1 peptide, Lachesana tarabaevi",0
236,Antimicrobial Cationic Peptides,"Ltc2a peptide, Lachesana tarabaevi",0
237,Antimicrobial Cationic Peptides,CEC(dir)-CEC(ret) protein,0
238,Antimicrobial Cationic Peptides,"odorranain-NR, Odorrana grahami",0
239,Oxazolidinones,PF 00422602,0
240,Oxazolidinones,"4,6-di-O-acetyl-N-acetyloxazolidinone",0
241,Oxazolidinones,locostatin,0
242,Oxazolidinones,"3-oxo-1,1-diphenyltetrahydrooxazolo(3,4-a)pyrazine-7-carboxylic acid 4-fluorobenzylamide",0
243,Non-Fibrillar Collagens,"dpy-17 protein, C elegans",0
244,Mitochondrial Proteins,"NLRX1 protein, human",0
245,Mitochondrial Proteins,"Iba57 protein, S cerevisiae",0
246,Mitochondrial Proteins,"Rip11 protein, mouse",0
247,Mitochondrial Proteins,"DGS1 protein, Arabidopsis",0
248,Mitochondrial Proteins,"PGAM5 protein, human",0
249,Mitochondrial Proteins,"COQ4 protein, human",0
250,Mitochondrial Proteins,"NDUFAF6 protein, human",0
251,Mitochondrial Proteins,"MPV17 protein, human",0
252,Mitochondrial Proteins,"HMRF1L protein, human",0
253,HMGB2 Protein,"high-mobility group protein 2-like 1 protein, human",0
254,Voltage-Gated Potassium Channel,"KAT2 protein, Arabidopsis",0
255,Fluoroquinolones,"7-(7-amino-7-methyl-5-azaspiro(2.4)heptan-5-yl)-6-fluoro-1-(2-fluoro-1-cyclopropyl)-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid",0
256,Glycogen Phosphorylase,"glycogen phosphorylase BB, human",0
257,Mitochondrial Proton-Translocating ATPases,"ATPase beta-subunit, rat",0
258,Mitochondrial Proton-Translocating ATPases,"ATP5b protein, mouse",0
259,vacuolar H+-ATPase,"ATP6V0A1 protein, human",0
260,vacuolar H+-ATPase,"VHA-a1 protein, Arabidopsis",0
261,6-Phosphofructo-2-kinase,"Pfkfb3 protein, rat",0
262,Tumor Suppressor Proteins,"STAT5A protein, human",0
263,Tumor Suppressor Proteins,"Melanoma Inhibitory Activity Protein 2, Human",0
264,Tumor Suppressor Proteins,"YueF protein, human",0
265,Tumor Suppressor Proteins,"MGMT protein, mouse",0
266,Tumor Suppressor Proteins,"HRPT2 protein, mouse",0
267,Tumor Suppressor Proteins,"Ifi206 protein, mouse",0
268,Tumor Suppressor Proteins,"EEF1E1 protein, human",0
269,Tumor Suppressor Proteins,"Hrasls5 protein, rat",0
270,Ubiquitin,"Ubb protein, mouse",0
271,Small Ubiquitin-Related Modifier Proteins,"SUMO2 protein, rat",0
272,Small Ubiquitin-Related Modifier Proteins,"SUMO3 protein, rat",0
273,SUMO-1 Protein,"SUMO1 protein, human",0
274,Indole Alkaloids,methuenine,0
275,Indole Alkaloids,goniomitine,0
276,Indole Alkaloids,welwitindolinone A isonitrile,0
277,Indole Alkaloids,"5,6-dibromo-N,N-dimethyltryptamine",0
278,Indole Alkaloids,scholarisine A,0
279,Indole Alkaloids,picrinine,0
280,Indole Alkaloids,monaspyranoindole,0
281,Indole Alkaloids,versicolamide B,0
282,Indole Alkaloids,mersicarpine,0
283,MADS Domain Proteins,"XAL1 protein, Arabidopsis",0
284,Ecdysteroids,polyporoid A,0
285,Ecdysteroids,polyporoid B,0
286,Ecdysteroids,polyporoid C,0
287,Membrane Transport Proteins,"Flvcr1 protein, mouse",0
288,Membrane Transport Proteins,"Gup1 protein, mouse",0
289,Membrane Transport Proteins,"Thi9 protein, S pombe",0
290,Membrane Transport Proteins,"SbmA protein, E coli",0
291,Membrane Transport Proteins,"PUG1 protein, S cerevisiae",0
292,"Amino Acid Transport Systems, Neutral","glnH protein, E coli",0
293,"Antigens, CD98 Light Chains","SLC7A8 protein, mouse",0
294,Organic Anion Transporters,"SLC22A13 protein, human",0
295,Monocarboxylic Acid Transporters,"SLC16A12 protein, human",0
296,Cation Transport Proteins,"kctd12.1 protein, zebrafish",0
297,Cation Transport Proteins,"Zip8 protein, human",0
298,Cation Transport Proteins,"DtpB protein, E coli",0
299,Organic Cation Transporter 1,"organic cation transporter like-1 protein, mouse",0
300,Symporters,"D1 protein, Leishmania",0
301,Symporters,monosaccharide-hydrogen cotransporter,0
302,Symporters,"INOSITOL TRANSPORTER 2, Arabidopsis",0
303,Sodium-Bicarbonate Symporters,"SLC4A10 protein, human",0
304,Inorganic Phosphate Transporter,"ANTR-1 protein, Arabidopsis",0
305,Nuclear Pore Complex Proteins,"AAAS protein, rat",0
306,Nuclear Pore Complex Proteins,"NUP133 protein, mouse",0
307,Karyopherins,"importin 13, human",0
308,alpha Karyopherins,"KPNA1 protein, mouse",0
309,beta Karyopherins,"IPO8 protein, human",0
310,Activin Receptor,"Acvrl1 protein, rat",0
311,Arabidopsis Proteins,"cytochrome P-450 735A1, Arabidopsis",0
312,Arabidopsis Proteins,"cytochrome P-450 735A2, Arabidopsis",0
313,Arabidopsis Proteins,"AVP1 protein, Arabidopsis",0
314,Arabidopsis Proteins,"ZFHD1 protein, Arabidopsis",0
315,Arabidopsis Proteins,"IBM1 protein, Arabidopsis",0
316,Arabidopsis Proteins,"CSLD5 protein, Arabidopsis",0
317,Arabidopsis Proteins,"PIP5K4 protein, Arabidopsis",0
318,Arabidopsis Proteins,"HRB1 protein, Arabidopsis",0
319,Arabidopsis Proteins,"TRZ1 protein, Arabidopsis",0
320,Arabidopsis Proteins,"Xrn3 protein, Arabidopsis",0
321,Arabidopsis Proteins,"Bin4 protein, Arabidopsis",0
322,Arabidopsis Proteins,"RpoTp protein, Arabidopsis",0
323,Arabidopsis Proteins,"RpoTmp protein, Arabidopsis",0
324,Arabidopsis Proteins,"CLASP protein, Arabidopsis",0
325,Arabidopsis Proteins,"LOV1 protein, Arabidopsis",0
326,Arabidopsis Proteins,"metacaspase-8, Arabidopsis",0
327,Arabidopsis Proteins,"RTL2 protein, Arabidopsis",0
328,Arabidopsis Proteins,"PGRL1 protein, Arabidopsis",0
329,Arabidopsis Proteins,"MKK9 protein, Arabidopsis",0
330,Arabidopsis Proteins,"IAA12 protein, Arabidopsis",0
331,Arabidopsis Proteins,"ATG12 protein, Arabidopsis",0
332,Arabidopsis Proteins,"ECA3 protein, Arabidopsis",0
333,Arabidopsis Proteins,"INOSITOL TRANSPORTER 2, Arabidopsis",0
334,Arabidopsis Proteins,"ACA2 protein, Arabidopsis",0
335,Arabidopsis Proteins,"CYP710A1 protein, Arabidopsis",0
336,Arabidopsis Proteins,"CYP710A4 protein, Arabidopsis",0
337,Arabidopsis Proteins,"XLG2 protein, Arabidopsis",0
338,Arabidopsis Proteins,"XLG3 protein, Arabidopsis",0
339,Arabidopsis Proteins,"CPR5 protein, Arabidopsis",0
340,Arabidopsis Proteins,"Hos15 protein, Arabidopsis",0
341,Arabidopsis Proteins,"TERT protein, Arabidopsis",0
342,Arabidopsis Proteins,"POT1A protein, Arabidopsis",0
343,Arabidopsis Proteins,"PTL protein, Arabidopsis",0
344,Arabidopsis Proteins,"SLAC1 protein, Arabidopsis",0
345,Arabidopsis Proteins,"PDLP1a protein, Arabidopsis",0
346,Arabidopsis Proteins,"At3g28950 protein, Arabidopsis",0
347,Arabidopsis Proteins,"D-amino acid aminotransferase, Arabidopsis thaliana",0
348,Arabidopsis Proteins,"SOB3 protein, Arabidopsis",0
349,Arabidopsis Proteins,"ESC protein, Arabidopsis",0
350,Arabidopsis Proteins,"GASSHO1 protein, Arabidopsis",0
351,Arabidopsis Proteins,"GASSHO2 protein, Arabidopsis",0
352,Arabidopsis Proteins,"MGD1 protein, Arabidopsis",0
353,Arabidopsis Proteins,"SFD2 protein, Arabidopsis",0
354,Arabidopsis Proteins,"DGS1 protein, Arabidopsis",0
355,Arabidopsis Proteins,"CstF77 protein, Arabidopsis",0
356,Arabidopsis Proteins,"GRX4 protein, Arabidopsis",0
357,Arabidopsis Proteins,"UEV1D protein, Arabidopsis",0
358,Arabidopsis Proteins,"MYB76 protein, Arabidopsis",0
359,Arabidopsis Proteins,"RBK1 protein, Arabidopsis",0
360,Arabidopsis Proteins,"NCRK protein, Arabidopsis",0
361,Arabidopsis Proteins,"ZIP16 protein, Arabidopsis",0
362,Arabidopsis Proteins,"ZIP68 protein, Arabidopsis",0
363,Arabidopsis Proteins,"ROXY1 protein, Arabidopsis",0
364,Arabidopsis Proteins,"ROXY2 protein, Arabidopsis",0
365,Arabidopsis Proteins,"Myb113 protein, Arabidopsis",0
366,Arabidopsis Proteins,"Myb114 protein, Arabidopsis",0
367,Arabidopsis Proteins,"EGL3 protein, Arabidopsis",0
368,Arabidopsis Proteins,"SKP2A protein, Arabidopsis",0
369,Arabidopsis Proteins,"RP1 protein, Arabidopsis",0
370,Arabidopsis Proteins,"RP2 protein, Arabidopsis",0
371,Arabidopsis Proteins,"LZF1 protein, Arabidopsis",0
372,Arabidopsis Proteins,"AAE14 protein, Arabidopsis",0
373,Arabidopsis Proteins,"DMS3 protein, Arabidopsis",0
374,Arabidopsis Proteins,"SWC6 protein, Arabidopsis",0
375,Arabidopsis Proteins,"RBP29 protein, Arabidopsis",0
376,Arabidopsis Proteins,"CRSH protein, Arabidopsis",0
377,Arabidopsis Proteins,"FLX protein, Arabidopsis",0
378,Arabidopsis Proteins,"PAP15 protein, Arabidopsis",0
379,Arabidopsis Proteins,"MYB44 protein, Arabidopsis",0
380,Arabidopsis Proteins,"ACA10 protein, Arabidopsis",0
381,Arabidopsis Proteins,"PHOS32 protein, Arabidopsis",0
382,Arabidopsis Proteins,"PHOS34 protein, Arabidopsis",0
383,Arabidopsis Proteins,"PRMT10 protein, Arabidopsis",0
384,Arabidopsis Proteins,"RNase E, Arabidopsis",0
385,Arabidopsis Proteins,"ELF6 protein, Arabidopsis",0
386,Arabidopsis Proteins,"REF6 protein, Arabidopsis",0
387,Arabidopsis Proteins,"ATG10 protein, Arabidopsis thaliana",0
388,Arabidopsis Proteins,"VSR3 protein, Arabidopsis",0
389,Arabidopsis Proteins,"MYB11 protein, Arabidopsis",0
390,Arabidopsis Proteins,"REF4 protein, Arabidopsis",0
391,Arabidopsis Proteins,"AGO10 protein, Arabidopsis",0
392,Arabidopsis Proteins,"HSP23.6 protein, Arabidopsis",0
393,Arabidopsis Proteins,"POT1b protein, Arabidopsis",0
394,Arabidopsis Proteins,"TRB2 protein, Arabidopsis",0
395,Arabidopsis Proteins,"TRB3 protein, Arabidopsis",0
396,Arabidopsis Proteins,"Lhcb6 protein, Arabidopsis",0
397,Arabidopsis Proteins,"ANTR-1 protein, Arabidopsis",0
398,Arabidopsis Proteins,"Arp8 protein, Arabidopsis",0
399,Arabidopsis Proteins,"RALF1 protein, Arabidopsis",0
400,Arabidopsis Proteins,"MRH2 protein, Arabidopsis",0
401,Arabidopsis Proteins,"DA1 protein, Arabidopsis",0
402,Arabidopsis Proteins,"EYE protein, Arabidopsis",0
403,Arabidopsis Proteins,"VHA-a1 protein, Arabidopsis",0
404,Arabidopsis Proteins,"branched-chain aminotransferase-3, Arabidopsis",0
405,Arabidopsis Proteins,"peroxin IIb, Arabidopsis",0
406,Arabidopsis Proteins,"XAL1 protein, Arabidopsis",0
407,Arabidopsis Proteins,"Myb72 protein, Arabidopsis",0
408,Arabidopsis Proteins,"zinc finger protein 2, Arabidopsis",0
409,Arabidopsis Proteins,"Lcb2 protein, Arabidopsis",0
410,Arabidopsis Proteins,"ETG1 protein, Arabidopsis",0
411,Arabidopsis Proteins,"DDB2 protein, Arabidopsis",0
412,Arabidopsis Proteins,"NIP7;1 protein, Arabidopsis",0
413,Arabidopsis Proteins,"FIONA1 protein, Arabidopsis",0
414,Arabidopsis Proteins,"EMB2473 protein, Arabidopsis",0
415,Arabidopsis Proteins,"MSL9 protein, Arabidopsis",0
416,Arabidopsis Proteins,"MSL10 protein, Arabidopsis",0
417,Arabidopsis Proteins,"GCP3 protein, Arabidopsis",0
418,Arabidopsis Proteins,"cytochrome P-450 79B2 protein, Arabidopsis",0
419,Arabidopsis Proteins,"cytochrome P-450 79B3, Arabidopsis",0
420,Arabidopsis Proteins,"Ahp4 protein, Arabidopsis",0
421,Arabidopsis Proteins,"MSH5 protein, Arabidopsis",0
422,Arabidopsis Proteins,"bZIP28 protein, Arabidopsis",0
423,Arabidopsis Proteins,"XIE protein, Arabidopsis",0
424,Arabidopsis Proteins,"brassinosteroid-signaling kinase1, Arabidopsis",0
425,Arabidopsis Proteins,"brassinosteroid-signaling kinase2, Arabidopsis",0
426,Arabidopsis Proteins,"brassinosteroid-signaling kinase3, Arabidopsis",0
427,Saccharomyces cerevisiae Proteins,"Rad3 protein, S cerevisiae",0
428,Saccharomyces cerevisiae Proteins,"NuA4 protein, S cerevisiae",0
429,Saccharomyces cerevisiae Proteins,"Erg11 protein, S cerevisiae",0
430,Saccharomyces cerevisiae Proteins,"Elp3 protein, S cerevisiae",0
431,Saccharomyces cerevisiae Proteins,"Rga1 protein, S cerevisiae",0
432,Saccharomyces cerevisiae Proteins,"Cox1 protein, S cerevisiae",0
433,Saccharomyces cerevisiae Proteins,"Yap5 protein, S cerevisiae",0
434,Saccharomyces cerevisiae Proteins,"Mub1 protein, S cerevisiae",0
435,Saccharomyces cerevisiae Proteins,"FAS1 protein, S cerevisiae",0
436,Saccharomyces cerevisiae Proteins,"SAS3 protein, S cerevisiae",0
437,Saccharomyces cerevisiae Proteins,"KHR1 protein, S cerevisiae",0
438,Saccharomyces cerevisiae Proteins,"Iba57 protein, S cerevisiae",0
439,Saccharomyces cerevisiae Proteins,"Fld1 protein, S cerevisiae",0
440,Saccharomyces cerevisiae Proteins,"Grx6 protein, S cerevisiae",0
441,Saccharomyces cerevisiae Proteins,"POC4 protein, S cerevisiae",0
442,Saccharomyces cerevisiae Proteins,"IRC25 protein, S cerevisiae",0
443,Saccharomyces cerevisiae Proteins,"CCT4 protein, S cerevisiae",0
444,Saccharomyces cerevisiae Proteins,"Rds2 protein, S cerevisiae",0
445,Saccharomyces cerevisiae Proteins,"Spo16 protein, S cerevisiae",0
446,Saccharomyces cerevisiae Proteins,"Spo22 protein, S cerevisiae",0
447,Saccharomyces cerevisiae Proteins,"Grx2 protein, S cerevisiae",0
448,Saccharomyces cerevisiae Proteins,"Gvp36 protein, S cerevisiae",0
449,Saccharomyces cerevisiae Proteins,"MAK31 protein, S cerevisiae",0
450,Saccharomyces cerevisiae Proteins,"Pch2 protein, S cerevisiae",0
451,Saccharomyces cerevisiae Proteins,"Snu56 protein, S cerevisiae",0
452,Saccharomyces cerevisiae Proteins,"Eaf5 protein, S cerevisiae",0
453,Saccharomyces cerevisiae Proteins,"Eaf6 protein, S cerevisiae",0
454,Saccharomyces cerevisiae Proteins,"Eaf7 protein, S cerevisiae",0
455,Saccharomyces cerevisiae Proteins,"Eaf1 protein, S cerevisiae",0
456,Saccharomyces cerevisiae Proteins,"Ptp2 protein, S cerevisiae",0
457,Saccharomyces cerevisiae Proteins,"Stm1 protein, S cerevisiae",0
458,Saccharomyces cerevisiae Proteins,"GID2 protein, S cerevisiae",0
459,Saccharomyces cerevisiae Proteins,"VID28 protein, S cerevisiae",0
460,Saccharomyces cerevisiae Proteins,"PET18 protein, S cerevisiae",0
461,Saccharomyces cerevisiae Proteins,"THI22 protein, S cerevisiae",0
462,Saccharomyces cerevisiae Proteins,"YFH7 protein, S cerevisiae",0
463,Saccharomyces cerevisiae Proteins,"SDH1 protein, S cerevisiae",0
464,Saccharomyces cerevisiae Proteins,"Inn1 protein, S cerevisiae",0
465,Saccharomyces cerevisiae Proteins,"Grx5 protein, S cerevisiae",0
466,Saccharomyces cerevisiae Proteins,"SRL4 protein, S cerevisiae",0
467,Saccharomyces cerevisiae Proteins,"Nrt1 protein, S cerevisiae",0
468,Saccharomyces cerevisiae Proteins,"Siw14 protein, S cerevisiae",0
469,Saccharomyces cerevisiae Proteins,"Vps74 protein, S cerevisiae",0
470,Saccharomyces cerevisiae Proteins,"Get3 protein, S cerevisiae",0
471,Saccharomyces cerevisiae Proteins,"NHP10 protein, S cerevisiae",0
472,Saccharomyces cerevisiae Proteins,"Msa1 protein, S cerevisiae",0
473,Saccharomyces cerevisiae Proteins,"Dpb2 protein, S cerevisiae",0
474,Saccharomyces cerevisiae Proteins,"PDR10 protein, S cerevisiae",0
475,Saccharomyces cerevisiae Proteins,"PDR15 protein, S cerevisiae",0
476,Saccharomyces cerevisiae Proteins,"FRA1 protein, S cerevisiae",0
477,Saccharomyces cerevisiae Proteins,"FRA2 protein, S cerevisiae",0
478,Saccharomyces cerevisiae Proteins,"Pet54 protein, S cerevisiae",0
479,Saccharomyces cerevisiae Proteins,"Rex1 exonuclease, S cerevisiae",0
480,Saccharomyces cerevisiae Proteins,"Lpx1 protein, S cerevisiae",0
481,Saccharomyces cerevisiae Proteins,"Phs1 protein, S cerevisiae",0
482,Saccharomyces cerevisiae Proteins,"RPN13 protein, S cerevisiae",0
483,Saccharomyces cerevisiae Proteins,"Myr1 protein, S cerevisiae",0
484,Saccharomyces cerevisiae Proteins,"Ecm11 protein, S cerevisiae",0
485,Saccharomyces cerevisiae Proteins,"CMC1 protein, S cerevisiae",0
486,Saccharomyces cerevisiae Proteins,"Nsa1 protein, S cerevisiae",0
487,Saccharomyces cerevisiae Proteins,"PUG1 protein, S cerevisiae",0
488,Saccharomyces cerevisiae Proteins,"Irs4 protein, S cerevisiae",0
489,Saccharomyces cerevisiae Proteins,"Tax4 protein, S cerevisiae",0
490,Saccharomyces cerevisiae Proteins,"Cox5a protein, S cerevisiae",0
491,Saccharomyces cerevisiae Proteins,"Cox5b protein, S cerevisiae",0
492,Saccharomyces cerevisiae Proteins,"CSM4 protein, S cerevisiae",0
493,Saccharomyces cerevisiae Proteins,"Rtr1 protein, S cerevisiae",0
494,Saccharomyces cerevisiae Proteins,"Mms1 protein, S cerevisiae",0
495,Saccharomyces cerevisiae Proteins,"Afi1 protein, S cerevisiae",0
496,Saccharomyces cerevisiae Proteins,"Dfm1 protein, S cerevisiae",0
497,Saccharomyces cerevisiae Proteins,"Ubx7 protein, S cerevisiae",0
498,Saccharomyces cerevisiae Proteins,"Guf1 protein, S cerevisiae",0
499,Schizosaccharomyces pombe Proteins,"Sim3 protein, S pombe",0
500,Schizosaccharomyces pombe Proteins,"sir2 protein, S pombe",0
501,Schizosaccharomyces pombe Proteins,"Set2 protein, S pombe",0
502,Schizosaccharomyces pombe Proteins,"Rrn3 protein, S pombe",0
503,Schizosaccharomyces pombe Proteins,"Sly1 protein, S pombe",0
504,Schizosaccharomyces pombe Proteins,"Dcp1 protein, S pombe",0
505,Schizosaccharomyces pombe Proteins,"Dam1 protein, S pombe",0
506,Schizosaccharomyces pombe Proteins,"Set11 protein, S pombe",0
507,Schizosaccharomyces pombe Proteins,"Rpl12 protein, S pombe",0
508,Schizosaccharomyces pombe Proteins,"Rga4 protein, S pombe",0
509,Schizosaccharomyces pombe Proteins,"Poz1 protein, S pombe",0
510,Schizosaccharomyces pombe Proteins,"Tpz1 protein, S pombe",0
511,Schizosaccharomyces pombe Proteins,"Ccq1 protein, S pombe",0
512,Schizosaccharomyces pombe Proteins,"positive cofactor 4, S pombe",0
513,Schizosaccharomyces pombe Proteins,"Hst4 protein, S pombe",0
514,Schizosaccharomyces pombe Proteins,"Snf2SR protein, S pombe",0
515,Schizosaccharomyces pombe Proteins,"Sst4 protein, S pombe",0
516,Schizosaccharomyces pombe Proteins,"Spt16 protein, S pombe",0
517,Drosophila Proteins,"CYP6A8 protein, Drosophila",0
518,Drosophila Proteins,"Cul3 protein, Drosophila",0
519,Drosophila Proteins,"Poxm protein, Drosophila",0
520,Drosophila Proteins,"fray protein, Drosophila",0
521,Drosophila Proteins,"sex peptide receptor, Drosophila",0
522,Drosophila Proteins,"taspase1, Drosophila",0
523,Drosophila Proteins,"cer protein, Drosophila",0
524,Drosophila Proteins,"HIP14 protein, Drosophila",0
525,Drosophila Proteins,"Zasp52 protein, Drosophila",0
526,Drosophila Proteins,"Npc2a protein, Drosophila",0
527,Drosophila Proteins,"Akirin1 protein, Drosophila",0
528,Drosophila Proteins,"Pabp protein, Drosophila",0
529,Drosophila Proteins,"Med31 protein, Drosophila",0
530,Drosophila Proteins,"Myo10A protein, Drosophila",0
531,Drosophila Proteins,"Xmas-2 protein, Drosophila",0
532,Drosophila Proteins,"NSD protein, Drosophila",0
533,Drosophila Proteins,"OPA1 protein, Drosophila",0
534,Drosophila Proteins,"Marf protein, Drosophila",0
535,Drosophila Proteins,"PCID2 protein, Drosophila",0
536,Drosophila Proteins,"FRQ2 protein, Drosophila",0
537,Drosophila Proteins,"Sgf11 protein, Drosophila",0
538,Drosophila Proteins,"pgc protein, Drosophila",0
539,Drosophila Proteins,"Vps35 protein, Drosophila",0
540,Drosophila Proteins,"UTX protein, Drosophila",0
541,Drosophila Proteins,"aust protein, Drosophila",0
542,Drosophila Proteins,"Atg8a protein, Drosophila",0
543,Drosophila Proteins,"Rumi protein, Drosophila",0
544,Drosophila Proteins,"dnd protein, Drosophila",0
545,Drosophila Proteins,"tyramine beta-monooxygenase, Drosophila",0
546,Drosophila Proteins,"CLIC protein, Drosophila",0
547,Drosophila Proteins,"insulin-like peptide 7, Drosophila",0
548,Drosophila Proteins,"Keap1 protein, Drosophila",0
549,Drosophila Proteins,"CHD3 protein, Drosophila",0
550,Drosophila Proteins,"stj protein, Drosophila",0
551,Drosophila Proteins,"Cindr protein, Drosophila",0
552,Drosophila Proteins,"Vps26 protein, Drosophila",0
553,Drosophila Proteins,"for protein, Drosophila",0
554,Drosophila Proteins,"Wech protein, Drosophila",0
555,Drosophila Proteins,"NimC4 protein, Drosophila",0
556,Drosophila Proteins,"Orb2 protein, Drosophila",0
557,Drosophila Proteins,"Pxt protein, Drosophila",0
558,Drosophila Proteins,"Ak6 protein, Drosophila",0
559,Drosophila Proteins,"bun protein, Drosophila",0
560,Drosophila Proteins,"SPD-2 protein, Drosophila",0
561,Drosophila Proteins,"desaturase F, Drosophila melanogaster",0
562,Drosophila Proteins,"swm protein, Drosophila",0
563,Drosophila Proteins,"mts protein, Drosophila",0
564,Drosophila Proteins,"rudhira protein, Drosophila",0
565,Drosophila Proteins,"CAP-D3 protein, Drosophila",0
566,Drosophila Proteins,"Rgn protein, Drosophila",0
567,Drosophila Proteins,"acid-labile subunit, Drosophila",0
568,Drosophila Proteins,"Or67d protein, Drosophila",0
569,Drosophila Proteins,"ScsbetaA protein, Drosophila",0
570,Drosophila Proteins,"Atg7 protein, Drosophila",0
571,Drosophila Proteins,"Eig71Ee protein, Drosophila",0
572,Drosophila Proteins,"HtrA2 protein, Drosophila",0
573,Drosophila Proteins,"Qvr protein, Drosophila",0
574,Caenorhabditis elegans Proteins,"mbl-1 protein, C elegans",0
575,Caenorhabditis elegans Proteins,"CAM-1 protein, C elegans",0
576,Caenorhabditis elegans Proteins,"CWN-1 protein, C elegans",0
577,Caenorhabditis elegans Proteins,"LAD-2 protein, C elegans",0
578,Caenorhabditis elegans Proteins,"Plx-2 protein, C elegans",0
579,Caenorhabditis elegans Proteins,"Unc-41 protein, C elegans",0
580,Caenorhabditis elegans Proteins,"Cdr-6 protein, C elegans",0
581,Caenorhabditis elegans Proteins,"Cdr-4 protein, C elegans",0
582,Caenorhabditis elegans Proteins,"GSTO-1 protein, C elegans",0
583,Caenorhabditis elegans Proteins,"mtss-1 protein, C elegans",0
584,Caenorhabditis elegans Proteins,"hsp-16.1 protein, C elegans",0
585,Caenorhabditis elegans Proteins,"Nhr-6 protein, C elegans",0
586,Caenorhabditis elegans Proteins,"Exoc-8 protein, C elegans",0
587,Caenorhabditis elegans Proteins,"PROM-1 protein, C elegans",0
588,Caenorhabditis elegans Proteins,"PBO-4 protein, C elegans",0
589,Caenorhabditis elegans Proteins,"PBO-5 protein, C elegans",0
590,Caenorhabditis elegans Proteins,"CIN-4 protein, C elegans",0
591,Caenorhabditis elegans Proteins,"HTP-3 protein, C elegans",0
592,Caenorhabditis elegans Proteins,"PKD-2 protein, C elegans",0
593,Caenorhabditis elegans Proteins,"Dpy-23 protein, C elegans",0
594,Caenorhabditis elegans Proteins,"Mig-14 protein, C elegans",0
595,Caenorhabditis elegans Proteins,"gck-3 protein, C elegans",0
596,Caenorhabditis elegans Proteins,"adpr-1 protein, C elegans",0
597,Caenorhabditis elegans Proteins,"ACR-23 protein, C elegans",0
598,Caenorhabditis elegans Proteins,"LNP-1 protein, C elegans",0
599,Caenorhabditis elegans Proteins,"CASY-1 protein, C elegans",0
600,Caenorhabditis elegans Proteins,"Ruvb-1 protein, C elegans",0
601,Caenorhabditis elegans Proteins,"fli-1 protein, C elegans",0
602,Caenorhabditis elegans Proteins,"BRC-1 protein, C elegans",0
603,Caenorhabditis elegans Proteins,"CDH-4 protein, C elegans",0
604,Caenorhabditis elegans Proteins,"SGT-1 protein, C elegans",0
605,Caenorhabditis elegans Proteins,"Rab-35 protein, C elegans",0
606,Caenorhabditis elegans Proteins,"RME-4 protein, C elegans",0
607,Caenorhabditis elegans Proteins,"Exc-9 protein, C elegans",0
608,Caenorhabditis elegans Proteins,"VALV-1 protein, C elegans",0
609,Caenorhabditis elegans Proteins,"CLEC-38 protein, C elegans",0
610,Caenorhabditis elegans Proteins,"nstp-5 protein, C elegans",0
611,Caenorhabditis elegans Proteins,"RDE-2 protein, C elegans",0
612,Caenorhabditis elegans Proteins,"DEPS-1 protein, C elegans",0
613,Caenorhabditis elegans Proteins,"UNC-29 protein, C elegans",0
614,Caenorhabditis elegans Proteins,"Ekl protein, c elegans",0
615,Caenorhabditis elegans Proteins,"HMG-12 protein, C elegans",0
616,Caenorhabditis elegans Proteins,"DYF-11 protein, C elegans",0
617,Caenorhabditis elegans Proteins,"RSD-2 protein, C elegans",0
618,Caenorhabditis elegans Proteins,"RSD-6 protein, C elegans",0
619,Caenorhabditis elegans Proteins,"F08A8.5 protein, C elegans",0
620,Caenorhabditis elegans Proteins,"VPR-1 protein, C elegans",0
621,Caenorhabditis elegans Proteins,"unc-85 protein, C elegans",0
622,Caenorhabditis elegans Proteins,"LARP-1 protein, C elegans",0
623,Caenorhabditis elegans Proteins,"PAC-1 protein, C elegans",0
624,Caenorhabditis elegans Proteins,"PDFR-1 protein, C elegans",0
625,Caenorhabditis elegans Proteins,"ITSN-1 protein, C elegans",0
626,Caenorhabditis elegans Proteins,"Ehs-1 protein, C elegans",0
627,Caenorhabditis elegans Proteins,"Dnj-11 protein, C elegans",0
628,Caenorhabditis elegans Proteins,"BUS-8 protein, C elegans",0
629,Caenorhabditis elegans Proteins,"CRA-1 protein, C elegans",0
630,Caenorhabditis elegans Proteins,"FSN-1 protein, C elegans",0
631,Caenorhabditis elegans Proteins,"PRG-1 protein, C elegans",0
632,Caenorhabditis elegans Proteins,"NIPI-3 protein, C elegans",0
633,Caenorhabditis elegans Proteins,"NRDE-3 protein, C elegans",0
634,Amphibian Proteins,sauvagine,0
635,Xenopus Proteins,"bmp4 protein, Xenopus",0
636,Xenopus Proteins,"bmp7.1 protein, Xenopus",0
637,Xenopus Proteins,"bmp7.2 protein, Xenopus",0
638,Xenopus Proteins,"irs1 protein, Xenopus",0
639,Xenopus Proteins,"RCC2 protein, Xenopus",0
640,Xenopus Proteins,"xP1-L protein, Xenopus",0
641,Xenopus Proteins,"galectin-VIa protein, Xenopus",0
642,Xenopus Proteins,"ARNT protein, Xenopus",0
643,Xenopus Proteins,"HIF1A protein, Xenopus",0
644,Xenopus Proteins,"cetn4 protein, Xenopus",0
645,Xenopus Proteins,"pou5f3.2 protein, Xenopus",0
646,Xenopus Proteins,"Lmo2 protein, Xenopus",0
647,Xenopus Proteins,"CECR1 protein, Xenopus",0
648,Xenopus Proteins,"sox2 protein, Xenopus",0
649,Xenopus Proteins,"Sox3 protein, Xenopus",0
650,Xenopus Proteins,"CACNA1B protein, Xenopus",0
651,Xenopus Proteins,"Rdd3 protein, Xenopus",0
652,Xenopus Proteins,"Rdd2 protein, Xenopus",0
653,Xenopus Proteins,"Rdd4 protein, Xenopus",0
654,Xenopus Proteins,"FGF4 protein, Xenopus",0
655,Xenopus Proteins,"spry1 protein, Xenopus",0
656,Xenopus Proteins,"Mkrn2 protein, Xenopus",0
657,Xenopus Proteins,"CASZ1 protein, Xenopus",0
658,Xenopus Proteins,"GPRx protein, Xenopus",0
659,Xenopus Proteins,"Ing1 protein, Xenopus",0
660,Xenopus Proteins,"GlyT1 protein, Xenopus",0
661,Xenopus Proteins,"SLC6A5 protein, Xenopus",0
662,Xenopus Proteins,"VIAAT protein, Xenopus",0
663,Xenopus Proteins,"CLTRN protein, Xenopus",0
664,Xenopus Proteins,"zyx protein, Xenopus",0
665,Xenopus Proteins,"Wnt6 protein, Xenopus",0
666,Xenopus Proteins,"Lrig3 protein, Xenopus",0
667,Xenopus Proteins,"rbfox2 protein, Xenopus",0
668,Xenopus Proteins,"HAPLN3 protein, Xenopus",0
669,Xenopus Proteins,"PACSIN2 protein, Xenopus",0
670,Xenopus Proteins,"NEDD1 protein, Xenopus",0
671,Xenopus Proteins,"WEE1 protein, Xenopus",0
672,Xenopus Proteins,"Polk protein, Xenopus",0
673,Xenopus Proteins,"Mespb protein, Xenopus",0
674,Xenopus Proteins,"Rasgrp2 protein, Xenopus",0
675,Xenopus Proteins,"Sec8 protein, Xenopus",0
676,Xenopus Proteins,"RAP2A protein, Xenopus",0
677,Fish Proteins,"Wap65 protein, channel catfish",0
678,Zebrafish Proteins,"TICAM1 protein, zebrafish",0
679,Zebrafish Proteins,"bmp4 protein, zebrafish",0
680,Zebrafish Proteins,"bmp7a protein, zebrafish",0
681,Zebrafish Proteins,"Mstnb protein, zebrafish",0
682,Zebrafish Proteins,"Sox7 protein, zebrafish",0
683,Zebrafish Proteins,"Sox18 protein, zebrafish",0
684,Zebrafish Proteins,"churc1 protein, zebrafish",0
685,Zebrafish Proteins,"vgll2b protein, zebrafish",0
686,Zebrafish Proteins,"tead3a protein, zebrafish",0
687,Zebrafish Proteins,"Enigma homolog protein, zebrafish",0
688,Zebrafish Proteins,"Pdlim7 protein, zebrafish",0
689,Zebrafish Proteins,"vps39 vacuolar protein sorting 39, Danio rerio",0
690,Zebrafish Proteins,"ric8b protein, zebrafish",0
691,Zebrafish Proteins,"Erg protein, zebrafish",0
692,Zebrafish Proteins,"Zic4 protein, zebrafish",0
693,Zebrafish Proteins,"Bmpr2a protein, zebrafish",0
694,Zebrafish Proteins,"Bmpr2b protein, zebrafish",0
695,Zebrafish Proteins,"Keap1a protein, zebrafish",0
696,Zebrafish Proteins,"Keap1b protein, zebrafish",0
697,Zebrafish Proteins,"kif1bp protein, zebrafish",0
698,Zebrafish Proteins,"Kiss1 protein, zebrafish",0
699,Zebrafish Proteins,"kiss1ra protein, zebrafish",0
700,Zebrafish Proteins,"spint1a protein, zebrafish",0
701,Zebrafish Proteins,"gemin2 protein, zebrafish",0
702,Zebrafish Proteins,"Oc90 protein, zebrafish",0
703,Zebrafish Proteins,"znf148 protein, zebrafish",0
704,Zebrafish Proteins,"Cx36.7 protein, zebrafish",0
705,Zebrafish Proteins,"Nkx2.5 protein, zebrafish",0
706,Zebrafish Proteins,"twist1a protein, zebrafish",0
707,Zebrafish Proteins,"CRIP2 protein, zebrafish",0
708,Zebrafish Proteins,"traf3ip1 protein, zebrafish",0
709,Zebrafish Proteins,"col15a1a protein, zebrafish",0
710,Zebrafish Proteins,"Kif17 protein, zebrafish",0
711,Zebrafish Proteins,"Foxn4 protein, zebrafish",0
712,Zebrafish Proteins,"Appl1 protein, zebrafish",0
713,Zebrafish Proteins,"Appl2 protein, zebrafish",0
714,Zebrafish Proteins,"Mych protein, zebrafish",0
715,Zebrafish Proteins,"aldh1a3 protein, zebrafish",0
716,Zebrafish Proteins,"aldh8a1 protein, zebrafish",0
717,Zebrafish Proteins,"Cdx1b protein, zebrafish",0
718,Zebrafish Proteins,"onecut3a protein, zebrafish",0
719,Zebrafish Proteins,"Kera protein, zebrafish",0
720,Zebrafish Proteins,"Unc45a protein, zebrafish",0
721,Zebrafish Proteins,"protocadherin-18, zebrafish",0
722,Zebrafish Proteins,"SBDS protein, zebrafish",0
723,Zebrafish Proteins,"GRIFIN protein, zebrafish",0
724,Zebrafish Proteins,"Fabp11b protein, zebrafish",0
725,Zebrafish Proteins,"Lrrc6 protein, zebrafish",0
726,Zebrafish Proteins,"Ewsr1a protein, zebrafish",0
727,Zebrafish Proteins,"Wsb1 protein, zebrafish",0
728,Zebrafish Proteins,"Mlh1 protein, zebrafish",0
729,Zebrafish Proteins,"Bbs1 protein, zebrafish",0
730,Zebrafish Proteins,"Ndrg4 protein, zebrafish",0
731,Zebrafish Proteins,"sh3gl1a protein, zebrafish",0
732,Zebrafish Proteins,"bcl2l11 protein, zebrafish",0
733,Zebrafish Proteins,"Brd4 protein, zebrafish",0
734,Escherichia coli Proteins,"GlpR protein, E coli",0
735,Escherichia coli Proteins,"GDP-4-keto-6-deoxymannose-3-dehydratase, E coli",0
736,Escherichia coli Proteins,"FocB protein, E coli",0
737,Escherichia coli Proteins,"dsbA protein, E coli",0
738,Escherichia coli Proteins,"dsbC protein, E coli",0
739,Escherichia coli Proteins,"RppH protein, E coli",0
740,Escherichia coli Proteins,"AlsK protein, E coli",0
741,Escherichia coli Proteins,"RhlE protein, E coli",0
742,Escherichia coli Proteins,"subtilase cytotoxin, E coli",0
743,Escherichia coli Proteins,"ParR protein, E coli",0
744,Escherichia coli Proteins,"WbiP protein, E coli",0
745,Escherichia coli Proteins,"FyuA protein, E coli",0
746,Escherichia coli Proteins,"EntH protein, E coli",0
747,Escherichia coli Proteins,"yjeA protein, E coli",0
748,Escherichia coli Proteins,"YjhT protein, E coli",0
749,Escherichia coli Proteins,"NrfG protein, E coli",0
750,Escherichia coli Proteins,"YeaG protein, E coli",0
751,Escherichia coli Proteins,"YhjD protein, E coli",0
752,Escherichia coli Proteins,"NanC protein, E coli",0
753,Escherichia coli Proteins,"glnH protein, E coli",0
754,Escherichia coli Proteins,"YqhD protein, E coli",0
755,Escherichia coli Proteins,"MltF protein, E coli",0
756,Escherichia coli Proteins,"IraM protein, E coli",0
757,Escherichia coli Proteins,"GspK protein, E coli",0
758,Escherichia coli Proteins,"GspI protein, E coli",0
759,Escherichia coli Proteins,"GspJ protein, E coli",0
760,Escherichia coli Proteins,"DrrB protein, Escherichia coli",0
761,Escherichia coli Proteins,"YjjQ protein, E coli",0
762,Escherichia coli Proteins,"LptF protein, E coli",0
763,Escherichia coli Proteins,"LptG protein, E coli",0
764,Escherichia coli Proteins,"FimG protein, E coli",0
765,Escherichia coli Proteins,"YejM protein, E coli",0
766,Escherichia coli Proteins,"EscU protein, E coli",0
767,Escherichia coli Proteins,"SpaS protein, E coli",0
768,Escherichia coli Proteins,"SbmA protein, E coli",0
769,Escherichia coli Proteins,"YgfO protein, E coli",0
770,Escherichia coli Proteins,"NfuA protein, E coli",0
771,Escherichia coli Proteins,"NsrR protein, E coli",0
772,Escherichia coli Proteins,"PtsN protein, E coli",0
773,Escherichia coli Proteins,"YgaV protein, E coli",0
774,Escherichia coli Proteins,"YgaP protein, E coli",0
775,Escherichia coli Proteins,"YdcF protein, E coli",0
776,Escherichia coli Proteins,"DtpB protein, E coli",0
777,Escherichia coli Proteins,"PpiD protein, E coli",0
778,Escherichia coli Proteins,"DraD invasin, E coli",0
779,Escherichia coli Proteins,"McbR protein, E coli",0
780,Avian Proteins,"ECH protein, Gallus gallus",0
781,Soybean Proteins,cytochrome P450 CYP93A1 (Glycine max),0
782,Soybean Proteins,"SBTX protein, soybean",0
783,Nucleobase Transport Proteins,"YgfO protein, E coli",0
784,Nucleotide Transport Proteins,"Slc35d1 protein, mouse",0
785,Nucleotide Transport Proteins,"nstp-5 protein, C elegans",0
786,Nucleotide Transport Proteins,"Slc17a9 protein, human",0
787,Nucleotide Transport Proteins,"YdcF protein, E coli",0
788,Iron-Binding Proteins,"YtgA protein, Chlamydia trachomatis",0
789,Vesicular Transport Proteins,"Unc-41 protein, C elegans",0
790,Vesicular Transport Proteins,"vps39 vacuolar protein sorting 39, Danio rerio",0
791,Vesicular Transport Proteins,"Exoc-8 protein, C elegans",0
792,Vesicular Transport Proteins,"Vps35 protein, Drosophila",0
793,Vesicular Transport Proteins,"Sly1 protein, human",0
794,Vesicular Transport Proteins,"Sly1 protein, S pombe",0
795,Vesicular Transport Proteins,"girdin protein, mouse",0
796,Vesicular Transport Proteins,"Vps26 protein, Drosophila",0
797,Vesicular Transport Proteins,"Pacs2 protein, mouse",0
798,Vesicular Transport Proteins,"Sec3 protein, human",0
799,Vesicular Transport Proteins,"Exoc3l protein, mouse",0
800,Vesicular Transport Proteins,"Sec8 protein, Xenopus",0
801,"Adaptor Proteins, Vesicular Transport","ITSN-1 protein, C elegans",0
802,"Adaptor Proteins, Vesicular Transport","Ehs-1 protein, C elegans",0
803,"Adaptor Proteins, Vesicular Transport","Tax4 protein, S cerevisiae",0
804,Adaptor Protein Complex 2,"Dpy-23 protein, C elegans",0
805,Epothilones,sagopilone,0
806,Telomere-Binding Proteins,"Tel2 protein, mouse",0
807,Telomere-Binding Proteins,"POT1b protein, Arabidopsis",0
808,Telomere-Binding Proteins,"TRB2 protein, Arabidopsis",0
809,Telomere-Binding Proteins,"TRB3 protein, Arabidopsis",0
810,"RNA, Small Interfering",ISIS 121736,0
811,Telomeric Repeat Binding Protein 2,"TERF2 protein, human",0
812,MicroRNAs,"MIRN29 microRNA, rat",0
813,MicroRNAs,"MIRN370 microRNA, human",0
814,MicroRNAs,"mir-8 microRNA, Drosophila",0
815,MicroRNAs,"MIRN126 microRNA, human",0
816,MicroRNAs,"MIRN373 microRNA, human",0
817,MicroRNAs,"Mirn125 microRNA, mouse",0
818,MicroRNAs,"MIRN26A microRNA, human",0
819,MicroRNAs,"Mirn24 microRNA, mouse",0
820,MicroRNAs,"mirn181 microRNA, mouse",0
821,MicroRNAs,"Mirn150 microRNA, mouse",0
822,MicroRNAs,"Mirn142 microRNA, mouse",0
823,Oxocins,beta-naphthoylbrevetoxin,0
824,Oxocins,furanoyessotoxin,0
825,Capsid Proteins,"VP2 protein, porcine parvovirus",0
826,Capsid Proteins,"coat protein, papaya mosiac virus",0
827,Ginsenosides,25-hydroxyprotopanaxatriol,0
828,Ginsenosides,25-hydroxyprotopanaxadiol,0
829,Intercellular Signaling Peptides and Proteins,"Retnla protein, mouse",0
830,Intercellular Signaling Peptides and Proteins,"salusin-beta, rat",0
831,Pterocarpans,glyceollin,0
832,Pterocarpans,cristacarpin,0
833,Pterocarpans,phaseollidin,0
834,Pterocarpans,neorautenol,0
835,Pterocarpans,1-methoxyerythrabyssin II,0
836,peptide hormone,sauvagine,0
837,peptide hormone,"RALF1 protein, Arabidopsis",0
838,Diarylheptanoids,5-O-methylhirsutanonol,0
839,Limonins,malleastrone A,0
840,Limonins,malleastrone B,0
841,Limonins,malleastrone C,0
842,Limonins,cipadonoid A,0
843,Limonins,anthothecol,0
844,Fimbriae Proteins,"FimG protein, E coli",0
845,Fimbriae Proteins,"DraD invasin, E coli",0
846,Plant Lectins,"aloctin I, Aloe vera",0
847,Galactose Binding Lectin,"galectin-8, mouse",0
848,Galactose Binding Lectin,"galectin-VIa protein, Xenopus",0
849,Galactose Binding Lectin,"GRIFIN protein, zebrafish",0
850,"Lectins, C-Type","CLEC2A protein, human",0
851,"Lectins, C-Type","Dcir protein, mouse",0
852,"Lectins, C-Type","trowaglerix protein, Tropidolaemus wagleri",0
853,"Lectins, C-Type","CLEC-38 protein, C elegans",0
854,"Lectins, C-Type","CLEC12A protein, mouse",0
855,"Lectins, C-Type","CLEC-2 protein, mouse",0
856,Virulence Factors,"Ail protein, Yersinia pestis",0
857,Virulence Factors,"Gpm1 protein, Candida albicans",0
858,Virulence Factors,"DupA protein, Helicobacter pylori",0
859,Artemisinins,10beta-(trifluoropropyloxy)dihydroartemisinin,0
860,Fullerenes,glutathione C(60)-fullerene complex,0
861,Fullerenes,C70H38 compound,0
862,Fullerenes,"N,N-dimethyl-2-(4'-N,N,N-trimethylaminophenyl)fulleropyrrolidinium iodide",0
863,Fullerenes,pristine (C60),0
864,Sirtuins,"SIRT5 protein, rat",0
865,Galactolipids,arabidopside G,0
866,Integrin alpha Chains,"integrin alphaD, mouse",0
867,Poly(A)-Binding Proteins,"Pabp protein, Drosophila",0
868,mRNA Cleavage and Polyadenylation Factors,"Fip1 protein, Arabidopsis",0
869,mRNA Cleavage and Polyadenylation Factors,"Orb2 protein, Drosophila",0
870,Cleavage And Polyadenylation Specificity Factor,"Nudt21 protein, mouse",0
871,Cleavage And Polyadenylation Specificity Factor,"CPSF6 protein, mouse",0
872,Cleavage Stimulation Factor,"CstF77 protein, Arabidopsis",0
873,Monoterpenes,calebin-A,0
874,Monoterpenes,dehydromenthofurolactone,0
875,Monoterpenes,junionone,0
876,Monoterpenes,globulusin A,0
877,Monoterpenes,globulusin B,0
878,Monoterpenes,"2-hydroxy-1,8-cineole beta-d-glucopyranoside",0
879,Iridoids,iridodial,0
880,Iridoids,anthocleistenolide,0
881,Iridoids,8-deoxyshanzhiside,0
882,Iridoids,oruwacin,0
883,Iridoids,lonijaposide A,0
884,Iridoids,lonijaposide B,0
885,Iridoids,lonijaposide C,0
886,Neural Cell Adhesion Molecule L1,"LAD-2 protein, C elegans",0
887,Semaphorins,"Sema3b protein, mouse",0
888,Semaphorins,"semaphorin 6D, zebrafish",0
889,Semaphorins,"Sema 3D protein, mouse",0
890,Vascular Endothelial Growth Factors,"Pvf2 protein, Drosophila",0
891,Vascular Endothelial Growth Factor A,64Cu-DOTA-VEGF(DEE),0
892,4-Quinolones,2-heptyl-4-quinolone,0
893,Positive Transcriptional Elongation Factor B,"pgc protein, Drosophila",0
894,Aldehyde oxidase,"AOX1 protein, human",0
895,CYTOCHROME B5 REDUCTASE,"Cyb5R3 protein, rat",0
896,Electron Transport Complex I,"NDUFA11 protein, human",0
897,Electron Transport Complex I,"NDUFAB1 protein, human",0
898,lipoprotein-associated phospholipase A(2),"Pafah2 protein, mouse",0
899,ubiquitin C-terminal hydrolase,"UCHL3 protein, mouse",0
900,Ribonuclease III,"RTL2 protein, Arabidopsis",0
901,G-Protein-Coupled Receptors,"Prokr2 protein, mouse",0
902,G-Protein-Coupled Receptors,"GPR56 protein, rat",0
903,G-Protein-Coupled Receptors,"Mrge protein, mouse",0
904,G-Protein-Coupled Receptors,"SREB2 protein, mouse",0
905,G-Protein-Coupled Receptors,"GPRx protein, Xenopus",0
906,G-Protein-Coupled Receptors,"GPCR101 protein, rat",0
907,G-Protein-Coupled Receptors,"G protein-coupled receptor 81, mouse",0
908,G-Protein-Coupled Receptors,"GPR20 protein, human",0
909,G-Protein-Coupled Receptors,"PDFR-1 protein, C elegans",0
910,G-Protein-Coupled Receptors,"OR5l1 protein, human",0
911,Pheromone Receptors,"V1rb2 protein, mouse",0
912,Taxoids,5(12)-oxa-3(11)-cyclotaxane,0
913,Crown Ethers,"1,16-hexadecanoylbis(2-aminomethyl)-18-crown-6",0
914,Crown Ethers,bis-4-xylyl(26)crown-6,0
915,Crown Ethers,dibenzo-21-crown-7,0
916,Crown Ethers,"(3,3'-diphenyl-1,1'-binaphthyl)-20-crown-6",0
917,cannabinoid receptor,"GPR55 protein, mouse",0
918,Xanthones,N-(2-ethoxyethyl)gambogamide,0
919,Xanthones,"1,5-dihydroxy-2,3-dimethoxyxanthone",0
920,Xanthones,"3,6-bis-(omega-N,N-diethylaminoamyloxy)-4,5-difluoroxanthone",0
921,Xanthones,"1,3,5,6-tetrahydroxyxanthone",0
922,Xanthones,"2-(5-methylhexahydropyrrolo(3,4-c)pyrrol-2-yl)xanthen-9-one",0
923,Xanthones,"1,2-dihydro-1,8,10-trihydroxy-2-(2-hydroxypropan-2-yl)-9-(3-methylbut-2-enyl)furo(3,2-a)xanthen-11-one",0
924,Xanthones,(aR)-2'-methoxyvinaxanthone,0
925,Xanthones,swertiabisxanthone-I 8'-O-beta- D-glucopyranoside,0
926,Tetrahydroisoquinolines,JNJ-28583867,0
927,Tetrahydroisoquinolines,RESPIR 4-95,0
928,Tetrahydroisoquinolines,"6,7-dimethoxytetrahydroisoquinoline",0
929,Tetrahydroisoquinolines,EDL-155,0
930,Tetrahydroisoquinolines,AG525E1,0
931,Benzylisoquinolines,cepharanthine,0
932,Benzylisoquinolines,pseudocoptisine,0
933,GTP-Binding Protein gamma Subunits,"G protein gamma 7 protein, human",0
934,Benzeneacetamides,N-(2-(4-t-butylbenzyl)-3-(pivaloyloxy)propyl)-2-(3-fluoro-4-(methylsulfonylamino)phenyl)propionamide,0
935,Benzeneacetamides,N-(2-(4-t-butylbenzyl)-3-(pivaloyloxy)propyl)-2-(3-chloro-4-(methylsulfonylamino)phenyl)propionamide,0
936,Benzeneacetamides,4-(2-amino-1-methyl-2-oxoethyl)phenyl trifluoromethanesulfonate,0
937,Ubiquitin-Conjugating Enzymes,"UEV1D protein, Arabidopsis",0
938,ubiquitin-protein ligase,"Hectd3 protein, human",0
939,ubiquitin-protein ligase,"MARCH1 protein, human",0
940,ubiquitin-protein ligase,"Ubr4 protein, mouse",0
941,ubiquitin-protein ligase,"RNF5 protein, mouse",0
942,F-Box Proteins,"PROM-1 protein, C elegans",0
943,F-Box Proteins,"FBW5 protein, human",0
944,F-Box Proteins,"SKP2A protein, Arabidopsis",0
945,F-Box Proteins,"XAF1 protein, mouse",0
946,F-Box Proteins,"Fbxw15 protein, mouse",0
947,F-Box Proteins,"Arp8 protein, Arabidopsis",0
948,F-Box Proteins,"Fbl6 protein, human",0
949,F-Box Proteins,"FSN-1 protein, C elegans",0
950,Oxidoreductases Acting on CH-CH Group Donors,"2-amino-2-deoxyisochorismate dehydrogenase, Streptomyces globisporus",0
951,Oxidoreductases Acting on CH-CH Group Donors,"eugenol synthase, Ocimum basilium",0
952,Fatty Acid Desaturases,"SFD2 protein, Arabidopsis",0
953,Fatty Acid Desaturases,"desaturase F, Drosophila melanogaster",0
954,Biflavonoids,neochamaejasmin A,0
955,Flavonols,isorhamnetin-7-O-beta-D-glucopyranoside,0
956,Flavonols,"3',4'-dihydroxyflavonol",0
957,Kaempferols,trifolin acetate,0
958,Kaempferols,kaempferol 3-O-(2(G)-(E)-coumaroyl-3(G)-O-beta-D-glucosyl-3(R)-O-beta-D-glucosylrutinoside),0
959,Flavanones,"trans-3,4'-dimethyl-3-hydroxyflavanone",0
960,Flavanones,"5,7,4'-trihydroxy-6-prenylisoflavanone",0
961,Flavanones,"2',4'-dihydroxy-5'-(1'''-dimethylallyl)-6-prenylpinocembrin",0
962,Flavanones,naringenin-7-O-glucoside,0
963,Flavanones,erigeroflavanone,0
964,Flavanones,"7-hydroxy-5-methoxy-6,8-dimethylflavanone",0
965,Thiazolidinediones,"N-(-4-(N-(biphenyl-2-ylmethyl)-N-2-methylpropylamino)- 1-(2-(2,4-difluorobenzoyl)benzoyl)pyrrolidin- 2-yl)methyl-3-(4-(2,4-dioxothiazolidin-5-ylidenemethyl) phenyl)acrylamide",0
966,DNA Repair Enzymes,"MGMT protein, mouse",0
967,DNA Repair Enzymes,"PNKP protein, human",0
968,Metalloproteases,"crotarhagin, Crotalus horridus horridus",0
969,Metalloproteases,"albolatin, Trimeresurus albolabris",0
970,Abietanes,"(N-(4-(2,2,2-trifluoroethyl) benzylidene) (7-isopropyl-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthren-1-yl) meth-anamine)",0
971,Abietanes,"8,20-dihydroxy-9(11),13-abietadien-12-one",0
972,Abietanes,O-methyl pisiferic acid,0
973,Abietanes,"20-nor-3alpha-acetoxyabieta-5,7,9,11,13-pentaene",0
974,Abietanes,"20-nor-3alpha-acetoxy-12-hydroxy-abieta-5,7,9,11,13-pentaene",0
975,Abietanes,"6,11,12,14,16-pentahydroxyabieta-5,8,11,13-tetraen-7-one",0
976,Abietanes,uncinatone,0
977,Abietanes,parnapimarol,0
978,"Diterpenes, Clerodane",salvinorin A,0
979,"Diterpenes, Clerodane",tinosposinenside A,0
980,"Diterpenes, Clerodane",tinosposinenside B,0
981,"Diterpenes, Clerodane",tinosposinenside C,0
982,"Diterpenes, Kaurane","3-acetoxykauran-16,17-diol",0
983,"Diterpenes, Kaurane",nervonin A,0
984,"Diterpenes, Kaurane","ent-kaurane-2,16-diol",0
985,"Diterpenes, Kaurane","ent-kaurane-15,16-epoxy-17-al-19-oic acid",0
986,"Diterpenes, Kaurane","ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate",0
987,"Diterpenes, Kaurane",lushanruhescensins F,0
988,"Diterpenes, Kaurane",maoyecrystal J,0
989,"Sesquiterpenes, Eudesmane","C13-norisoprenoid, 3alpha,6alpha-dihydroxymegastigman-7-en-9-one 3- O-beta-D-apiofuranosyl-(1-6)-beta-D-glucopyranoside",0
990,"Sesquiterpenes, Eudesmane",halichonadin E,0
991,"Sesquiterpenes, Eudesmane",sorangiadenosine,0
992,"Sesquiterpenes, Germacrane","4,5-dihydroxy-3,3',alpha-trimethoxybibenzyl",0
993,"Sesquiterpenes, Germacrane","4,4'-dihydroxy-3,3',5,alpha-tetramethoxybibenzyl",0
994,"Sesquiterpenes, Germacrane","4-hydroxy-3,3',4',5,alpha-pentamethoxybibenzyl",0
995,"Sesquiterpenes, Germacrane",nobilin D,0
996,"Sesquiterpenes, Germacrane",nobilin E,0
997,"Sesquiterpenes, Germacrane",salviadienol A,0
998,"Sesquiterpenes, Germacrane",salviadienol B,0
999,"Sesquiterpenes, Guaiane","8alpha-O-(2',3'-dihydroxyisobutyryl)11beta,13-dihydrodesacylcynaropicrin",0
1000,"Sesquiterpenes, Guaiane",8alpha-O-(3'-hydroxy-3'-methylbutyryl)desacylcynaropicrin,0
1001,"Sesquiterpenes, Guaiane",sulfocostunolide A,0
1002,"Sesquiterpenes, Guaiane",sulfocostunolide B,0
1003,Norisoprenoids,"3-hydroxyl-4,7-megastigmadien-9-one",0
1004,Norisoprenoids,"3-hydroxy-5,6-epoxy-7-megastigmene-9-one",0
1005,Macrocyclic Compounds,ulimorelin,0
1006,"Lactams, Macrocyclic",DMAG-N-oxide,0
1007,Pyrazolones,1-(2-naphthyl)-3-methyl-5-pyrazolone,0
1008,Pyrazolones,"pyrrolo(3,4-c)pyrazole-4,6-dione",0
1009,beta-Lactams,faropenem medoxomil,0
1010,Amaryllidaceae Alkaloids,7-deoxypancratistatin-1-carboxaldehyde,0
1011,Amaryllidaceae Alkaloids,crinine,0
1012,Amaryllidaceae Alkaloids,"sodium pancratistatin 3,4- O-cyclic phosphate",0
1013,Cyclotides,cycloviolacin Y5,0
1014,Cyclotides,cycloviolacin Y4,0
1015,Cyclotides,cycloviolacin O13,0
1016,Cyclotides,cycloviolacin O14,0
1017,Cyclotides,cycloviolacin O24,0
1018,Cyclotides,"kalata B7, Oldenlandia affinis",0
1019,Chalcones,munchiwarin,0
1020,Chalcones,"2,2'-dimethoxydibenzoylmethane",0
1021,Chalcones,4-iodo-4'-boranylchalcone,0
1022,Chalcones,nothofagin,0
1023,Chalcones,"2',4'-dihydroxy-4-methoxy-3'-prenyldihydrochalcone",0
1024,Chalcones,"2',4',4-trihydroxy-3'-prenylchalcone",0
1025,Chalcones,"2',4-dihydroxy-3',4'-(2,2-dimethylchromene)chalcone",0
1026,Crown Compounds,4'-aminobenzo-15-crown-5,0
1027,Calixarenes,resorcinarene,0
1028,Calixarenes,undecylcalix(4)-resorcinarene,0
1029,Calixarenes,tetrathiafulvalene calix(4)pyrrole,0
1030,Calixarenes,calix(4)diquinone,0
1031,Calixarenes,4-carboxylatocalix(4)arene-O-methyl ether,0
1032,Calixarenes,"4-tert-butylcalix(4)arene-1,3-bis(allyloxyethyl) ether",0
1033,Calixarenes,compound 0118,0
1034,Flavones,norwogonin,0
1035,Flavones,"6,7-dihydroxyflavone",0
1036,Flavones,icariside I,0
1037,Flavones,"flavone-3,4',7-trihydroxy-3'-methoxy-7-glucoside",0
1038,Flavones,ladanetin,0
1039,Flavones,nitensoside A,0
1040,Flavones,nitensoside B,0
1041,Flavones,apigenin-7-O-rhamnosyl-1-6-glucoside,0
1042,Flavones,luteolin-7-O-glucoside,0
1043,Flavones,luteolin-7-O-(2-rhamnosylglucoside),0
1044,Flavones,8-hydroxyflavone,0
1045,Flavones,tricin 7-O-glucopyranoside,0
1046,Flavones,tricin 4'-O-guaiacylglyceryl ether,0
1047,Apigenin,apigenin-7-O-(6''-butyryl-beta-glucopyranoside),0
1048,Apigenin,"apigenin-6,8-di-C-glycopyranoside",0
1049,Hydrolyzable Tannins,vescalagin,0
1050,Hydrolyzable Tannins,balanophotannin E,0
1051,Hydrolyzable Tannins,sanguiin H-5,0
1052,alpha-Cyclodextrins,"gadolinium per(3,6-anhydro)-alpha-cyclodextrin",0
1053,beta-Cyclodextrins,beta-cyclodextrin-poly(amidoamine) copolymer,0
1054,beta-Cyclodextrins,mono-6-(3-methylimidazolium)-6-deoxyperphenylcarbamoyl-beta-cyclodextrin,0
1055,beta-Cyclodextrins,mono-6-deoxy-6-oxytocinyl-beta-cyclodextrin 5,0
1056,Depsipeptides,cyanopeptolin 1138,0
1057,Depsipeptides,symplocamide A,0
1058,Depsipeptides,largazole,0
1059,Depsipeptides,grassypeptolide,0
1060,Depsipeptides,salinamide A,0
1061,Depsipeptides,19-O-acetylchaetoglobosin D,0
1062,Depsipeptides,19-O-acetylchaetoglobosin B,0
1063,Depsipeptides,unnarmicin A,0
1064,Depsipeptides,unnarmicin C,0
1065,Depsipeptides,serratamolide A,0
1066,Depsipeptides,spiruchostatin B,0
1067,Depsipeptides,coibamide A,0
1068,Depsipeptides,malevamide E,0
1069,Depsipeptides,dolastatin 14,0
1070,Intracellular Signaling Peptides and Proteins,"DCLK1 protein, human",0
1071,Intracellular Signaling Peptides and Proteins,"hpo protein, Drosophila",0
1072,Intracellular Signaling Peptides and Proteins,"MPZL1 protein, mouse",0
1073,Intracellular Signaling Peptides and Proteins,"Sema3C protein, rat",0
1074,Intracellular Signaling Peptides and Proteins,"vps39 vacuolar protein sorting 39, Danio rerio",0
1075,Intracellular Signaling Peptides and Proteins,"Eps15 protein, rat",0
1076,Intracellular Signaling Peptides and Proteins,"endophilin II, mouse",0
1077,Intracellular Signaling Peptides and Proteins,"TRIM30 alpha protein, mouse",0
1078,Intracellular Signaling Peptides and Proteins,"Zimp10 protein, mouse",0
1079,Intracellular Signaling Peptides and Proteins,"TIPE2 protein, mouse",0
1080,Intracellular Signaling Peptides and Proteins,"TLRR protein, mouse",0
1081,Intracellular Signaling Peptides and Proteins,"FRA1 protein, S cerevisiae",0
1082,Intracellular Signaling Peptides and Proteins,"FRA2 protein, S cerevisiae",0
1083,Intracellular Signaling Peptides and Proteins,"Unc45 protein, mouse",0
1084,Intracellular Signaling Peptides and Proteins,"sh3gl1a protein, zebrafish",0
1085,Intracellular Signaling Peptides and Proteins,"NUMBL protein, human",0
1086,Chitosan,HEP-40,0
1087,Chitosan,pilopool,0
1088,Imidazolines,p-hydroxybenzylideneimidazolinone,0
1089,Imidazolines,amino-p-hydroxybenzylideneimidazolinone,0
1090,Imidazolines,desnitroimidacloprid,0
1091,Imidazolidines,"2-(1-benzyl-2-hydroxyethyl)imino-1,3-dimethylimidazolidine",0
1092,Imidazolidines,"3,3-dimethoxy-1-(imidazolidin-2-ylidene)propan-2-one",0
1093,Imidazolidines,"5-benzyl-2,2,3-trimethyl-4-oxoimidazolidin-1-ium",0
1094,Imidazolidines,"1-hydroxy-2,2,5,5-tetramethyl-3-imidazoline-3-oxide",0
1095,Imidazolidines,imidazolidin-2-one-4-carboxylate,0
1096,Benzoxazines,"3-(benzyl(2-(4-carbamimidoylbenzyl)-4-methyl-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)amino)-3-oxopropanoic acid",0
1097,Benzoxazines,"10-(3-cyclopropylaminomethyl-4-fluoro-1-pyrrolidinyl)-9-fluoro-3-fluoromethyl-2,3-dihydro-7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine-6-carboxylic acid",0
1098,"Adaptor Proteins, Signal Transducing","TYROBP protein, human",0
1099,"Adaptor Proteins, Signal Transducing",Ran binding protein 9,0
1100,"Adaptor Proteins, Signal Transducing","ECSIT protein, Drosophila",0
1101,"Adaptor Proteins, Signal Transducing","RCAN3 protein, human",0
1102,"Adaptor Proteins, Signal Transducing","Mlph protein, mouse",0
1103,"Adaptor Proteins, Signal Transducing","PCIF1 protein, human",0
1104,"Adaptor Proteins, Signal Transducing","Mlph protein, rat",0
1105,"Adaptor Proteins, Signal Transducing","Daxx protein, Drosophila",0
1106,"Adaptor Proteins, Signal Transducing","Enigma homolog protein, zebrafish",0
1107,"Adaptor Proteins, Signal Transducing","Pdlim7 protein, zebrafish",0
1108,"Adaptor Proteins, Signal Transducing","CCAR2 protein, human",0
1109,"Adaptor Proteins, Signal Transducing","Tab3 protein, mouse",0
1110,"Adaptor Proteins, Signal Transducing","Sh3glb2 protein, mouse",0
1111,"Adaptor Proteins, Signal Transducing","THM1 protein, mouse",0
1112,"Adaptor Proteins, Signal Transducing","Daxx protein, rat",0
1113,"Adaptor Proteins, Signal Transducing","FEZ1 protein, human",0
1114,"Adaptor Proteins, Signal Transducing","KLHL12 protein, mouse",0
1115,"Adaptor Proteins, Signal Transducing","NALP1 protein, mouse",0
1116,"Adaptor Proteins, Signal Transducing","PACSIN2 protein, Xenopus",0
1117,Sarcoglycans,"SGCD protein, human",0
1118,Sarcoglycans,"SGCA protein, human",0
1119,Sarcoglycans,"SGCE protein, human",0
1120,Sarcoglycans,"SGCG protein, human",0
1121,Dioxygenases,"hydroxymandelate synthase, Amycolatopsis orientalis",0
1122,"Receptors, Lysosphingolipid","Sphingosine 1-Phosphate Receptor 2, Human",0
1123,"Receptors, Lysophosphatidic Acid","GPR87 protein, human",0
1124,"Receptors, Lysophosphatidic Acid","GPR87 protein, mouse",0
1125,Green Fluorescent Proteins,enhanced cyan fluorescent protein,0
1126,Isocoumarins,(3R)-7-hydroxy-5-methylmellein,0
1127,Isocoumarins,seco-milbemycin A,0
1128,Isocoumarins,seco-milbemycin B,0
1129,Isocoumarins,1-deoxyrubralactone,0
1130,TRPC Cation Channels,"Trpc5 protein, rat",0
1131,TRPM Cation Channels,"Trpm6 protein, mouse",0
1132,Dendrimers,G4-S-nitroso-N-acetylpenicillamine,0
1133,Dendrimers,G4-S-nitroso-N-acetylcysteine,0
1134,TRPP Cation Channels,"PKD-2 protein, C elegans",0
1135,glycine transporter,"GlyT1 protein, Xenopus",0
1136,glycine transporter,"SLC6A5 protein, Xenopus",0
1137,Vesicular Inhibitory Amino Acid Transport Proteins,"VIAAT protein, Xenopus",0
1138,Mutant Chimeric Proteins,"TRIM5-cyclophilin A protein, Macaca nemestrina",0
1139,3-Isopropylmalate dehydrogenase,"LEU2 protein, S cerevisiae",0
1140,Fatty Acid-Binding Proteins,gastrotropin,0
1141,Fatty Acid-Binding Proteins,"intestinal fatty acid-binding protein (1-19), human",0
1142,Fatty Acid-Binding Proteins,"intestinal fatty acid-binding protein (91-107), human",0
1143,Fatty Acid-Binding Proteins,"intestinal fatty acid-binding protein (121-131), human",0
1144,Fatty Acid-Binding Proteins,"Fabp11b protein, zebrafish",0
1145,Organogold Compounds,(2-naphthyl)(triphenylphosphine)gold(I),0
1146,Organogold Compounds,(mu-2-naphthyl)bis((triphenylphosphine)gold(I)),0
1147,Retinal dehydrogenase,"aldh1a3 protein, zebrafish",0
1148,Retinal dehydrogenase,"aldh8a1 protein, zebrafish",0
1149,Proto-Oncogene Proteins c-ets,"ELF5 protein, human",0
1150,POU Domain Factors,"pou5f3.2 protein, Xenopus",0
1151,Suppressor of Cytokine Signaling Proteins,"Wsb1 protein, zebrafish",0
1152,Suppressor of Cytokine Signaling Proteins,"Asb4 protein, mouse",0
1153,Interferon Regulatory Factors,"IRF6 protein, mouse",0
1154,Oxidoreductases Acting on Sulfur Group Donors,"sulfiredoxin protein, mouse",0
1155,HSP40 Heat-Shock Proteins,"ERdj5 protein, mouse",0
1156,Basic-Leucine Zipper Transcription Factors,"Yap5 protein, S cerevisiae",0
1157,Basic-Leucine Zipper Transcription Factors,"ZIP16 protein, Arabidopsis",0
1158,Basic-Leucine Zipper Transcription Factors,"ZIP68 protein, Arabidopsis",0
1159,Basic-Leucine Zipper Transcription Factors,"bZIP28 protein, Arabidopsis",0
1160,Apoptosis Regulatory Proteins,"PPP1R13B protein, human",0
1161,Apoptosis Regulatory Proteins,"MUDENG protein, human",0
1162,Apoptosis Regulatory Proteins,"NALP1 protein, mouse",0
1163,Apoptosis Regulatory Proteins,"Aifm2 protein, mouse",0
1164,Apoptosis Regulatory Proteins,"Iag-1 protein, rat",0
1165,Apoptosis Regulatory Proteins,"bcl2l11 protein, zebrafish",0
1166,Apoptosis Regulatory Proteins,"mAtNOS1 protein, human",0
1167,PTEN Phosphohydrolase,TAT-PTEN fusion protein,0
1168,serine palmitoyltransferase,"Lcb2 protein, Arabidopsis",0
1169,Wnt Proteins,"Wnt-9a protein, rat",0
1170,Wnt Proteins,"CWN-1 protein, C elegans",0
1171,Wnt Proteins,"Wnt6 protein, Xenopus",0
1172,Toll-Like Receptor 3,"TLR3 protein, rat",0
1173,pituitary adenylate cyclase activating polypeptide,p66 - pituitary adenylate cyclase-activating peptide analog,0
1174,Sodium-Glucose Transport Proteins,"SMIT2 protein, rat",0
1175,Wiskott-Aldrich Syndrome Protein,"HA2 protein, Helicoverpa armigera nucleopolyhedrovirus",0
1176,cytochrome P450 3A,"cytochrome P450 3A4 protein, human",0
1177,cytochrome P450 3A,"CYP3A5 protein, human",0
1178,histone acetyltransferase,"Elp3 protein, S cerevisiae",0
1179,histone acetyltransferase,"SAS3 protein, S cerevisiae",0
1180,Ether-A-Go-Go Potassium Channels,"Erg protein, zebrafish",0
1181,Kruppel-Like Transcription Factors,"Sp6 protein, rat",0
1182,Kruppel-Like Transcription Factors,"Klf3 protein, mouse",0
1183,AraC Transcription Factor,"GadX protein, E coli",0
1184,Aryl Hydrocarbon Receptor Nuclear Translocator,"ARNT protein, Xenopus",0
1185,Basic Helix-Loop-Helix Transcription Factors,"twist1a protein, zebrafish",0
1186,Basic Helix-Loop-Helix Transcription Factors,"Mespb protein, Xenopus",0
1187,HIF1alpha protein,"HIF1A protein, Xenopus",0
1188,Tristetraprolin,"ZFP36L3 protein, mouse",0
1189,Forkhead Transcription Factors,"FOXI1 protein, Xenopus",0
1190,Forkhead Transcription Factors,"FoxE1 protein, rat",0
1191,Forkhead Transcription Factors,"FoxF2 protein, rat",0
1192,Forkhead Transcription Factors,"Foxn4 protein, zebrafish",0
1193,fms-Like Tyrosine Kinase 3,"FLT3 protein, rat",0
1194,bone morphogenetic protein receptor type II,"Bmpr2a protein, zebrafish",0
1195,bone morphogenetic protein receptor type II,"Bmpr2b protein, zebrafish",0
1196,Benzodioxoles,retrofractamide A,0
1197,Benzodioxoles,"9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-",0
1198,Benzodioxoles,scutifoliamide A,0
1199,Benzodioxoles,scutifoliamide B,0
1200,Benzodioxoles,"2,2-difluorobenzo(1,3)dioxole-5-carboxylic acid indan-2-ylamide",0
1201,Benzodioxoles,"(2-(2,4-dichlorophenyl)-6-fluoro-2-(4-fluorophenyl)benzo(1,3)dioxol-5-yl)morpholin-4-ylmethanone",0
1202,Benzodioxoles,laserine,0
1203,Benzodioxoles,"7-(isopropoxymethyl)-5-phenyl-7,8-dihydro-5H-(1,3)dioxolo(4,5-g)isochromene",0
1204,"Aptamers, Nucleotide",ARC 1779,0
1205,"Aptamers, Nucleotide","NOX-E36-3'PEG, mouse",0
1206,Benzothiazoles,fluorenylmethoxycarbonyl-2-mercaptobenzothiazole,0
1207,Benzothiazoles,2-argininylbenzothiazole,0
1208,Benzothiazoles,"N,N-dicyclohexyl-2-benzothiazolesulfenamide",0
1209,Benzothiazoles,N-methyl-(11)C)2-(4'-(methylaminophenyl)benzothiazole,0
1210,Benzothiazoles,(N-methyl-(11)C)2-(3'-methyl-4'-(methylamino)phenyl)benzothiazole,0
1211,Benzothiazoles,"2-((2-(1H-imidazol-4-yl)ethyl)sulfanyl)-1,3-benzothiazole",0
1212,Benzothiazoles,3-amino-5-nitrobenzisothiazole,0
1213,Benzothiazoles,benzothiazole styrylcyanine,0
1214,Benzothiazoles,TM 179,0
1215,Benzothiazoles,T2384,0
1216,Benzothiazoles,"N(6)-(2-(4-(biphenyl-4-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo(d)thiazole-2,6-diamine",0
1217,Benzothiazoles,sagopilone,0
1218,"Antigens, Plant","cruciferin protein, Brassica napus",0
1219,"Antigens, Plant","Bra j protein, Brassica juncea",0
1220,"Antigens, Plant","Ara h II protein, Arachis hypogaea",0
1221,"Antigens, Plant",allergen Ara h3,0
1222,"Antigens, Plant","Ara h 6 allergen, Arachis hypogaea",0
1223,"Antigens, Plant","Art v 4 allergen, Artemisia vulgaris",0
1224,"Antigens, Plant","Cor a 8 allergen, Corylus avellana",0
1225,"Antigens, Plant","Pru du amandin allergen, Prunus dulcis",0
1226,"Antigens, Plant","Che a 3 allergen, Chenopodium album",0
1227,"Antigens, Plant","P39-1 allergen, Glycine max",0
1228,"Antigens, Plant","Gly m 4 allergen, Glycine max",0
1229,Phycobilins,phycoviolobilin,0
1230,Cyclohexenes,allyl alpha-ionone,0
1231,Cyclohexenes,cis-alpha-damascone,0
1232,Cyclohexenes,"3-methyl-4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",0
1233,Cyclohexenes,"4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-3-buten-2-one",0
1234,Cyclohexenes,4-(3-cyclohexen-1-yl)pyridine,0
1235,Polyynes,poly(3-acetylthiophene),0
1236,Polyynes,hederyne A,0
1237,Chromogranin A,chromogranin A (344-358),0
1238,CARD Signaling Adaptor Proteins,"Card6 protein, mouse",0
1239,DEAD-box RNA Helicases,"RhlE protein, E coli",0
1240,DEAD-box RNA Helicases,"DDX21 protein, mouse",0
1241,DEAD-box RNA Helicases,"DDX18 protein, human",0
1242,"Proteinase Inhibitory Proteins, Secretory","spint1a protein, zebrafish",0
1243,Keratin-6,"Krt75 protein, mouse",0
1244,adrenomedullin,proadrenomedullin,0
1245,Naphthalimides,N-hydroxynaphthalimide triflate,0
1246,Interleukin-5 Receptor alpha Subunit,"interleukin-5- receptor alpha, mouse",0
1247,Latent TGF-beta Binding Proteins,"LTBP3 protein, rat",0
1248,Latent TGF-beta Binding Proteins,"LTBP4 protein, rat",0
1249,Azabicyclo Compounds,EAA-090,0
1250,Azabicyclo Compounds,triazabicyclodecene,0
1251,Azabicyclo Compounds,"6-benzyl-2-methoxy-8-(4-methoxybenzyl)-6,8-diazabicyclo(3.2.2)nonane",0
1252,Azabicyclo Compounds,aplaminal,0
1253,Azabicyclo Compounds,SM16 compound,0
1254,Azabicyclo Compounds,"1-(10-((E)-3-phenyl-allyl)-3,10-diaza-bicyclo(4.3.1)dec-3-yl)propan-1-one",0
1255,Azabicyclo Compounds,"1,3,3,5-tetramethyl-6-azabicyclo(3.2.1)octane",0
1256,Azabicyclo Compounds,AC-262536,0
1257,"tat Gene Products, Human Immunodeficiency Virus",TAT-PTEN fusion protein,0
1258,Withanolides,withangulatin I,0
1259,Chemokine CXCL12,technetium 99m MAS3-SDF-1alpha,0
1260,Acetogenins,laurenmariallene,0
1261,Acetogenins,22-epicalamistrin,0
1262,Phospholipases A2,"Cr-IV 1 myotoxin, Calloselasma rhodostoma",0
1263,glutaredoxin,"Grx6 protein, S cerevisiae",0
1264,glutaredoxin,"Grx2 protein, S cerevisiae",0
1265,glutaredoxin,"GRX4 protein, Arabidopsis",0
1266,glutaredoxin,"Grx5 protein, S cerevisiae",0
1267,glutaredoxin,"ROXY1 protein, Arabidopsis",0
1268,glutaredoxin,"ROXY2 protein, Arabidopsis",0
1269,"Protein Tyrosine Phosphatases, Non-Receptor","Sbf2 protein, mouse",0
1270,protein tyrosine phosphatase BL,"Ptpn13 protein, rat",0
1271,Dual-Specificity Phosphatases,"Dusp7 protein, mouse",0
1272,Protein Phosphatase 1,"PPP1CA protein, mouse",0
1273,"Cyclic Nucleotide Phosphodiesterases, Type 1","Pde1A protein, mouse",0
1274,Phosphorothioate Oligonucleotides,alicaforsen,0
1275,Phytochelatins,ELPEC20,0
1276,Cyclic Nucleotide-Gated Cation Channels,"Cngb1 protein, mouse",0
1277,Sesterterpenes,acanthosulfate,0
1278,Acridones,"1,3-dihydroxy-5-methoxyacridone",0
1279,Acridones,"1,7-dihydroxy-3-methoxyacridone",0
1280,Isoindoles,"2-(2-(3,4-dichlorophenyl)-2,3-dihydro-1H-isoindol-5-ylamino)nicotinic acid",0
1281,Isoindoles,"(3aS-(3aalpha,4beta,5beta,7beta,7aalpha))-4-(octahydro-5-hydroxy-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-iodobenzonitrile",0
1282,Indolizidines,6-N-(2'-pyrrolidinylcarbonyl)amino-6-(2-methylpropyl)-8a-carboxamidoindolizidine-5-one,0
1283,Quinolizidines,lutenurine,0
1284,Quinolizidines,9a-homocastanospermine,0
1285,Quinolizidines,9-deoxy-9a-homocastanospermine,0
1286,Quinolizidines,cermizine D,0
1287,"Retinol-Binding Proteins, Cellular","RBP5 protein, human",0
1288,Lincosamides,celesticetin A,0
1289,Lincosamides,lincomycin-B,0
1290,Lincosamides,"3-N,N-dimethylamino-3-deoxy lincomycin",0
1291,Cornified Envelope Proline-Rich Proteins,"SPRR2A protein, human",0
1292,Cornified Envelope Proline-Rich Proteins,"SPRR3 protein, human",0
1293,Cornified Envelope Proline-Rich Proteins,"Sprr2b protein, mouse",0
1294,Cornified Envelope Proline-Rich Proteins,"Lce3c protein, mouse",0
1295,Cornified Envelope Proline-Rich Proteins,"SPRR4 protein, human",0
1296,Cornified Envelope Proline-Rich Proteins,"Sprr2a protein, mouse",0
1297,Cornified Envelope Proline-Rich Proteins,"Sprr2k protein, mouse",0
1298,Cornified Envelope Proline-Rich Proteins,"Sprr2j protein, mouse",0
1299,Cornified Envelope Proline-Rich Proteins,"Sprr2i protein, mouse",0
1300,Cornified Envelope Proline-Rich Proteins,"Sprr2h protein, mouse",0
1301,Cornified Envelope Proline-Rich Proteins,"Sprr2g protein, mouse",0
1302,Cornified Envelope Proline-Rich Proteins,"Sprr2f protein, mouse",0
1303,Cornified Envelope Proline-Rich Proteins,"Sprr2d protein, mouse",0
1304,Cornified Envelope Proline-Rich Proteins,"Sprr2e protein, mouse",0
1305,Cornified Envelope Proline-Rich Proteins,"SPRR2B protein, human",0
1306,Cornified Envelope Proline-Rich Proteins,"SPRR2D protein, human",0
1307,Cornified Envelope Proline-Rich Proteins,"Sprr4 protein, mouse",0
1308,Cornified Envelope Proline-Rich Proteins,"LELP1 protein, human",0
1309,Cornified Envelope Proline-Rich Proteins,"SPRR1A protein, human",0
1310,Cornified Envelope Proline-Rich Proteins,"Sprr1a protein, mouse",0
1311,Cornified Envelope Proline-Rich Proteins,"SPRR1B protein, human",0
1312,Cornified Envelope Proline-Rich Proteins,"Sprr1b protein, mouse",0
1313,Cornified Envelope Proline-Rich Proteins,"LCE1B protein, human",0
1314,Cornified Envelope Proline-Rich Proteins,"LCE2B protein, human",0
1315,Cornified Envelope Proline-Rich Proteins,"LCE2D protein, human",0
1316,Cornified Envelope Proline-Rich Proteins,"LCE3C protein, human",0
1317,Cornified Envelope Proline-Rich Proteins,"LCE3D protein, human",0
1318,Cornified Envelope Proline-Rich Proteins,"LCE4A protein, human",0
1319,Cornified Envelope Proline-Rich Proteins,"LCE5A protein, human",0
1320,Cornified Envelope Proline-Rich Proteins,"SPRR2C protein, human",0
1321,Cornified Envelope Proline-Rich Proteins,"SPRR2E protein, human",0
1322,Cornified Envelope Proline-Rich Proteins,"SPRR2F protein, human",0
1323,Cornified Envelope Proline-Rich Proteins,"SPRR2G protein, human",0
1324,Mucin-5B,"MUC5B protein, human",0
1325,Mucin-5B,"Muc5b protein, mouse",0
1326,Mucin-2,"MUC2 protein, human",0
1327,Mucin-2,"Muc2 protein, mouse",0
1328,Mucin-2,"Muc2 protein, rat",0
1329,Mucin-3,"Muc3 protein, mouse",0
1330,Mucin-3,"Muc3 protein, rat",0
1331,Mucin-3,"MUC3A protein, human",0
1332,Mucin-3,"MUC3B protein, human",0
1333,Mucin-4,"MUC4 protein, human",0
1334,Mucin-4,"Muc4 protein, mouse",0
1335,Mucin-4,"Muc4 protein, rat",0
1336,Mucin 5AC,"MUC5AC protein, human",0
1337,Mucin 5AC,"Muc5ac protein, mouse",0
1338,Mucin 5AC,"Muc5ac protein, rat",0
1339,Mucin-6,"MUC6 protein, human",0
1340,Mucin-6,"Muc6 protein, mouse",0
1341,Mucin-6,"Muc6 protein, rat",0
1342,Salivary Proline-Rich Proteins,"PRH1 protein, human",0
1343,Salivary Proline-Rich Proteins,"Sgp158 protein, rat",0
1344,Salivary Proline-Rich Proteins,salivary peptide P-C,0
1345,Salivary Proline-Rich Proteins,"PRB1 protein, human",0
1346,Salivary Proline-Rich Proteins,"PRB2 protein, human",0
1347,Salivary Proline-Rich Proteins,"PRB3 protein, human",0
1348,Salivary Proline-Rich Proteins,"PRB4 protein, human",0
1349,Salivary Proline-Rich Proteins,"PRH2 protein, human",0
1350,Salivary alpha-Amylases,"AMY1A protein, human",0
1351,Salivary alpha-Amylases,"AMY1B protein, human",0
1352,Salivary alpha-Amylases,"AMY1C protein, human",0
1353,Salivary alpha-Amylases,"Amy1 protein, mouse",0
1354,Pancreatic alpha-Amylases,"AMY2A protein, human",0
1355,Pancreatic alpha-Amylases,"AMY2B protein, human",0
1356,Pancreatic alpha-Amylases,"Amy2 protein, mouse",0
1357,Pancreatic alpha-Amylases,"Amy2 protein, rat",0
1358,Urokinase Plasminogen Activator Receptor,"PLAUR protein, human",0
1359,Urokinase Plasminogen Activator Receptor,"Plaur protein, mouse",0
1360,Urokinase Plasminogen Activator Receptor,"Plaur protein, rat",0
1361,Cystatin A,"Stfa1 protein, mouse",0
1362,Cystatin A,"Stfa2 protein, mouse",0
1363,Cystatin A,"Stfa3 protein, mouse",0
1364,Cystatin B,"Cstb protein, mouse",0
1365,Cystatin B,"CSTB protein, human",0
1366,Seed Storage Proteins,"beta-conglycinin protein, Glycine max",0
1367,Seed Storage Proteins,"vicilin protein, plant",0
1368,Seed Storage Proteins,"conglutin protein, Lupinus angustifolius",0
1369,Seed Storage Proteins,"WBA-1 protein, Psophocarpus tetragonolobus",0
1370,Seed Storage Proteins,"cruciferin protein, Brassica napus",0
1371,Seed Storage Proteins,"vicilin-like protein, plant",0
1372,Seed Storage Proteins,"PSP protein, Phaseolus vulgaris",0
1373,Seed Storage Proteins,"WG-55 protein, Triticum aestivum",0
1374,Seed Storage Proteins,allergen Ara h3,0
1375,Seed Storage Proteins,"cruciferin C, Arabidopsis",0
1376,Cystatin C (substance),"CST3 protein, human",0
1377,Cystatin C (substance),"Cst3 protein, mouse",0
1378,Cystatin C (substance),"Cst3 protein, rat",0
1379,cystatin E protein,"Cst6 protein, rat",0
1380,cystatin E protein,"Cst6 protein, mouse",0
1381,cystatin E protein,"CST6 protein, human",0
1382,Salivary Cystatins,"CST1 protein, human",0
1383,Salivary Cystatins,"CST2 protein, human",0
1384,Salivary Cystatins,"CST4 protein, human",0
1385,Salivary Cystatins,"Cyss protein, rat",0
1386,AMP-Activated Protein Kinases,"SNF4Agamma protein, Drosophila",0
1387,AMP-Activated Protein Kinases,"AMPKalpha protein, Drosophila",0
1388,AMP-Activated Protein Kinases,"PRKAA1 protein, human",0
1389,AMP-Activated Protein Kinases,"PRKAA2 protein, human",0
1390,AMP-Activated Protein Kinases,"PRKAB1 protein, human",0
1391,AMP-Activated Protein Kinases,"PRKAB2 protein, human",0
1392,AMP-Activated Protein Kinases,"Prkag3 protein, mouse",0
1393,AMP-Activated Protein Kinases,"PRKAG1 protein, human",0
1394,AMP-Activated Protein Kinases,"PRKAG2 protein, human",0
1395,AMP-Activated Protein Kinases,"Prkag1 protein, mouse",0
1396,AMP-Activated Protein Kinases,"PRKAG3 protein, human",0
1397,Tolloid-Like Metalloproteinases,"tld protein, Drosophila",0
1398,Tolloid-Like Metalloproteinases,"Tll2 protein, mouse",0
1399,Tolloid-Like Metalloproteinases,"Tll1 protein, mouse",0
1400,Tolloid-Like Metalloproteinases,"TLL1 protein, human",0
1401,Tolloid-Like Metalloproteinases,"TLL2 protein, human",0
1402,Tolloid-Like Metalloproteinases,"Tll1 protein, rat",0
1403,Tolloid-Like Metalloproteinases,"tll1 protein, zebrafish",0
1404,Bone Morphogenetic Protein 1,"Tok protein, Drosophila",0
1405,Bone Morphogenetic Protein 1,"BMP1 protein, human",0
1406,Bone Morphogenetic Protein 1,"Bmp1 protein, mouse",0
1407,Bone Morphogenetic Protein 1,"Bmp1 protein, rat",0
1408,bone morphogenetic protein 2,"bmp2b protein, zebrafish",0
1409,bone morphogenetic protein 2,"Bmp2 protein, Xenopus",0
1410,bone morphogenetic protein 2,"BMP2 protein, human",0
1411,bone morphogenetic protein 2,"Bmp2 protein, mouse",0
1412,bone morphogenetic protein 2,"Bmp2 protein, rat",0
1413,Bone Morphogenetic Protein 3,"BMP3 protein, human",0
1414,Bone Morphogenetic Protein 3,"Bmp3 protein, mouse",0
1415,Bone Morphogenetic Protein 3,"Bmp3 protein, rat",0
1416,Growth Differentiation Factors,"Gdf11 protein, mouse",0
1417,Growth Differentiation Factors,"GDF7 protein, Xenopus",0
1418,Growth Differentiation Factors,"GDF11 protein, human",0
1419,Growth Differentiation Factors,"Gdf11 protein, rat",0
1420,Growth Differentiation Factors,"GDF7 protein, human",0
1421,Growth Differentiation Factors,"Gdf7 protein, mouse",0
1422,Growth Differentiation Factors,"Gdf7 protein, rat",0
1423,Growth Differentiation Factors,"gdf7 protein, zebrafish",0
1424,Growth Differentiation Factors,"GDF11 protein, zebrafish",0
1425,Growth Differentiation Factors,"GDF2 protein, human",0
1426,growth differentiation factor 10,"Gdf10 protein, mouse",0
1427,growth differentiation factor 10,"GDF10 protein, human",0
1428,growth differentiation factor 10,"Gdf10 protein, rat",0
1429,bone morphogenetic protein 4,"BMP4 protein, human",0
1430,bone morphogenetic protein 4,"Bmp4 protein, mouse",0
1431,bone morphogenetic protein 4,"Bmp4 protein, rat",0
1432,bone morphogenetic protein 4,"bmp4 protein, Xenopus",0
1433,bone morphogenetic protein 4,"bmp4 protein, zebrafish",0
1434,bone morphogenetic protein 5,"BMP5 protein, human",0
1435,bone morphogenetic protein 5,"Bmp5 protein, mouse",0
1436,bone morphogenetic protein 6,"BMP6 protein, human",0
1437,bone morphogenetic protein 6,"Bmp6 protein, mouse",0
1438,bone morphogenetic protein 6,"Bmp6 protein, rat",0
1439,bone morphogenetic protein 7,"BMP7 protein, human",0
1440,bone morphogenetic protein 7,"bmp7 protein, mouse",0
1441,bone morphogenetic protein 7,"Bmp7 protein, rat",0
1442,bone morphogenetic protein 7,"bmp7.1 protein, Xenopus",0
1443,bone morphogenetic protein 7,"bmp7.2 protein, Xenopus",0
1444,bone morphogenetic protein 7,"bmp7a protein, zebrafish",0
1445,Growth Differentiation Factor 2,"Gdf2 protein, mouse",0
1446,growth differentiation factor 5,"GDF5 protein, zebrafish",0
1447,growth differentiation factor 5,"GDF5 protein, human",0
1448,growth differentiation factor 5,"Gdf5 protein, mouse",0
1449,Growth Differentiation Factor 9,"GDF9 protein, human",0
1450,Growth Differentiation Factor 9,"Gdf9 protein, mouse",0
1451,Growth Differentiation Factor 9,"Gdf9 protein, rat",0
1452,bone morphogenetic protein 15,"BMP15 protein, human",0
1453,bone morphogenetic protein 15,"Bmp15 protein, mouse",0
1454,bone morphogenetic protein 15,"Bmp15 protein, rat",0
1455,growth differentiation factor 6,"GDF6B protein, zebrafish",0
1456,growth differentiation factor 6,"gdf6a protein, zebrafish",0
1457,growth differentiation factor 6,"GDF6 protein, human",0
1458,growth differentiation factor 6,"Gdf6 protein, mouse",0
1459,growth differentiation factor 6,"Gdf6 protein, rat",0
1460,growth-differentiation factor 8,"GDF8 protein, human",0
1461,growth-differentiation factor 8,"Mstn protein, mouse",0
1462,growth-differentiation factor 8,"Gdf8 protein, rat",0
1463,growth-differentiation factor 8,"Mstnb protein, zebrafish",0
1464,Growth Differentiation Factor 15,"GDF15 protein, human",0
1465,Growth Differentiation Factor 15,"Gdf15 protein, mouse",0
1466,Growth Differentiation Factor 15,"Gdf15 protein, rat",0
1467,growth differentiation factor 3,"GDF3 protein, human",0
1468,growth differentiation factor 3,"Gdf3 protein, mouse",0
1469,Growth Differentiation Factor 1,"GDF1 protein, human",0
1470,Growth Differentiation Factor 1,"Gdf1 protein, mouse",0
1471,Growth Differentiation Factor 1,"Gdf1 protein, rat",0
1472,Nodal Signaling Ligands,"ndr1 protein, zebrafish",0
1473,Nodal Protein,"NODAL protein, human",0
1474,Nodal Protein,"Nodal protein, mouse",0
1475,Left-Right Determination Factors,"Lefty1 protein, mouse",0
1476,Left-Right Determination Factors,"lft1 protein, zebrafish",0
1477,Left-Right Determination Factors,"LEFTY2 protein, human",0
1478,Left-Right Determination Factors,"lefty protein, Xenopus",0
1479,Left-Right Determination Factors,"LEFTB protein, human",0
1480,Left-Right Determination Factors,"Lefty2 protein, mouse",0
1481,Insulin Receptor Substrate Proteins,"IRS4 protein, human",0
1482,Insulin Receptor Substrate Proteins,"Irs3 protein, mouse",0
1483,Insulin Receptor Substrate Proteins,"irs2-A protein, Xenopus",0
1484,Insulin Receptor Substrate Proteins,"Irs4 protein, mouse",0
1485,Insulin Receptor Substrate Proteins,"IRS4 protein, rat",0
1486,Insulin Receptor Substrate Proteins,"Irs3 protein, rat",0
1487,Insulin Receptor Substrate Proteins,"IRS3P protein, human",0
1488,Insulin Receptor Substrate Proteins,"IRS1 protein, human",0
1489,Insulin Receptor Substrate Proteins,"irs1 protein, Xenopus",0
1490,Insulin Receptor Substrate Proteins,"Irs1 protein, mouse",0
1491,Insulin Receptor Substrate Proteins,"Irs1 protein, rat",0
1492,Insulin Receptor Substrate Proteins,"IRS2 protein, human",0
1493,Insulin Receptor Substrate Proteins,"Irs2 protein, mouse",0
1494,Insulin Receptor Substrate Proteins,"Irs2 protein, rat",0
1495,Insulin Receptor Substrate Proteins,"Irs4 protein, S cerevisiae",0
1496,connective tissue growth factor,"Ctgf protein, rat",0
1497,connective tissue growth factor,"CTGF protein, human",0
1498,connective tissue growth factor,"Ctgf protein, mouse",0
1499,Nephroblastoma Overexpressed Protein,"NOV protein, human",0
1500,Nephroblastoma Overexpressed Protein,"Nov protein, mouse",0
1501,Cysteine-Rich Protein 61,"Cyr61 protein, mouse",0
1502,Cysteine-Rich Protein 61,"CYR61 protein, human",0
1503,Cysteine-Rich Protein 61,"Cyr61 protein, rat",0
1504,Cysteine-Rich Protein 61,"CCN1 protein, Xenopus",0
1505,"2S Albumins, Plant","methionine-rich 2S protein, Helianthus",0
1506,"2S Albumins, Plant",pea seed albumin 2,0
1507,"2S Albumins, Plant","Bra j protein, Brassica juncea",0
1508,"2S Albumins, Plant","Ara h II protein, Arachis hypogaea",0
1509,"2S Albumins, Plant","2S albumin, brazil nut",0
1510,"2S Albumins, Plant","Ara h 6 allergen, Arachis hypogaea",0
1511,snRNP Core Proteins,"SNRPB protein, human",0
1512,snRNP Core Proteins,"SNRPB2 protein, human",0
1513,snRNP Core Proteins,"SNRPD1 protein, human",0
1514,snRNP Core Proteins,"SNRPD2 protein, human",0
1515,snRNP Core Proteins,"SNRPD3 protein, human",0
1516,snRNP Core Proteins,"SNRPE protein, human",0
1517,snRNP Core Proteins,"SNRPF protein, human",0
1518,snRNP Core Proteins,"SNRPG protein, human",0
1519,snRNP Core Proteins,"Snrpb protein, mouse",0
1520,snRNP Core Proteins,"SNRPN protein, human",0
1521,SMN Complex Proteins,"SMNDC1 protein, human",0
1522,Survival of Motor Neuron 1 Protein,"SMN1 protein, human",0
1523,Survival of Motor Neuron 1 Protein,"Smn1 protein, mouse",0
1524,Survival of Motor Neuron 1 Protein,"Smn1 protein, rat",0
1525,Survival of Motor Neuron 1 Protein,"smn1 protein, zebrafish",0
1526,DEAD Box Protein 20,"DDX20 protein, human",0
1527,DEAD Box Protein 20,"Ddx20 protein, mouse",0
1528,DEAD Box Protein 20,"Ddx20 protein, rat",0
1529,beta-Globins,"beta-globin readthrough protein, Oryctolagus cuniculus",0
1530,beta-Globins,beta(A-T87Q) globin,0
1531,Heat Shock Protein 27,"HSPB1 protein, human",0
1532,Heat Shock Protein 27,"HSPB2 protein, human",0
1533,Heat Shock Protein 27,"Hspb1 protein, rat",0
1534,Heat Shock Protein 27,"Hspb2 protein, mouse",0
1535,Heat Shock Protein 27,"Hspb2 protein, rat",0
1536,Heat Shock Protein 27,"hspb1 protein, zebrafish",0
1537,Acid Ceramidase,"ASAH1 protein, human",0
1538,Acid Ceramidase,"Asah1 protein, mouse",0
1539,Acid Ceramidase,"Asah1 protein, rat",0
1540,Alkaline Ceramidase,"ACER1 protein, human",0
1541,Alkaline Ceramidase,"Acer1 protein, mouse",0
1542,Alkaline Ceramidase,"ACER2 protein, human",0
1543,Neutral Ceramidase,"neutral ceramidase, zebrafish",0
1544,Neutral Ceramidase,"ASAH2 protein, human",0
1545,Neutral Ceramidase,"Asah2 protein, mouse",0
1546,Neutral Ceramidase,"Asah2 protein, rat",0
1547,"Receptors, Natural Killer Cell","KLRF1 protein, human",0
1548,"Antigens, CD1d","CD1D protein, human",0
1549,"Antigens, CD1d","Cd1d1 protein, mouse",0
1550,Natural Cytotoxicity Triggering Receptor 1,"NCR1 protein, human",0
1551,Natural Cytotoxicity Triggering Receptor 1,"Ncr1 protein, mouse",0
1552,Natural Cytotoxicity Triggering Receptor 1,"Ncr1 protein, rat",0
1553,Natural Cytotoxicity Triggering Receptor 3,"NCR3 protein, human",0
1554,Natural Cytotoxicity Triggering Receptor 3,"Ncr3 protein, rat",0
1555,Natural Cytotoxicity Triggering Receptor 2,"NCR2 protein, human",0
1556,"Killer Factors, Yeast","KHR1 protein, S cerevisiae",0
1557,LY-49 receptor,"Klra1 protein, mouse",0
1558,LY-49 receptor,"Klra17 protein, mouse",0
1559,LY-49 receptor,"Klra2 protein, mouse",0
1560,LY-49 receptor,"Klra3 protein, mouse",0
1561,LY-49 receptor,"Klra4 protein, mouse",0
1562,LY-49 receptor,"Klra5 protein, mouse",0
1563,LY-49 receptor,"Klra6 protein, mouse",0
1564,LY-49 receptor,"Klra7 protein, mouse",0
1565,LY-49 receptor,"Klra8 protein, mouse",0
1566,NK Cell Lectin-Like Receptor Subfamily B,"KLRB1 protein, human",0
1567,NK Cell Lectin-Like Receptor Subfamily B,"Klrb1c protein, mouse",0
1568,NK Cell Lectin-Like Receptor Subfamily B,"Klrb1b protein, mouse",0
1569,NK Cell Lectin-Like Receptor Subfamily C,"KLRC1 protein, human",0
1570,NK Cell Lectin-Like Receptor Subfamily C,"Klrc1 protein, mouse",0
1571,NK Cell Lectin-Like Receptor Subfamily C,"KLRC2 protein, human",0
1572,NK Cell Lectin-Like Receptor Subfamily C,"Klrc2 protein, mouse",0
1573,NK Cell Lectin-Like Receptor Subfamily C,"Klrc2 protein, rat",0
1574,NK Cell Lectin-Like Receptor Subfamily C,"KLRC3 protein, human",0
1575,NK Cell Lectin-Like Receptor Subfamily C,"Klrc3 protein, mouse",0
1576,NK Cell Lectin-Like Receptor Subfamily C,"Klrc3 protein, rat",0
1577,NK Cell Lectin-Like Receptor Subfamily C,"KLRC4 protein, human",0
1578,NK Cell Lectin-Like Receptor Subfamily K,"KLRK1 protein, human",0
1579,NK Cell Lectin-Like Receptor Subfamily K,"Klrk1 protein, mouse",0
1580,Lipopeptides,amphomycin,0
1581,Lipopeptides,surfactin peptide,0
1582,Lipopeptides,octapeptin antibiotics,0
1583,Lipopeptides,tsushimycin,0
1584,Lipopeptides,"2,3-bis(palmitoyloxy)-2-propyl-N-palmitoyl-cysteinyl-seryl-seryl-asparaginyl-alanine",0
1585,Lipopeptides,fengycin,0
1586,Lipopeptides,arthrofactin,0
1587,Lipopeptides,lipopeptide 84-201,0
1588,Lipopeptides,lipopeptide 86-450,0
1589,Lipopeptides,"surfactin, Leu(7)-",0
1590,Lipopeptides,"surfactin, Ile(7)-",0
1591,Lipopeptides,trichogin A IV,0
1592,Lipopeptides,WF 11899A,0
1593,Lipopeptides,WF 11899B,0
1594,Lipopeptides,WF 11899C,0
1595,Lipopeptides,Theradigm-HBV,0
1596,Lipopeptides,enamidonin,0
1597,Lipopeptides,TAN 1511 A,0
1598,Lipopeptides,TAN 1511 B,0
1599,Lipopeptides,TAN 1511 C,0
1600,Lipopeptides,bacillopeptin A,0
1601,Lipopeptides,bacillopeptin B,0
1602,Lipopeptides,bacillopeptin C,0
1603,Lipopeptides,rakicidin A,0
1604,Lipopeptides,rakicidin B,0
1605,Lipopeptides,gordonin,0
1606,Lipopeptides,macrophage stimulatory lipopeptide 2,0
1607,Lipopeptides,JBT-3002,0
1608,Lipopeptides,trichogin GA IV,0
1609,Lipopeptides,antillatoxin,0
1610,Lipopeptides,Lp44 lipopeptide,0
1611,Lipopeptides,Pam-Gly(-1)-Lys(0)-Arg(1)-Pro(2)-Pro(3)-Gly(4)-Phe(5)-Ser(6)-Pro(7)-Phe(8)-Arg(9)-OH,0
1612,Lipopeptides,Pam-Lys(0)-Arg(1)-Pro(2)-Pro(3)-Gly(4)-Phe(5)-Ser(6)-Pro(7)-Phe(8)-Arg(9)-OH,0
1613,Lipopeptides,RGD-lipopeptide,0
1614,Lipopeptides,spiroidesin,0
1615,Lipopeptides,aminocandin,0
1616,Lipopeptides,HMR 1043,0
1617,Lipopeptides,jamaicamide A,0
1618,Lipopeptides,jamaicamide B,0
1619,Lipopeptides,jamaicamide C,0
1620,Lipopeptides,hassallidin A,0
1621,Lipopeptides,Pam(3)CSK(4) peptide,0
1622,Lipopeptides,FR 209602,0
1623,Lipopeptides,HIV type 1 lipopeptide vaccine,0
1624,Lipopeptides,fellutamide B,0
1625,Lipopeptides,laspartomycin C,0
1626,Lipopeptides,"cyclic lipopeptide, Bacillus subtilis",0
1627,Lipopeptides,tauramamide,0
1628,Stage-Specific Embryonic Antigens,stage-specific embryonic antigen-3,0
1629,Stage-Specific Embryonic Antigens,stage-specific embryonic antigen-4,0
1630,SOX Transcription Factors,"Sox15 protein, mouse",0
1631,SOX Transcription Factors,"Sox19a protein, zebrafish",0
1632,SOX Transcription Factors,"SOX15 protein, human",0
1633,SOX Transcription Factors,"D protein, Drosophila",0
1634,SOX Transcription Factors,"SoxN protein, Drosophila",0
1635,SOX Transcription Factors,"sox19b protein, zebrafish",0
1636,SOX Transcription Factors,"sox32 protein, zebrafish",0
1637,SOX Transcription Factors,"SOX33 protein, Xenopus",0
1638,SOX Transcription Factors,"sox11b protein, zebrafish",0
1639,SOXB1 Transcription Factors,"Sox1 protein, mouse",0
1640,SOXB1 Transcription Factors,"SoxB1 protein, Strongylocentrotus purpuratus",0
1641,SOXB1 Transcription Factors,"Sox1 protein, Xenopus",0
1642,SOXB1 Transcription Factors,"SOX1 protein, human",0
1643,SOXB1 Transcription Factors,"Sox1 protein, rat",0
1644,SOXB1 Transcription Factors,"sox2 protein, Xenopus",0
1645,SOXB1 Transcription Factors,"SOX2 protein, human",0
1646,SOXB1 Transcription Factors,"Sox2 protein, mouse",0
1647,SOXB1 Transcription Factors,"Sox2 protein, rat",0
1648,SOXB1 Transcription Factors,"SOX3 protein, human",0
1649,SOXB1 Transcription Factors,"Sox3 protein, mouse",0
1650,SOXB1 Transcription Factors,"Sox3 protein, Xenopus",0
1651,SOXB2 Transcription Factors,"SOX14 protein, human",0
1652,SOXB2 Transcription Factors,"sox21a protein, zebrafish",0
1653,SOXB2 Transcription Factors,"SOX21 protein, human",0
1654,SOXB2 Transcription Factors,"Sox21 protein, mouse",0
1655,SOXB2 Transcription Factors,"Sox21 protein, Gallus gallus",0
1656,SOXB2 Transcription Factors,"Sox14 protein, Drosophila",0
1657,SOXB2 Transcription Factors,"Sox14 protein, mouse",0
1658,SOXC Transcription Factors,"SOX4 protein, human",0
1659,SOXC Transcription Factors,"SOX11 protein, human",0
1660,SOXC Transcription Factors,"SOX12 protein, human",0
1661,SOXC Transcription Factors,"Sox4 protein, mouse",0
1662,SOXC Transcription Factors,"Sox11 protein, Xenopus",0
1663,SOXC Transcription Factors,"Sox11 protein, mouse",0
1664,SOXC Transcription Factors,"sox11a protein, zebrafish",0
1665,SOXC Transcription Factors,"Sox12 protein, mouse",0
1666,SOXD Transcription Factors,"Sox5 protein, mouse",0
1667,SOXD Transcription Factors,"Sox6 protein, mouse",0
1668,SOXD Transcription Factors,"SOX6 protein, human",0
1669,SOXD Transcription Factors,"SOX5 protein, human",0
1670,SOXD Transcription Factors,"Sox5 protein, Xenopus",0
1671,SOXD Transcription Factors,"SOX13 protein, human",0
1672,SOXD Transcription Factors,"Sox5 protein, zebrafish",0
1673,SOXE Transcription Factors,"SOX8 protein, human",0
1674,SOXE Transcription Factors,"sox10 protein, zebrafish",0
1675,SOXE Transcription Factors,"Sox8 protein, mouse",0
1676,SOXE Transcription Factors,"Sox8 protein, Xenopus",0
1677,SOXE Transcription Factors,"SOX10 protein, human",0
1678,SOXE Transcription Factors,"Sox10 protein, mouse",0
1679,SOXE Transcription Factors,"Sox10 protein, rat",0
1680,SOX9 Transcription Factor,"Sox100B protein, Drosophila",0
1681,SOX9 Transcription Factor,"Sox9a protein, zebrafish",0
1682,SOX9 Transcription Factor,"Sox9b protein, zebrafish",0
1683,SOX9 Transcription Factor,"SOX9 protein, human",0
1684,SOX9 Transcription Factor,"Sox9 protein, mouse",0
1685,SOXF Transcription Factors,"SOX18 protein, human",0
1686,SOXF Transcription Factors,"Sox7 protein, mouse",0
1687,SOXF Transcription Factors,"SOX17 protein, human",0
1688,SOXF Transcription Factors,"SOX7 protein, human",0
1689,SOXF Transcription Factors,"Sox7 protein, Xenopus",0
1690,SOXF Transcription Factors,"Sox18 protein, mouse",0
1691,SOXF Transcription Factors,"sox18 protein, Xenopus",0
1692,SOXF Transcription Factors,"sox17b.1 protein, Xenopus",0
1693,SOXF Transcription Factors,"sox17a protein, Xenopus",0
1694,SOXF Transcription Factors,"sox17 protein, zebrafish",0
1695,SOXF Transcription Factors,"Sox17 protein, mouse",0
1696,SOXF Transcription Factors,"Sox7 protein, zebrafish",0
1697,SOXF Transcription Factors,"Sox18 protein, zebrafish",0
1698,Shc Signaling Adaptor Proteins,"Shc protein, Drosophila",0
1699,Shc Signaling Adaptor Proteins,"Shcbp1 protein, mouse",0
1700,Shc Signaling Adaptor Proteins,"SHC1 protein, S cerevisiae",0
1701,Shc Signaling Adaptor Proteins,"SHC4 protein, human",0
1702,Shc Signaling Adaptor Proteins,"Shc4 protein, mouse",0
1703,Halogenated Diphenyl Ethers,2-chloro-4-trifluoromethylphenyl 4-nitrophenyl ether,0
1704,Halogenated Diphenyl Ethers,hexachlorodiphenyloxide,0
1705,Halogenated Diphenyl Ethers,fluorodifen,0
1706,Halogenated Diphenyl Ethers,decabromobiphenyl ether,0
1707,Halogenated Diphenyl Ethers,butylated monochlorodiphenyl oxide,0
1708,Halogenated Diphenyl Ethers,predioxin,0
1709,Halogenated Diphenyl Ethers,dichlorfop-methyl,0
1710,Halogenated Diphenyl Ethers,oxyfluorofen,0
1711,Halogenated Diphenyl Ethers,polychlorinated diphenyl ethers,0
1712,Halogenated Diphenyl Ethers,nonachloropredioxin,0
1713,Halogenated Diphenyl Ethers,Kayahope,0
1714,Halogenated Diphenyl Ethers,4-hydroxynonachlorodiphenyl ether,0
1715,Halogenated Diphenyl Ethers,octachloro-2-phenoxyphenol,0
1716,Halogenated Diphenyl Ethers,"2-hydroxy-2',3',4,4',5,5',6'-heptachlorodiphenyl ether",0
1717,Halogenated Diphenyl Ethers,4-chlorodiphenyl ether,0
1718,Halogenated Diphenyl Ethers,lactofen,0
1719,Halogenated Diphenyl Ethers,"2,2',4,4',6-pentachlorodiphenyl ether",0
1720,Halogenated Diphenyl Ethers,"2,2',4,4',5,6-hexachlorodiphenyl ether",0
1721,Halogenated Diphenyl Ethers,"2,2',3,3',4,6'-hexachlorodiphenyl ether",0
1722,Halogenated Diphenyl Ethers,Bromkal 70,0
1723,Halogenated Diphenyl Ethers,decachlorodiphenyl ether,0
1724,Halogenated Diphenyl Ethers,"2,2',4,4',5,5'-hexachlorodiphenyl ether",0
1725,Halogenated Diphenyl Ethers,"2,2',3,4,4',6,6'-heptachlorodiphenyl ether",0
1726,Halogenated Diphenyl Ethers,bastadin 8,0
1727,Halogenated Diphenyl Ethers,bastadin 9,0
1728,Halogenated Diphenyl Ethers,bastadin 14,0
1729,Halogenated Diphenyl Ethers,"3,5-dibromo-2-(2,4-dibromophenoxy)phenol",0
1730,Halogenated Diphenyl Ethers,pentabromodiphenyl ether,0
1731,Halogenated Diphenyl Ethers,bastadin 10,0
1732,Halogenated Diphenyl Ethers,bastadin 12,0
1733,Halogenated Diphenyl Ethers,bastadin 20,0
1734,Halogenated Diphenyl Ethers,bastadin 5,0
1735,Halogenated Diphenyl Ethers,"CP 471,474",0
1736,Halogenated Diphenyl Ethers,bastadin 21,0
1737,Halogenated Diphenyl Ethers,bastadin 4,0
1738,Halogenated Diphenyl Ethers,"2,2',4,4',5-brominated diphenyl ether",0
1739,Halogenated Diphenyl Ethers,"2,2',4,4',5,5'-hexabrominated diphenyl ether",0
1740,Halogenated Diphenyl Ethers,"2,2',3,4,4',5',6-heptabromodiphenyl ether",0
1741,Halogenated Diphenyl Ethers,"2,2',4,4'-tetrabromodiphenyl ether",0
1742,Halogenated Diphenyl Ethers,"2,2',3,3',4,4',6,6'-octabromodiphenyl ether",0
1743,Halogenated Diphenyl Ethers,"2,2',3,3',4,4',5,5',6-nonabromodiphenyl ether",0
1744,Halogenated Diphenyl Ethers,"2,2',3,3',4,4',5,6,6'-nonabromodiphenyl ether",0
1745,Halogenated Diphenyl Ethers,"2,2',3,3',4,5,5',6,6'-nonabromodiphenyl ether",0
1746,Halogenated Diphenyl Ethers,bastadin 6,0
1747,Halogenated Diphenyl Ethers,diclosan,0
1748,Acenaphthenes,bis(1-naphthylimino)acenaphthene,0
1749,Acetamides,"2-(4-(4-cyano-phenoxy)-3,5-dicyclopropyl-1H-pyrazol-1-yl)-N-methylacetamide",0
1750,Acetaminophen,HIFENAC MR,0
1751,Acetanilides,"N-(4-((4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl)amino)phenyl)acetamide",0
1752,Acetanilides,3'-methylacetanilide,0
1753,Acetanilides,2-(2-methylquinolin-4-ylamino)-N-(2-chlorophenyl)acetamide,0
1754,Acetates,"(((1,3-dibenzyl-2,5-dioxo-4-imidazolidinylidene) methyl)sulfanyl) methyl acetate",0
1755,Acetates,"(10E,12Z)-hexadecadien-1-yl acetate",0
1756,Acetates,sinapyl acetate,0
1757,Acetates,methyl 2-chloro-2-cyclopropylideneacetate,0
1758,Acetates,lanthanum(III) acetate,0
1759,Acetates,(8-hydroxymethylen)trieicosanyl acetate,0
1760,Acetates,"2,3-dihydro-1,3-benzothiazol-2-iminium hydrogen oxydiacetate",0
1761,Acetoacetates,2-(methacryloyloxy)ethyl acetocetate,0
1762,Acetophenones,"3,5-dimethyl-6-hydroxy-2-methoxy-4-O-D-glucopyranosyl-oxy-acetophenone",0
1763,Acetophenones,annphenone,0
1764,Acetylcholinesterase,"ColQ protein, rat",0
1765,Acetylcholinesterase,"Colq protein, mouse",0
1766,Acetyltransferase,"elongase-2, rat",0
1767,Acetyltransferase,"TmcA protein, E coli",0
1768,Acetyltransferase,"San protein, Drosophila",0
1769,Heterocyclic Acids,PSN 632408,0
1770,"Acids, Noncarboxylic",bromic acid,0
1771,Acridines,"2',6'-dimethyl-4'-(n-succinimidyloxycarbonyl) phenyl-10-methyl-acridinium-9-carboxylate methosulfate",0
1772,Acridines,"3,3,6,6,10-pentamethyl-3,4,6,7-tetrahydro-(1,8(2H,5H)-dion)acridine chloride",0
1773,Acridines,N-((N-(2-dimethylamino)ethyl)acridine-4-carboxamide)-alpha-alanine,0
1774,Acrylamides,poly(N-isopropylacrylamide)-graft-polypropylene,0
1775,Acrylamides,poly(N-isopropylacrylamide-co-N-(3-(dimethylamino)propyl)methacrylamide)-b-polyethyleneimine,0
1776,Acrylamides,"3-(1-((2,4-dichlorophenyl)methyl)-5-fluoro-3-methyl-1H-indol-7-yl)-N-((4,5-dichloro-2-thienyl)sulfonyl)-2-propenamide",0
1777,Acrylamides,"2-(2,6-dichloro-4-((3-furan-2-ylacryloylamino)methyl)benzoylamino)-3-((thiazolidine-4-carbonyl)amino)propionic acid",0
1778,Acrylamides,poly(carboxybetaine acrylamide),0
1779,Acrylates,poly(oligoethylene glycol methyl ether acrylate),0
1780,Acrylates,pentaerythritol diacrylate monostearate,0
1781,Acrylates,pentaerythritol tetraacrylate,0
1782,Acrylates,"methyl 3-(4-(4,5-bis(4-(isopropyl(methyl)amino)phenyl)-1H-imidazol-2-yl)phenyl)acrylate",0
1783,Acrylates,poly(tert-butyl acrylate),0
1784,Acrylates,"glycerol 1,3-diglycerolate diacrylate",0
1785,Acrylates,"2,2-bis(4-(2-hydroxy-3-acryloxypropoxy)phenyl)propane",0
1786,Acrylic Resins,streptavidin-poly(N-isopropylacrylamide),0
1787,Acrylic Resins,poly(N-isopropylacrylamide)-co-polystyrene,0
1788,Acrylic Resins,poly(N-isopropylacrylamide-vinyl pyrrolidone-acrylic acid),0
1789,Acrylic Resins,poly(N-vinylcaprolactam-co-(2-(acryloxy)ethyl)trimethylammonium chloride),0
1790,Acrylic Resins,"poly(hexyl acrylate-co-1,4-butanediol diacrylate-co-(2-(acryloyloxy)ethyl)trimethyl ammonium chloride)",0
1791,Acrylic Resins,lignin-starch-acrylamide-acrylic acid copolymer,0
1792,Acrylic Resins,starch-graft-polyacrylamide-co-sodium xanthate,0
1793,Acrylic Resins,Ortho-Coat,0
1794,Acrylic Resins,poly(N-isopropylacrylamide-co-acrylamide-co-allylamine),0
1795,Actins,"Arpm1 protein, mouse",0
1796,Acyl Coenzyme A,oct-2-en-4-ynoyl-coenzyme A,0
1797,Acyltransferase,"AKR1 protein, S cerevisiae",0
1798,Acyltransferase,"YdcS protein, E coli",0
1799,Acyltransferase,"glycerophosphocholine acyltransferase, S cerevisiae",0
1800,Acyltransferase,"Rv1347c, Mycobacterium tuberculosis",0
1801,Acyltransferase,"ZDHHC2 protein, human",0
1802,Acyltransferase,"ghrelin O-acyltransferase, rat",0
1803,Acyltransferase,"Bus-1 protein, C elegans",0
1804,Acyltransferase,"ZDHHC8 protein, mouse",0
1805,"Mitochondrial ADP, ATP Translocases","Aac3 protein, S cerevisiae",0
1806,Adenosine Triphosphatases,"Get3 protein, S cerevisiae",0
1807,Albumins,"albinterferon alfa-2b, human",0
1808,Albumins,haishengsu,0
1809,Alcohol dehydrogenase,"ADH protein, Drosophila",0
1810,Alcohol Oxidoreductases,"CTBP2 protein, human",0
1811,Alcohol Oxidoreductases,"perakine reductase, Rauvolfia serpentina",0
1812,Alcohol Oxidoreductases,"CBR1 protein, human",0
1813,Alcohol Oxidoreductases,"CBR3 protein, human",0
1814,Alcohol Oxidoreductases,"menthone (3S)-neomenthol reductase, Arabidopsis",0
1815,Octanols,"3,7-dimethyloct-1-en-3-ol",0
1816,Octanols,"2,6-dimethylocta-3,5-dien-2-ol",0
1817,Octanols,"3,7-dimethyloct-6-en-3-ol",0
1818,Octanols,"3,7-dimethyloct-7-en-1-ol",0
1819,Octanols,"3,7-dimethyloctane-1,7-diol",0
1820,Octanols,7-hydroxy-7-methyl-3-methylene-1-octene,0
1821,Octanols,"2,6-dimethyl-5,7-octadien-2-ol",0
1822,Octanols,rhodinol,0
1823,Octanols,"2,6-dimethyl-6-octanol",0
1824,Octanols,"3,7-dimethylocten-2-ol",0
1825,Octanols,"2,6-dimethyloctan-2-ol",0
1826,Aldehyde dehydrogenase (NAD+),"ALDH1L1 protein, human",0
1827,Aldehydes,xanthialdehyde,0
1828,Aldehydes,faranal,0
1829,Alkadienes,"(1E,6E)-4-(4-aminophenyl)-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione",0
1830,Alkaloids,"18,19-dehydrocorynoxinic acid B",0
1831,Alkaloids,"18,19-dehydrocorynoxinic acid",0
1832,Alkaloids,brevisamide,0
1833,Alkaloids,pyriferine A,0
1834,Alkaloids,pyriferine B,0
1835,Alkaloids,pyriferine C,0
1836,Alkaloids,malycorin A,0
1837,Alkaloids,malycorin B,0
1838,Alkaloids,malycorin C,0
1839,Alkaloids,hupehenine,0
1840,Alkaloids,thiacarpine,0
1841,Alkaloids,securinol B,0
1842,Alkaloids,lehmannine,0
1843,Alkanes,R-125528,0
1844,Alkanes,"5,9,13,17-tetramethyloctadecanoyl",0
1845,Alkanes,"5,9,13,17-tetramethyloctadecyl",0
1846,Alkanes,"9,9-dimethyl hexacosane",0
1847,Alkenes,complanine,0
1848,Alkenes,ethyl 3-(2-chlorophenyl)propenoate,0
1849,Alkenes,"N-Boc-(2R,3R,8R,9R,4E,6E)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecadenoic acid",0
1850,Alkenes,macranthol,0
1851,Alkenes,micromolide,0
1852,Alkenes,"2,4,6-triphenyl-1-hexene",0
1853,Alkenes,ceriporic acid D,0
1854,Alkynes,propargyl ether,0
1855,Alkynes,oilgo(2-phenyleneethynylene-alt-4-phenyleneethynylene),0
1856,Alkynes,"14-acetoxy-12-senecioyloxytetradeca-2E,8E,10E-trien-4,6-diyn-1-ol",0
1857,Alkynes,"14-acetoxy-12-methylbutyl-2E,8E,10E-trien-4,6-diyn-1-ol",0
1858,Alloys,Ti-18Nb-4Sn alloy,0
1859,Allyl Compounds,acarviosinyl-(1-9)-3-glucopyranosylpropene,0
1860,Allyl Compounds,4-methoxyhonokiol,0
1861,Alpha-glucosidase,"CWH41 protein, S cerevisiae",0
1862,Aluminum Hydroxide,ASO4 mixture,0
1863,Aluminum Hydroxide,aluminum sesquichlorohydrate,0
1864,Aluminum Silicates,polyaluminum silicate chloride,0
1865,Amides,1-ethyl-3-methyl-imidazolium dicyanoamide,0
1866,Amides,"N-(1,3-dihydroxyisopropyl)-2-hexyl-3-oxodecanamide",0
1867,Amides,N-(2-methylbenzylidene)-phenylglycine amide,0
1868,Amides,bistellettazine A,0
1869,Amides,bistellettazine B,0
1870,Amides,bistellettazine C,0
1871,Amides,bistellettazole A,0
1872,Amides,N-(3-(dimethylamino)propyl)docosanamide,0
1873,Amides,"1,2-bis(dodecylamido)cyclohexane",0
1874,Amides,3-(4-hydroxyphenyl)-N-benzylpropionamide,0
1875,Amides,ammosamide A,0
1876,Amides,ammosamide B,0
1877,Amidines,"6,7-dimethoxy-1-(3,4-dimethoxy)benzyl-2-(N-n-octyl-N'-cyano)guanyl-1,2,3,4-tetrahydroisoquinoline",0
1878,Amidines,CR 3294,0
1879,Amidohydrolases,"N-acylhomoserine lactone-acylase, Shewanella",0
1880,Amidohydrolases,"ARGAH1 protein, Arabidopsis",0
1881,Amidohydrolases,"ARGAH2 protein, Arabidopsis",0
1882,Amidohydrolases,"ILL2 protein, Arabidopsis",0
1883,Amidophosphoribosyltransferase,"PRAT protein, Drosophila",0
1884,Amines,1-(4-nitrophenyl)-1H-tetrazol-5-amine,0
1885,Amino Acids,Cellfood,0
1886,Amino Acids,4-amino-5-mercapto-N-(2-aminoethyl)pentanamide,0
1887,Amino Acids,(4-amino-5-mercaptopentanoylamino)acetic acid,0
1888,Amino Acids,LY 2140023,0
1889,"Amino Acids, Cyclic",6-aminobicyclo(2.2.1)heptane-2-carboxylic acid,0
1890,Amino Alcohols,threoninol,0
1891,Aminopeptidase,"cytosolic aminopeptidase P, human",0
1892,Aminopeptidase,"aminopeptidase P, E coli",0
1893,Aminopyridines,"1-(2-hydroxy-2-methylpropyl)-N-(5-(7-methoxyquinolin-4-yloxy)pyridin-2-yl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide",0
1894,Aminopyridines,3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-((methylamino)methyl)-2-thiophenecarboxamide,0
1895,Aminopyridines,"3-chloro-N-(4-chloro-2-(((5-chloro-2-pyridinyl)amino)carbonyl)-6-methoxyphenyl)-4-(((4,5-dihydro-2-oxazolyl)methylamino)methyl)-2-thiophenecarboxamide",0
1896,Aminopyridines,2-amino-3-hydroxypyridine,0
1897,Aminopyridines,5-fluoro-2-(1-(4-fluorophenyl)ethylamino)-6-(5-methyl-1H-pyrazol-3-ylamino)nicotinonitrile,0
1898,Aminopyridines,2-(2-pyridylamino)ethylamine,0
1899,Aminopyridines,2-chloro-N-(6-cyanopyridin-3-yl)propanamide,0
1900,Aminoquinolines,EKB 569,0
1901,Aminoquinolines,"6-chloro-N-(3-(3-(2-chloro-4-fluorophenyl)-1,2,4-oxadiazol-5-yl)propyl)quinolin-3-amine",0
1902,Aminoquinolines,"4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium",0
1903,Aminoquinolines,"5-(3-dimethylaminopropylamino)-3,10-dimethyl-10H-pyrimido(4,5-b)quinoline-2,4-dione",0
1904,Aminoquinolines,2-(2-methylquinolin-4-ylamino)-N-(2-chlorophenyl)acetamide,0
1905,Aminoquinolines,"1,2,3,4-tetrahydro-4-quinolinamine",0
1906,Quaternary Ammonium Compounds,complanine,0
1907,Quaternary Ammonium Compounds,ANNINE-6plus,0
1908,Quaternary Ammonium Compounds,trimethyl(4-aminophenyl)ammonium,0
1909,Quaternary Ammonium Compounds,"1,1,2,2-tetrakis(4-(2-triethylammonioethoxy)phenyl)ethene tetrabromide",0
1910,Quaternary Ammonium Compounds,di(2-hydroxyethyl)methyldodecylammonium,0
1911,Quaternary Ammonium Compounds,"trimethylene-1, 3-bis (dodecyldimethylammonium bromide)",0
1912,Quaternary Ammonium Compounds,"N,N-diethyl-N-methyl(2-methoxyethyl)ammonium tetrafluoroborate",0
1913,Quaternary Ammonium Compounds,"N,N,N-trimethyl-N-propylammonium bis(trifluoromethanesulfony)imide",0
1914,Quaternary Ammonium Compounds,erucyl bis(hydroxymethyl)methylammonium,0
1915,Androstadienes,"17-chloro-16-formylandrosta-5,16-dien-3beta-yl acetate",0
1916,Androstadienes,"17-chloroandrosta-5,16-dien-3beta-yl acetate",0
1917,Androstenes,drospirenone / Ethinyl Estradiol,0
1918,Anilides,"2,2,7-trimethyl-4-(3-nitrophenyl)-5-oxo-N-(4-chlorophenyl)-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide",0
1919,Anilides,3-chloro-4-(4-methylpiperazin-1-ylmethyl)-N-(4-methyl-3-(4-pyridin-3-ylpyrimidin-2-ylamino)phenyl)benzamide,0
1920,Anilides,N1-(2-aminophenyl)-N7-phenylheptanediamide,0
1921,Anilides,fasentin,0
1922,Anilides,N-(4-methoxyphenyl)-4-menthone-3-carboxamide,0
1923,Anilides,(4-(tetradecanoylamino)benzyl)phosphonic acid,0
1924,Anilides,T 3095,0
1925,Anilides,T 3157,0
1926,Anilides,"2-butanoylamine-1,4-naphthoquinone",0
1927,Anilides,"2-propanoylamine-1,4-naphthoquinone",0
1928,Anilides,2-chloro-N-(6-cyanopyridin-3-yl)propanamide,0
1929,Aniline Compounds,EKB 569,0
1930,Aniline Compounds,"(3,4-dichlorophenyl)methyl(2-oxo-2-(3-phenyl-2-(1-pyrrolidinylmethyl)-1-piperidinyl)ethyl)amine",0
1931,Aniline Compounds,"1,3-diisopropyl-4,5-dimethylimidazole-2-xylidine",0
1932,Aniline Compounds,4-aminophenyl arsenic acid,0
1933,Aniline Compounds,"4-anilino-n-methoxyfuro(2,3-b)quinoline",0
1934,Aniline Compounds,"N,N-bis(4-bromobutyl)-4-nitrobenzenamine",0
1935,Aniline Compounds,phenylaminoacetohydrazide,0
1936,Aniline Compounds,BIX 02188,0
1937,Aniline Compounds,BIX 02189,0
1938,Aniline Compounds,3-methylamino-4-nitrophenoxyethanol,0
1939,Aniline Compounds,"4,4'-diamino-3,3'-dichloro-5-nitrobiphenyl",0
1940,Aniline Compounds,4-nitro-4'-methylbenzylidene aniline,0
1941,Aniline Compounds,"N,N-dimethyl-4-nitroaniline",0
1942,Anisoles,"1,1-dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane",0
1943,Anisoles,pestalachloride A,0
1944,Ant Venoms,"pilosulin 5, Myrmecia pilosula",0
1945,Anthocyanins,pelargonidin 3-malylglucoside,0
1946,Anthracenes,"diethyl N,N'-anthra-9,10-chinone-2,3-bis(oxamate)",0
1947,Anthracenes,"1,4-dimethyl-9-silyltriptycene",0
1948,Anthracenes,"1,4-dichloro-silyltriptycene",0
1949,Anthracenes,"1,4-dibromo-silyltriptycene",0
1950,Anthracenes,10-hydroxyanthrone-C-glucoside cassialoin,0
1951,Anthracenes,9-anthraldehyde-thiosemicarbazone,0
1952,Anthraquinones,anthrasesamone F,0
1953,Anthraquinones,"6(hydroxymethyl)-1,4-anthracenedione",0
1954,Anthraquinones,disperse blue 7,0
1955,Anthraquinones,2-hydroxy-7-hydroxymethyl-3-methoxyanthraquinone,0
1956,Anthraquinones,"2,6-dihydroxy-3-methyl-4-methoxyanthraquinone",0
1957,Anthraquinones,phaeosphenone,0
1958,Anthraquinones,"1-amino-4-(2,4,6-trimethylanilino)anthraquinone-2-sulfonate",0
1959,Anthraquinones,"3,3',7,7',8,8'-hexahydroxy-5,5'-dimethylbianthraquinone",0
1960,Anthraquinones,moromycin A,0
1961,Anthraquinones,moromycin B,0
1962,Anthraquinones,2-(trifluoroacetylamino)anthraquinone,0
1963,Anthraquinones,PI-080,0
1964,Anthraquinones,caeruleoramularin,0
1965,Anthraquinones,"4,11-dimethoxynaphtho(2,3-f)indole-5,10-dione",0
1966,Anthraquinones,chrysophanol-8-O-glycopyranoside,0
1967,Anthraquinones,"1,3-dihydroxy-5,6-dimethoxy-2-methoxymethyl-9,10-anthraquinone",0
1968,Anthraquinones,"2-hydroxymethyl-1-methoxy-9,10-anthraquinone",0
1969,Anthraquinones,LLL-3 compound,0
1970,Antibodies,afala,0
1971,Antibodies,IMPAZA,0
1972,Monoclonal Antibodies,FR255734 monoclonal antibody,0
1973,Monoclonal Antibodies,CR002,0
1974,Monoclonal Antibodies,apomab,0
1975,Monoclonal Antibodies,23C3 monoclonal antibody,0
1976,Monoclonal Antibodies,KM3413,0
1977,Monoclonal Antibodies,64Cu-DOTA-cetuximab,0
1978,Monoclonal Antibodies,JTA-009,0
1979,Monoclonal Antibodies,Eat2 monoclonal antibody,0
1980,Monoclonal Antibodies,CNTO 528 monoclonal antibody,0
1981,"Antigens, Bacterial","factor H-binding protein, Neisseria meningitidis",0
1982,"Antigens, Bacterial","Rv1168c protein, Mycobacterium tuberculosis",0
1983,"Antigens, Bacterial","Hrp1 protein, Mycobacterium tuberculosis",0
1984,"Antigens, Neoplasm","MELOE-1 antigen, human",0
1985,"Antigens, Neoplasm","CAB39L protein, human",0
1986,"Antigens, Neoplasm","EBAG9 protein, mouse",0
1987,"Antigens, Neoplasm","TCC52 protein, human",0
1988,Antimony,phosphoantimonylmolybdenum blue,0
1989,Antineoplastic Combined Chemotherapy Protocols,Vincristine-Dactinomycin-Doxorubicin Wilm's Tumor Regimen,0
1990,Apolipoproteins A,"KV11 peptide, human",0
1991,Aporphines,"5-methoxy-2,3-dihydrooxoisoaporphine",0
1992,Aporphines,scortechiniine A,0
1993,Aporphines,scortechiniine B,0
1994,Aporphines,norannuradhapurine,0
1995,Arginine,arginine-grafted bioreducible poly(disulfide amine)polymer,0
1996,ARGININOSUCCINATE LYASE,"Arg4 protein, S cerevisiae",0
1997,Arsenates,4-aminophenyl arsenic acid,0
1998,Arsenicals,arsenic triiodide,0
1999,Arsenicals,p-aminophenylarsine oxide,0
2000,Arsenicals,"N-(4-(1,3,2)dithiarsolan-2-yl-phenyl)hexahydro-2-oxo-(3aS,4S,6aR)-1H-trieno(3,4-d)imidazole-4-pentamide",0
2001,Arsenicals,"3-(2,6-dibromo-4-sulfophenylazo)-6-(2-arsenophenylazo)-4,5-dihydroxynaphthalene-2,7-disulfonic acid",0
2002,Arsenicals,tetraarsenic tetrasulfide,0
2003,Autoantigens,"melanin-associated antigen, rat",0
2004,Aza Compounds,azatrimethylenemethane,0
2005,Aza Compounds,azatriphenylene,0
2006,Azepines,"4-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)-1-(4-fluuorophenyl)butan-1-one",0
2007,Azepines,"diazepino(2,3-h)quinoline",0
2008,Azepines,"3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo(3,4-f)(1,2,3,5)tetrazepin-4(3H)-one",0
2009,Azepines,CID755673,0
2010,Azides,"6-azidomethyl-1-hydroxy-3,8-dimethoxy-9,10-anthraquinone",0
2011,Azides,"2,3,4,6-tetra-O-acetyl-alpha-D-glucopyranosyl azide",0
2012,Azides,DAz-1 compound,0
2013,Azides,propidium monoazide,0
2014,Azides,N(epsilon)-(2-azidobenzyloxycarbonyl)lysine,0
2015,Aziridines,2-hydroxymethyl-1-(N-phthaloyltryptophyl)aziridine,0
2016,Aziridines,N-((aziridin-2-yl)methyl)benzimidazolequinone,0
2017,Aziridines,"tris(2,2-dimethyl-1-aziridinyl)phosphine oxide",0
2018,Aziridines,"2,5-dichlorodiaziridinyl-1,4-benzoquinone",0
2019,Azo Compounds,"Poly(4-amino-1-1'-azobenzene-3, 4'-disulfonic acid)",0
2020,Azo Compounds,"3-O-(2-diazo-2-phenylacetyl)-1,2-5,6-di-O-isopropylideneallofuranose",0
2021,Azo Compounds,4-(4-carboxylbenzeneazo)calix(4)arene,0
2022,Azo Compounds,diphenyldiazomethane,0
2023,Azo Compounds,5-(4-ethoxyphenylazo)tropolone,0
2024,Azo Compounds,"4-(bis(9,9-dimethylfluoren-2-yl)amino)azobenzene",0
2025,Azo Compounds,"3-(2,6-dibromo-4-sulfophenylazo)-6-(2-arsenophenylazo)-4,5-dihydroxynaphthalene-2,7-disulfonic acid",0
2026,Azo Compounds,2-diazo-1-naphthol-5-sulfonic acid,0
2027,Azo Compounds,"3,3'-diazene-1,2-diylbis(6-(2-sulfonato-4-(chloroacetylamino)phenylethynyl))benzenesulfonic acid",0
2028,Azo Compounds,"4,4'-azobisbiphenyl",0
2029,Bacterial Outer Membrane Proteins,"omc A protein, Shewanella putrefaciens",0
2030,Bacterial Outer Membrane Proteins,"ErpP protein, Borrelia burgdorferi",0
2031,Bacterial Outer Membrane Proteins,"ErpA protein, Borrelia burgdorferi",0
2032,Bacterial Outer Membrane Proteins,"ErpC protein, Borrelia burgdorferi",0
2033,Bacterial Proteins,"ScpB protein, M tuberculosis",0
2034,Bacterial Proteins,"ScpA protein, M tuberculosis",0
2035,Bacterial Proteins,"NMB1468 protein, Neisseria meningitidis",0
2036,Bacterial Proteins,"DivIB protein, Streptococcus pneumoniae",0
2037,Bacterial Proteins,"SfnR protein, Pseudomonas putida",0
2038,Bacterial Proteins,"PdpD protein, Francisella tularensis",0
2039,Bacterial Proteins,"AgrC protein, Staphylococcus",0
2040,Bacterial Proteins,"Hpa2 protein, Xanthomonas oryzae",0
2041,Bacterial Proteins,"carbapenemase-2, Klebsiella pneumoniae",0
2042,Bacterial Proteins,"RamA protein, Salmonella typhimurium",0
2043,Bacterial Proteins,"CalD protein, Streptomyces coelicolor",0
2044,Bacterial Proteins,"GlmU protein, Mycobacterium tuberculosis",0
2045,Bacterial Proteins,"CotA protein, Bacillus licheniformis",0
2046,Bacterial Proteins,"Pup protein, Mycobacterium tuberculosis",0
2047,Bacterial Proteins,"Rv1009 protein, Mycobacterium tuberculosis",0
2048,Bacterial Proteins,"ClpC1 protein, Mycobacterium tuberculosis",0
2049,Bacterial Proteins,"NapA protein, Borrelia burgdorferi",0
2050,Bacterial Proteins,"SidC protein, Legionella pneumophila",0
2051,Bacterial Proteins,"HrpA protein, Neisseria meningitidis",0
2052,Bacterial Proteins,"AcrE protein, Salmonella enterica",0
2053,Bacterial Proteins,"Cj1211 protein, Campylobacter jejuni",0
2054,Bacterial Toxins,"Pet protein, E coli",0
2055,Bacterial Toxins,"NetB protein, Clostridium perfringens",0
2056,bacteriocin,"paenibacillin protein, Paenibacillus polymyxa",0
2057,bacteriocin,"carnocyclin A, Carnobacterium maltaromaticum",0
2058,bacteriocin,"nukacin KQU-131, Staphylococcus hominis",0
2059,bacteriocin,"durancin TW-49M, Enterococcus durans",0
2060,BCG Vaccine,rBCG85C vaccine,0
2061,Benzaldehydes,o-trimethylsilylbenzaldehyde,0
2062,Benzaldehydes,abutilon A,0
2063,Benzaldehydes,2-formylphenylboronic acid,0
2064,Benzaldehydes,"3,4,5-trihydroxybenzaldehyde",0
2065,Benzaldehydes,"2,4-dihydroxy-3,6-dimethylbenzaldehyde",0
2066,Benzamides,JBIR 06,0
2067,Benzamides,N-(4-bromo-phenyl)-4-nitrothiobenzamide,0
2068,Benzamides,N-(4-nitrophenyl)-4-nitrothiobenzamide,0
2069,Benzamides,N-(4-trifluoromethyl-phenyl)-4-nitrothiobenzamide,0
2070,Benzamides,RM 4819,0
2071,Benzamides,"N-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide",0
2072,Benzamides,"2-(N-(2,3-dimethylphenyl)carbamoyl)benzenesulfonamide",0
2073,Benzamides,"2-(N-(3,4-dimethylphenyl)carbamoyl)benzenesulfonamide",0
2074,Benzamides,"2-(N-(2,6-dimethylphenyl)carbamoyl)benzenesulfonamide",0
2075,Benzamides,"5-chloro-2-nitro-N-(4-(6-oxo-1,4,5,6-teetrahydroopyridazin-3-yl)phenyl)benzamide",0
2076,Benzamides,"2,5 difluoro-N-(4-pyridyl)benzamide",0
2077,Benzamides,"2,3 difluoro-N-(4-pyridyl)benzamide",0
2078,Benzamides,"2,4 difluoro-N-(4-pyridyl)benzamide",0
2079,Benzamides,"2-methyl-3-(2,6-dimethyl-4-carbamoylphenyl)propanoic acid",0
2080,Benzamides,N-(3-aminopropyl)-2-(((3-methylphenyl) methyl)oxy)-N-(2-thienylmethyl)benzamide hydrochloride salt,0
2081,Benzamides,"N,N-diethyl-4-(5-hydroxyspiro(chromene-2,4'-piperidine)-4-yl)benzamide",0
2082,Benzamides,N-(1'-methoxycarbonyl-2'-phenylethyl)-4-hydroxybenzamide,0
2083,Benzamides,"4-benzyloxy-3,5-dimethoxy-N-(1-(dimethylaminocyclopently)methyl)benzamide",0
2084,Benzamides,"N-(1,3,5-trimethylpyrazole-4-yl)-4-bromobenzamide",0
2085,Benzamides,"N-(1,3,5-trimethylpyrazole-4-yl)-4-fluorobenzamide",0
2086,Benzamides,"N-(1,3,5-trimethylpyrazole-4-yl)-4-chlorobenzamide",0
2087,Benzamides,"3,4,5-tris(dodecyloxy)benzamide",0
2088,Benzamides,N-(adamantan-1-ylmethyl)-5-((3-aminopyrrolidin-1-yl)methyl)-2-chlorobenzamide,0
2089,Benzamides,4-dimethylamino-N-(5-(2-mercaptoacetylamino)pentyl)benzamide,0
2090,Benzamides,"N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide",0
2091,Benzamides,"5-chloro-N-(5-hydroxy-5,6,7,8-tetrahydronaphthalen-2-yl)-1H-indole-2-carboxamide",0
2092,Benzamides,"amino-pyrazole 2,6-dichloro-N-ethyl benzamide",0
2093,Benzamides,"methyl 6-(benzyloxycarbonylamino)-2-(2-(2,6-dioxo-3-(3,4,5-trimethoxybenzamido)piperidin-1-yl)acetamido)hexanoate",0
2094,Benzamides,N-(1-ethyl-2-pyrrolidinyl)methyl-2-hydroxy-6-methoxybenzamide,0
2095,Benzamides,4-hydroxy-N-(4-((E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enamido)butyl)benzamide,0
2096,Benz(a)Anthracenes,N-acetoxy-3-aminobenzanthrone,0
2097,Benzazepines,"5-ethyl-5,8-dihydroindolo(2,3-d)(2)benzazepin-7(6H)-one",0
2098,Benzazepines,"(2SR,4RS)-7-chloro-2-exo-((E)-styryl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2099,Benzazepines,"(2R,4R)-7-fluoro-2-endo-((E)-styryl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2100,Benzazepines,"(2SR,4RS)-7-chloro-2-exo-(4-chlorophenyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2101,Benzazepines,"(2S,4R)-7-chloro-2-exo-(1-naphthyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2102,Benzazepines,"(2SR,4RS)-7-fluoro-2-exo-(2-furyl)-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2103,Benzazepines,"(2SR,4RS)-2-exo-(5-bromo-2-thienyl)-7-fluoro-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2104,Benzazepines,"(2S,4R)-2-exo-(5-bromo-2-thienyl)-7-trifluoromethoxy-2,3,4,5-tetrahydro-1H-1,4-epoxy-1-benzazepine",0
2105,Benzazepines,"2,4-diamino-6-(2'-hydroxydibenz(b,f)azepin-5-yl)methylpteridine",0
2106,Benzazepines,"2,4-methanoadamantane-benzazepine",0
2107,Benzazepines,SCH 23390,0
2108,Benzene Derivatives,"1,2-bis(N,N,N',N'-tetramethylguanidino)benzene",0
2109,Benzene Derivatives,oilgo(2-phenyleneethynylene-alt-4-phenyleneethynylene),0
2110,Benzene Derivatives,"tetrakis(methylthio)-1,4-benzenedicarboxylic acid",0
2111,Benzene Derivatives,tert-butyl phenyl carbonate,0
2112,Benzene Derivatives,"1,3-di(1,2,3-triazol-4-yl)benzene",0
2113,Benzenesulfonates,"sodium-4,5-dihydroxy-1,3-benzene disulfonate",0
2114,Benzenesulfonates,duolite C20,0
2115,Benzenesulfonates,"3,3'-diazene-1,2-diylbis(6-(2-sulfonato-4-(chloroacetylamino)phenylethynyl))benzenesulfonic acid",0
2116,Benzimidazoles,DB(5) compound,0
2117,Benzimidazoles,JNJ 37654032,0
2118,Benzimidazoles,"3,5-bis(benzimidazol-2-yl)pyrazole",0
2119,Benzimidazoles,4-(2-(4-chloro-1H-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1H-benzo(d)imidazol-2-yl)pyridin-2(1H)-one,0
2120,Benzimidazoles,"1-(1'-(2-methylbenzyl)-1,4'-bipiperidin-4-yl)-1H-benzo(d)imidazol-2-(3H)-one",0
2121,Benzimidazoles,"1,3-dihydro-1-(1-((4-(6-phenyl-1H-imidazo(4,5-g)quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one",0
2122,Benzimidazoles,"1-carboxymethyl-2-dimethylamino-4,5,6,7-tetrabromobenzimidazole",0
2123,Benzimidazoles,"2-((carboxymethyl)(6-cyano-7-imino-2-methoxy-7H-chromeno(3',2'-3,4)pyrido(1,2-a)(1,3)benzimidazol-3-yl)amino)acetic acid",0
2124,Benzimidazoles,"N-((5-(3-(4,6-difluoro-1H-benzimidazol-2-yl)-1H-indazol-5-yl)-4-methylpyridin-3-yl)methyl)ethanamine",0
2125,Benzimidazoles,3'-(5-(1-hydroxy-1-methylethyl)benzoimidazol-1-yl)biphenyl-2-carbonitrile,0
2126,Benzimidazoles,N-((aziridin-2-yl)methyl)benzimidazolequinone,0
2127,Benzimidazoles,HKI 46F08,0
2128,Benzimidazoles,(N-benzimidazolepropanoic acid)-glycyl-alanyl-alanine,0
2129,Benzimidazoles,2-(methoxycarbonyl(4-methoxyphenyl)methylsulfanyl)-1H-benzimidazole-4-carboxylic acid amide,0
2130,Benzimidazoles,"4,5-dichloro-1,3-diethyl-1,3-dihydrobenzoimidazol-2-one",0
2131,Benzimidazoles,2-(1-propylpiperidin-4-yl)-1H-benzimidazole-4-carboxamide,0
2132,Benzoates,butyl 4-(butyryloxy)benzoate,0
2133,Benzoates,"(2S,3S)-2-methyl-3-((1S)-1-phenylethoxy)cyclopent-5-en-1-yl benzoate",0
2134,Benzodiazepines,GWL 78,0
2135,Benzodiazepines,"2-(5-cyclohexyl-1-(2-cyclopentyl-2-oxoethyl)-2-oxo-1,2-dihydro-3H-1,3,4-benzotriazepin-3-yl)-N-(3-(5-oxo-2,5-dihydro-(1,2,4)oxadiazol-3-yl)phenyl)acetamide",0
2136,Benzodiazepines,"ethyl 8-fluoro-6-(3-nitrophenyl)-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate",0
2137,Benzodiazepines,PWZ-029,0
2138,Benzodiazepines,"quino(7,8-b)benzodiazepine",0
2139,Benzodiazepinones,circumdatin A,0
2140,Benzodiazepinones,circumdatin B,0
2141,Benzodiazepinones,PF 00477736,0
2142,Benzofurans,lespedezavirgatol,0
2143,Benzofurans,lespedezavirgatal,0
2144,Benzofurans,"3-(hydroxymethyl)-6-methyl-6,7-dihydrobenzofuran-4(5H)-one",0
2145,Benzofurans,tashinone IIA,0
2146,Benzofurans,"6,7-dihydroxy-3-(-prop-1-enyl)isobenzofuran-1(3H)-one",0
2147,Benzofurans,"4,5,6,7-tetrachlorophthalide",0
2148,Benzofurans,xyloallenolide B,0
2149,Benzofurans,xyloketal J,0
2150,Benzofurans,xyloester A,0
2151,Benzofurans,dioxabenzosapphyrin,0
2152,Benzofurans,"(R,S)-5,7-di-tert-butyl-3-hydroxy-3-trifluoromethyl-3H-benzofuran-2-one",0
2153,Benzofurans,pestalachloride C,0
2154,Benzofurans,sorocenol G,0
2155,Benzofurans,sorocenol H,0
2156,Benzofurans,pongamol,0
2157,Benzofurans,artopetelin M,0
2158,Benzofurans,artopetelin L,0
2159,Benzofurans,miyabenol A,0
2160,Benzofurans,"1-((3-benzyl-3-methyl-2,3-dihydro-1-benzofuran-6-yl)carbonyl)piperidine",0
2161,Benzofurans,CID755673,0
2162,Benzofurans,cleroindicin F,0
2163,Benzofurans,cleroindicin C,0
2164,Benzophenones,3-(4-chlorobenzoyl)quinoline-2-carboxaldehyde,0
2165,Benzopyrans,"7,9-difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno(3,4-f)quinoline",0
2166,Benzopyrans,5-methyl-8-(4-methyl-piperazin-1-yl)-4-oxo-4H-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)amide,0
2167,Benzopyrans,xanthohumol C,0
2168,Benzopyrans,"N,N-diethyl-4-(5-hydroxyspiro(chromene-2,4'-piperidine)-4-yl)benzamide",0
2169,Benzopyrans,3-(6-methoxy-1-methyl-1-trifluoromethylisochroman-7-yl)methylamino-2-phenylpiperidine,0
2170,Benzopyrans,palomid 529,0
2171,Benzopyrans,"2-((carboxymethyl)(6-cyano-7-imino-2-methoxy-7H-chromeno(3',2'-3,4)pyrido(1,2-a)(1,3)benzimidazol-3-yl)amino)acetic acid",0
2172,Benzopyrans,isolespeol,0
2173,Benzopyrans,dicyanomethylene-4H-chromene,0
2174,Benzopyrans,"3,3'-bis(3,4-dihydro-4-hydroxy-6,8-dimethoxy-2H-1-benzopyran)",0
2175,Benzopyrans,"8'-methoxy-3,3'-bis(3,4-dihydro-4-hydroxy-6-methoxy-2H-1-benzopyran)",0
2176,Benzoxazoles,5-nitro-2-(4-fluorophenyl)benzoxazole,0
2177,Benzoxepins,dihydrobenzodioxepine cymserine,0
2178,Benzoxepins,pestalachloride B,0
2179,Benzyl Alcohols,1'-acetoxychavicol acetate,0
2180,Benzyl Compounds,diethyl 4-nitrobenzylphosphonate,0
2181,Benzyl Compounds,N-(2-methylbenzylidene)-phenylglycine amide,0
2182,Benzyl Compounds,"N, N'-dimethyl- N, N'-bis(3,5-di- t-butyl-2-hydroxybenzyl)-1,2-diaminoethane",0
2183,Benzyl Compounds,"tris(2-((3,4-dihydroxybenzylidene)imino)ethyl)amine",0
2184,Benzyl Compounds,N-benzyloxy-1H-benzotriazole-1-carboxamide,0
2185,Benzyl Compounds,p-hydroxybenzylidenedimethylimidazolinone,0
2186,Benzyl Compounds,p-methyletherbenzylidenedimethylimidazolinone,0
2187,Benzyl Compounds,3-(4-hydroxyphenyl)-N-benzylpropionamide,0
2188,Benzylamines,alpha-amino phenylalanine tetrazole,0
2189,Benzylamines,1-(isopropylamino)-3-(5-((isopropylamino)methyl)-2-methoxyphenoxy)propan-2-ol,0
2190,Berberine Alkaloids,cerasonine,0
2191,beta-Lactamase,"LACTB protein, human",0
2192,beta-Lactamase,"carbapenemase-2, Klebsiella pneumoniae",0
2193,beta-Lactamase,"metallo-beta-lactamase (VIM-13), Pseudomonas aeruginosa",0
2194,beta-Lactamase,"beta-lactamase IND, Chryseobacterium indologenes",0
2195,beta-Lactamase,"beta-lactmase VIM-6, Pseudomonas aeruginosa",0
2196,beta-Lactamase,"beta-lactamase OXA-58, Acinetobacter baumannii",0
2197,Bibenzyls,"(Z)-2-(4'-methoxy-3'-aminophenyl)-1-(3,4,5-trifluorophenyl)ethene",0
2198,Bibenzyls,bibenzyl xyloside,0
2199,Bibenzyls,trigonopol A,0
2200,Bibenzyls,trigonopol B,0
2201,Bibenzyls,14-hydroxylunularin,0
2202,Bibenzyls,lunularin-4-O-beta-D-glucoside,0
2203,Bridged Bicyclo Compounds,daucene,0
2204,Bridged Bicyclo Compounds,"9,9-dimethyl hexacosane",0
2205,Bridged Bicyclo Compounds,trimethylbicyclo(5.4.0)undecane,0
2206,Biological Products,MCS-18,0
2207,Biotin,biotinylated linoleoylglycerylphosphatidylcholine,0
2208,Biphenyl Compounds,"(R,S)-4-((4'-methoxy-4-(methyl)-3-((4-methoxyphenyl)ethynyl)biphenyl-2-yl)(4-methoxyphenyl)methylene)-2,5-cyclohexadien-1-one,",0
2209,Biphenyl Compounds,"(R,S)-4-((4'-hydroxy-3-((4-hydroxyphenyl)ethynyl)biphenyl-2-yl)(4-hydroxyphenyl)methylene)-2,5-cyclohexadien-1-one",0
2210,Biphenyl Compounds,4-methoxyhonokiol,0
2211,Biphenyl Compounds,S 35225,0
2212,Biphenyl Compounds,ferristatin,0
2213,Biphenyl Compounds,liposomal honokiol,0
2214,Biphenyl Compounds,"4,4'-bis(N-1-napthyl-N-phenyl-amino)biphenyl",0
2215,Biphenyl Compounds,"4,4'-diamino-3,3'-dichloro-5-nitrobiphenyl",0
2216,Biphenyl Compounds,(1-(2-(4'-piperidinomethyl-biphenyl-4-yl)ethyl)piperidine),0
2217,Biphenyl Compounds,"4,4'-azobisbiphenyl",0
2218,Bismuth,bismuth trichloride,0
2219,Boranes,selectride,0
2220,Borates,"3A-methyl-5,6-dihydrofuro(2,3-d)(1,3,2)dioxaborole-2,2,6,6A-tetraol",0
2221,Borates,"N,N-diethyl-N-methyl(2-methoxyethyl)ammonium tetrafluoroborate",0
2222,Camphanes,pribelance,0
2223,Camphanes,"4-methyl-2,6-diisobornylphenol",0
2224,Borohydrides,calcium borohydride,0
2225,Boron Compounds,"4,4-difluoro-5-(2-thienyl)-4-bora-3a,4a-diaza-s-indacene-3-dodecanoic acid",0
2226,Boron Compounds,"4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-dodecanoic acid",0
2227,Boron Compounds,zirconium diboride,0
2228,Boron Compounds,azido-BODIPY acid,0
2229,Boron Compounds,tetrakis(4-carboranylthiotetrafluorophenyl)chlorin,0
2230,Boron Compounds,"2,3,5,6-tetrafluorophenyl 3-(nido-carboranyl)propionate",0
2231,Boronic Acids,(1-(((1-(1-oxo-2-N-((phenylmethoxy)carbonyl)-3-phenylpropyl)pyrrolidin-2-yl)carbonyl)amino)-4-methoxybutyl)-1-boronic acid,0
2232,Boronic Acids,2-formylphenylboronic acid,0
2233,Boronic Acids,thiophene-3-boronic acid,0
2234,Bridged-Ring Compounds,isishippuric acid A,0
2235,Bridged-Ring Compounds,longithorone C,0
2236,Bridged-Ring Compounds,MBC94,0
2237,Bridged-Ring Compounds,deoxypukalide,0
2238,Bridged-Ring Compounds,NVP 231,0
2239,Bridged-Ring Compounds,NVP 995,0
2240,Bridged-Ring Compounds,helminthosporic acid,0
2241,Butadienes,"4,4'-butylidenebis(6-t-butyl-m-cresol)",0
2242,Butadienes,"1,3-butadiene diepoxide",0
2243,Butylene Glycols,threoninol,0
2244,Butanones,2-methyl-1-phenyl-4-pyridin-2-yl-2-(2-pyridin-2-ylethyl)butan-1-one,0
2245,Butyrates,communiol A,0
2246,Butyrates,wuxistatin,0
2247,Butyrates,2-O-butyryl-2-phenylacetic acid,0
2248,Butyrophenones,"4-(4-(4-chlorophenyl)-1,4-diazepan-1-yl)-1-(4-fluuorophenyl)butan-1-one",0
2249,Caffeic Acids,methyl ferulate,0
2250,Caffeic Acids,trans-feruloylgluconic acid,0
2251,Caffeic Acids,trans-caffeoylgluconic acid,0
2252,Caffeic Acids,N-caffeoylserotonin,0
2253,calcium hydroxide,UltraCal XS,0
2254,calcium hydroxide,magnesium alba,0
2255,Calcium-Binding Proteins,"EFHD2 protein, mouse",0
2256,Calcium-Binding Proteins,"CalD protein, Streptomyces coelicolor",0
2257,Calcium-Binding Proteins,"Cib2 protein, mouse",0
2258,Calcium-Binding Proteins,"Calu protein, rat",0
2259,Calcium-Binding Proteins,"Iba2 protein, human",0
2260,Calcium-Binding Proteins,"CAS protein, Arabidopsis",0
2261,Calcium-Binding Proteins,"necab1 protein, zebrafish",0
2262,Calcium-Binding Proteins,"E-Syt2 protein, mouse",0
2263,Caprylates,6-O-octanoylglucose,0
2264,Caprylates,FF8181-A,0
2265,Carbamates,naphthalen-2-ylmethylcarbamic acid biphenyl-3-yl ester,0
2266,Carbamates,naphthalen-2-ylmethylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester,0
2267,Carbamates,TATTU carbamate fungicide,0
2268,Carbamates,CAY 10499,0
2269,Carbazoles,"5,6-dimethyl-9-hydroxy-1-(4'-amino-2'-methoxy)phenyl-6H-pyrido(4,3-b)carbazole",0
2270,Carbazoles,clausine L,0
2271,Carbazoles,pityriazole,0
2272,Carbazoles,"2-methoxy-12-(2-hydroxyethyl)-13,14-dihydronaphthol(2,1-a)pyrrolo(3,4-c)carbazole-5-one",0
2273,Carbazoles,"2-isopropoxy-12-(2-hydroxyethyl)-13,14-dihydronaphthol(2,1-a)pyrrolo(3,4-c)carbazole-5-one",0
2274,Carbazoles,"N-(2,6-dimethoxypyridine-3-yl)-9-methylcarbazole-3-sulfonamide",0
2275,Carbazoles,incentrom A,0
2276,Carbazoles,CAY 10471,0
2277,Carbazoles,1-hydroxy-3-methyl-9H-carbazole,0
2278,Carbazoles,1-(3-methylbut-2-enyloxy)-3-methyl-9H-carbazole,0
2279,Carbazoles,"1-(2,3,4,6-tetra-O-acetyl-alpha-D-O-glucopyranosyl)-3-methyl-9H-carbazole",0
2280,Carbazoles,"9-ethyl-1,4-dimethyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole",0
2281,Carbazoles,"6-bromo-9-ethyl-1,4-dimethyl-9H-carbazole",0
2282,Carbohydrate Epimerases,"D-allulose 6-phosphate 3-epimerase, E coli",0
2283,Carbolines,8-methoxymanzamine A,0
2284,Carbolines,"8,12-diacetoxymanzamine A",0
2285,Carbonates,hydrocerussite,0
2286,Carbonates,lodenafil carbonate,0
2287,Carbonates,tert-butyl phenyl carbonate,0
2288,Carboxylic Acids,1-pyrenecarboxylic acid,0
2289,Carboxylic Acids,"pyrrole-2,3,4,5-tetracarboxylic acid",0
2290,Carboxylic Acids,4-acetyl-5-methyl-1-phenyl-1H-pyrazole-3-carboxylic acid,0
2291,Carboxylic Acids,1-aminocyclopent-3-ene-1-carboxylic acid,0
2292,Carboxylic Acids,"tetrakis(methylthio)-1,4-benzenedicarboxylic acid",0
2293,Carboxylic Acids,"1,3-dioxoindane-2-carboxylic acid",0
2294,Carboxylic Acids,"6-benzoyl-3-oxo-2,3-dihydropyridazine-4-carboxylic acid",0
2295,Carboxylic Acids,"6-(furan-2-carbonyl)-3-oxo-2,3-dihydropyridazine-4-carboxylic acid",0
2296,Carboxylic Acids,"3-oxo-6-(thiophene-2-carbonyl)- 2,3-dihydropyridazine-4-carboxylic acid",0
2297,Carboxylic Acids,endiandric acid,0
2298,Carboxylic Acids,erythrophloin C,0
2299,Carboxylic Ester Hydrolases,"NTE-related esterase, mouse",0
2300,Carboxylic Ester Hydrolases,"LipA protein, Aspergillus nidulans",0
2301,Carotenoids,diapolycopenedioic acid xylosyl ester A,0
2302,Carotenoids,diapolycopenedioic acid xylosyl ester B,0
2303,Carotenoids,diapolycopenedioic acid xylosyl ester C,0
2304,Carotenoids,cucurbitaxanthin A,0
2305,Carotenoids,cycloviolaxanthin,0
2306,Carotenoids,"capsanthin 3,6-epoxide",0
2307,Carotenoids,synechoxanthin,0
2308,Carotenoids,"3,3'-dihydroxyisorenieratene",0
2309,Carrier Proteins,"ODAM protein, human",0
2310,Carrier Proteins,"TRIP12 protein, human",0
2311,Carrier Proteins,"gec1 protein, rat",0
2312,Carrier Proteins,"IFT80 protein, human",0
2313,Carrier Proteins,"RH5 protein, Plasmodium falciparum",0
2314,Carrier Proteins,"RPAP3 protein, human",0
2315,Carrier Proteins,"CKIP-1 protein, mouse",0
2316,Carrier Proteins,"ugene protein, human",0
2317,Carrier Proteins,"HOPS protein, mouse",0
2318,Carrier Proteins,"Brpf1 protein, zebrafish",0
2319,Carrier Proteins,"UBXD7 protein, human",0
2320,Carrier Proteins,RXP-E peptide,0
2321,Carrier Proteins,"LptA protein, E coli",0
2322,Carrier Proteins,"UNI protein, Arabidopsis",0
2323,Carrier Proteins,"Frmpd1 protein, human",0
2324,Carrier Proteins,"Frmpd1 protein, rat",0
2325,Carrier Proteins,"TRIM10 protein, mouse",0
2326,Carrier Proteins,"CPNE5 protein, mouse",0
2327,Carrier Proteins,"RLM3 protein, Arabidopsis",0
2328,Carrier Proteins,"ACBP6 protein, Arabidopsis",0
2329,Carrier Proteins,"DYC-1 protein, C elegans",0
2330,Carrier Proteins,"Atg16l1 protein, mouse",0
2331,Carrier Proteins,"ZC3H10 protein, human",0
2332,Carrier Proteins,"HSV2 protein, S cerevisiae",0
2333,Carrier Proteins,"Mycbp2 protein, mouse",0
2334,Carrier Proteins,"INCA1 protein, rat",0
2335,Carrier Proteins,"RSB-66 protein, rat",0
2336,Carrier Proteins,"ZOO-1 protein, C elegans",0
2337,Carrier Proteins,"NSE1 protein, human",0
2338,Carrier Proteins,"SOMNUS protein, Arabidopsis",0
2339,Carrier Proteins,"PP4R4 protein, human",0
2340,Carrier Proteins,"Ubxd1 protein, human",0
2341,Carrier Proteins,"Sugt1 protein, rat",0
2342,Carrier Proteins,"CP12-1 protein, Arabidopsis",0
2343,Carrier Proteins,"CP12-2 protein, Arabidopsis",0
2344,Carrier Proteins,"CP12-3 protein, Arabidopsis",0
2345,Carrier Proteins,"SimNIPhom protein, human",0
2346,Carrier Proteins,"SCYL1BP1 protein, human",0
2347,Carrier Proteins,"SMG7 protein, Arabidopsis",0
2348,Carrier Proteins,"PLEKHA7 protein, human",0
2349,Carrier Proteins,"LDB19 protein, S cerevisiae",0
2350,Carrier Proteins,"hypoxia-associated factor, human",0
2351,Carrier Proteins,"ADBP-1 protein, C elegans",0
2352,Carrier Proteins,"IGFN1 protein, human",0
2353,Carrier Proteins,"kindlin-1 protein, mouse",0
2354,Carrier Proteins,"Mrtl protein, human",0
2355,Carrier Proteins,"KRAB-O protein, mouse",0
2356,Carrier Proteins,"bbip1 protein, zebrafish",0
2357,Carrier Proteins,"CEP135 protein, human",0
2358,Carrier Proteins,"Bud13 protein, S cerevisiae",0
2359,Carrier Proteins,"Pml1 protein, S cerevisiae",0
2360,Carrier Proteins,"Nbp35 protein, Arabidopsis",0
2361,Carrier Proteins,"Trim36 protein, Xenopus",0
2362,Carrier Proteins,"GIT-1 protein, C elegans",0
2363,Carrier Proteins,"PIX-1 protein, C elegans",0
2364,Carrier Proteins,"Cip4 protein, Drosophila",0
2365,Carrier Proteins,"RMI1 protein, Arabidopsis",0
2366,Carrier Proteins,"YmdB protein, E coli",0
2367,Carrier Proteins,"XPC protein, rat",0
2368,Carrier Proteins,"overdrive protein, Drosophila",0
2369,Carrier Proteins,"FP6 protein, Arabidopsis",0
2370,Catechols,8-gingerol,0
2371,Cathepsins B,"CTSB protein, human",0
2372,Cathepsins B,"Ctsb protein, mouse",0
2373,Cathepsins B,"Ctsb protein, rat",0
2374,CATHEPSIN D,"CTSD protein, human",0
2375,CATHEPSIN D,"Ctsd protein, mouse",0
2376,CATHEPSIN D,"Ctsd protein, rat",0
2377,Ceramics,SiO2-CaO-P2O5-Ag2O,0
2378,Ceramides,K112PC-5 compound,0
2379,Ceramides,iotrochotamide I,0
2380,Ceramides,iotrochotamide II,0
2381,Cerebrosides,spathoside,0
2382,Cerium,cerium(IV) ammonium nitrate,0
2383,Chitin Synthase,"CHS3 protein, S cerevisiae",0
2384,Chlorhexidine,metrogil denta,0
2385,Chlorides,aluminum sesquichlorohydrate,0
2386,Chlorides,bismuth trichloride,0
2387,Chlorobenzoates,"3-carboxyanilinium 2-carboxy-4,5-dichlorobenzoate",0
2388,Chlorobenzoates,"2-carboxyanilinium 2-carboxy-4,5-dichlorobenzoate dihydrate",0
2389,Chlorobenzoates,"4-carboxyanilinium 2-carboxy-4,5-dichlorobenzoate",0
2390,Chlorophenols,"3,4,5-trichlorophenol",0
2391,Chlorzoxazone,HIFENAC MR,0
2392,Cholestanols,"3,4,7,26-tetrahydroxycholestane-3,26-disulfate",0
2393,Cholestenes,cholest-5-en-3-oxazolo,0
2394,Cholestenes,delta7-dafachronic acid,0
2395,Cholestenes,delta4-dafachronic acid,0
2396,Cholestenes,dafachronic acid,0
2397,Cholestenes,23-ethyl-cholest-23-en-3beta-ol,0
2398,Cholestenones,"3-hydroxy-24-methylcholesta-8(14),22-dien-15-one",0
2399,Cholestenones,3beta-(hydroxymethyl)-A-nor-5-cholest-14-en-16-one,0
2400,Cholesterol 7-alpha-Monooxygenase,"CYP7A1 protein, rat",0
2401,Cholic Acids,"N-fluoresceinyl-3,7,12-trihydroxycholan-24-amide",0
2402,Chromans,ubichromanol-9,0
2403,Chromones,3'-O-acetylhamaudol,0
2404,Chromones,3-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one,0
2405,Chromones,dalbergioidin,0
2406,Chromones,chrobisiamone A,0
2407,Chromones,5-acetonyl-7-hydroxy-2-methylchromone,0
2408,Chromones,pinetoric acid I,0
2409,Chromones,pinetoric acid II,0
2410,Chromones,"3,5,7-trihydroxychromone-3-O-arabinopyranoside",0
2411,Chromones,cimifugin,0
2412,Chromones,"5,7-dihydroxy-6-geranylchromone",0
2413,"Chromosomal Proteins, Non-Histone","TIPT protein, mouse",0
2414,"Chromosomal Proteins, Non-Histone","HILS1 protein, human",0
2415,"Chromosomal Proteins, Non-Histone","DSN1 protein, human",0
2416,"Chromosomal Proteins, Non-Histone","MatP protein, E coli",0
2417,"Chromosomal Proteins, Non-Histone","LAB-1 protein, C elegans",0
2418,"Chromosomal Proteins, Non-Histone","ZHP-3 protein, C elegans",0
2419,"Chromosomal Proteins, Non-Histone","Chp2 protein, S cerevisiae",0
2420,"Chromosomal Proteins, Non-Histone","CENPW protein, human",0
2421,"Chromosomal Proteins, Non-Histone","CENPT protein, human",0
2422,"Chromosomal Proteins, Non-Histone","WDR82 protein, human",0
2423,"Chromosomal Proteins, Non-Histone","STN1 protein, Arabidopsis",0
2424,Chrysenes,ANNINE-6plus,0
2425,Chrysenes,tridioxyethylenetriphenylene,0
2426,Chrysenes,"18,18'-dihexyl(9,9')biphenanthro(9,10-b)triphenylene",0
2427,Chrysenes,azatriphenylene,0
2428,Cinnamates,CE 156811,0
2429,Cinnamates,ethyl 4-methoxycinnamate,0
2430,Cinnamates,"sodium N,N'-di(4-n-butyloxy cinnamoly)-L-cystine",0
2431,Cinnamates,anhydromarmeline,0
2432,Cinnamates,aegelinoside A,0
2433,Cinnamates,aegelinoside B,0
2434,Cinnamates,4-chloro-alpha-cyanocinnamic acid,0
2435,Cinnamates,tribulusimide C,0
2436,Citrates,viadent dentifrice,0
2437,Cobamides,beta-cyano-neocobyrate,0
2438,colicin,"colicin Y protein, E coli",0
2439,Collagen,matriderm,0
2440,Collagen,"ColQ protein, rat",0
2441,Collagen,"Colq protein, mouse",0
2442,Composite Resins,tetric ceram bleach,0
2443,Composite Resins,filtek Z350,0
2444,Composite Resins,gradio,0
2445,Contractile Proteins,"MAGP-36 protein, rat",0
2446,Coumaric Acids,amurenlactone A,0
2447,Coumaric Acids,amurenamide A,0
2448,Coumaric Acids,"3beta-O-(E)-3,5-dihydroxycinnamoyl-11-oxo-olean-12-ene",0
2449,Coumaric Acids,keayanidine B,0
2450,Coumaric Acids,kearanine,0
2451,Coumaric Acids,1'-methyl-2'-hydroxyethyl ferulate,0
2452,Coumaric Acids,hidropiperoside B,0
2453,Coumarins,gilvocarcin V,0
2454,Coumarins,gilvocarcin M,0
2455,Coumarins,gilvocarcin E,0
2456,Coumarins,lespedezacoumestan,0
2457,Coumarins,fraxisecoside,0
2458,Coumarins,adenosine triphosphate (7-(diethylamino)coumarin-4-yl)methyl ester,0
2459,Coumarins,"3-carboxy-5,6-benzocoumarinic acid",0
2460,Coumarins,edgeworoside A,0
2461,Coumarins,3'-(7-diethylaminocoumarin-3-carbonylamino)-3'-deoxyadenosine-5'-triphosphate,0
2462,Coumarins,illudalic acid,0
2463,Coumarins,1-phenyl-3-(coumarin-6-yl)sulfonylurea,0
2464,Coumarins,"2-isocyano-6,7-dihydroxycoumarin",0
2465,Coumarins,kayeassamin A,0
2466,Coumarins,kayeassamin B,0
2467,Coumarins,feronielloside,0
2468,Coumarins,collinin,0
2469,Coumarins,7-methyl-4-bromomethylcoumarin,0
2470,Coumarins,"6,6'-methylene-bis-(3-(2-anilinoacetyl)-4-hydroxycoumarin)",0
2471,Coumarins,polycarcin V,0
2472,Coumarins,"3-cyanomethyl-4-methyl-3',4'-di-O-camphanoylkhellactone",0
2473,Cresols,cyperin,0
2474,Cresols,"4-methyl-2,6-diisobornylphenol",0
2475,Cresols,"4,4'-butylidenebis(6-t-butyl-m-cresol)",0
2476,Crotalid Venoms,"thrombin-like protein, Agkistrodon acutus",0
2477,Crystallins,"crystallin alpha-B protein, rat",0
2478,Cyclic N-Oxides,UDP-TEMPO,0
2479,Cyclic N-Oxides,5-N-beta-cyclodextrin-carboxamide-5-methyl-1-pyrroline N-oxide,0
2480,Cyclic N-Oxides,DOV 315090,0
2481,Cyclic S-Oxides,"1-(2-(2-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl)morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1(3H),4'-piperidine)-2-oxide",0
2482,Cyclic S-Oxides,"4-ethyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",0
2483,Cyclic S-Oxides,"3-(hydroxy(phenyl)methyl)-2,5,7-trimethyl-2,3-dihydropyrido(3,2-e)(1,2)thiazin-4-one 1,1-dioxide",0
2484,Cyclic S-Oxides,"3-(1-hydroxyethylidene)-2,5,7-trimethyl-2,3-dihydropyrido(3,2-e)(1,2)thiazin-4-one 1,1-dioxide",0
2485,Cyclic S-Oxides,cyamemazine sulfoxide,0
2486,Cyclobutanes,"bis(3,5-diiodo-2,4,6-trihydroxyphenyl)squaraine",0
2487,Cyclobutanes,Boc5 compound,0
2488,Cyclohexanecarboxylic Acids,"1,2-bis(dodecylamido)cyclohexane",0
2489,Cyclohexanecarboxylic Acids,"cyclohexane-1,2-dicarboxylic acid",0
2490,Cyclohexanes,"1,1,3-tris(3-indolyl)cyclohexane",0
2491,Cyclohexanes,"1,2,3,4,5,6-cyclohexanehexacarboxylate",0
2492,Cyclohexanes,N-(3-triethoxysilylpropyl)-4-(isothiocyanatomethyl)cyclohexane-1-carboxamide,0
2493,Cyclohexanes,"7-(2-amino-1-oxo-3-thio-propyl)-8-cyclohexylmethyl-2-phenyl-5,6,7,8-tetrahydro-imidazo-(1,2a)-pyrazine dimer, hydrochloride",0
2494,Cyclohexanes,"(2RS,3SR,4RS,6SR)-3-benzoyl-4-hydroxy-2,4,6-triphenylcyclohexane-1,1-dicarbonitrile",0
2495,Cyclohexanes,isocyanocyclohexane,0
2496,Cyclohexanes,cyanocyclohexane,0
2497,Cyclohexanols,1-(2''-hydroxycyclohexyl)-3'-aminopropyl-4-(3'-aminopropyl)piperazine,0
2498,Cyclohexanols,"1-(4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl)-3-methylcyclohexanol",0
2499,Cyclohexanols,bisacurone,0
2500,Cyclohexanols,4-(2-hydroxycyclohexyl)-2-(trifluoromethyl)benzonitrile,0
2501,Cyclohexanols,"3-aminocyclohexane-1,2-diol",0
2502,Cyclohexanols,"(1S)-3,4-epoxy-2,2,5,5-tetramethylcyclohexanol",0
2503,Cyclohexanones,aculeatin A,0
2504,Cyclohexanones,"(R,S)-4-((4'-methoxy-4-(methyl)-3-((4-methoxyphenyl)ethynyl)biphenyl-2-yl)(4-methoxyphenyl)methylene)-2,5-cyclohexadien-1-one,",0
2505,Cyclohexanones,"(R,S)-4-((4'-hydroxy-3-((4-hydroxyphenyl)ethynyl)biphenyl-2-yl)(4-hydroxyphenyl)methylene)-2,5-cyclohexadien-1-one",0
2506,Cyclohexanones,leptosphaerone C,0
2507,Cyclohexanones,2-(1-hydroxy-2-oxocyclohexyl)acetic acid,0
2508,Cyclohexanones,physanoside A,0
2509,Cyclohexanones,"9-(2-hydroxy-4,4,-dimethyl-6-oxo-1-cyclohexen-1-yl)-3,3-dimethyl-2,3,4,9-tetrahydro-1H-xanthen-1-one",0
2510,Cyclohexanones,"3,3'-5,5'-tetra-tert-butyl-4,4'-diphenoquinone",0
2511,Cyclohexanones,2-methylcyclohexanone,0
2512,Cyclohexanones,2-nitrocyclohexanone,0
2513,Cyclohexylamines,purfalcamine,0
2514,Cyclohexylamines,"N,N'-bis(salicylidene)-1',2'-cyclohexanediamine",0
2515,Cyclohexylamines,"3-aminocyclohexane-1,2-diol",0
2516,Cyclopentanes,"2-aminomethylene-4-cyclopentene-1,3-dione",0
2517,Cyclopentanes,"5-amino-3-hydroxycyclopentane-1,2-diol",0
2518,Cyclopentanes,1-aminocyclopent-3-ene-1-carboxylic acid,0
2519,Cyclopentanes,jasmonoyl-isoleucine,0
2520,Cyclopentanes,"(2S,3S)-2-methyl-3-((1S)-1-phenylethoxy)cyclopent-5-en-1-yl benzoate",0
2521,Cyclopropanes,"1,1-dichloro-2-(4-methoxyphenyl)-3-phenylcyclopropane",0
2522,Cyclopropanes,2-(1-(4-fluorophenyl)cyclopropyl)-4-(pyridin-4-yl)thiazol,0
2523,Cyclopropanes,cyclopropyl selenocyanate,0
2524,Cyclopropanes,methyl 2-chloro-2-cyclopropylideneacetate,0
2525,Cyclopropanes,trans-1-toluenesulfonyloxymethyl-2-fluoromethyl-cyclopropane,0
2526,Cystathionine beta-Synthase,"CDCP2 protein, Arabidopsis",0
2527,Cysteine Endopeptidases,"cysteine protease 2, Giardia lamblia",0
2528,Cysteine Endopeptidases,"mepS protein, E coli",0
2529,Cysteine Endopeptidases,"TbcatB protein, Trypanosoma brucei",0
2530,Cytochrome b Group,"nemy protein, Drosophila",0
2531,Cytochrome P450,"CYP20A1 protein, human",0
2532,Cytochrome P450,"cytochrome P-450 26c protein, Xenopus",0
2533,Cytochrome P450,"CYP77A4 protein, Arabidopsis",0
2534,Cytoskeletal Proteins,"DUO1 protein, S cerevisiae",0
2535,Cytoskeletal Proteins,"Ady4 protein, S cerevisiae",0
2536,Cytoskeletal Proteins,"Cdc12 protein, S pombe",0
2537,Cytoskeletal Proteins,"Pxl1 protein, S pombe",0
2538,Dactinomycin,Vincristine-Dactinomycin-Doxorubicin Wilm's Tumor Regimen,0
2539,Decanoic Acids,"N-Boc-(2R,3R,8R,9R,4E,6E)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldecadenoic acid",0
2540,Dental Alloys,Ti50-Ni47.2-Co2.8,0
2541,Deoxy Sugars,6-deoxy-ido-heptopyranose,0
2542,Deoxyadenosines,7-fluoro-7-deaza-2'-deoxyadenosine,0
2543,Deoxyribonucleosides,"1-(2-deoxyribofuranosyl)-2,4-difluoro-5-iodobenzene",0
2544,Deuteroporphyrins,deuxemether,0
2545,Dextrans,dextran-co-poly(methyl methacrylate),0
2546,Dextrans,dextran methacylate phthalate,0
2547,Diamines,"N,N,N',N'-tetramethylchloroformamidinium",0
2548,Diamines,"N1-(2-(4-(dimethylamino)phenyl)benzothiazol-5-yl)butane-1,4-diamine",0
2549,Diamines,REP8839,0
2550,Dicarboxylic Acids,isishippuric acid A,0
2551,Dicarboxylic Acids,ceriporic acid D,0
2552,Dicarboxylic Acids,"cyclohexane-1,2-dicarboxylic acid",0
2553,Dietary Carbohydrates,Glucerna,0
2554,"Dietary Fats, Unsaturated",Glucerna,0
2555,Diglycerides,"3-fluoro-1,2-dipalmitoylglycerol",0
2556,Dihydropyridines,OSI 1210,0
2557,Dihydropyridines,etaftoron,0
2558,Dihydropyridines,OSI 3802,0
2559,Dimethylallyltranstransferase,"FtmPT1 protein, Aspergillus fumigatus",0
2560,Dimethylallyltranstransferase,"CdpNPT protein, Aspergillus fumigatus",0
2561,Dimethylpolysiloxanes,"alpha,omega-triethoxysilylpropyl-polydimethylsiloxane",0
2562,Dinitrobenzenes,"3,5-dinitrobenzoylglycine",0
2563,Dioxanes,"4-(2-(3-(4-hydroxy-3,5-dimethoxyphenyl)-2-hydroxymethyl-8-methoxy-2,3-dihydrobenzo(1,4)dioxin-6-yl)ethyl)-1-methoxybenzene",0
2564,Dioxanes,"3-methylene-6-methyl-1,4-dioxane-2,5-dione",0
2565,Dioxanes,"spiro(6-methyl-1,4-dioxane-2,5-dione-3,2'-bicyclo(2.2.1)hept(5)ene)",0
2566,Dioxolanes,naphthyl-TADDOL,0
2567,Dioxolanes,methylpiperate,0
2568,Dioxolanes,"(4R,5S,alpha'R)-2,2-dimethyl-alpha,alpha,alpha'-tris(perfluorooctyl)-2,3-dioxolane-4,5-dimethanol",0
2569,Dioxoles,CE 156811,0
2570,Dioxoles,LY2365109,0
2571,Dipeptides,"N(alpha),-N(epsilon)-bis(2,3-dihydroxybenzoyl)-l-lysyl-(gamma-N-methyl-N-hydroxyamido)-L-glutamic acid",0
2572,Dipeptides,guadinomine A,0
2573,Dipeptides,guadinomine B,0
2574,Dipeptides,guadinomine C,0
2575,Dipeptides,guadinomine D,0
2576,Dipeptides,guadinomine E,0
2577,Dipeptides,GWL 78,0
2578,Dipeptides,gamma-glutamyl-S-methylcysteine,0
2579,Dipeptides,xenortide A,0
2580,Dipeptides,xenortide B,0
2581,Dipeptides,glycine-valine-lopinavir,0
2582,Dipeptides,valine-valine-lopinavir,0
2583,Dipeptides,(1-(((1-(1-oxo-2-N-((phenylmethoxy)carbonyl)-3-phenylpropyl)pyrrolidin-2-yl)carbonyl)amino)-4-methoxybutyl)-1-boronic acid,0
2584,Dipeptides,N-morpholinourea-leucine-homophenylalanine-phenyl-vinylsulfone,0
2585,Dipeptides,CGS 37808,0
2586,Dipeptides,5'-phenylalanyl-tyrosyl-floxuridine,0
2587,Dipeptides,5'-phenylalanyl-glycyl-floxuridine,0
2588,Dipeptides,5'-isoleucyl-glycyl-floxuridine,0
2589,Dipeptides,guadinomine C2,0
2590,Dipeptides,benzyloxycarbonyl-tert-leucyl-aspartic acid,0
2591,Dipeptides,prolyl-4-hydroxyproline,0
2592,Dipeptides,tetramethylammonium N-dodecanoyl phenylalanylphenylalaninate,0
2593,Dipeptides,(DOTAM-glycyl-phenylalanine)europium(III),0
2594,Diphenylacetic Acids,"2,2-diphenyl-2-hydroxyethanoic acid",0
2595,Diphosphonates,"2-(1-imidazole)-1-hydroxy-1,1'-ethylidenediphosphonic acid",0
2596,Diphosphonates,"1-((N-(2,3,4,5,6-pentafluorocinnamoyl)-O-(2,6-dichlorobenzyl))tyrosyl)-4-(bis(diethoxyphosphono))methylaminiopiperidine",0
2597,Disaccharides,beta-primeverosylamidine,0
2598,Disaccharides,physanoside A,0
2599,Disaccharides,pseudoacarviosin,0
2600,Disaccharides,ethyl galactopyranosyl-1-4-galactopyranoside,0
2601,Disaccharides,acarviosinyl-(1-9)-3-glucopyranosylpropene,0
2602,Disaccharides,glucopyranosyl-1-1-lyxopyrranoside,0
2603,Disaccharides,octane-1-en-3-ol-3-O-beta-D-glucopyranosyl (1-2)-beta-D-glucopyranoside,0
2604,Disaccharides,hidropiperoside B,0
2605,Disaccharides,IVX-0142,0
2606,Disaccharides,"4,6-dimethyl-5-O-(alpha-L-rhamnopyranosyl-(1-6)-alpha-D-glucopyranosyl)",0
2607,Disulfides,1-(2-((1-ethoxycarbonyloxyethoxycarbonylmethyl)carbamoyl)-3-phenylpropyldisulfanylmethyl)-3-methylsulfanylpropylamine,0
2608,Diterpenes,coronarin A,0
2609,Diterpenes,briaexcavatin,0
2610,Diterpenes,cyanthiwigin F,0
2611,Diterpenes,(-)-7beta-hydroxy-8alpha-methoxydeepoxysarcophytoxide,0
2612,Diterpenes,"2,3-dihydrogeranylgeranoic acid",0
2613,Diterpenes,17-acetoxyjolkinolide B,0
2614,Diterpenes,ent-halimanolide 2,0
2615,Diterpenes,ent-halimic acid,0
2616,Diterpenes,4-O-acetyl-5-O-benzoyl-3beta-hydroxy-20-deoxyingenol,0
2617,Diterpenes,sinulaflexiolide D,0
2618,Diterpenes,sinulaflexiolide E,0
2619,Diterpenes,sarcostolide E,0
2620,Diterpenes,sucutinirane A,0
2621,Diterpenes,sucutinirane B,0
2622,Diterpenes,fujenal,0
2623,Diterpenes,sinulaflexiolide F,0
2624,Diterpenes,9-O-(kaur-15-en-17-oxyl)cubebin,0
2625,Diterpenes,phorbasin I,0
2626,Diterpenes,phorbasin H,0
2627,Diterpenes,phorbasin G,0
2628,Diterpenes,flexusine A,0
2629,Diterpenes,flexusine B,0
2630,Diterpenes,epimukulol,0
2631,Diterpenes,6alpha-acetoxymanoyl oxide,0
2632,Diterpenes,6alpha-malonyloxy-n-butyl ester manoyl oxide,0
2633,Diterpenes,6alpha-malonyloxymanoyl oxide,0
2634,Diterpenes,ottensinin,0
2635,Diterpenes,"3beta,5alpha-dihydroxy-15beta-cinnamoyloxy-14-oxolathyra-6Z,12E-diene",0
2636,Diterpenes,"3beta,5alpha,20-trihydroxy-15beta-cinnamoyloxy-14-oxolathyra-6Z,12E-diene",0
2637,Diterpenes,leptodienone A,0
2638,Diterpenes,leptodienone B,0
2639,Diterpenes,dasyscyphin D,0
2640,Diterpenes,dasyscyphin E,0
2641,Diterpenes,coronarin D,0
2642,Diterpenes,fusicoccane A,0
2643,Diterpenes,fusicoccane B,0
2644,Diterpenes,clavirolide C,0
2645,Diterpenes,salvileucalin B,0
2646,Diterpenes,sinulodurin B,0
2647,Diterpenes,sinulodurin A,0
2648,Diterpenes,"12,16-dideoxyaegyptinone B",0
2649,Diterpenes,neodolabellane,0
2650,Diterpenes,"6beta-hydroxy-labda-8,13-dien-15-ol",0
2651,Diterpenes,"3,19-isovaleroyl-6beta,9alpha-dihydroxylabda-delta(8,17),13-dien-15-oic acid",0
2652,Diterpenes,isocohumulone,0
2653,Diterpenes,"18,19-epoxyxenic-19-methoxy-18-hydroxy-4-acetoxy-6,9,13-triene",0
2654,Diterpenes,"18,19-epoxyxenic-18,19-dimethoxy-4-hydroxy-6,9,13-triene",0
2655,Diterpenes,"14,17-cyclolabda-12,14(17)-diene-15,16-dial",0
2656,Diterpenes,blumiolide C,0
2657,Diterpenes,inumakiol A,0
2658,Diterpenes,inumakiol B,0
2659,Diterpenes,coronalactoside I,0
2660,Diterpenes,coronalactoside II,0
2661,Diterpenes,coronadiene,0
2662,Diterpenes,multifolone,0
2663,Diterpenes,(4E)-jatrogrossidentadione acetate,0
2664,Diterpenes,"3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraen-3-ol",0
2665,Diterpenes,lipidyl pseudopterane A,0
2666,Diterpenes,cespihypotin T,0
2667,Diterpenes,8-epidiosbulbin E acetate,0
2668,Diterpenes,16-O-alpha-D-tetraacetylglucopyranosyl hymatoxin C,0
2669,Diterpenes,majusine A,0
2670,Diterpenes,majusine B,0
2671,Diterpenes,majusine C,0
2672,DNA Polymerase II,"Dpb2 protein, S cerevisiae",0
2673,DNA Polymerase III,"POL31 protein, S cerevisiae",0
2674,DNA Polymerase III,"POL3 protein, S cerevisiae",0
2675,DNA Helicases,"ERI-7 protein, C elegans",0
2676,DNA Helicases,"ERI-6 protein, C elegans",0
2677,DNA Helicases,"RTEL1 protein, human",0
2678,DNA Helicases,"rcq-5 protein, C elegans",0
2679,DNA Helicases,"DNA2 protein, Xenopus",0
2680,DNA-Binding Proteins,"CRZ1 protein, S cerevisiae",0
2681,DNA-Binding Proteins,"WOC protein, Drosophila",0
2682,DNA-Binding Proteins,"MLL4 protein, human",0
2683,DNA-Binding Proteins,"SSDP1 protein, human",0
2684,DNA-Binding Proteins,"Zfp-57 protein, human",0
2685,DNA-Binding Proteins,"maelstrom protein, mouse",0
2686,DNA-Binding Proteins,"AtTRB1 protein, Arabidopsis",0
2687,DNA-Binding Proteins,"VIM2 protein, Arabidopsis",0
2688,DNA-Binding Proteins,"VIM3 protein, Arabidopsis",0
2689,DNA-Binding Proteins,"HILS1 protein, human",0
2690,DNA-Binding Proteins,"NuiP protein, mouse",0
2691,DNA-Binding Proteins,"RMI2 protein, human",0
2692,DNA-Binding Proteins,"MRC1 protein, S pombe",0
2693,DNA-Binding Proteins,"Smyd4 protein, Drosophila",0
2694,DNA-Binding Proteins,"SNAP190 protein, Drosophila",0
2695,DNA-Binding Proteins,"SNAP50 protein, Drosophila",0
2696,DNA-Binding Proteins,"DDB2 protein, zebrafish",0
2697,DNA-Binding Proteins,"SYCP2 protein, human",0
2698,DNA-Binding Proteins,"RPA3 protein, human",0
2699,"DNA, Bacterial",CIA07 adjuvant,0
2700,Recombinant DNA,Allovectin-7,0
2701,Doxorubicin,Vincristine-Dactinomycin-Doxorubicin Wilm's Tumor Regimen,0
2702,Drug Combinations,fantac,0
2703,Drug Combinations,"piracetam, vinpocetine drug combination",0
2704,Drug Combinations,metrogil denta,0
2705,Drug Combinations,kalinox,0
2706,Drug Combinations,DRF 7295,0
2707,Drug Combinations,NanoBone,0
2708,"Drugs, Chinese Herbal",Myelophil,0
2709,"Drugs, Chinese Herbal",houpu sanwu,0
2710,"Drugs, Chinese Herbal",ku huang,0
2711,"Drugs, Chinese Herbal",jiawei sini,0
2712,"Drugs, Chinese Herbal",yiqi mingmu,0
2713,"Drugs, Chinese Herbal",yigong,0
2714,"Drugs, Chinese Herbal",shensongyangxin,0
2715,"Drugs, Chinese Herbal",yunnan baiyao,0
2716,"Drugs, Chinese Herbal",Qingdai compound,0
2717,"Drugs, Chinese Herbal",Shuangling Fuzheng anticancer preparation,0
2718,"Drugs, Chinese Herbal",xiaoyu zhixue,0
2719,"Drugs, Chinese Herbal",jieze No. 1,0
2720,"Drugs, Chinese Herbal",weicao,0
2721,"Drugs, Chinese Herbal",zibu piyin,0
2722,"Drugs, Chinese Herbal",danzhi xiaoyao,0
2723,"Drugs, Chinese Herbal",dihuang zhixue,0
2724,"Drugs, Chinese Herbal",lidan,0
2725,"Drugs, Chinese Herbal",danggui-shaoyao-san,0
2726,"Drugs, Chinese Herbal",Yueju-Wan,0
2727,"Drugs, Chinese Herbal",yang wei kang liu,0
2728,"Drugs, Chinese Herbal",rukuaixiao,0
2729,"Drugs, Chinese Herbal",chi-zhi-huang,0
2730,"Drugs, Chinese Herbal",bu-wang-san,0
2731,"Drugs, Chinese Herbal",shuxuetong,0
2732,"Drugs, Chinese Herbal",cinnamomi cortex,0
2733,"Drugs, Chinese Herbal",xiaoyaosan,0
2734,"Drugs, Chinese Herbal",xiaobuxin-tang,0
2735,"Drugs, Chinese Herbal",kushen tang,0
2736,"Drugs, Chinese Herbal",tianwang buxinwan,0
2737,"Drugs, Chinese Herbal",guipiwan,0
2738,"Drugs, Chinese Herbal",wenxin keli,0
2739,"Drugs, Chinese Herbal",shuangshen ningxin,0
2740,"Drugs, Chinese Herbal",Fushile,0
2741,"Drugs, Chinese Herbal",Shenshuaining,0
2742,"Drugs, Chinese Herbal",Chuanxinlian,0
2743,"Drugs, Chinese Herbal",maipuxin,0
2744,"Drugs, Chinese Herbal",shengli,0
2745,"Drugs, Chinese Herbal",qianlieantong,0
2746,"Drugs, Chinese Herbal",shengjingbao,0
2747,"Drugs, Chinese Herbal",haishengsu,0
2748,"Drugs, Chinese Herbal",fuzheng huayu,0
2749,"Drugs, Chinese Herbal",shengjing,0
2750,"Drugs, Chinese Herbal",tongguan,0
2751,"Drugs, Chinese Herbal",qiangxin fumai,0
2752,"Drugs, Chinese Herbal",yishen tiaojing,0
2753,"Drugs, Chinese Herbal",ping-wei,0
2754,"Drugs, Chinese Herbal",yupingfeng,0
2755,"Drugs, Chinese Herbal",jinhuang-1,0
2756,"Drugs, Chinese Herbal",baoji,0
2757,"Drugs, Chinese Herbal",xinnaoxin,0
2758,"Drugs, Chinese Herbal",shenwu,0
2759,"Drugs, Chinese Herbal",sanhuang,0
2760,"Drugs, Chinese Herbal",quxie,0
2761,"Drugs, Chinese Herbal",neiyi kangfu,0
2762,"Drugs, Chinese Herbal",shen ling bai zhu,0
2763,"Drugs, Chinese Herbal",di dang tang,0
2764,"Drugs, Chinese Herbal",ziao er zhi chuan tang,0
2765,"Drugs, Chinese Herbal",nao xue shuan,0
2766,"Drugs, Chinese Herbal",migu,0
2767,"Drugs, Chinese Herbal",chaihu taoren,0
2768,"Drugs, Chinese Herbal",kangquan,0
2769,"Drugs, Chinese Herbal",suifukang,0
2770,"Drugs, Chinese Herbal",qingbi,0
2771,"Drugs, Chinese Herbal",zhongfu,0
2772,"Drugs, Chinese Herbal",haikun shenxi,0
2773,"Drugs, Chinese Herbal",kangxianling,0
2774,"Drugs, Chinese Herbal",qushi huayu,0
2775,"Drugs, Chinese Herbal",qiangyue,0
2776,"Drugs, Chinese Herbal",jianwei yuyang,0
2777,"Drugs, Chinese Herbal",qifang weitong,0
2778,"Drugs, Chinese Herbal",wuling,0
2779,"Drugs, Chinese Herbal",wenshen huatan,0
2780,"Drugs, Chinese Herbal",feiji,0
2781,"Drugs, Chinese Herbal",qingre liqi,0
2782,"Drugs, Chinese Herbal",panlongqi,0
2783,"Drugs, Chinese Herbal",wenmaitong,0
2784,"Drugs, Chinese Herbal",fuzheng yiliu,0
2785,"Drugs, Chinese Herbal",huaxian,0
2786,"Drugs, Chinese Herbal",jieyu anshen,0
2787,"Drugs, Chinese Herbal",erzhi tiangui,0
2788,"Drugs, Chinese Herbal",kangyi zhongyu,0
2789,"Drugs, Chinese Herbal",xiaokang zhongzi,0
2790,"Drugs, Chinese Herbal",liuwu shengjing,0
2791,"Drugs, Chinese Herbal",fangchuan,0
2792,"Drugs, Chinese Herbal",feixianping,0
2793,"Drugs, Chinese Herbal",zhixue baotai,0
2794,"Drugs, Chinese Herbal",lin'erlai,0
2795,"Drugs, Chinese Herbal",bushen huayu qutan,0
2796,"Drugs, Chinese Herbal",yanghe,0
2797,"Drugs, Chinese Herbal",bailing capsules,0
2798,"Drugs, Chinese Herbal",shugan qingzhi,0
2799,"Drugs, Chinese Herbal",qingyi,0
2800,"Drugs, Chinese Herbal",fuzheng hewei,0
2801,"Drugs, Chinese Herbal",tiaomian huayu,0
2802,"Drugs, Chinese Herbal",yiguan,0
2803,"Drugs, Chinese Herbal",guben yiliu II,0
2804,"Drugs, Chinese Herbal",fuzheng jiedu,0
2805,"Drugs, Chinese Herbal",xinfeng,0
2806,"Drugs, Chinese Herbal",shengqi jiangtang,0
2807,"Drugs, Chinese Herbal",jiangzhuo huoxue yishen,0
2808,"Drugs, Chinese Herbal",yiqi bufei,0
2809,"Drugs, Chinese Herbal",xinhuang,0
2810,"Drugs, Chinese Herbal",gandou IV,0
2811,"Drugs, Chinese Herbal",shenyin,0
2812,"Drugs, Chinese Herbal",pabing 1,0
2813,"Drugs, Chinese Herbal",zhiling,0
2814,"Drugs, Chinese Herbal",naoweikang,0
2815,"Drugs, Chinese Herbal",naoningkang,0
2816,"Drugs, Chinese Herbal",caoguo zhimu,0
2817,"Drugs, Chinese Herbal",ruxian I,0
2818,"Drugs, Chinese Herbal",buchang naoxintong,0
2819,"Drugs, Chinese Herbal",penqiangyan,0
2820,"Drugs, Chinese Herbal",bakumijiogan,0
2821,"Drugs, Chinese Herbal",qishen huoxue,0
2822,"Drugs, Chinese Herbal",gengxueting,0
2823,"Drugs, Chinese Herbal",bushen antai,0
2824,"Drugs, Chinese Herbal",ningxin hongqi,0
2825,"Drugs, Chinese Herbal",kangyanling,0
2826,"Drugs, Chinese Herbal",qianlie huazhuo,0
2827,"Drugs, Chinese Herbal",tongdatang,0
2828,"Drugs, Chinese Herbal",bu shen hui yu tang,0
2829,"Drugs, Chinese Herbal",he yuan yuan kai tang,0
2830,"Drugs, Chinese Herbal",changqing,0
2831,"Drugs, Chinese Herbal",heluoshugan,0
2832,"Drugs, Chinese Herbal",xin-kang,0
2833,"Drugs, Chinese Herbal",yuchangning,0
2834,"Drugs, Chinese Herbal",jiedu tongluo lishi,0
2835,"Drugs, Chinese Herbal",chuanxiong rhizome preparation,0
2836,"Drugs, Chinese Herbal",guan xin II,0
2837,"Drugs, Chinese Herbal",langchuang,0
2838,"Drugs, Chinese Herbal",shugan jianpi,0
2839,"Drugs, Chinese Herbal",jisuikang,0
2840,"Drugs, Chinese Herbal",jinguo weikang,0
2841,"Drugs, Chinese Herbal",sangrovit,0
2842,"Drugs, Chinese Herbal",mailuoning,0
2843,Elastin,matriderm,0
2844,endodeoxyribonuclease,"CRN-4 protein, C elegans",0
2845,endonuclease,"ORF2 protein, human",0
2846,endonuclease,"DNA2 protein, Xenopus",0
2847,Endoribonucleases,"Dom34 protein, S cerevisiae",0
2848,Endoribonucleases,"DCP2 protein, S cerevisiae",0
2849,Endoribonucleases,"tRNase Z, human",0
2850,Endoribonucleases,"SMG6 protein, Drosophila",0
2851,Endoribonucleases,"tRNase Z protein, E coli",0
2852,Enterotoxins,"Pet protein, E coli",0
2853,Enterotoxins,"NetB protein, Clostridium perfringens",0
2854,Enzymes,Cellfood,0
2855,Epoxy Compounds,phomolide A,0
2856,Epoxy Compounds,phomolide B,0
2857,Epoxy Compounds,Ymf 1029A,0
2858,Epoxy Compounds,"1,2-epoxy-5-hexene",0
2859,Epoxy Compounds,isobutylene oxide,0
2860,Epoxy Compounds,baccharis oxide,0
2861,Epoxy Compounds,"(1S)-3,4-epoxy-2,2,5,5-tetramethylcyclohexanol",0
2862,Epoxy Compounds,isodaucene epoxide,0
2863,Epoxy Compounds,"1-((4-triethoxysilyl)phenyl)-4,4,4-trifluoro-1,3-butanedione",0
2864,Epoxy Compounds,"1,3-butadiene diepoxide",0
2865,Epoxy Resins,epoxy resin-based root canal sealer,0
2866,Ergocalciferols,"24a-homo-1,15-dihydroxyergocalciferol",0
2867,Erucic Acids,erucyl bis(hydroxymethyl)methylammonium,0
2868,Ethanolamines,"2-amino-1,2-diphenylethanol",0
2869,Ethanolamines,N-myristoylethanolamine,0
2870,Ethers,propargyl ether,0
2871,Ethers,4-trifluoromethylbenzenepropargyl ether,0
2872,Ethers,perfluoropolyether phosphate,0
2873,"Ethers, Cyclic",spiroether,0
2874,Ethinyl Estradiol,drospirenone / Ethinyl Estradiol,0
2875,Ethylamines,"N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine",0
2876,Ethylamines,"N, N'-dimethyl- N, N'-bis(3,5-di- t-butyl-2-hydroxybenzyl)-1,2-diaminoethane",0
2877,Ethylamines,"tris(2-((3,4-dihydroxybenzylidene)imino)ethyl)amine",0
2878,Ethylamines,2-fluoroethylamine,0
2879,Ethylamines,2-(2-pyridylamino)ethylamine,0
2880,Ethylenediamines,"N,N,N',N'-tetrakis(1-isoquinolylmethyl)ethylenediamine",0
2881,Ethylenediamines,"N,N,N',N'-tetrakis(3-isoquinolylmethyl)ethylenediamine",0
2882,Exoribonucleases,"SDN1 protein, Arabidopsis",0
2883,Exoribonucleases,"cNOT6 protein, human",0
2884,Eye Proteins,"EYS protein, human",0
2885,Eye Proteins,"retinin protein, Drosophila",0
2886,Fatty Acids,besarhanamide B,0
2887,Fatty Acids,dipentaerythritol fatty acid ester,0
2888,Fatty Acids,lipidyl pseudopterane A,0
2889,"Fatty Acids, Monounsaturated",14-oxo-11(Z)-eicosenoic acid,0
2890,"Fatty Acids, Monounsaturated",besarhanamide A,0
2891,"Fatty Acids, Monounsaturated",urticic acid,0
2892,"Fatty Acids, Monounsaturated",2-epi-myriocin,0
2893,"Fatty Acids, Unsaturated",centipedic acid,0
2894,"Fatty Acids, Unsaturated",DMDK compound,0
2895,"Fatty Acids, Unsaturated",bolineol,0
2896,Fatty Alcohols,hexyldecanol,0
2897,Fatty Alcohols,8-gingerol,0
2898,Ferric Compounds,Iron(III)-salophene,0
2899,Ferritin,"ferritin A, E coli",0
2900,Ferrous Compounds,"N, N, N, N-(dimethyl, ethyl, ferrocenecarboxylic amidodimethylene)ammonium fluoborate",0
2901,Ferrous Compounds,ferrociphenol,0
2902,Fish Oils,efalex,0
2903,Flavins,C4a-hydroperoxyflavin,0
2904,Flavonoids,afzelechin,0
2905,Flavonoids,glycyrol,0
2906,Flavonoids,Flavin7,0
2907,Flavonoids,mirtogenol,0
2908,Flavonoids,xiaobuxin-tang,0
2909,Flavonoids,glabratephrin,0
2910,Flavonoids,"6-trans-(2''-O-alpha-rhamnopyranosyl)ethenyl-5,7,3',4'-tetrahydroxyflavone",0
2911,Flavonoids,luteolin 6-C-beta-boivinopyranoside,0
2912,Flavonoids,"3,7-bis(2-hydroxyethyl)icaritin",0
2913,Flavonoids,diosmetin 7-O-alpha-l-rhamnopyranosyl-(1-2)-(beta-d-xylopyranosyl-(1-6))-beta-d-glucopyranoside,0
2914,Flavonoids,"3,5,7,3',4',3'',5'',7'',3''',4'''-decahydroxyl-(8-CH(2)-8'')-biflavone",0
2915,Flavonoids,5-methoxy-7-beta-D-glucopyranosyl-afzelechin,0
2916,Flavonoids,luteolin 7-O-alpha-L-rhamnoside-4'-O-beta-D-glucoside,0
2917,Flavonoids,quercetin 3-O-beta-D-glucoside-4'-O-alpha-L-rhamnoside,0
2918,Flavonoids,rhodiosin,0
2919,Flavonoids,dorsilurin F,0
2920,Fluorenes,"2,3,6,7-tetraamino-9,9-bis(2-ethylhexyl)fluorene",0
2921,Fluorenes,"4-(bis(9,9-dimethylfluoren-2-yl)amino)azobenzene",0
2922,Fluorenes,9-fluorenylmethanol,0
2923,Fluoresceins,B 10380,0
2924,Fluoresceins,"N-fluoresceinyl-3,7,12-trihydroxycholan-24-amide",0
2925,Fluoresceins,fluoro-jade C,0
2926,Fluorides,cadmium fluoride,0
2927,Fluorides,nitrogen trifluoride,0
2928,"Fluorides, Topical",shellac F,0
2929,Fluorobenzenes,JLK1360,0
2930,Fluorocarbons,perfluoropolyether phosphate,0
2931,Fluorocarbons,"(4R,5S,alpha'R)-2,2-dimethyl-alpha,alpha,alpha'-tris(perfluorooctyl)-2,3-dioxolane-4,5-dimethanol",0
2932,Fluorocarbons,perfluorobutylpentane,0
2933,Folic Acid,fantac,0
2934,Formamides,2-pyridineformamide,0
2935,Formamides,"N-(2-amino-6-((2-deoxy-beta-D-erythro-pentofuranosyl)amino)-3,4-dihydro-4-oxo-5-pyrimidinyl)-N-(2-oxoethyl)-formamide",0
2936,Formates,"2,2,3,3,3-pentafluoropropyl chloroformate",0
2937,Formates,tert-butyl formate,0
2938,Fucosidase,"GH95 alpha1,2-fucosidase protein, Arabidopsis",0
2939,Fungal Proteins,"CrzA protein, Aspergillus fumigatus",0
2940,Fungal Proteins,"marmorin protein, Hypsizigus marmoreus",0
2941,Furans,SB-699393,0
2942,Furans,"5,5'-dibutoxy-2,2'-bifuran",0
2943,Furans,"7-methoxy-4-(4-nitrophenylthio)furo(2,3-b)quinoline",0
2944,Furans,centipedic acid,0
2945,Furans,communiol A,0
2946,Furans,communiol B,0
2947,Furans,communiol C,0
2948,Furans,cetalox,0
2949,Furans,bullacin B,0
2950,Furans,3-(4'-dimethylaminophenyl)-1-(2-furanyl)prop-2-en-1-one,0
2951,Furans,"4-oxo-4,7-dihydrofuro(2,3-b)pyridine-5-carboxamide",0
2952,Furans,anastrephin,0
2953,Furans,aureonitol,0
2954,Furans,tricyanofuran,0
2955,Furans,(E)-3-(2-chloro-6-methylquinolin-3-yl)-1-(5-methyl-2-furyl)prop-2-en-1-one,0
2956,Furans,feronielloside,0
2957,Furans,montanin A,0
2958,Furans,teuscorolide,0
2959,Furans,sarcodifurine A,0
2960,Furans,sarcodifurine B,0
2961,Furans,3-bromo-2-triisopropylsilyloxyfuran,0
2962,Furans,"3-methyl-5-(tetrahydrofuran-2-yl)methyl 2,6-dimethyl-4-(2'-nitrophenyl)pyridine-3,5-dicarboxylate",0
2963,Furans,7-oxamuricatacin,0
2964,Galactans,LZ-D-1 fucogalactan,0
2965,Galactosylceramides,"4-deoxy-4,4-difluoro-KRN7000",0
2966,Germanium,zinc germanate,0
2967,Gibberellins,gibberellin A4,0
2968,Globosides,6-O-sulfosialylparagloboside,0
2969,Glucans,PS3 glucan,0
2970,Gluconates,N-gluconyl glutamic acid didecyl ester,0
2971,Glucosides,triglochinin,0
2972,Glucosides,amburoside A,0
2973,Glucosides,pelargonidin 3-malylglucoside,0
2974,Glucosides,1-O-malylglucose,0
2975,Glucosides,methyl 6-bromoglucopyranoside,0
2976,Glucosides,kaempferol 3-O-(3-O-acetyl-6-O-(E)-p-coumaroyl)-b-d-glucopyranoside,0
2977,Glucosides,remogliflozin etabonate,0
2978,Glucosides,indoxylglucopyranoside,0
2979,Glucosides,annphenone,0
2980,Glucosides,5-methoxy-7-beta-D-glucopyranosyl-afzelechin,0
2981,Glucosides,ericarborin,0
2982,Glucosides,"2-(4''-hydroxy-3'',5''-dimethoxybenzyl)-3-(5'-methoxy-3', 4'-methylenedioxybenzyl)butyrolactone-4''-O-beta-D-glucopyranoside",0
2983,Glucosides,chrysophanol-8-O-glycopyranoside,0
2984,Glucosides,"5,11-epoxymegastigmane glucoside",0
2985,Glucosides,(24R)-5-stigmast-9-(11)-en-3beta-D-glucopyranoside,0
2986,Glucosides,paesuffrioside,0
2987,Glucosides,"(3beta,16beta,21beta)-16,21,28-trihydroxyolean-12-en-3-O-beta-D-glucopyranosyl(1-2)-beta-D-glucuronopyranoside",0
2988,Glucosides,"chalcone-2',4-dihydroxy-4'-O-beta-D-glucoside",0
2989,Glucosides,10-hydroxyanthrone-C-glucoside cassialoin,0
2990,Glucosides,16-O-alpha-D-tetraacetylglucopyranosyl hymatoxin C,0
2991,Glucosides,glucopyranosyl 12-hydroxyjasmonic acid,0
2992,Glucosides,lunularin-4-O-beta-D-glucoside,0
2993,Glucosyltransferases,"WOL protein, Drosophila",0
2994,Glucosyltransferases,"glucosyl-3-phosphoglycerate synthase, Mycobacterium tuberculosis",0
2995,Glutamates,"diethyl N-(4-((2-(2,4-diamino-5-(2,3-dibromopropyl)-5,6,7,8-tetrahydropyrido(3,2-d)pyrimidin-6-yl)methyl)amino)-3-bromobenzoyl)glutamate",0
2996,Glutamates,"N-(4-((2-(2,4-diamino-5-(2,3-dibromopropyl)-5,6,7,8-tetrahydropyrido(3,2-d)pyrimidin-6-yl)methyl)amino)-3-bromobenzoyl)glutamic acid",0
2997,Glutamates,N-gluconyl glutamic acid didecyl ester,0
2998,Glutarates,"2-amino-4-(3-(2,2-diphenylethylamino)-3-oxopropyl)pentanedioic acid",0
2999,Glutarates,"3,3-tetramethyleneglutaric anhydride",0
3000,Glycopeptides,tyrosyl-glycyl-phenylalanyl-leucyl-(O-lactosyl)serinamide,0
3001,Glycoproteins,"DAN1 protein, S cerevisiae",0
3002,Glycoproteins,"MAGP-36 protein, human",0
3003,Glycoproteins,"LRG1 protein, mouse",0
3004,Glycoproteins,"MAGP-36 protein, rat",0
3005,Glycoproteins,"Pir3 protein, S cerevisiae",0
3006,Glycoproteins,"GP-1D8 glycoprotein, human",0
3007,Glycoproteins,"pregnancy-specific glycoprotein 19, mouse",0
3008,Glycoproteins,"CTRP9 protein, mouse",0
3009,Glycosaminoglycans,OTR4120,0
3010,Glycosaminoglycans,enterosan,0
3011,Glycoside Hydrolases,"cyclic maltosyl-1-6-maltose hydrolase, Arthrobacter globiformis",0
3012,Glycosides,gilvocarcin V,0
3013,Glycosides,gilvocarcin M,0
3014,Glycosides,gilvocarcin E,0
3015,Glycosides,2alpha-pinan-3-one-2-O-beta-glucopyranoside,0
3016,Glycosides,"3-O-(2-diazo-2-phenylacetyl)-1,2-5,6-di-O-isopropylideneallofuranose",0
3017,Glycosides,arguside D,0
3018,Glycosides,arguside E,0
3019,Glycosides,tarecilioside A,0
3020,Glycosides,tarecilioside G,0
3021,Glycosides,C-xylopyranoside-2-hydroxypropane,0
3022,Glycosides,cimicidol-3-O-beta-D-xyloside,0
3023,Glycosides,"2-feruloyl-O-alpha-D-glucopyranoyl-(1'-2)-3,6-O-feruloyl-beta-D-fructofuranoside",0
3024,Glycosides,"3beta, 7beta, 24beta, 25, 30-pentahydroxycycloartane-24, 30-di-O-beta-D-glucopyranoside",0
3025,Glycosides,"3,5-dimethyl-6-hydroxy-2-methoxy-4-O-D-glucopyranosyl-oxy-acetophenone",0
3026,Glycosides,"23(R),24(S),25(R),26(S)-16beta23,23,26,24,25-triepoxy-6alpha,26-dihydroxy-9,19-cyclolanosta-3-O-beta-xyloside",0
3027,Glycosides,"6alpha-hydroxy-23-methoxy-16beta,23(R)-epoxy-24,25,26,27-tetranor-9,19-cyclolanosta-3-O-beta-xyloside",0
3028,Glycosides,clerspide A,0
3029,Glycosides,clerspide B,0
3030,Glycosides,caudatin-3-O-beta-D-cymaropyranosyl-(1-4)-beta-D-digitoxopyranoside,0
3031,Glycosides,caudatin-3-O-beta-D-oleandropyranosyl-(1-4)-beta-D-cymaropyranoside,0
3032,Glycosides,"3'-(2'',4''-dihydroxybenzyloxy)acanthophorin B",0
3033,Glycosides,suspensoside A,0
3034,Glycosides,actinoside C,0
3035,Glycosides,"7-hydroxymethyl-1,4,5- trihydroxynaphthalene-4-O-beta-D-xylopyranosyl(1-6)-beta-D-glucopyranoside",0
3036,Glycosides,feronielloside,0
3037,Glycosides,ansaetherone,0
3038,Glycosides,"3beta-hydroxypregna-5,16-dien-20-one-3-O-alpha-L-rhamnopyranosyl(1 -4)-alpha-L-rhamnopyranosyl(1-4)-(alpha-L-rhamnopyranosyl(1- 2))-beta-D-glucopyranoside",0
3039,Glycosides,polycarcin V,0
3040,Glycosides,"4',5,6-trimethoxyisoflavone-7-O-rhamnopyranosyl-(1-6)-glucopyranoside",0
3041,Glycosides,"4',5,6-trimethoxyisoflavone-7-O-rhamnopyranosyl(1-6)-glucopyranosyl(1-3)-(rhamnopyranosyl(1-6))-glucopyranoside",0
3042,Glycosides,"4',5,6-trimethoxyisoflavone-7-O-glucopyranosyl(1-4)-rhamnopyranosyl(1-6)-glucopyranosyl(1-3)-(rhamnopyranosyl(1-6))-glucopyranoside",0
3043,Glycosides,frondoside A,0
3044,Guanidines,clavatadine A,0
3045,Guanidines,N-succinimidyl 3-astato-5-guanidinomethylbenzoate,0
3046,Guanidines,"1,2-bis(N,N,N',N'-tetramethylguanidino)benzene",0
3047,Guanidines,"1,1,3,3-tetramethylguanidium lactate",0
3048,Heat shock proteins,"Hsf2 protein, mouse",0
3049,Heat shock proteins,"Hsp104 protein, rat",0
3050,Heat shock proteins,"ClpC1 protein, Mycobacterium tuberculosis",0
3051,Hematoporphyrins,MPA79,0
3052,Hemeproteins,"DAP1 protein, S cerevisiae",0
3053,Abnormal Hemoglobins,hemoglobin Heraklion,0
3054,Abnormal Hemoglobins,hemoglobin Voreppe,0
3055,Abnormal Hemoglobins,hemoglobin Noah Mehmet Oeztuerk,0
3056,Abnormal Hemoglobins,hemoglobin Southern Italy,0
3057,Abnormal Hemoglobins,hemoglobin Caserta,0
3058,Hemolysin,"HlyE protein, Salmonella enterica",0
3059,Hemolysin,"listeriolysin S, Listeria monocytogenes",0
3060,Hepatitis B Core Antigen,"p22 core protein, hepatitis B virus",0
3061,Heptanes,"3-(6-bromopyridin-3-yl)-3,6-diazabicyclo(3.1.1)heptane",0
3062,Heptanoic Acids,"5(S),6(R)-7-trihydroxyheptanoic acid, methyl ester",0
3063,"Heterocyclic Compounds, 1-Ring","6,7-dimethoxyazacyclooct-4-yne",0
3064,"Heterocyclic Compounds, 1-Ring","3,4-dihydroxy-1-selenolane oxide",0
3065,"Heterocyclic Compounds, 1-Ring","(4-(2-(biscarboxymethylamino)-3-(4-nitrophenyl)propyl)-7-carboxymethyl(1,4,7)triazonan-1-yl)acetic acid",0
3066,"Heterocyclic Compounds, 1-Ring","(4-carboxymethyl-7-(2-(carboxymethylamino)-3-(4-nitrophenyl)propyl)(1,4,7)triazonan-1-yl)acetic acid",0
3067,"Heterocyclic Compounds, 1-Ring","3-(4-benzylamino)-1,2,4,5-tetrazine",0
3068,"Heterocyclic Compounds, 2-Ring",beta-alanine-arm-ICAT,0
3069,"Heterocyclic Compounds, 2-Ring",daldinin C,0
3070,"Heterocyclic Compounds, 2-Ring",2106 A,0
3071,"Heterocyclic Compounds, 2-Ring","5-(4-hydroxyphenyl)-3,4-ethylenedioxythienyl alcohol",0
3072,"Heterocyclic Compounds, 3-Ring",IR820-PEI,0
3073,"Heterocyclic Compounds, 3-Ring",daldinin B,0
3074,"Heterocyclic Compounds, 3-Ring",daldinin A,0
3075,"Heterocyclic Compounds, 3-Ring",5-epi-hydroxycornexistin,0
3076,"Heterocyclic Compounds, 3-Ring",quinadoline B,0
3077,"Heterocyclic Compounds, 3-Ring",cephalosol,0
3078,"Heterocyclic Compounds, 3-Ring","(2S,3R,4S,5R)-diethyl 2-(10,10-dimethyl-3,3-dioxo-3lambda(6)-thia-4-azatricyclo(5.2.1.0(1,5))decan-4-ylcarbonyl)-5-phenylpyrrolidine-3,4-dicarboxylate",0
3079,"Heterocyclic Compounds, 3-Ring",ammosamide A,0
3080,"Heterocyclic Compounds, 3-Ring",ammosamide B,0
3081,"Heterocyclic Compounds, 3-Ring","1,3,5,7-tetramethyl-8-phenyl-(2-maleimide)-difluoroboradiaza-s-indacene",0
3082,"Heterocyclic Compounds, 4 or More Rings",Ymf 1029A,0
3083,"Heterocyclic Compounds, 4 or More Rings","8-ethyl-2,5,6,12-tetrahydro-3,10,10-trimethyl-9-oxopyrazolo(4',3'-6,7)cyclohepta(1,2-b)pyrrolo(2,3-f)indole",0
3084,"Heterocyclic Compounds, 4 or More Rings",faurinone,0
3085,"Heterocyclic Compounds, 4 or More Rings",carpanone,0
3086,"Heterocyclic Compounds, 4 or More Rings",0433YC1,0
3087,"Heterocyclic Compounds, 4 or More Rings",0433YC2,0
3088,"Heterocyclic Compounds, 4 or More Rings",euchrestifoline,0
3089,"Heterocyclic Compounds, 4 or More Rings",coumberone,0
3090,"Heterocyclic Compounds, 4 or More Rings",laurelliptinhexadecan-1-one,0
3091,"Heterocyclic Compounds, 4 or More Rings",laurelliptinoctadecan-1-one,0
3092,"Heterocyclic Compounds, 4 or More Rings",frondosin D,0
3093,"Heterocyclic Compounds, 4 or More Rings",desmorostratine,0
3094,"Heterocyclic Compounds, 4 or More Rings",discretine N-oxide,0
3095,"Heterocyclic Compounds, 4 or More Rings",discretine,0
3096,"Heterocyclic Compounds, 4 or More Rings",SNX 2112,0
3097,Hexanes,3-azabicyclo(3.1.0)hexane,0
3098,Hexosamines,salbostatin,0
3099,Hexoses,"2-((3,4,5)-trihydroxy-6-hydroxymethyltetrahydropyran-2-yloxymethyl)acrylonitrile",0
3100,Hirudins,lepidurin,0
3101,Histone Deacetylase,"Sap18 protein, mouse",0
3102,Homovanillic Acid,homovanillic alcohol,0
3103,Hyaluronidase,"MGEA5 protein, human",0
3104,Hyaluronidase,"BmHYA1 protein, Buthus martensi",0
3105,Hydrazines,"4-(((3,4-dimethyl pyrrole-2-carbonyl)hydrazono)(phenyl)methyl)-3-methyl-1-phenylpyrazol-5-ol",0
3106,Swelling,Subungual exostoses,1
3107,Adulthood Lesion,Lugano Classification Adult Non-Hodgkin Lymphoma by AJCC v8 Stage,1
3108,Pathologic TNM Finding,Pathologic Stage III Esophageal Adenocarcinoma AJCC v8,1
3109,Osseous Differentiation,Chondroblastic osteosarcoma,1
3110,Malignant Cellular Infiltrate,Uterine Corpus High Grade Endometrial Stromal Sarcoma,1
3111,Cutaneous Involvement,Syringocystadenoma Papilliferum,1
3112,Immunoglobulin Deposition,Light chain disease,1
3113,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma 55 Years and Older AJCC v8,1
3114,Benign Cellular Infiltrate,Fallopian tube leiomyoma,1
3115,Carcinomatous Component Present,Stage II Vaginal Cancer AJCC v8,1
3116,Carcinomatous Component Present,Stage I Vulvar Carcinoma,1
3117,Carcinomatous Component Present,Ampulla of Vater Signet Ring Cell Carcinoma,1
3118,Slow Growing Mass,Papillary ependymoma,1
3119,Sebaceous Differentiation,Benign neoplasm of sebaceous gland,1
3120,Carcinomatous Component Present,Lung Squamous Cell Carcinoma In Situ,1
3121,Cutaneous Involvement,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
3122,Malignant Cellular Infiltrate,Stage I Uterine Corpus Adenosarcoma AJCC v8,1
3123,Carcinomatous Component Present,Intramucosal Adenocarcinoma,1
3124,Malignant Cellular Infiltrate,Metastatic Squamous Cell Carcinoma of the Nasopharynx,1
3125,Neuroendocrine Differentiation,Pancreatic Somatostatinoma,1
3126,Cutaneous Involvement,Eccrine porocarcinoma,1
3127,Thyroglobulin Positive Neoplastic Cells Present,Clear Cell Variant Thyroid Gland Follicular Carcinoma,1
3128,Cutaneous Involvement,Clinical Stage II Cutaneous Melanoma AJCC v8,1
3129,Apple Green Dichromism Present in Polarized Congo-Red Stained Sections,Amyloidosis,1
3130,Slow Growing Mass,Third Ventricle Pilocytic Astrocytoma,1
3131,Stromal Invasion,Refractory Ovarian Carcinoma,1
3132,Epithelial Component Present,Stage I Lip Carcinoma,1
3133,Malignant Cellular Infiltrate,Stage 0a Urethral Cancer AJCC v8,1
3134,Epithelial Component Present,Stage IIIA Eyelid Carcinoma AJCC v8,1
3135,Poorly Differentiated Lesion,Large cell lung cancer recurrent,1
3136,Chondromyxoid Stroma Formation,Ectomesenchymal Chondromyxoid Tumor,1
3137,Single Cell Necrosis,Stage IV Merkel Cell Carcinoma AJCC v7,1
3138,Severe dysplasia,Stage 0 Vulvar Cancer,1
3139,Absence of Stromal Invasion,"Papillary mucinous cystadenoma, borderline malignancy",1
3140,Malignant Cellular Infiltrate,Chest Wall Sarcoma,1
3141,Bone Marrow Involvement,Waldenstrom's macroglobulinemia recurrent,1
3142,Benign Cellular Infiltrate,Thyroid Gland Hemangioma,1
3143,Carcinomatous Component Present,Lung Mucinous Adenocarcinoma In Situ,1
3144,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
3145,Neuroendocrine Differentiation,large cell neuroendocrine carcinoma of appendix,1
3146,Malignant Cellular Infiltrate,Stage IIB Esophageal Carcinoma,1
3147,bone marrow fibrosis,Acute panmyelosis with myelofibrosis,1
3148,Epithelial Component Present,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,1
3149,Invasive Lesion,"Follicular Variant Thyroid Gland Papillary Carcinoma, Infiltrative Subtype",1
3150,Dentin formation,Ameloblastic fibrodentinoma,1
3151,Chronic lymphocytic inflammation,Temporal Lobe Pleomorphic Xanthoastrocytoma,1
3152,Carcinomatous Component Present,Retroperitoneal Carcinoma,1
3153,Diffuse Lesion,Meningeal Carcinomatosis,1
3154,Clinical TNM Finding,Clinical Stage II Esophageal Adenocarcinoma AJCC v8,1
3155,In Situ Lesion,Skin Squamous Cell Carcinoma In Situ,1
3156,Neuroectodermal Differentiation,Neuroblastoma of brain,1
3157,Malignant Cellular Infiltrate,Unresectable Ureter Urothelial Carcinoma,1
3158,Malignant Cellular Infiltrate,Recurrent Myelodysplastic Syndrome,1
3159,Carcinomatous Component Present,Acquired cystic disease associated renal cell carcinoma,1
3160,Extraosseous Lesion,Extraskeletal osteosarcoma non-metastatic,1
3161,Tubular Pattern,Malignant Pancreatic Somatostatinoma,1
3162,Diffuse Lesion,Papillomatosis,1
3163,Stromal Invasion,FIGO Stage IIIB Ovarian Cancer,1
3164,Malignant Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
3165,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
3166,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Renal Cell Carcinoma,1
3167,Carcinomatous Component Present,Refractory Small Intestinal Carcinoma,1
3168,Epithelial Component Present,Stage IIA Breast Carcinoma,1
3169,Malignant Cellular Infiltrate,Combined Lung Small Cell and Squamous Cell Carcinoma,1
3170,Absence of Stromal Invasion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
3171,Carcinomatous Component Present,Stage IVA Appendix Carcinoma AJCC v7,1
3172,Primary Lesion,Primary Systemic Amyloidosis,1
3173,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
3174,Unfavorable Clinical Outcome,B-lymphoblastic leukemia lymphoma BCR-ABL1-like,1
3175,Childhood Lesion,Refractory Childhood Acute Lymphoblastic Leukemia,1
3176,Epithelial Component Present,Stage I Adrenal Cortex Carcinoma AJCC v8,1
3177,Carcinomatous Component Present,Basal cell carcinoma - adenoid,1
3178,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor,1
3179,Malignant Cellular Infiltrate,Mediastinal Granulocytic Sarcoma,1
3180,Benign Cellular Infiltrate,Uterine Corpus Myxoid Leiomyoma,1
3181,Cutaneous Involvement,Hereditary Melanoma,1
3182,Carcinomatous Component Present,Ductal Carcinoma In Situ with Microinvasion,1
3183,Firm mass,Childhood Malignant Peripheral Nerve Sheath Tumor,1
3184,Malignant Cellular Infiltrate,Stage IV Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v7,1
3185,Malignant Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v8,1
3186,Erythema,Inflammatory carcinoma of breast stage III,1
3187,Microglandular Pattern,Cervical Microglandular Polyp,1
3188,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v7,1
3189,Carcinomatous Component Present,Pathologic Stage IB Esophageal Squamous Cell Carcinoma AJCC v8,1
3190,Neonatal Lesion,Neonatal leukemia,1
3191,Dysplasia,Flat adenoma,1
3192,Pseudolobular Pattern,Ovarian Sclerosing Stromal Tumor,1
3193,Indolent Clinical Course,Angiomyofibroblastoma,1
3194,Local disease,Localized Askin Tumor,1
3195,Refractory Disease,Refractory Malignant Endocrine Neoplasm,1
3196,Epithelial Component Present,Clear cell squamous cell carcinoma of skin,1
3197,Exophytic Polypoid Lesion,Tubular adenoma,1
3198,Malignant Cellular Infiltrate,Carcinoma in situ of prostate,1
3199,Cutaneous Involvement,Primary Cutaneous Follicle Center Lymphoma,1
3200,Carcinomatous Component Present,Esophageal Large Cell Neuroendocrine Carcinoma,1
3201,Epithelial Component Present,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
3202,Childhood Lesion,Childhood Rhabdomyosarcoma with Mixed Embryonal and Alveolar Features,1
3203,Epithelial Component Present,Stage II Vulvar Cancer AJCC v8,1
3204,High Grade Lesion,"Glioblastoma, IDH-Mutant",1
3205,Absence of Invasion,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
3206,Malignant Cellular Infiltrate,Malignant Lung Hilum Neoplasm,1
3207,Carcinomatous Component Present,Adenocarcinoma of Skene Gland Origin,1
3208,Epithelial Component Present,Fallopian Tube Papilloma,1
3209,Exophytic Papillary Lesion,verrucous carcinoma of vagina,1
3210,Cutaneous Involvement,Stage II Skin Cancer,1
3211,Carcinomatous Component Present,Breast Carcinoma,1
3212,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor,1
3213,High Grade Lesion,Unresectable Rhabdomyosarcoma,1
3214,Malignant Cellular Infiltrate,Gastric Burkitt Lymphoma,1
3215,Epithelial Component Present,Respiratory papilloma,1
3216,Clinical TNM Finding,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
3217,Epithelial Component Present,Recurrent Liver Carcinoma,1
3218,Malignant Cellular Infiltrate,"Mediastinal B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma",1
3219,Intraluminal Tumor Growth,Gallbladder papillary adenocarcinoma,1
3220,Malignant Cellular Infiltrate,Pleuropulmonary blastoma type II,1
3221,Unilineage Dysplasia Present,Refractory cytopenia with unilineage dysplasia,1
3222,Hereditary Lesion,Familial Nonmedullary Thyroid Gland Carcinoma,1
3223,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis,1
3224,Mixed Cellular Population,Stage IVB Uterine Corpus Adenosarcoma AJCC v8,1
3225,Absence of Invasion,Stage 0 Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
3226,Carcinomatous Component Present,Vaginal Undifferentiated Carcinoma,1
3227,Malignant Cellular Infiltrate,Immunodeficiency-Related Malignant Neoplasm,1
3228,Epithelial Component Present,Ovarian Granulosa-Stromal Cell Tumor,1
3229,Aggressive Clinical Course,Malignant Epithelioid Cell Type Gastrointestinal Stromal Tumor,1
3230,Mesenchymal Component Present,Mixed Salivary Gland Tumor,1
3231,Myxoid Stroma Formation,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vulva,1
3232,Primary Lesion,Cerebral Astrocytoma,1
3233,Epithelial Component Present,Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7,1
3234,Pathologic TNM Finding,Pathologic Stage 0 Esophageal Adenocarcinoma AJCC v8,1
3235,Malignant Cellular Infiltrate,Malignant germ cell neoplasm of mediastinum,1
3236,Cutaneous Involvement,Metastatic Dermatofibrosarcoma Protuberans,1
3237,Primary Lesion,Recurrent Childhood Anaplastic Oligodendroglioma,1
3238,Sarcomatous Component Present,Parotid Gland Carcinosarcoma,1
3239,Benign Cellular Infiltrate,Vulvar Congenital Melanocytic Nevus,1
3240,Infiltrative Growth Pattern,Recurrent Giant Cell Glioblastoma,1
3241,Benign Cellular Infiltrate,Broad Ligament Serous Adenofibroma,1
3242,High Mitotic Activity,"Leydig cell tumor, malignant",1
3243,Malignant Cellular Infiltrate,Primary malignant neoplasm,1
3244,Cutaneous Involvement,Acantholytic squamous cell carcinoma of skin,1
3245,Carcinomatous Component Present,Adenocarcinoma of salivary gland,1
3246,Epithelial Component Present,Adenocarcinoma of ampulla of Vater,1
3247,CDKN2A-p16 Negative,p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma,1
3248,Biphasic Pattern,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
3249,Malignant Cellular Infiltrate,leiomyosarcoma of mediastinum,1
3250,Epithelial Component Present,Lung Squamous Cell Carcinoma In Situ,1
3251,Recurrent disease,Anal cancer recurrent,1
3252,Multifocal Lesion,Central Nervous System Erdheim-Chester Disease,1
3253,Well-Circumscribed Lesion,Giant cell angiofibroma,1
3254,Diffuse Pattern,MCD Diffuse Large B-Cell Lymphoma,1
3255,Carcinomatous Component Present,Hilar Cholangiocarcinoma by AJCC v7 Stage,1
3256,Epithelial Component Present,Stage III Renal Pelvis Cancer AJCC v8,1
3257,Epithelial Component Present,Basal cell carcinoma of vulva,1
3258,Epithelial Component Present,Thyroid Gland Mucoepidermoid Carcinoma,1
3259,Carcinomatous Component Present,Stage I Hypopharyngeal Carcinoma AJCC v7,1
3260,Malignant Cellular Infiltrate,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,1
3261,Indolent Clinical Course,Intracranial lipoma,1
3262,Malignant Cellular Infiltrate,Pericardial Synovial Sarcoma,1
3263,Epithelial Component Present,Anatomic Stage I Breast Cancer AJCC v8,1
3264,Malignant Cellular Infiltrate,Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
3265,Carcinomatous Component Present,Maxillary Sinus Squamous Cell Carcinoma,1
3266,Epithelial Component Present,Non-small cell lung cancer stage III,1
3267,Cartilaginous Component Present,Osteochondromyxoma,1
3268,Well Differentiated Lesion,"Retinoblastoma, differentiated",1
3269,Carcinomatous Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
3270,Epithelial Component Present,Stage IIA Eyelid Carcinoma AJCC v8,1
3271,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
3272,Carcinomatous Component Present,Noninfiltrating Intraductal Carcinoma,1
3273,Epithelial Component Present,Non-squamous non-small cell lung cancer,1
3274,Low Cellularity Present,Adult Pilocytic Astrocytoma,1
3275,S-100-Positive Neoplastic Cells Present,Malignant Uterine Corpus PEComa,1
3276,Malignant Cellular Infiltrate,"Kaposi's sarcoma, metastatic",1
3277,Metastatic/Recurrent Disease,Clear Cell Sarcoma of Soft Tissue,1
3278,Carcinomatous Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
3279,Follicular Cell Differentiation,Papillary Thyroid Microcarcinoma,1
3280,Malignant Cellular Infiltrate,Choroid Spindle Cell Type A Melanoma,1
3281,Malignant Cellular Infiltrate,Intracranial Germinoma,1
3282,Lymphoplasmacytic Infiltrate,Childhood Brain Germinoma,1
3283,Malignant Cellular Infiltrate,Stage III Uterine Corpus Adenosarcoma AJCC v8,1
3284,Benign Cellular Infiltrate,Uterine Corpus Epithelioid Leiomyoma,1
3285,Pregnancy Complications,Stage IIIA Gestational Trophoblastic Tumor AJCC v7,1
3286,Serum IgM Monoclonal Gammopathy of Less than 30g/L,IgM monoclonal gammopathy of uncertain significance,1
3287,Malignant Cellular Infiltrate,undifferentiated carcinoma of appendix,1
3288,Metastatic Lesion,Melanoma of Unknown Primary,1
3289,Recurrent disease,Acute lymphoblastic leukemia recurrent,1
3290,Epithelial Component Present,Prostate Carcinoma by Gene Expression Profile,1
3291,Diffuse Pattern,Double expressor lymphoma,1
3292,Subcutaneous Involvement,"Histiocytoma, Angiomatoid Fibrous",1
3293,Adnexal Differentiation,Malignant Proliferating Pilar Tumor,1
3294,Epithelial Component Present,External Ear Basal Cell Carcinoma,1
3295,Malignant Cellular Infiltrate,Stage IV Skin Cancer,1
3296,Favorable Clinical Outcome,Colon Ganglioneuroma,1
3297,Ring Sideroblasts 15 Percent or More of Erythroid Precursors,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
3298,Epithelial Component Present,Seborrheic keratosis of eyelid,1
3299,Low Mitotic Activity,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
3300,Epithelial Component Present,Stage II Hepatocellular Carcinoma AJCC v8,1
3301,High Grade Lesion,Diffuse Blastoid B-Cell Lymphoma,1
3302,Malignant Cellular Infiltrate,Stage I Hepatocellular Carcinoma AJCC v8,1
3303,Mixed Cellular Population,Ovarian Serous Adenofibroma,1
3304,Carcinomatous Component Present,Stage IIA2 Cervical Cancer AJCC v7,1
3305,Multinodular Mass,Thyroid Angiosarcoma,1
3306,Infiltrating Tumor Margins Present,Stage IVA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
3307,Endophytic Tumor Growth,Buccal Mucosa Verrucous Carcinoma,1
3308,Carcinomatous Component Present,Acinic Cell Breast Carcinoma,1
3309,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
3310,Abundance of Small Lymphocytes,Lymphocyte Rich Classical Hodgkin Lymphoma,1
3311,Malignant Cellular Infiltrate,"NK-Cell Lymphoma, Unclassifiable",1
3312,Malignant Cellular Infiltrate,B-Cell Non-Hodgkin Lymphoma by Ann Arbor Stage,1
3313,Adulthood Lesion,Adult Acute Lymphocytic Leukemia,1
3314,Indolent Clinical Course,Benign neoplasm of oral cavity,1
3315,Benign Cellular Infiltrate,Pyogenic granuloma of skin and subcutaneous tissue,1
3316,Secondary Lesion,Radiation-Related Osteosarcoma,1
3317,Malignant Cellular Infiltrate,Neuroblastomas of the Adrenal Gland and Sympathetic Nervous System,1
3318,Epithelial Component Present,Prognostic Stage III Breast Cancer AJCC v8,1
3319,Malignant Cellular Infiltrate,ALK positive large B-cell lymphoma,1
3320,Cartilaginous Differentiation,Central Nervous System Chondroma,1
3321,Carcinomatous Component Present,Low grade appendiceal mucinous neoplasm,1
3322,Primary Lesion,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
3323,Malignant Cellular Infiltrate,ROSE Cluster 1,1
3324,Carcinomatous Component Present,Ampulla of Vater Mixed Adenoneuroendocrine Carcinoma,1
3325,Malignant Cellular Infiltrate,"Thymoma, type B3",1
3326,Malignant Cellular Infiltrate,Primary cerebral lymphoma,1
3327,Malignant Cellular Infiltrate,Stage II Bladder Cancer AJCC v6 and v7,1
3328,Borderline Lesion,Grade I Lymphomatoid Granulomatosis,1
3329,Epithelial Component Present,Adenocarcinoma in adenomatous polyposis coli,1
3330,Regional Disease,Regional Adrenal Gland Pheochromocytoma,1
3331,Absence of Invasion,Pathologic Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8,1
3332,Anaplasia,Giant cell carcinoma of lung,1
3333,Cutaneous Involvement,Invasive Apocrine Breast Carcinoma,1
3334,Intraductal Lesion,Pancreatic Intraductal Neoplasms,1
3335,Carcinomatous Component Present,Unresectable Adrenal Cortex Carcinoma,1
3336,Ionizing Radiation Toxicity,Ionizing Radiation-Related Malignant Neoplasm,1
3337,Cutaneous Involvement,Lentigo maligna recurrent,1
3338,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8,1
3339,Calcitonin serum level increased,Recurrent Thyroid Gland Medullary Carcinoma,1
3340,Collagenous Stroma Formation,Mammary-Type Myofibroblastoma,1
3341,Malignant Cellular Infiltrate,Periosteal Osteosarcoma,1
3342,Epithelial Component Present,Stage I Thyroid Gland Follicular Carcinoma AJCC v7,1
3343,Carcinomatous Component Present,Small cell carcinoma of ovary,1
3344,Squamous Metaplasia of Malignant Cells Present,adenocarcinoma of breast with squamous metaplasia,1
3345,Malignant Cellular Infiltrate,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
3346,Malignant Cellular Infiltrate,Malignant ovarian cyst,1
3347,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
3348,Anaplasia,Glioblastoma,1
3349,Refractory Disease,Refractory Mediastinal Lymphoma,1
3350,Cutaneous Involvement,Non-Neoplastic Hair Disorder,1
3351,Vascular Channel Formation,Metastatic Epithelioid Hemangioendothelioma,1
3352,More than 5 Mitoses per 50HPF,Stage IB Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
3353,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
3354,Well Differentiated Neuroendocrine Lesion,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
3355,Carcinomatous Component Present,Carcinoma of ampulla of Vater,1
3356,Papillary Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
3357,Epithelial Component Present,Prostate Neuroendocrine Neoplasm,1
3358,Indolent Clinical Course,Benign Glomus Tumor,1
3359,Absence of Invasion,Bladder squamous cell carcinoma stage 0,1
3360,Malignant Cellular Infiltrate,Primary Cutaneous Plasmablastic Lymphoma,1
3361,Carcinomatous Component Present,Adenocarcinoma of anal glands,1
3362,Cutaneous Involvement,Stage IVA Basal Cell Lip Carcinoma,1
3363,Epithelial Component Present,Verrucous carcinoma of the oral cavity recurrent,1
3364,Carcinomatous Component Present,squamous cell carcinoma of ovary,1
3365,Epithelial Component Present,Rectal Micropapillary Adenocarcinoma,1
3366,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
3367,Malignant Cellular Infiltrate,Stage 0 Intrahepatic Bile Duct Cancer AJCC v8,1
3368,Neuroendocrine Differentiation,Thymic Atypical Carcinoid Tumor,1
3369,Blasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myelomonocytic Leukemia,1
3370,Vascular Channel Formation,Peripheral Intraneural Angiosarcoma,1
3371,Blasts Expressing CD56 and Immature T-Cell Markers Present,NK-lymphoblastic leukemia/lymphoma,1
3372,Well-Circumscribed Lesion,Stage IV Kidney Wilms Tumor,1
3373,Tubular Pattern,Pancreatic Intraductal Tubulopapillary Neoplasm,1
3374,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
3375,Epithelial Component Present,Human Papillomavirus-Related Urethral Squamous Cell Carcinoma,1
3376,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Liver,1
3377,Childhood Lesion,Childhood Central Nervous System Immature Teratoma,1
3378,Well Differentiated Neuroendocrine Lesion,Meckel Diverticulum Neuroendocrine Tumor G1,1
3379,Dysplasia,"Glandular intraepithelial neoplasia, low grade",1
3380,Cutaneous Involvement,Precancerous skin lesion,1
3381,Keratin pearl formation,Skin Pseudovascular Squamous Cell Carcinoma,1
3382,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ovary,1
3383,Regional Disease,Urethral cancer regional,1
3384,Poorly Differentiated Lesion,Recurrent Pancreatic Neuroendocrine Carcinoma,1
3385,Malignant Cellular Infiltrate,carcinosarcoma of extrahepatic bile duct,1
3386,Nuclear Molding,Stage III Lung Small Cell Carcinoma AJCC v7,1
3387,Epithelial Component Present,Stage IIIA Hilar Cholangiocarcinoma AJCC v8,1
3388,Metastatic Lesion,Metastatic hepatocellular carcinoma,1
3389,Recurrent disease,Recurrent Giant Cell Glioblastoma,1
3390,Malignant Cellular Infiltrate,Malignant melanoma of retina,1
3391,Benign Cellular Infiltrate,Giant Cell Lesion of Small Bones,1
3392,Malignant Cellular Infiltrate,Malignant neoplasm of clitoris,1
3393,Epithelial Component Present,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
3394,Adulthood Lesion,Adult Anaplastic Oligodendroglioma,1
3395,Malignant Cellular Infiltrate,Small cell carcinoma of ovary,1
3396,Epithelial Component Present,Bladder transitional cell carcinoma stage III,1
3397,Increased Cellularity Present,Undifferentiated Neuroblastoma,1
3398,High Mitotic Activity,Recurrent Anaplastic Oligodendroglioma,1
3399,Carcinomatous Component Present,Squamous cell breast carcinoma,1
3400,Diffuse Pattern,Grade III Lymphomatoid Granulomatosis,1
3401,Malignant Cellular Infiltrate,Pancreatic Cancer by AJCC v8 Stage,1
3402,Malignant Cellular Infiltrate,Orbital Melanoma,1
3403,Slow Growing Mass,Ganglioglioma,1
3404,Malignant Cellular Infiltrate,Minor Salivary Gland Mucoepidermoid Carcinoma,1
3405,Benign Cellular Infiltrate,Senile angioma,1
3406,Neoplastic Plasma Cells Present in Bone Marrow,Smoldering myeloma,1
3407,Borderline Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
3408,Epithelial Component Present,Malignant neoplasm of stomach stage IV,1
3409,Moderate dysplasia,Moderate epithelial dysplasia,1
3410,Drug Exposure,Alkylating Agent-Related Acute Myeloid Leukemia,1
3411,Epithelial Component Present,Stage IIIC Eyelid Carcinoma AJCC v7,1
3412,Well Differentiated Lesion,Conventional Schwannoma,1
3413,Carcinomatous Component Present,Distal Esophagus Adenocarcinoma,1
3414,Carcinomatous Component Present,Salivary gland carcinoma,1
3415,Aggressive Clinical Course,Malignant mastocytosis,1
3416,Myxoid Changes Present,Dermal nerve sheath myxoma,1
3417,Malignant Cellular Infiltrate,Stage IVB Mycosis Fungoides and Sezary Syndrome AJCC v8,1
3418,Epithelial Component Present,Metastatic Carcinoma in the Adrenal Medulla,1
3419,atypia morphology,Borderline Ovarian Serous Tumor with Microinvasion,1
3420,Epithelial Component Present,Pathologic Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
3421,Non-Contiguous Disease,Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma,1
3422,Primary Lesion,Early Hepatocellular Carcinoma,1
3423,Carcinomatous Component Present,Clinical Stage II Gastric Cancer AJCC v8,1
3424,Tubular Pattern,Ampulla of Vater Tubulovillous Adenoma,1
3425,Carcinomatous Component Present,Stage IA Lung Small Cell Carcinoma AJCC v7,1
3426,Diffuse Pattern,"Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type",1
3427,Epithelial Component Present,adenocarcinoma of breast with spindle cell metaplasia,1
3428,Immunosuppression-Related Post-Transplant Toxicity,Post-transplant lymphoproliferative disorder,1
3429,Carcinomatous Component Present,undifferentiated carcinoma of gallbladder,1
3430,Mucoid Stroma Formation,Microcystic meningioma,1
3431,Cystic Lesion,Childhood Craniopharyngioma,1
3432,Epithelial Component Present,Adenocarcinoma in tubular adenoma,1
3433,Carcinomatous Component Present,Merkel Cell Carcinoma by AJCC v8 Stage,1
3434,Carcinomatous Component Present,Squamous cell carcinoma,1
3435,Metastatic Lesion,Refractory Metastatic Digestive System Carcinoma,1
3436,Hyperkeratosis,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
3437,Malignant Cellular Infiltrate,Overt Primary Myelofibrosis,1
3438,Slow Growing Mass,Recurrent Olfactory Neuroblastoma,1
3439,Increased Cellularity Present,Neuroblastoma recurrent,1
3440,Papillary Pattern,Mixed Type Pancreatic Intraductal Papillary-Mucinous Neoplasm,1
3441,High Grade Lesion,Stage IIIB Lung Small Cell Carcinoma without Pleural Effusion AJCC v7,1
3442,Edematous Stroma Formation,Testicular Spermatocytic Seminoma with Sarcoma,1
3443,Cutaneous Involvement,Pagetoid reticulosis,1
3444,Biphasic Pattern,carcinosarcoma of liver,1
3445,Microcystic Change,Lymphangioma circumscriptum,1
3446,Malignant Cellular Infiltrate,Stage III Prostate Cancer AJCC v7,1
3447,Malignant Cellular Infiltrate,Unresectable Extrahepatic Bile Duct Carcinoma,1
3448,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v8 Stage,1
3449,Granulocytes Increased in Bone Marrow,Prefibrotic/Early Primary Myelofibrosis,1
3450,Epithelial Component Present,Virus-Related Carcinoma,1
3451,Collagenous Stroma Formation,Malignant Kidney Mixed Epithelial and Stromal Tumor,1
3452,Carcinomatous Component Present,Stage IV Pancreatic Cancer AJCC v6 and v7,1
3453,Local disease,Intracranial lipoma,1
3454,Monomorphic Cellular Infiltrate,Vaginal Basaloid Carcinoma,1
3455,Metastatic Lesion,Stage IV Esophageal Adenocarcinoma,1
3456,Carcinomatous Component Present,Stage IIC Fallopian Tube Cancer AJCC v6 and v7,1
3457,Malignant Cellular Infiltrate,Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
3458,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma,1
3459,Epithelial Component Present,Vaginal Mesonephric Adenocarcinoma,1
3460,Hyaline Cartilage Differentiation,Chondroma,1
3461,Epithelial Component Present,Refractory Thyroid Gland Carcinoma,1
3462,Refractory Disease,Refractory Glioblastoma,1
3463,Epithelial Component Present,Colorectal Micropapillary Adenocarcinoma,1
3464,Tissue Differentiation Uncertain,Pleural Synovial Sarcoma,1
3465,Postneoadjuvant Therapy Pathologic TNM Finding,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
3466,Pain,Malignant Osteoclastic Giant Cell-Rich Tumor of Bone,1
3467,Epithelial Component Present,Unresectable Thymic Carcinoma,1
3468,Epithelial Component Present,Stage I Rectal Cancer AJCC v8,1
3469,Microfollicular Structures Present,Microfollicular adenoma,1
3470,Carcinomatous Component Present,Recurrent Metastatic Squamous Cell Carcinoma in the Neck with Occult Primary,1
3471,Bone Marrow Dysplasia Present,Refractory cytopenia with multilineage dysplasia and ringed sideroblasts,1
3472,Fibrotic Stroma Formation,Resectable Pancreatic Ductal Adenocarcinoma,1
3473,Malignant Cellular Infiltrate,Stage II AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
3474,Malignant Cellular Infiltrate,Intraductal Cribriform Breast Adenocarcinoma,1
3475,Indolent Clinical Course,Deep Lipoma,1
3476,Benign Cellular Infiltrate,Benign neoplasm of female breast,1
3477,Malignant Cellular Infiltrate,Resectable Renal Cell Carcinoma,1
3478,Trabecular Pattern,Moderately Differentiated Hepatocellular Carcinoma,1
3479,Papillary Pattern,Plantar Verrucous Skin Carcinoma,1
3480,Secondary Lesion,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
3481,Dilated Vascular Space Formation,Glomangioma,1
3482,Malignant Cellular Infiltrate,Stage I Pancreatic Cancer AJCC v6 and v7,1
3483,Malignant Cellular Infiltrate,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant without Heterologous Elements",1
3484,Epithelial Component Present,Adenocarcinoma of rete ovarii,1
3485,Malignant Cellular Infiltrate,Malignant neoplasm of middle third of esophagus,1
3486,Poorly Differentiated Neuroendocrine Lesion,small cell carcinoma of gallbladder,1
3487,Malignant Cellular Infiltrate,Colorectal Small Cell Neuroendocrine Carcinoma,1
3488,Unicystic Lesion,intraductal papilloma of salivary gland,1
3489,Borderline Lesion,Borderline Ovarian Mucinous Tumor,1
3490,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of bladder,1
3491,Well-Circumscribed Lesion,Familial medullary thyroid carcinoma,1
3492,Malignant Cellular Infiltrate,High Grade Broad Ligament Serous Adenocarcinoma,1
3493,Malignant Cellular Infiltrate,Childhood Neuroblastoma,1
3494,Tissue of Mullerian Origin Present,Borderline Ovarian Clear Cell Cystadenofibroma,1
3495,Epithelial Component Present,Carcinoma of anal margin,1
3496,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v6 Stage,1
3497,Myxoid Stroma Formation,Chondroid lipoma,1
3498,Monomorphic Cellular Infiltrate,Cellular Ependymoma,1
3499,In Situ Lesion,Pathologic Stage 0 Gastric Cancer AJCC v8,1
3500,Carcinomatous Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
3501,Infiltrative Growth Pattern,Neural Glioblastoma,1
3502,Epithelial Component Present,Appendix adenoma,1
3503,Cutaneous Involvement,Eccrine carcinoma of skin,1
3504,Epithelial Component Present,Vaginal Adenoma,1
3505,Carcinomatous Component Present,Carcinoma ex pleomorphic adenoma of lacrimal gland,1
3506,Tubular Structures Present,Benign mixed epithelial and stromal tumor of kidney,1
3507,Human Papillomavirus Positive,Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,1
3508,Epithelial Component Present,Stage II Vulvar Cancer AJCC v7,1
3509,Carcinomatous Component Present,Adenosquamous cell lung cancer stage IV,1
3510,Metastatic Lesion,Advanced Extracranial Malignant Solid Neoplasm,1
3511,Carcinomatous Component Present,Ovarian Serous Adenocarcinoma,1
3512,Malignant Cellular Infiltrate,Malignant neoplasm tonsil,1
3513,Papillary Pattern,Noninfiltrating intraductal papillary adenocarcinoma,1
3514,Malignant Cellular Infiltrate,Rectosigmoid cancer,1
3515,Mature Neutrophils Present,Differentiated Granulocytic Sarcoma,1
3516,Epithelial Component Present,Papillary squamous cell carcinoma,1
3517,Koilocytotic atypia,Human Papillomavirus-Related Squamous Cell Carcinoma,1
3518,Adulthood Lesion,Ann Arbor Stage III Aggressive Adult Non-Hodgkin Lymphoma,1
3519,Hereditary Lesion,"FANCONI ANEMIA, COMPLEMENTATION GROUP D1",1
3520,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Liver,1
3521,Carcinomatous Component Present,Metastatic Triple-Negative Breast Carcinoma,1
3522,Composite Lesion,"Ganglioneuroblastoma, Nodular",1
3523,Nodular and Diffuse Pattern,Large B-cell lymphoma with IRF4 rearrangement,1
3524,atypia morphology,Actinic keratosis,1
3525,Carcinomatous Component Present,Appendix Mixed Adenoneuroendocrine Carcinoma,1
3526,Non-Invasive Lesion,Bladder Non-Invasive Urothelial Neoplasm,1
3527,Epithelial Component Present,Adrenal Cortex Carcinoma by ENSAT Stage,1
3528,Epithelial Component Present,Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8,1
3529,Carcinomatous Component Present,Renal Pelvis Cancer by AJCC v7 Stage,1
3530,Childhood Lesion,Childhood Osteosarcoma,1
3531,Immunologic Deficiency Syndromes,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
3532,Childhood Lesion,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
3533,Neuroendocrine Differentiation,Extrahepatic Bile Duct Neuroendocrine Tumor G2,1
3534,High Grade Lesion,Orbital Alveolar Soft Part Sarcoma,1
3535,Carcinomatous Component Present,Stage I Colon Cancer AJCC v8,1
3536,Epithelial Component Present,Stage IIA Rectal Neuroendocrine Tumor AJCC v8,1
3537,Epithelial Component Present,adenoid cystic carcinoma of pharynx,1
3538,Malignant Cellular Infiltrate,Stage IIIA Gastric Carcinoma,1
3539,Carcinomatous Component Present,Laryngeal Mucoepidermoid Carcinoma,1
3540,Neuroectodermal Differentiation,Stage 2 Neuroblastoma,1
3541,Benign Cellular Infiltrate,Cervical Adenofibroma,1
3542,Epithelial Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
3543,Malignant Cellular Infiltrate,Stage IA Pleural Malignant Mesothelioma AJCC v8,1
3544,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor with Mesenchymal Differentiation,1
3545,Childhood Lesion,Childhood Atypical Choroid Plexus Papilloma,1
3546,Refractory Disease,Acute myeloid leukemia refractory,1
3547,Malignant Cellular Infiltrate,Testicular embryonal carcinoma stage II,1
3548,Well Differentiated Lesion,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
3549,Slow Growing Mass,Cellular Ependymoma,1
3550,Carcinomatous Component Present,Childhood Salivary Gland Carcinoma,1
3551,Malignant Cellular Infiltrate,Breast cancer recurrent,1
3552,Stromal Invasion,Recurrent Ovarian Adenocarcinoma,1
3553,Microvascular Proliferation,Neural Glioblastoma,1
3554,Epithelial Component Present,Stage IIIA Esophageal Adenocarcinoma AJCC v7,1
3555,Epithelial Component Present,Vulval intraepithelial neoplasia grade 2,1
3556,Epithelial Component Present,Cloacogenic carcinoma,1
3557,Tubular Pattern,Vulvar Syringoma,1
3558,Malignant Cellular Infiltrate,Stage IV Hypopharyngeal Carcinoma AJCC v8,1
3559,Microvascular Proliferation,Pilocytic Astrocytoma,1
3560,Pseudoencapsulated Mass,Malignant Peripheral Nerve Sheath Tumor,1
3561,Malignant Cellular Infiltrate,Primary cutaneous lymphoma,1
3562,Myxoid Stroma Formation,Central Nervous System Epithelioid Hemangioendothelioma,1
3563,Malignant Cellular Infiltrate,Intestinal T-cell lymphoma stage IV,1
3564,Recurrent disease,Recurrent Metastatic Malignant Neoplasm,1
3565,Epithelial Component Present,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
3566,Carcinomatous Component Present,clear cell adenocarcinoma of urethra,1
3567,Epithelial Component Present,Stage IB Vulvar Cancer AJCC v7,1
3568,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Papillary Pattern",1
3569,Tissue Differentiation Uncertain,Alveolar Soft Part Sarcoma,1
3570,Carcinomatous Component Present,Postneoadjuvant Therapy Stage IV Esophageal Adenocarcinoma AJCC v8,1
3571,CD56-Positive Neoplastic Cells Present,Nasal Type NK/T-Cell Lymphoma by Ann Arbor Stage,1
3572,Refractory Disease,Refractory WHO Grade II Glioma,1
3573,Benign Cellular Infiltrate,Intramuscular lipoma,1
3574,Organoid Pattern,Adult Alveolar Soft Part Sarcoma,1
3575,Epithelial Component Present,"Leydig cell tumor, malignant",1
3576,High Mitotic Activity,Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
3577,Papillary Pattern,Cervical Verrucous Carcinoma,1
3578,Metastatic Lesion,Medulloblastoma with Leptomeningeal Spread,1
3579,Cutaneous Involvement,Mycosis fungoides stage IV,1
3580,Malignant Cellular Infiltrate,Clear Cell Hepatocellular Carcinoma,1
3581,Recurrent disease,Small cell lung cancer recurrent,1
3582,Floret-Like Pattern,Pleomorphic Lipoma,1
3583,Carcinomatous Component Present,Carcinoma of sublingual gland,1
3584,Malignant Cellular Infiltrate,Stage I Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7,1
3585,Malignant Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
3586,Firm mass,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
3587,High Mitotic Activity,large cell neuroendocrine carcinoma of bladder,1
3588,Myxoid Stroma Formation,Chondromyxoid fibroma,1
3589,Adnexal Differentiation,Trichoadenoma,1
3590,Absence of Invasion,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
3591,Malignant Cellular Infiltrate,Cardiac Malignant Fibrous Histiocytoma,1
3592,Malignant Cellular Infiltrate,"Acute Leukemia of Ambiguous Lineage, Not Otherwise Specified",1
3593,Cutaneous Involvement,Type B Tylosis,1
3594,Malignant Cellular Infiltrate,"Glycogen-Rich, Clear Cell Breast Carcinoma",1
3595,Infiltrative Growth Pattern,Small cell glioblastoma,1
3596,Carcinomatous Component Present,Stage 0 Lung Adenocarcinoma AJCC v6 and v7,1
3597,Malignant Cellular Infiltrate,Core binding factor acute myeloid leukemia,1
3598,Rapidly Enlarging Mass,Rhabdomyosarcoma,1
3599,Tissue Differentiation Uncertain,Ovarian Myxoma,1
3600,Vascular Channel Formation,Brain Hemangioma,1
3601,Well Differentiated Lesion,Stage IVB Laryngeal Verrucous Carcinoma AJCC v7,1
3602,Invasive Lesion,Pituitary carcinoma,1
3603,Epithelial Component Present,Stage IVC Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
3604,Severe dysplasia,Stage 0 Colon Cancer AJCC v6 and v7,1
3605,Neuroendocrine Differentiation,Extra-Adrenal Retroperitoneal Paraganglioma,1
3606,Epithelial Component Present,adenosquamous carcinoma of breast,1
3607,atypia morphology,External Ear Actinic Keratosis,1
3608,Epithelial Component Present,Nasal Cavity and Paranasal Sinus Cancer by AJCC v6 Stage,1
3609,Malignant Cellular Infiltrate,Cutaneous Melanoma of the Extremity,1
3610,Malignant Cellular Infiltrate,Plasma cell myeloma refractory,1
3611,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with t(11;17)(q13;q21),1
3612,Erythema,Inflammatory carcinoma of breast stage IV,1
3613,Thyroglobulin Positive Neoplastic Cells Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
3614,Absence of Stromal Invasion,Fallopian Tube Metaplastic Papillary Tumor,1
3615,Immunologic Deficiency Syndromes,AIDS-Related Non-Hodgkin Lymphoma of the Cervix,1
3616,Juvenile Lesion,Scheuermann's Disease,1
3617,Capillary Sized Vascular Channel Formation,Epithelioid hemangioma of skin,1
3618,Carcinomatous Component Present,Metastatic Triple-Negative Breast Carcinoma,1
3619,Nuclear Pseudoinclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
3620,CD30-Positive Neoplastic Cells Present,"lymphomatoid papulosis, type A",1
3621,Malignant Cellular Infiltrate,Esophageal Rhabdomyosarcoma,1
3622,Osseous Differentiation,Asynchronous Multifocal Osteosarcoma,1
3623,Malignant Cellular Infiltrate,Recurrent Primary Amyloidosis,1
3624,Pathologic TNM Finding,Pathologic Stage IB Esophageal Adenocarcinoma AJCC v8,1
3625,Epithelial Component Present,Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall,1
3626,Epithelial Component Present,Stage IA Esophageal Cancer AJCC v7,1
3627,Acanthosis,Cervical Verrucous Carcinoma,1
3628,Malignant Cellular Infiltrate,Recurrent Classic Hodgkin Lymphoma,1
3629,Glandular Pattern,Lung Enteric Adenocarcinoma,1
3630,Carcinomatous Component Present,Human Papillomavirus-Related Anal Squamous Cell Carcinoma,1
3631,Angiodestructive Pattern,Lymphomatoid Granulomatosis,1
3632,Fibrotic Stroma Formation,Intermediate Grade Salivary Gland Mucoepidermoid Carcinoma,1
3633,Locally Aggressive Lesion,"Ossifying fibromyxoid tumor, malignant",1
3634,Benign Cellular Infiltrate,Hemangioma acquired,1
3635,Malignant Cellular Infiltrate,Mantle cell lymphoma stage III,1
3636,Antoni A Pattern,Jugular Foramen Schwannoma,1
3637,Childhood Lesion,Childhood T Lymphoblastic Lymphoma,1
3638,Fibrotic Stroma Formation,Fibrolipoma,1
3639,More than 10 Mitoses per 10HPF,Combined Lung Small Cell Carcinoma and Lung Adenocarcinoma,1
3640,Odontogenic Cysts,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
3641,Malignant Cellular Infiltrate,leiomyosarcoma of anus,1
3642,Pseudorosette Formation,Pancreatic Gastrin-Producing Neuroendocrine Tumor,1
3643,Carcinomatous Component Present,Invasive Ductal and Lobular Carcinoma,1
3644,Hyperplastic Tissue Present,Atypical Breast Myoepitheliosis,1
3645,Intestinal metaplasia,Vaginal Adenoma,1
3646,Mallory Bodies,Acute alcoholic liver disease,1
3647,Immunologic Deficiency Syndromes,AIDS-Related Gastric Kaposi Sarcoma,1
3648,Nerve palsy,Cranial nerve palsies,1
3649,Malignant Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
3650,Anaplasia,Glioblastoma,1
3651,Low Grade Lesion,Metastatic Epithelioid Hemangioendothelioma,1
3652,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v7 Stage,1
3653,Malignant Cellular Infiltrate,Stage III Hepatocellular Carcinoma AJCC v8,1
3654,Benign Cellular Infiltrate,Cystadenofibroma of fallopian tube,1
3655,Secondary Lesion,Metastatic Neoplasm to the Bladder,1
3656,Adulthood Lesion,Cutaneous Adult T-Cell Leukemia/Lymphoma,1
3657,Hereditary Lesion,Schwannomatosis,1
3658,Carcinomatous Component Present,"Carcinoma, Skin Appendage",1
3659,Myxoid Stroma Formation,Intracranial Extraskeletal Myxoid Chondrosarcoma,1
3660,Regional Disease,Locally Advanced Unresectable Bone Sarcoma,1
3661,Microvascular Proliferation,Neural Glioblastoma,1
3662,Painless Mass,chondroma of lung,1
3663,Malignant Cellular Infiltrate,Stage IVB Fallopian Tube Cancer AJCC v8,1
3664,Malignant Cellular Infiltrate,Malignant tenosynovial giant cell tumor,1
3665,Epithelial Component Present,Hepatitis Virus-Related Hepatocellular Carcinoma,1
3666,Multinodular Mass,Angiosarcoma of liver,1
3667,Regional Disease,Locally Advanced Soft Tissue Sarcoma,1
3668,Malignant Cellular Infiltrate,Stage IIIA Hilar Cholangiocarcinoma AJCC v7,1
3669,Malignant Cellular Infiltrate,Refractory Hematologic Malignancy,1
3670,Less than 2 Mitoses per 10HPF,Lung Typical Carcinoid Tumor,1
3671,Carcinomatous Component Present,Recurrent Adult Hepatocellular Carcinoma,1
3672,In Situ Lesion,Stage 0 Pancreatic Cancer AJCC v6 and v7,1
3673,Anaplasia,"Carcinoma, Spindle-Cell",1
3674,Childhood Lesion,Recurrent Childhood Protoplasmic Astrocytoma,1
3675,Cutaneous Involvement,Dartoic myoma,1
3676,Epithelial Component Present,Gastric Pylorus Carcinoma,1
3677,Carcinomatous Component Present,Lower Gingival Squamous Cell Carcinoma,1
3678,Malignant Cellular Infiltrate,Ann Arbor Stage IA Hodgkin Lymphoma,1
3679,Low Grade Lesion,Low Grade Liver Dysplastic Nodule,1
3680,Malignant Cellular Infiltrate,Bladder transitional cell carcinoma stage IV,1
3681,High Grade Lesion,Adult Brain Stem Gliosarcoma,1
3682,Malignant Cellular Infiltrate,Thyroid Lymphoma,1
3683,Epithelial Component Present,Ampulla of Vater Cancer by AJCC v7 Stage,1
3684,Invasive Lesion,Metaplastic carcinoma of breast,1
3685,Local disease,Fibromyxolipoma,1
3686,Malignant Cellular Infiltrate,Intestinal T-Cell Lymphoma,1
3687,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Childhood Choriocarcinoma,1
3688,Perineural spread,Adenoid cystic carcinoma of the oral cavity,1
3689,Malignant Cellular Infiltrate,Intrahepatic Bile Duct Cancer by AJCC v8 Stage,1
3690,Malignant Cellular Infiltrate,Stage II Bone Cancer AJCC v8,1
3691,Epithelial Component Present,Stage IA Ampulla of Vater Cancer AJCC v7,1
3692,Metastatic Lesion,Secondary Central Nervous System Lymphoma,1
3693,Malignant Cellular Infiltrate,Malignant tumor of renal pelvis,1
3694,Invasive Lesion,lipid-rich carcinoma of breast,1
3695,Epithelial Component Present,Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7,1
3696,Epithelial Component Present,verrucous carcinoma of esophagus,1
3697,Epithelial Component Present,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
3698,Slow Growing Mass,Childhood Myxopapillary Ependymoma,1
3699,Microvascular Proliferation,Supratentorial Glioblastoma,1
3700,Malignant Cellular Infiltrate,Laryngeal Adenosquamous Carcinoma,1
3701,Malignant Cellular Infiltrate,fibrosarcoma of soft tissue,1
3702,Refractory Disease,Refractory WHO Grade III Glioma,1
3703,Malignant Cellular Infiltrate,Recurrent Chronic Myelomonocytic Leukemia,1
3704,Thyroglobulin Positive Neoplastic Cells Present,Stage IVB Thyroid Gland Follicular Carcinoma AJCC v8,1
3705,Non-Invasive Lesion,Renal Pelvis Inverted Papilloma,1
3706,Recurrent disease,Recurrent Acute Leukemia,1
3707,Hemorrhagic,Adrenal Gland Angiosarcoma,1
3708,Well Differentiated Neuroendocrine Lesion,"Glucagonoma, malignant",1
3709,High Grade Lesion,Spindle Cell/Sclerosing Rhabdomyosarcoma,1
3710,Epithelial Component Present,Recurrent Pancreatic Ductal Adenocarcinoma,1
3711,Indolent Clinical Course,chondroma of lung,1
3712,Malignant Cellular Infiltrate,Gastric carcinoma stage IV,1
3713,Malignant Cellular Infiltrate,Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
3714,Mixture of Germ Cell Neoplastic Components Present,Testicular germ cell tumor mixed stage I,1
3715,Malignant Germinomatous Cellular Infiltrate,"Testicular Seminoma, Cribriform Variant",1
3716,Malignant Cellular Infiltrate,Stage IA1 Cervical Cancer AJCC v8,1
3717,Malignant Cellular Infiltrate,Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
3718,Malignant Cellular Infiltrate,Stage IV Adult Burkitt Lymphoma,1
3719,Mixed Cellular Population,Pituitary Gland Mixed Gangliocytoma-Adenoma,1
3720,Malignant Cellular Infiltrate,Anaplastic thyroid carcinoma,1
3721,Perineural spread,Hard Palate Adenoid Cystic Carcinoma,1
3722,Epithelial Component Present,Advanced Cervical Carcinoma,1
3723,Thick-Walled Hyalinized Vessels Present,Schwannoma of the Twelfth Cranial Nerve,1
3724,Epithelial Component Present,Stage II Prostate Carcinoma,1
3725,Neuroendocrine Differentiation,Small cell lung cancer extensive stage,1
3726,Papillary Pattern,Invasive micropapillary carcinoma of breast,1
3727,Malignant Cellular Infiltrate,Stage 0 Major Salivary Gland Cancer AJCC v8,1
3728,Malignant Cellular Infiltrate,Stage I Childhood Anaplastic Large Cell Lymphoma,1
3729,Humoral hypercalcemia of malignancy (disorder),"Metastatic Ovarian Small Cell Carcinoma, Hypercalcemic Type",1
3730,Adulthood Lesion,Adult Yolk Sac Tumor,1
3731,Refractory Disease,Refractory Neurofibromatosis Type 1,1
3732,Vascular Channel Formation,lymphangiosarcoma,1
3733,Malignant Cellular Infiltrate,Grade 1 Diffuse Follicular Lymphoma,1
3734,Epithelial Component Present,Prognostic Stage IA Breast Cancer AJCC v8,1
3735,Recurrent disease,Recurrent Nevus,1
3736,No Identifiable Line of Differentiation,Unresectable Undifferentiated Pleomorphic Sarcoma,1
3737,Benign Cellular Infiltrate,Childhood Cystic Nephroma,1
3738,Malignant Cellular Infiltrate,"Recurrent Cervical Mucinous Adenocarcinoma, Endocervical Type",1
3739,Peripheral Nuclear Palisading,Small cell lung cancer extensive stage,1
3740,Epithelial Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma,1
3741,Breast Microcalcification,Recurrent Childhood Oligodendroglioma,1
3742,Carcinomatous Component Present,Hormone refractory prostate cancer,1
3743,Neuroendocrine Differentiation,Breast Neuroendocrine Neoplasm,1
3744,Indolent Clinical Course,Superficial angiomyxoma,1
3745,Carcinomatous Component Present,Carcinoma of Cowper Glands,1
3746,In Situ Lesion,"Stage 0 Laryngeal Verrucous Carcinoma AJCC v6, v7, and v8",1
3747,Cutaneous Involvement,Malignant Cutaneous Granular Cell Tumor,1
3748,Epithelial Component Present,Contralateral Breast Carcinoma,1
3749,Epithelial Component Present,Testicular gonadoblastoma,1
3750,Mixed Cellular Population,Childhood Anaplastic Oligoastrocytoma,1
3751,Epithelial Component Present,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
3752,Cutaneous Involvement,Impetigo,1
3753,Carcinomatous Component Present,Esophageal Squamous Cell Carcinoma by AJCC v7 Stage,1
3754,Malignant Cellular Infiltrate,Childhood Bladder Carcinoma,1
3755,Unresectable Mass,Unresectable Pancreatic Neuroendocrine Carcinoma,1
3756,Adulthood Lesion,Adult Anaplastic Astrocytoma,1
3757,Mixture of Germ Cell Neoplastic Components Present,Sellar Mixed Germ Cell Tumor,1
3758,Malignant Cellular Infiltrate,Primary leiomyosarcoma,1
3759,Metastatic Lesion,Lung squamous cell carcinoma stage IV,1
3760,Malignant Cellular Infiltrate,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
3761,Generalized illness,Disseminated Malignant Neoplasm,1
3762,Carcinomatous Component Present,Clear cell odontogenic carcinoma,1
3763,Epithelial Component Present,Vaginal Carcinosarcoma,1
3764,Malignant Cellular Infiltrate,Recurrent Bone Ewing Sarcoma,1
3765,Nodular lesions,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
3766,Carcinomatous Component Present,papillary carcinoma of penis,1
3767,Epithelial Component Present,Stage IV Prostate Cancer AJCC v7,1
3768,Carcinomatous Component Present,Childhood Salivary Gland Carcinoma,1
3769,Indolent Clinical Course,Benign Cutaneous Vascular Neoplasm,1
3770,Unilineage Dysplasia Present,Refractory Thrombocytopenia,1
3771,Intermediate Grade Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G2,1
3772,Storiform Growth Pattern,Adult Undifferentiated Pleomorphic Sarcoma,1
3773,Increased NFkappaB Pathway Activation,Mediastinal (Thymic) Large B-Cell Lymphoma,1
3774,Malignant Cellular Infiltrate,Central Nervous System Carcinoma,1
3775,Calcitonin serum level increased,Medullary carcinoma of thyroid,1
3776,Carcinomatous Component Present,"Carcinoma, Neuroendocrine",1
3777,Refractory Disease,Intestinal T-cell lymphoma refractory,1
3778,Mixed Cellular Population,Vaginal Mixed Epithelial and Mesenchymal Neoplasm,1
3779,Neuroectodermal Differentiation,Localized Peripheral Primitive Neuroectodermal Tumor,1
3780,Childhood Lesion,Childhood T Acute Lymphoblastic Leukemia,1
3781,Congenital Abnormality,Vulvar Congenital Melanocytic Nevus,1
3782,Malignant Cellular Infiltrate,Refractory Central Nervous System Lymphoma,1
3783,Exophytic Polypoid Lesion,Polyp of gallbladder,1
3784,Lymphadenopathy,Nodal marginal zone B-cell lymphoma refractory,1
3785,Malignant Cellular Infiltrate,Refractory Lymphoblastic Lymphoma,1
3786,Malignant Cellular Infiltrate,Mesothelioma malignant localized,1
3787,Malignant Cellular Infiltrate,Metastatic Thyroid Gland Follicular Carcinoma,1
3788,Well Differentiated Neuroendocrine Lesion,Stage IIIB Colorectal Neuroendocrine Tumor AJCC v8,1
3789,Epithelial Component Present,basal cell adenocarcinoma of salivary gland,1
3790,Epithelial Component Present,Intestinal Intraepithelial Neoplasia,1
3791,Malignant Cellular Infiltrate,Malignant Cardiac Germ Cell Tumor,1
3792,Malignant Cellular Infiltrate,Prostate Adenoid Cystic Carcinoma,1
3793,Nuclear Palisading,Palisaded Lymph Node Myofibroblastoma,1
3794,Malignant Cellular Infiltrate,Stage IA Soft Tissue Sarcoma AJCC v7,1
3795,Cutaneous Involvement,Cutaneous Melanoma by AJCC v8 Stage,1
3796,Epithelial Component Present,Vulvar Trichoepithelioma,1
3797,Carcinomatous Component Present,ACTH-Producing Pituitary Gland Carcinoma,1
3798,Malignant Cellular Infiltrate,Adult T-Cell Lymphoma/Leukemia,1
3799,Neuroendocrine Differentiation,Refractory Abdominal Neuroendocrine Neoplasm,1
3800,Malignant Cellular Infiltrate,Stage IV Uterine Corpus Leiomyosarcoma AJCC v8,1
3801,Epithelial Component Present,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
3802,Metastatic Lesion,Metastasizing Chondroblastoma,1
3803,Vascular Channel Formation,Blood Vessel Tumors,1
3804,Dysplasia,Transitional cell carcinoma in situ,1
3805,Malignant Cellular Infiltrate,Central Nervous System Yolk Sac Tumor,1
3806,Malignant Cellular Infiltrate,Pathologic Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
3807,Benign Cellular Infiltrate,Benign neoplasm of larynx,1
3808,Malignant Cellular Infiltrate,Chronic lymphocytic leukemia stage 4,1
3809,Secondary Lesion,Metastatic Prostate Small Cell Carcinoma,1
3810,Carcinomatous Component Present,Refractory Lung Carcinoma,1
3811,Absence of Basal Cell Layer,Recurrent Prostate Acinar Adenocarcinoma,1
3812,Malignant Cellular Infiltrate,Metastatic Carcinoma in the Lung,1
3813,Epithelial Component Present,BCLC Stage 0 Adult Hepatocellular Carcinoma,1
3814,Malignant Cellular Infiltrate,Cardiac Myeloid Sarcoma,1
3815,Pregnancy Complications,Pre-Eclampsia,1
3816,Carcinomatous Component Present,Stage IIIA Appendix Carcinoma AJCC v7,1
3817,Calcinosis,Calcifying Odontogenic Cyst,1
3818,Adulthood Lesion,Adult Subependymoma,1
3819,Solitary mass,Solitary Osseous Plasmacytoma,1
3820,Carcinomatous Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
3821,Epithelial Component Present,Benign epithelial neoplasm of skin,1
3822,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Poorly Differentiated Carcinoma,1
3823,Secondary Lesion,Carcinoma ex pleomorphic adenoma of parotid gland,1
3824,Macrocystic Change,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
3825,Complete Spontaneous Regression,Type E Lymphomatoid Papulosis,1
3826,Adnexal Differentiation,apocrine adenocarcinoma of vulva,1
3827,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Neuroendocrine Tumor G2,1
3828,Seminomatous Component Present,Testicular Mixed Embryonal Carcinoma and Yolk Sac Tumor with Seminoma,1
3829,Epithelial Component Present,Stage III Pharynx Carcinoma,1
3830,Infiltrating Tumor Margins Present,Malignant phyllodes tumor of breast,1
3831,Recurrent Genetic Abnormalities Present,"Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM",1
3832,Epithelial Component Present,Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
3833,Cutaneous Involvement,Non-neoplastic nevus of skin,1
3834,Secondary Lesion,Metastases to abdominal cavity,1
3835,Malignant Cellular Infiltrate,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
3836,Pregnancy Complications,Remote Placental Infarction,1
3837,Malignant Cellular Infiltrate,Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8,1
3838,Diffuse Pattern,Recurrent High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
3839,Well Differentiated Neuroendocrine Lesion,Gastro-enteropancreatic neuroendocrine tumor,1
3840,Rapidly Enlarging Mass,Childhood Pleomorphic Rhabdomyosarcoma,1
3841,Infantile Lesion,"Neuroectodermal Tumor, Melanotic",1
3842,Biphasic Pattern,Pericanalicular fibroadenoma,1
3843,Malignant Cellular Infiltrate,Gingival Squamous Cell Carcinoma,1
3844,Epithelial Component Present,"Pheochromocytoma, malignant",1
3845,Malignant Cellular Infiltrate,Recurrent Lymphocyte-Rich Classic Hodgkin Lymphoma,1
3846,Epithelial Component Present,Stage IIIB Colon Cancer AJCC v8,1
3847,Malignant Cellular Infiltrate,Medulloepithelioma,1
3848,Malignant Cellular Infiltrate,"Cranial Nerve Neoplasms, Malignant",1
3849,Malignant Cellular Infiltrate,Mediastinal T Lymphoblastic Lymphoma,1
3850,Malignant Cellular Infiltrate,Thyroid Gland Mucinous Carcinoma,1
3851,Carcinomatous Component Present,Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
3852,Epithelial Component Present,Tobacco Chewing-Related Carcinoma,1
3853,Benign Cellular Infiltrate,Metanephric adenoma,1
3854,Malignant Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma,1
3855,Cartilaginous Differentiation,Chondrosarcoma localised,1
3856,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IV,1
3857,Metaplasia,Bladder Squamous Cell Carcinoma,1
3858,Immunologic Deficiency Syndromes,AIDS-Related Retinopathy,1
3859,Malignant Cellular Infiltrate,Adrenal Gland Angiosarcoma,1
3860,Adulthood Lesion,Adult Central Nervous System Embryonal Carcinoma,1
3861,Local disease,Localized Primitive Neuroectodermal Tumor,1
3862,Malignant Cellular Infiltrate,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8,1
3863,Diffuse Lesion,Breast Angiomatosis,1
3864,Childhood Lesion,Childhood Paranasal Sinus Carcinoma,1
3865,Adulthood Lesion,Lugano Classification Stage II Adult Lymphoma AJCC v8,1
3866,Capillary Sized Vascular Channel Formation,Spinal hemangioblastoma,1
3867,Human Chorionic Gonadotropin Positive Neoplastic Cells Present,Gestational choriocarcinoma,1
3868,Microvascular Proliferation,Giant Cell Glioblastoma,1
3869,Mixed Cellular Population,Cellular Pleomorphic Adenoma,1
3870,Epithelial Component Present,intestinal type adenocarcinoma of gallbladder,1
3871,Radiation Sickness,Post-Radiotherapy Breast Angiosarcoma,1
3872,Carcinomatous Component Present,Follicular thyroid carcinoma,1
3873,Malignant Cellular Infiltrate,Refractory Ovarian Endometrioid Adenocarcinoma,1
3874,Anaplasia,gliosarcoma,1
3875,Absence of Invasion,Stage 0is Renal Pelvis Cancer AJCC v8,1
3876,Epithelial Component Present,Appendix Tubulovillous Adenoma,1
3877,Locally Aggressive Lesion,Retroperitoneal Inflammatory Myofibroblastic Tumor,1
3878,Epithelial Component Present,Infiltrating duct and lobular carcinoma,1
3879,Malignant Cellular Infiltrate,Grade II Chondrosarcoma,1
3880,Glomerular Hypertrophy,Chronic rejection of renal transplant,1
3881,Vascular Channel Formation,Colon Lymphangioma,1
3882,Epithelial Component Present,adenocarcinoma of gallbladder with squamous metaplasia,1
3883,CD4-Positive Neoplastic Cells Present,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
3884,Well Differentiated Neuroendocrine Lesion,Stage III Gastric Neuroendocrine Tumor AJCC v8,1
3885,Malignant Cellular Infiltrate,"Glomus tumor, malignant",1
3886,Prominent Elastic Tissue Cores Present,Papillary fibroelastoma,1
3887,Low Mitotic Activity,Transverse Colon Neuroendocrine Tumor G1,1
3888,Malignant Cellular Infiltrate,"Paget's Disease, Mammary",1
3889,Metastatic Lesion,Locally Advanced Angiosarcoma,1
3890,Epithelial Component Present,Primary Carcinoma Unspecified Site,1
3891,Malignant Cellular Infiltrate,Bile duct cancer recurrent,1
3892,Childhood Lesion,Childhood Nasal Cavity Carcinoma,1
3893,Epithelial Component Present,"Testicular Sex Cord-Gonadal Stromal Tumor, Mixed Forms",1
3894,Carcinomatous Component Present,Recurrent Fallopian Tube Carcinoma,1
3895,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage IV,1
3896,Recurrent disease,Extra-osseous Ewing's sarcoma recurrent,1
3897,Malignant Cellular Infiltrate,Neuroblastoma recurrent,1
3898,Epithelial Component Present,Thyroid Gland Adenocarcinoma,1
3899,Non-Invasive Lesion,Pancreatic Mucinous-Cystic Neoplasm with Low Grade Dysplasia,1
3900,Local disease,Lipoma of pleura,1
3901,Stromal Invasion,Stage IA Ovarian Cancer,1
3902,Absence of Stromal Invasion,Borderline serous tumor of ovary,1
3903,Childhood Lesion,Childhood Acute Myeloid Leukemia Not Otherwise Specified,1
3904,Thin Bands of Collagen Present,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
3905,Carcinomatous Component Present,Rectosigmoid Adenocarcinoma,1
3906,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland,1
3907,Cutaneous Involvement,Glomangioma of skin,1
3908,Lobulated Growth Pattern,Ventricular myxoma,1
3909,Carcinomatous Component Present,Stage III Carcinoma of Penis,1
3910,Malignant Primitive Cellular Infiltrate,"Ovarian Yolk Sac Tumor, Hepatoid Pattern",1
3911,Malignant Cellular Infiltrate,"Infiltrating Renal Pelvis Urothelial Carcinoma, Sarcomatoid Variant",1
3912,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v6,1
3913,"Adenocarcinoma, intestinal type",intestinal type adenocarcinoma of extrahepatic bile duct,1
3914,Dysplasia,"Glandular intraepithelial neoplasia, low grade",1
3915,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
3916,Malignant Cellular Infiltrate,Prostate Undifferentiated Carcinoma,1
3917,Carcinomatous Component Present,Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8,1
3918,Carcinomatous Component Present,Basal cell carcinoma - adenoid,1
3919,Epithelial Component Present,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
3920,Malignant Cellular Infiltrate,Cardiac Epithelioid Hemangioendothelioma,1
3921,Malignant Cellular Infiltrate,Ann Arbor Stage II Grade 2 Follicular Lymphoma,1
3922,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
3923,Malignant Cellular Infiltrate,Childhood Mixed Germ Cell Tumor,1
3924,Diffuse Pattern,Recurrent Childhood Oligoastrocytoma,1
3925,Multilocular Lesion,Peritoneal cystic mesothelioma,1
3926,Malignant Cellular Infiltrate,Stage IIB Lung Squamous Cell Carcinoma AJCC v7,1
3927,Diffuse Pattern,malignant peripheral nerve sheath tumor (MPNST) of mediastinum,1
3928,Malignant Cellular Infiltrate,Stage IV Prostate Cancer AJCC v7,1
3929,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
3930,Eccrine Differentiation,Ductal Eccrine Carcinoma with Spindle Cell Elements,1
3931,Hereditary Lesion,Myeloid Neoplasms with Germline Predisposition,1
3932,Malignant Cellular Infiltrate,Synovial sarcoma non-metastatic,1
3933,Carcinomatous Component Present,"Ameloblastic Carcinoma-Secondary Type (Dedifferentiated), Intraosseous",1
3934,Mitotic Activity,Glioblastoma with Primitive Neuronal Component,1
3935,Metastatic Lesion,Metastatic Lung Non-Squamous Non-Small Cell Carcinoma,1
3936,Malignant Cellular Infiltrate,Malignant tumor of small intestine,1
3937,Myxoid Stroma Formation,Vulvar Superficial Angiomyxoma,1
3938,Malignant Cellular Infiltrate,Small Intestinal T-Cell Non-Hodgkin Lymphoma,1
3939,Malignant Cellular Infiltrate,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor of Bone,1
3940,Malignant Cellular Infiltrate,Refractory Stage 0 Bladder Cancer AJCC v6 and v7,1
3941,Epithelial Component Present,Advanced Head and Neck Carcinoma,1
3942,Malignant Cellular Infiltrate,Carcinoma of the Appendix,1
3943,Intestinal metaplasia,Barrett's Adenocarcinoma,1
3944,More than 5 Mitoses per 50HPF,"Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8",1
3945,Carcinomatous Component Present,Stage II Major Salivary Gland Cancer AJCC v8,1
3946,Epithelial Component Present,Stage II Esophageal Cancer AJCC v7,1
3947,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8,1
3948,Diffuse Pattern,"Gemistocytic Astrocytoma, IDH-Mutant",1
3949,Malignant Cellular Infiltrate,Stage 0 Appendix Carcinoma AJCC v7,1
3950,Malignant Cellular Infiltrate,liposarcoma of kidney,1
3951,Epithelial Component Present,Pancreatic Serous Neoplasm,1
3952,Malignant Cellular Infiltrate,Thyroid Gland Adenocarcinoma,1
3953,Benign Cellular Infiltrate,Acanthoma,1
3954,atypia morphology,Dysplastic Nevus,1
3955,Malignant Cellular Infiltrate,Anaplastic Kidney Wilms Tumor,1
3956,Indolent Clinical Course,Colon Lipoma,1
3957,Malignant Cellular Infiltrate,Bone Cancer by AJCC v7 Stage,1
3958,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma,1
3959,Slow Growing Painless Mass,Lipofibromatosis,1
3960,Carcinomatous Component Present,"Squamous cell carcinoma, metastatic",1
3961,Absence of Invasion,Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8,1
3962,Malignant Cellular Infiltrate,"Urinary bladder carcinoma stage I, with cancer in situ",1
3963,Carcinomatous Component Present,Basaloid carcinoma,1
3964,Epithelial Component Present,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
3965,Malignant Cellular Infiltrate,Recurrent Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
3966,Glomerular Hypertrophy,Chronic rejection of renal transplant,1
3967,Benign Cellular Infiltrate,Mucinous adenofibroma,1
3968,Biphasic Pattern,Adenosarcoma,1
3969,Secondary Lesion,Metastatic Vaginal Carcinoma,1
3970,Malignant Cellular Infiltrate,Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
3971,Adnexal Differentiation,External Auditory Canal Ceruminous Adenoma,1
3972,Fibrotic Stroma Formation,undifferentiated carcinoma of pancreas,1
3973,Low Cellularity Present,Desmoplastic fibroblastoma,1
3974,Epithelial Component Present,Urethral Verrucous Carcinoma,1
3975,Carcinomatous Component Present,verrucous carcinoma of vulva,1
3976,Primary Lesion,Adult Pineal Gland Astrocytoma,1
3977,Benign Cellular Infiltrate,Deep Leiomyoma,1
3978,Carcinomatous Component Present,Stage IV Adrenal Cortex Carcinoma AJCC v8,1
3979,Insular Pattern,Somatostatinoma,1
3980,Neoplastic Granulocytes and Precursors 20 Percent or More of Bone Marrow Cells,Acute myeloid leukemia with abnormal marrow eosinophils,1
3981,Epithelial Component Present,Laryngeal verrucous carcinoma,1
3982,Dysplasia,Villous adenoma of duodenum,1
3983,Epithelial Component Present,Vestibular Papilloma,1
3984,Diffuse Pattern,Anaplastic astrocytoma,1
3985,Malignant Cellular Infiltrate,Pulmonary Artery Choriocarcinoma,1
3986,Non-Malignant Cellular Infiltrate,Postauricular lymphadenitis,1
3987,Low Mitotic Activity,Esophageal Neuroendocrine Tumor G1,1
3988,Regional Disease,Locally Advanced Skin Squamous Cell Carcinoma,1
3989,Eccrine Differentiation,Malignant Eccrine Neoplasm,1
3990,Poorly Differentiated Lesion,Stage IA Lung Large Cell Carcinoma AJCC v7,1
3991,Fibrotic Stroma Formation,Mucoepidermoid Breast Carcinoma,1
3992,Myxoid Stroma Formation,Cutaneous myxoma,1
3993,Epithelial Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma,1
3994,Carcinomatous Component Present,Stage III Liver Cancer,1
3995,Extensive Stage Lesion,Advanced Lung Carcinoma,1
3996,Malignant Cellular Infiltrate,Laryngeal squamous cell carcinoma recurrent,1
3997,Malignant Cellular Infiltrate,Localized tumors of the Ewing's family,1
3998,High Mitotic Activity,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
3999,Carcinomatous Component Present,Stage III Esophageal Cancer AJCC v7,1
4000,Malignant Cellular Infiltrate,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
4001,Epithelial Component Present,Prostate Carcinoma Metastatic in the Lung,1
4002,Malignant Cellular Infiltrate,Chronic Lymphocytic Leukemia- Binet Staging System,1
4003,Low Mitotic Activity,Ampulla of Vater Somatostatin-Producing Neuroendocrine Tumor,1
4004,Malignant Cellular Infiltrate,Cystadenocarcinoma of pancreas,1
4005,In Situ Lesion,Carcinoma in situ of penis,1
4006,Epithelial Component Present,Esophageal Neuroendocrine Neoplasm,1
4007,Malignant Cellular Infiltrate,Helicobacter Pylori-Related Gastric Adenocarcinoma,1
4008,"Amorphus, Eosinophilic, and Acellular Deposit",Primary Systemic Amyloidosis,1
4009,Cutaneous Involvement,Recurrent Primary Cutaneous Lymphoma,1
4010,Carcinomatous Component Present,HPV positive oropharyngeal squamous cell carcinoma,1
4011,Secondary Lesion,Bladder cancer stage IV,1
4012,Metastatic Lesion,Advanced Oral Cavity Squamous Cell Carcinoma,1
4013,Malignant Cellular Infiltrate,BCLC Stage B Hepatocellular Carcinoma,1
4014,Unresectable Mass,Unresectable Liposarcoma,1
4015,Benign Cellular Infiltrate,Benign pheochromocytoma of adrenal gland,1
4016,Cutaneous Involvement,Carcinoma Metastatic to the Skin,1
4017,Cutaneous Involvement,Skin tumor of smooth muscle origin,1
4018,Toxic effect,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
4019,Diffuse Pattern,High Grade Malignant Peripheral Nerve Sheath Tumor,1
4020,Tubular Pattern,"Somatostatinoma, malignant",1
4021,Adnexal Differentiation,Classical Poroma,1
4022,Papillary Pattern,Squamous papillomatosis,1
4023,Invasive Lesion,Prolactin-Producing Pituitary Gland Carcinoma,1
4024,Malignant Cellular Infiltrate,Colon Medullary Carcinoma,1
4025,Adnexal Differentiation,Trichodiscoma,1
4026,Lipomatous Component Present,Thymus Lipofibroadenoma,1
4027,Carcinomatous Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma,1
4028,Epithelial Component Present,insulinoma,1
4029,Hemorrhagic,Small Intestinal Angiosarcoma,1
4030,Malignant Cellular Infiltrate,Stage IVB Hypopharyngeal Carcinoma AJCC v7,1
4031,Tissue of Mullerian Origin Present,Fallopian Tube Adenosarcoma,1
4032,Malignant Cellular Infiltrate,squamous cell carcinoma of ureter,1
4033,Adulthood Lesion,Stage IIB Adult Soft Tissue Sarcoma AJCC v7,1
4034,Slow Growing Mass,Venous Angioleiomyoma,1
4035,Epithelial Component Present,Thymic Atypical Carcinoid Tumor,1
4036,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Refractory Uterine Corpus Carcinosarcoma,1
4037,Adnexal Differentiation,Benign Apocrine Neoplasm,1
4038,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,"Acute myeloid leukemia, minimal differentiation",1
4039,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast,1
4040,Carcinomatous Component Present,Infiltrating Bladder Urothelial Carcinoma Associated with Urethral Carcinoma,1
4041,Non-Invasive Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
4042,Carcinomatous Component Present,Childhood Salivary Gland Carcinoma,1
4043,Neuronal Differentiation,Ganglioglioma,1
4044,Malignant Cellular Infiltrate,Squamous cell carcinoma with horn formation,1
4045,Lymphadenopathy,HHV8-Positive Multicentric Castleman Disease,1
4046,Perivascular Arrangement of Tumor Cells,Venous Angioleiomyoma,1
4047,Unresectable Mass,Unresectable Renal Pelvis Urothelial Carcinoma,1
4048,Epithelial Component Present,Inflammatory carcinoma of breast stage IV,1
4049,Inflammatory infiltrate,Inflammatory Leiomyosarcoma,1
4050,Malignant Cellular Infiltrate,Mediastinal Mixed Germ Cell Tumor,1
4051,Malignant Cellular Infiltrate,Ann Arbor Stage IA Hodgkin Lymphoma,1
4052,Epithelial Component Present,Glomus Jugulare Tumor,1
4053,CD30-Positive Neoplastic Cells Present,Stage II Anaplastic Large Cell Lymphoma,1
4054,Secondary Lesion,"Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread",1
4055,Refractory Disease,Refractory Endometrial Clear Cell Adenocarcinoma,1
4056,Congenital Lesion,Congenital anomaly of eyelid,1
4057,Malignant Cellular Infiltrate,"Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
4058,Epithelial Component Present,Ectopic Cervical Thymoma,1
4059,Malignant Cellular Infiltrate,Stage II Adult Soft Tissue Sarcoma AJCC v7,1
4060,Malignant Cellular Infiltrate,Stage IIA Primary Peritoneal Cancer AJCC v8,1
4061,Carcinomatous Component Present,Stomach Carcinoma,1
4062,Adnexal Differentiation,Benign neoplasm of sebaceous gland,1
4063,Malignant Cellular Infiltrate,"Diffuse Large B-Cell Lymphoma, Not Otherwise Specified",1
4064,atypia morphology,Atypical Ductal Breast Hyperplasia,1
4065,Epithelial Component Present,Benign Sertoli Cell Tumor,1
4066,Adnexal Differentiation,Malignant Hair Follicle Neoplasm,1
4067,Benign Cellular Infiltrate,Benign Bone Schwannoma,1
4068,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
4069,Epithelial Component Present,Cystadenocarcinoma of pancreas,1
4070,Cystic Change,Seborrheic keratosis of eyelid,1
4071,Adulthood Lesion,Stage IIIC Adult Liver Cancer AJCC v7,1
4072,Monoclonal Langerhans Cells Present,Childhood Langerhans Cell Histiocytosis with Risk Organ Involvement,1
4073,atypia morphology,Borderline Fallopian Tube Neoplasm,1
4074,Malignant Cellular Infiltrate,large cell neuroendocrine carcinoma of gallbladder,1
4075,Epithelial Component Present,Unresectable Adrenal Cortex Carcinoma,1
4076,Childhood Lesion,Childhood Acute Myelomonocytic Leukemia,1
4077,Malignant Cellular Infiltrate,Stage IV Pharynx Carcinoma,1
4078,Ground Glass Nuclear Inclusion,Thyroid Gland Papillary Carcinoma with Fibromatosis/Fasciitis-Like Stroma,1
4079,Recurrent Genetic Abnormalities Present,B lymphoblastic leukemia lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1),1
4080,Carcinomatous Component Present,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
4081,Malignant Cellular Infiltrate,Stage IA Pancreatic Cancer AJCC v6 and v7,1
4082,Toxic effect,Solar Radiation-Related Cutaneous Melanoma,1
4083,Malignant Cellular Infiltrate,Stage IV Hodgkin Lymphoma,1
4084,Malignant Cellular Infiltrate,Mycosis fungoides refractory,1
4085,Indolent Clinical Course,Colon Leiomyoma,1
4086,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent,1
4087,Neoplastic Plasma Cells Present in Bone Marrow,RISS Stage I Plasma Cell Myeloma,1
4088,Cutaneous Involvement,Squamous Cell Carcinoma of Anal Margin,1
4089,Borderline Lesion,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
4090,Monoclonal Langerhans Cells Present,Refractory Langerhans Cell Histiocytosis,1
4091,Low Mitotic Activity,Ovarian Low Grade Endometrioid Stromal Sarcoma,1
4092,Epithelial Component Present,Grade 3 Colorectal Adenocarcinoma,1
4093,Calcitonin serum level increased,Stage II Thyroid Gland Medullary Carcinoma AJCC v7,1
4094,Carcinomatous Component Present,Submandibular Gland Undifferentiated Carcinoma,1
4095,Lymphoplasmacytic Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage I,1
4096,Epithelial Component Present,Adenocarcinoma of rete ovarii,1
4097,Epithelial Component Present,Stage I Vulvar Cancer,1
4098,Recurrent disease,Recurrent Childhood Rhabdomyosarcoma,1
4099,Mixed Cellular Population,Phyllodes Tumor,1
4100,Carcinomatous Component Present,Refractory Anal Carcinoma,1
4101,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Erythroleukemia (Erythroid/Myeloid),1
4102,Low Mitotic Activity,Stage IV Ileal Neuroendocrine Tumor AJCC v8,1
4103,Carcinomatous Component Present,Stage IIC Merkel Cell Carcinoma AJCC v7,1
4104,Epithelial Component Present,Type II Endometrial Adenocarcinoma,1
4105,Malignant Cellular Infiltrate,Malignant mastocytosis,1
4106,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intracranial Meningioma,1
4107,Malignant Cellular Infiltrate,Pleural mesothelioma malignant recurrent,1
4108,Epithelial Component Present,Stage I Renal Cell Cancer AJCC v8,1
4109,In Situ Lesion,Stage 0 Appendix Carcinoma AJCC v8,1
4110,Multinodular Mass,Pericardial Angiosarcoma,1
4111,Splenomegaly,"Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
4112,Cutaneous Involvement,"Dermatitis, Phototoxic",1
4113,Immunologic Deficiency Syndromes,AIDS-Related Oropharyngeal Candidiasis,1
4114,High Grade Lesion,gliosarcoma,1
4115,Invasive Lesion,malignant myoepithelioma of breast,1
4116,Cutaneous Involvement,Benign Apocrine Neoplasm,1
4117,Mixed Cellular Population,Ovarian Mucinous Cystadenofibroma,1
4118,Diffuse Pattern,Childhood Brain Stem Mixed Glioma,1
4119,Absence of Invasion,"Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8",1
4120,Intraluminal Tumor Growth,Pulmonary Artery Intimal Sarcoma,1
4121,atypia morphology,Angiocentric immunoproliferative lesion grade 2,1
4122,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of the oral cavity,1
4123,Secondary Lesion,Advanced Cervical Carcinoma,1
4124,Malignant Cellular Infiltrate,Anatomic Stage IA Breast Cancer AJCC v8,1
4125,Carcinomatous Component Present,Stage IV Thyroid Gland Papillary Carcinoma AJCC v8,1
4126,Epithelial Component Present,Anatomic Stage IIIA Breast Cancer AJCC v8,1
4127,Papillary Pattern,"Transitional cell carcinoma, micropapillary",1
4128,Malignant Cellular Infiltrate,Hereditary Malignant Urinary System Neoplasm,1
4129,Well-Circumscribed Lesion,Otic polyp,1
4130,Mixed Cellular Population,Borderline Ovarian Clear Cell Adenofibroma,1
4131,Epithelial Component Present,Papillary squamous cell carcinoma,1
4132,Carcinomatous Component Present,Unresectable Skin Squamous Cell Carcinoma,1
4133,Poorly Differentiated Lesion,Poorly Differentiated Prostate Adenocarcinoma,1
4134,Carcinomatous Component Present,Serous cystadenocarcinoma of pancreas,1
4135,Tumor Vascular Invasion,Malignant Testicular Sex Cord-Stromal Tumor,1
4136,Malignant Cellular Infiltrate,Gastrointestinal melanoma,1
4137,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
4138,Trabecular Pattern,"Adenoma, Trabecular",1
4139,Malignant Cellular Infiltrate,Stage II Adult Hodgkin Lymphoma,1
4140,Macrocystic Change,"Lymphangioma, Cystic",1
4141,Indolent Clinical Course,Adrenal Cortex Adenomatoid Tumor,1
4142,Unresectable Mass,Small intestine carcinoma non-resectable,1
4143,Collagenous Stroma Formation,Nuchal-type fibroma,1
4144,Malignant Cellular Infiltrate,Stage 0 Small Intestinal Adenocarcinoma AJCC v8,1
4145,Metastatic/Recurrent Disease,Pleural Biphasic Synovial Sarcoma,1
4146,Poorly Differentiated Lesion,Grade 3 Colon Adenocarcinoma,1
4147,Indolent Clinical Course,Myxoma,1
4148,Malignant Cellular Infiltrate,AIDS-Related Diffuse Large B-Cell Lymphoma Arising in HHV8-Positive Multicentric Castleman Disease,1
4149,Tissue of Mullerian Origin Present,Rete Ovarii Cystadenofibroma,1
4150,Low Cellularity Present,Juvenile Pilocytic Astrocytoma,1
4151,Epithelial Component Present,Pathologic Stage III Gastric Cancer AJCC v8,1
4152,Malignant Cellular Infiltrate,Stage IV Ovarian Cancer AJCC v8,1
4153,Glandular Pattern,Gastric Mixed Adenocarcinoma,1
4154,Clinical TNM Finding,Clinical Stage III Esophageal Adenocarcinoma AJCC v8,1
4155,Well-Circumscribed Lesion,Malignant phyllodes tumor of breast,1
4156,Epithelial Component Present,Recurrent Adult Hepatocellular Carcinoma,1
4157,Epithelial Component Present,Breast Carcinoma Metastatic in the Liver,1
4158,CD1a-Positive Neoplastic Cells Present,"Histiocytosis, Langerhans-Cell",1
4159,Malignant Cellular Infiltrate,Conventional Extraskeletal Myxoid Chondrosarcoma,1
4160,Epithelial Component Present,Human Papillomavirus-Related Vulvar Squamous Cell Carcinoma,1
4161,Carcinomatous Component Present,Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
4162,Cutaneous Involvement,Cutaneous Mature T-Cell and NK-Cell Neoplasm,1
4163,Indolent Clinical Course,"Synovioma, benign",1
4164,Microvascular Proliferation,Adult Glioblastoma,1
4165,Composite Lesion,"Ganglioneuroblastoma, Nodular",1
4166,Ground Glass Nuclear Inclusion,Oncocytic Variant Thyroid Gland Papillary Carcinoma,1
4167,Well Differentiated Neuroendocrine Lesion,Carcinoid tumor of the duodenum,1
4168,Carcinomatous Component Present,Malignant Breast Eccrine Spiradenoma,1
4169,Lobulated Growth Pattern,Pleomorphic hyalinizing angiectatic tumor of soft tissue,1
4170,Malignant Cellular Infiltrate,Conventional Angiosarcoma,1
4171,Malignant Cellular Infiltrate,Prostate cancer stage A,1
4172,Alopecia,Rothmund-Thomson syndrome,1
4173,Carcinomatous Component Present,Stage I Vulvar Carcinoma,1
4174,Recurrent disease,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
4175,Epithelial Component Present,Digestive System Neuroendocrine Neoplasm,1
4176,Invasive Lesion,Invasive Prostate Carcinoma,1
4177,Childhood Lesion,Recurrent Childhood Gliosarcoma,1
4178,Malignant Cellular Infiltrate,Stage II Adult Liver Cancer AJCC v7,1
4179,Carcinomatous Component Present,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
4180,Cribriform Pattern,Cribriform-Morular Variant Thyroid Gland Papillary Carcinoma,1
4181,Epithelial Component Present,"Serous cystadenoma, borderline malignancy",1
4182,Carcinomatous Component Present,Stage II Oral Cavity Cancer AJCC v6 and v7,1
4183,Malignant Cellular Infiltrate,Grade 3 Rectal Adenocarcinoma,1
4184,Malignant Cellular Infiltrate,Adult Central Nervous System Embryonal Carcinoma,1
4185,atypia morphology,Malignant Granulosa Cell Tumor,1
4186,Malignant Cellular Infiltrate,"Recurrent Medulloblastoma, SHH-Activated",1
4187,Malignant Cellular Infiltrate,sarcoma of tongue,1
4188,Carcinomatous Component Present,Stage IIA Fallopian Tube Cancer AJCC v8,1
4189,Epithelial Component Present,Papillary adenocarcinoma,1
4190,Neuroendocrine Differentiation,Gastroesophageal Junction Small Cell Neuroendocrine Carcinoma,1
4191,Malignant Cellular Infiltrate,Penile Cancer by AJCC v6 Stage,1
4192,Carcinomatous Component Present,Stage IV Pancreatic Cancer AJCC v8,1
4193,Malignant Cellular Infiltrate,Large cell carcinoma with rhabdoid phenotype,1
4194,Monomorphic Cellular Infiltrate,Basaloid carcinoma,1
4195,Epithelial Component Present,Urothelial Neoplasm,1
4196,Malignant Cellular Infiltrate,Stage IIIB Anal Canal Cancer AJCC v6 and v7,1
4197,Benign Cellular Infiltrate,Sternal Intraosseous Schwannoma,1
4198,Malignant Cellular Infiltrate,Ovarian cancer stage III,1
4199,Infiltrative Growth Pattern,Superficial fibromatosis,1
4200,Carcinomatous Component Present,Glycogen-rich carcinoma,1
4201,Carcinomatous Component Present,Pleural Carcinomatosis,1
4202,Organoid Pattern,Alveolar soft part sarcoma recurrent,1
4203,Invasive Lesion,Glomangiomatosis,1
4204,Cutaneous Involvement,Recurrent Primary Cutaneous Lymphoma,1
4205,Epithelial Component Present,Classic Variant of Chromophobe Renal Cell Carcinoma,1
4206,Epithelial Component Present,High Grade Corneal Intraepithelial Neoplasia,1
4207,Malignant Cellular Infiltrate,Human Papillomavirus-Related Penile Squamous Cell Carcinoma,1
4208,Epithelial Component Present,canalicular adenoma of salivary gland,1
4209,Carcinomatous Component Present,Unresectable Transitional Cell Carcinoma,1
4210,Spontaneous Regression,"Retinoblastoma, spontaneously regressed",1
4211,Carcinomatous Component Present,Laryngeal Basaloid Carcinoma,1
4212,Epithelial Component Present,Gallbladder Flat Biliary Intraepithelial Neoplasia,1
4213,Malignant Cellular Infiltrate,Locally Advanced Pancreatic Adenocarcinoma,1
4214,Recurrent disease,Laryngeal verrucous carcinoma recurrent,1
4215,Neuroendocrine Differentiation,Prostate Neuroendocrine Neoplasm,1
4216,Necrotic changes (finding),Thymic Small Cell Carcinoma,1
4217,Cutaneous Involvement,Stage III Cutaneous Melanoma AJCC v6,1
4218,Non-Hereditary Lesion,Sporadic Breast Carcinoma,1
4219,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides AJCC v7,1
4220,Dysplasia,Colorectal Filiform Serrated Adenoma,1
4221,Sebaceous Differentiation,Vulvar Sebaceous Carcinoma,1
4222,Malignant Cellular Infiltrate,Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1
4223,Cutaneous Involvement,Cutaneous Liposarcoma,1
4224,Carcinomatous Component Present,Squamous cell carcinoma of the hypopharynx stage IV,1
4225,Well Differentiated Lesion,Grade 1 Colorectal Adenocarcinoma,1
4226,Epithelial Component Present,Intestinal Neuroendocrine Tumor,1
4227,Malignant Epithelial Cells with Cytoplasmic Vacuoles or Flocculent Cytoplasmic Inclusions Containing Wispy Eosinophilic Material Present,Succinate Dehydrogenase-Deficient Renal Cell Carcinoma,1
4228,Malignant Cellular Infiltrate,Submandibular Gland Squamous Cell Carcinoma,1
4229,Angiocentric Pattern,Recurrent Childhood Lymphomatoid Granulomatosis,1
4230,Malignant Cellular Infiltrate,Malignant neoplasm of brain stem,1
4231,Myxoid Stroma Formation,Myxoid leiomyoma,1
4232,Well-Circumscribed Lesion,Esophageal squamous papilloma,1
4233,Increased Cellularity Present,Secondary Supratentorial Anaplastic Astrocytoma,1
4234,Malignant Cellular Infiltrate,Stage IIC Fallopian Tube Cancer AJCC v6 and v7,1
4235,Cutaneous Involvement,Merkel Cell Carcinoma by AJCC v7 Stage,1
4236,Epithelial Component Present,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
4237,Carcinomatous Component Present,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
4238,Keratin pearl formation,Spindle cell squamous cell carcinoma,1
4239,Malignant Cellular Infiltrate,Nasopharyngeal Papillary Adenocarcinoma,1
4240,Epithelial Component Present,"Thymoma, type A",1
4241,Diffuse Pattern,Mixed Astrocytoma-Ependymoma-Oligodendroglioma,1
4242,Mild cytologic atypia,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
4243,Hyperplastic Tissue Present,Ductal Breast Hyperplasia,1
4244,Invasive Lesion,minimally invasive follicular carcinoma of the thyroid gland,1
4245,Secondary Lesion,Locally Advanced Digestive System Neuroendocrine Carcinoma,1
4246,Epithelial Component Present,Extrapulmonary Small Cell Carcinoma,1
4247,Epithelial Component Present,Basal cell carcinoma - adamantinoid,1
4248,Cervical Glandular Dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
4249,Cystic Change,Thymic Mucoepidermoid Carcinoma,1
4250,Carcinomatous Component Present,Postneoadjuvant Therapy Stage II Esophageal Squamous Cell Carcinoma AJCC v8,1
4251,Malignant Cellular Infiltrate,Stage 0a Renal Pelvis Cancer AJCC v8,1
4252,Epithelial Component Present,Adenoid cystic carcinoma of lacrimal gland,1
4253,Malignant Cellular Infiltrate,Stage I Vulvar Carcinoma,1
4254,Malignant Cellular Infiltrate,Low grade appendiceal mucinous neoplasm,1
4255,Diffuse Pattern,Childhood Mixed Glioma,1
4256,Ground Glass Nuclear Inclusion,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
4257,Benign Cellular Infiltrate,neurofibroma of esophagus,1
4258,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Undifferentiated Carcinoma,1
4259,Carcinomatous Component Present,Stage II Eyelid Carcinoma AJCC v8,1
4260,Biphasic Pattern,Vulvar Composite Papillary Hidradenoma and Fibroadenoma,1
4261,Unilineage Dysplasia Present,Refractory Neutropenia,1
4262,Indolent Clinical Course,Squamous odontogenic tumor,1
4263,Well-Circumscribed Lesion,Filiform Serrated Adenoma,1
4264,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v8,1
4265,Papillary Pattern,Recurrent respiratory papillomatosis,1
4266,Malignant Cellular Infiltrate,Burkitt Lymphoma with Plasmacytoid Differentiation,1
4267,Carcinomatous Component Present,Oropharyngeal Carcinoma by AJCC v6 Stage,1
4268,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma,1
4269,S-100-Positive Neoplastic Cells Present,Tumors Derived from Langerhans Cells,1
4270,Epithelial Component Present,"Stage 0 Nasal Cavity Cancer AJCC v6, v7, and v8",1
4271,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v8,1
4272,Malignant Cellular Infiltrate,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
4273,Calcitonin Positive Neoplastic Cells Present,Familial medullary thyroid carcinoma,1
4274,Carcinomatous Component Present,Gastric Fundus Carcinoma,1
4275,Metastatic Lesion,Metastatic Paraganglioma,1
4276,Stromal Invasion,serous surface papillary carcinoma of ovary,1
4277,Plexiform Growth Pattern,Gastric Plexiform Fibromyxoma,1
4278,Malignant Cellular Infiltrate,Minor Salivary Gland Undifferentiated Carcinoma,1
4279,Epithelial Component Present,Stage IIIB Rectal Cancer AJCC v7,1
4280,Intraductal Lesion,Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
4281,Carcinomatous Component Present,Carcinoma in situ of skin,1
4282,Severe dysplasia,Stage 0 Appendix Carcinoma AJCC v7,1
4283,Recurrent Genetic Abnormalities Present,B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
4284,Therapy-Related Toxicity,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
4285,Diffuse Pattern,"Diffuse midline glioma, point mutation K27M in histone H3",1
4286,Malignant Cellular Infiltrate,Childhood Malignant Small Intestinal Neoplasm,1
4287,Malignant Cellular Infiltrate,Stage IIIB Colorectal Cancer AJCC v7,1
4288,Monoclonal Eosinophils Present,Chronic eosinophilic leukemia,1
4289,Malignant Cellular Infiltrate,Stage II Adult Non-Hodgkin Lymphoma,1
4290,Deep Lesion,Leiomyosarcoma of Deep Soft Tissue,1
4291,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Acute Erythroblastic Leukemia,1
4292,Tartrate Resistant Acid Phosphatase Positive Cells Present,Progressive Hairy Cell Leukemia Initial Treatment,1
4293,Local disease,Localized Castleman Disease,1
4294,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
4295,Follicular Cell Differentiation,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
4296,Primary Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
4297,Mixture of Germ Cell Neoplastic Components Present,Testicular Mixed Yolk Sac Tumor and Teratoma with Seminoma,1
4298,Indolent Clinical Course,Osteochondromatosis,1
4299,Malignant Cellular Infiltrate,Malignant Testicular Sex Cord-Stromal Tumor,1
4300,Benign Cellular Infiltrate,Central Nervous System Rhabdomyoma,1
4301,Recurrent disease,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
4302,Calcinosis,"Retinoblastoma, spontaneously regressed",1
4303,Tricholemmal Differentiation,Trichilemmoma,1
4304,Benign Cellular Infiltrate,Cerebral hemangioma,1
4305,Carcinomatous Component Present,Lung Basaloid Squamous Cell Carcinoma,1
4306,Adulthood Lesion,Stage II Contiguous Adult Indolent Non-Hodgkin Lymphoma,1
4307,High Grade Lesion,Refractory Extensive Stage Lung Small Cell Carcinoma,1
4308,Glandular Pattern,"Cervical Mucinous Adenocarcinoma, Intestinal-Type",1
4309,Malignant Cellular Infiltrate,AIDS-Related Non-Hodgkin Lymphoma,1
4310,Carcinomatous Component Present,Stage IVB Appendix Carcinoma AJCC v8,1
4311,Carcinomatous Component Present,Stage III Esophageal Cancer,1
4312,Malignant Cellular Infiltrate,Paget disease of anal canal,1
4313,Epithelial Component Present,Recurrent Thyroid Gland Anaplastic Carcinoma,1
4314,Metastatic Lesion,Metastatic urothelial carcinoma,1
4315,Recurrent disease,Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder,1
4316,Crystal deposition,Alveolar soft part sarcoma recurrent,1
4317,Malignant Cellular Infiltrate,"Cerebellopontine Angle Embryonal Tumor, Not Otherwise Specified",1
4318,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
4319,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
4320,Epithelial Component Present,signet ring cell carcinoma of gallbladder,1
4321,Pregnancy Complications,Hypertension associated disorders of pregnancy,1
4322,Carcinomatous Component Present,Intrahepatic Cholangiocarcinoma by AJCC v8 Stage,1
4323,Unresectable Mass,Locally Advanced Unresectable Prostate Adenocarcinoma,1
4324,Childhood Lesion,Pediatric Neoplasm,1
4325,Malignant Cellular Infiltrate,Oropharyngeal Basaloid Carcinoma,1
4326,Carcinomatous Component Present,Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8,1
4327,Burn injury,Old Burn Scar-Related Neoplasm,1
4328,Benign Cellular Infiltrate,Maturing Ganglioneuroma,1
4329,High Grade Lesion,Recurrent Glioblastoma,1
4330,Hyperplastic Tissue Present,Stromal hyperplasia,1
4331,Myxoid Stroma Formation,Ovarian Myxoma,1
4332,Malignant Cellular Infiltrate,Malignant Female Reproductive System Neoplasm,1
4333,Primary Lesion,Extra-osseous Ewing's sarcoma recurrent,1
4334,Epithelial Component Present,Stage IV Pharynx Carcinoma,1
4335,Benign Cellular Infiltrate,Benign neoplasm of ciliary body,1
4336,Papillary Pattern,Syringocystadenoma Papilliferum,1
4337,Low Mitotic Activity,Intestinal Gangliocytic Paraganglioma,1
4338,Indolent Clinical Course,Degeneration of uterine fibroid,1
4339,Epithelial Component Present,Infiltrating Bladder Urothelial Carcinoma with Glandular Differentiation,1
4340,Carcinomatous Component Present,Gastric Adenocarcinoma,1
4341,Adnexal Differentiation,Trichoepithelioma,1
4342,Cutaneous Involvement,Pseudoporphyria,1
4343,Resistance to Second-Generation Androgen Receptor Axis-Targeted Agents,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
4344,Follicular Cell Differentiation,Stage III Differentiated Thyroid Gland Carcinoma AJCC v7,1
4345,Malignant Cellular Infiltrate,Stage III Choroidal and Ciliary Body Melanoma AJCC v8,1
4346,Hyalinized Stroma Formation,Pleural Solitary Fibrous Tumor,1
4347,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
4348,Malignant Cellular Infiltrate,Bladder Cancer by AJCC v7 Stage,1
4349,Well-Circumscribed Lesion,Cortisol-Producing Adrenal Cortex Adenoma,1
4350,Cutaneous Involvement,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
4351,Neuroendocrine Differentiation,malignant gastrinoma of pancreas,1
4352,Osseous Differentiation,Osteosarcoma localised,1
4353,Malignant Cellular Infiltrate,Anal Rhabdomyosarcoma,1
4354,Metastatic/Recurrent Disease,Synovial sarcoma non-metastatic,1
4355,Vascular Channel Formation,Intravascular Angioleiomyoma,1
4356,Carcinomatous Component Present,Skin Squamous Cell Carcinoma In Situ,1
4357,Mammary Gland Type Features Present,Vulvar Adenocarcinoma of Mammary Gland Type,1
4358,Epithelial Component Present,Papillary transitional cell neoplasm of low malignant potential,1
4359,Osseous Differentiation,Multifocal osteosarcoma,1
4360,Malignant Cellular Infiltrate,Lymphocyte Rich Classical Hodgkin Lymphoma,1
4361,Carcinomatous Component Present,Human Papillomavirus-Related Endocervical Adenocarcinoma,1
4362,CD30-Positive Neoplastic Cells Present,Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma,1
4363,Carcinomatous Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
4364,Childhood Lesion,Childhood Gliosarcoma,1
4365,Anaplasia,Adult Glioblastoma,1
4366,Malignant Cellular Infiltrate,Metastatic Fallopian Tube Carcinoma,1
4367,Psammoma Body Formation,Calcifying Fibrous Pseudotumor,1
4368,Epithelial Component Present,Mammary Analog Secretory Carcinoma of Salivary Gland,1
4369,Epithelial Component Present,Stage I Lung Cancer AJCC v6,1
4370,Epithelial Component Present,Regional Urothelial Carcinoma of the Renal Pelvis and Ureter,1
4371,Epithelial Component Present,Non-Small Cell Lung Carcinoma,1
4372,Primary Lesion,Recurrent Central Nervous System Lymphoma,1
4373,Malignant Cellular Infiltrate,sarcoma of esophagus,1
4374,Necrotic changes (finding),large cell neuroendocrine carcinoma of thymus,1
4375,Diffuse Pattern,AIDS-Related Plasmablastic Lymphoma of Mucosa Site,1
4376,Carcinomatous Component Present,Stage 0 Major Salivary Gland Cancer AJCC v8,1
4377,Benign Cellular Infiltrate,Sebaceoma,1
4378,Epithelial Component Present,Broad Ligament Serous Cystadenoma,1
4379,Epithelial Component Present,Borderline serous tumor of ovary,1
4380,Malignant Cellular Infiltrate,FIGO Stage II Ovarian Cancer,1
4381,Carcinomatous Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
4382,Localized Lesion,Plasmacytoma,1
4383,Epithelial Component Present,Unresectable Craniopharyngioma,1
4384,Fibrotic Stroma Formation,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
4385,Dysplasia,Transitional cell carcinoma in situ,1
4386,Adnexal Differentiation,Benign Breast Eccrine Spiradenoma,1
4387,Pathologic TNM Finding,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
4388,Epithelial Component Present,Gonadoblastoma,1
4389,Epithelial Component Present,Invasive Mucinous Lung Adenocarcinoma,1
4390,Mitotic Activity,Teratocarcinoma,1
4391,Epithelial Component Present,Stage IV Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
4392,High Mitotic Activity,undifferentiated sarcoma of ovary,1
4393,Osseous metaplasia,Adenocarcinoma with osseous metaplasia,1
4394,Epithelial Component Present,Stage IV Distal Bile Duct Cancer AJCC v7,1
4395,Villous Pattern,Cervical Villoglandular Adenocarcinoma,1
4396,Recurrent disease,Recurrent Gliosarcoma,1
4397,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,MYELODYSPLASTIC SYNDROME,1
4398,Single Cell Necrosis,Stage IIIB Merkel Cell Carcinoma AJCC v7,1
4399,Cartilaginous Differentiation,Chondrosarcoma metastatic,1
4400,Hereditary Lesion,"FAMILIAL ADENOMATOUS POLYPOSIS, ATTENUATED (disorder)",1
4401,Pregnancy Complications,Subacute Placental Infarction,1
4402,Ground Glass Nuclear Inclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v8,1
4403,Geographic Necrosis,Ovarian Embryonal Carcinoma,1
4404,Epithelial Component Present,Urothelial carcinoma ureter metastatic,1
4405,Malignant Cellular Infiltrate,Localized Resectable Adult Hepatocellular Carcinoma,1
4406,Tissue of Mullerian Origin Present,Stage IIIB Uterine Corpus Adenosarcoma AJCC v8,1
4407,Anaplasia,Anaplastic Oligoastrocytoma,1
4408,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma refractory,1
4409,Pregnancy Complications,Funisitis (disorder),1
4410,Infiltrative Growth Pattern,Adult Glioblastoma,1
4411,Malignant Cellular Infiltrate,serous adenocarcinofibroma of ovary,1
4412,Carcinomatous Component Present,Stage IVB Primary Peritoneal Cancer AJCC v8,1
4413,Carcinomatous Component Present,Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4414,Malignant Cellular Infiltrate,Cervical Papillary Squamous Cell Carcinoma,1
4415,Malignant Cellular Infiltrate,Stage I Uveal Melanoma AJCC v7,1
4416,Carcinomatous Component Present,Bladder adenocarcinoma stage III,1
4417,Non-Malignant Cellular Infiltrate,Follicular Bronchitis/Bronchiolitis,1
4418,Malignant Cellular Infiltrate,Lung adenocarcinoma recurrent,1
4419,Tissue of Mullerian Origin Present,Uterine Corpus Carcinosarcoma,1
4420,Monomorphic Cellular Infiltrate,Brain Ependymoma,1
4421,Benign Cellular Infiltrate,Ovarian Endometrioid Cystadenofibroma,1
4422,Malignant Cellular Infiltrate,B-cell small lymphocytic lymphoma stage IV,1
4423,Malignant Cellular Infiltrate,Adult Central Nervous System Mixed Germ Cell Tumor,1
4424,Secondary Lesion,Secondary malignant neoplasm of lung,1
4425,Benign Cellular Infiltrate,Hemangioma of gingiva,1
4426,Carcinomatous Component Present,Advanced Neuroendocrine Carcinoma,1
4427,Carcinomatous Component Present,Stage I Urethral Cancer AJCC v8,1
4428,Invasive Lesion,"Prostate Ductal Adenocarcinoma, Solid Pattern",1
4429,Epithelial Component Present,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4430,Malignant Cellular Infiltrate,Adenosquamous cell lung cancer stage IIIA,1
4431,Multilayered Rosette Formation,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
4432,Malignant Cellular Infiltrate,Neuroblastoma recurrent,1
4433,Carcinomatous Component Present,Stage I Prostate Cancer AJCC v8,1
4434,Malignant Cellular Infiltrate,Stage IV Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
4435,Neuroendocrine Differentiation,Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8,1
4436,Acquired Lesion,Acquired kyphosis,1
4437,Metastatic Lesion,Metastatic Lung Non-Small Cell Squamous Carcinoma,1
4438,Malignant Cellular Infiltrate,Refractory Chronic Leukemia,1
4439,Non Lipogenic Sarcomatous Stroma Present,Recurrent Dedifferentiated Liposarcoma,1
4440,Immunologic Deficiency Syndromes,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
4441,Increased Cellularity Present,Secondary Supratentorial Anaplastic Astrocytoma,1
4442,Epithelial Component Present,Large cell carcinoma of lung,1
4443,High Mitotic Activity,Metastatic Prostate Small Cell Carcinoma,1
4444,Epithelial Component Present,Villoglandular Endometrial Endometrioid Adenocarcinoma,1
4445,Secondary Lesion,Advanced Neuroendocrine Carcinoma,1
4446,Epithelial Component Present,Tracheal Carcinoma,1
4447,Metastatic Lesion,Advanced Kaposi Sarcoma,1
4448,Secondary Lesion,"Neuroendocrine carcinoma, metastatic",1
4449,Neuroendocrine Differentiation,Jejunal Somatostatin-Producing Neuroendocrine Tumor,1
4450,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage III,1
4451,Florid Follicular Hyperplasia,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
4452,Diffuse Pattern,Adult Anaplastic Oligodendroglioma,1
4453,Metastatic Lesion,"Meningeal Chronic Myelogenous Leukemia, BCR-ABL1 Positive",1
4454,Epithelial Component Present,Unclassified Renal Cell Carcinoma,1
4455,Malignant Cellular Infiltrate,Pleural Monophasic Synovial Sarcoma,1
4456,Adulthood Lesion,Recurrent Adult Immunoblastic Lymphoma,1
4457,Neoplastic Plasma Cells Under 10 Percent of Bone Marrow Nucleated Cells,Non-IgM Monoclonal Gammopathy of Undetermined Significance,1
4458,Epithelial Component Present,Small Intestinal Villous Adenoma,1
4459,Epithelial Component Present,Primary Cutaneous Mucinous Carcinoma,1
4460,Biphasic Pattern,"Uterine Carcinosarcoma, Heterologous Type",1
4461,Tissue Differentiation Uncertain,Lymphangiomyoma,1
4462,Dysplasia,Pleomorphic lobular carcinoma in situ of breast,1
4463,Neuroendocrine Differentiation,Small Intestinal Large Cell Neuroendocrine Carcinoma,1
4464,Malignant Cellular Infiltrate,Stage IIB Cervical Cancer AJCC v8,1
4465,Calcitonin Positive Neoplastic Cells Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
4466,Malignant Cellular Infiltrate,Immunoblastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
4467,Malignant Cellular Infiltrate,small cell carcinoma of gallbladder,1
4468,Ineffective hematopoiesis,Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia,1
4469,Primary Lesion,Recurrent Childhood Gliosarcoma,1
4470,Perivascular Arrangement of Tumor Cells,Perivascular Epithelioid Cell Neoplasms,1
4471,Carcinomatous Component Present,Stage IVB Cervical Cancer AJCC v8,1
4472,Mitotic Activity,Glioblastoma by Gene Expression Profile,1
4473,Recurrent disease,Recurrent Childhood Lymphoblastic Lymphoma,1
4474,Epithelial Component Present,Fallopian Tube Carcinoma,1
4475,Tissue of Mullerian Origin Present,Recurrent Ovarian Carcinosarcoma,1
4476,Malignant Cellular Infiltrate,"Seminoma of testis, stage 1",1
4477,Cutaneous Involvement,Carcinoma in situ of skin,1
4478,Chromogranin A Positive Neoplastic Cells Present,Strumal carcinoid,1
4479,Malignant Cellular Infiltrate,Recurrent Fibrosarcoma,1
4480,Dysplasia,Ampulla of Vater Tubulovillous Adenoma,1
4481,"Promyelocytes, Myelocytes, and Mature Neutrophils 10 Percent or More of Bone Marrow Cells",Acute Myeloid Leukemia (AML-M2),1
4482,Epithelial Component Present,Stage III Hypopharyngeal Carcinoma AJCC v7,1
4483,Malignant Cellular Infiltrate,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
4484,Adulthood Lesion,Stage IIIA Adult Liver Cancer AJCC v7,1
4485,Well-Circumscribed Lesion,Appendix Tubular Adenoma,1
4486,Malignant Cellular Infiltrate,Mycosis Fungoides and Sezary Syndrome by AJCC v7 Stage,1
4487,Cavernous Vascular Space Formation,Cavernous hemangioma of the face,1
4488,Indolent Clinical Course,"Perivascular epithelioid tumor, benign",1
4489,Hyalinized Stroma Formation,Central Nervous System Solitary Fibrous Tumor/Hemangiopericytoma,1
4490,Malignant Cellular Infiltrate,Liver carcinoma,1
4491,Intravascular Fibrin Thrombus Formation,Infiltrating angiolipoma,1
4492,Epithelial Component Present,Stage I Vulvar Carcinoma,1
4493,Malignant Cellular Infiltrate,Pathologic Stage IA Cutaneous Melanoma AJCC v8,1
4494,Epithelial Component Present,Undifferentiated Carcinoma of Unknown Primary,1
4495,Thick-Walled Hyalinized Vessels Present,Benign Intraocular Schwannoma,1
4496,Locally Aggressive Lesion,Cardiac Inflammatory Myofibroblastic Tumor,1
4497,Neuroendocrine Differentiation,Localized Digestive System Neuroendocrine Tumor G1,1
4498,Carcinomatous Component Present,cystadenocarcinoma of salivary gland,1
4499,Adnexal Differentiation,Germinative Follicular Epithelium Neoplasm,1
4500,Epithelial Component Present,Refractory Fallopian Tube Carcinoma,1
4501,Precise Histogenesis Unknown,Retinal hemangioblastoma,1
4502,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma Under 55 Years AJCC v8,1
4503,Extensive Stage Lesion,Advanced Bile Duct Carcinoma,1
4504,Epithelial Component Present,High-Grade Prostatic Intraepithelial Neoplasia,1
4505,Malignant Cellular Infiltrate,Metastatic Breast Carcinoma,1
4506,HMB-45-Positive Neoplastic Cells Present,Benign Lung PEComa,1
4507,Neuroendocrine Differentiation,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
4508,Malignant Cellular Infiltrate,Prostatic Duct Urothelial Carcinoma,1
4509,Carcinomatous Component Present,BCLC Stage C Adult Hepatocellular Carcinoma,1
4510,Cystic Change,"Cystadenoma, Serous",1
4511,Epithelial Component Present,Refractory Extensive Stage Lung Small Cell Carcinoma,1
4512,In Situ Lesion,Adenocarcinoma in situ in villous adenoma,1
4513,Epithelial Component Present,Colorectal Intraepithelial Neoplasia,1
4514,Carcinomatous Component Present,Papillary carcinoma in situ,1
4515,Dysplasia,Noninfiltrating Intraductal Carcinoma,1
4516,Malignant Cellular Infiltrate,Stage IVA Osteosarcoma AJCC v7,1
4517,Epithelial Component Present,adenocarcinoma of urethra,1
4518,Adnexal Differentiation,Benign Germinative Follicular Epithelium Neoplasm,1
4519,Malignant Cellular Infiltrate,Stage 0 Oral Cavity Cancer AJCC v6 and v7,1
4520,Hereditary Lesion,Hereditary retinal dystrophy,1
4521,Secondary Lesion,Metastatic Oropharyngeal Carcinoma,1
4522,Refractory Disease,Refractory Ph-Like Acute Lymphoblastic Leukemia,1
4523,Immunologic Deficiency Syndromes,AIDS-related anal cancer recurrent,1
4524,Cutaneous Involvement,Unresectable Head and Neck Squamous Cell Carcinoma,1
4525,Exophytic Polypoid Lesion,Polyp of small intestine,1
4526,Carcinomatous Component Present,Stage IV Renal Cell Cancer,1
4527,Recurrent disease,Recurrent Nevus,1
4528,Benign Cellular Infiltrate,Benign neoplasm of small intestine,1
4529,Malignant Cellular Infiltrate,Stage IVA Uterine Corpus Adenosarcoma AJCC v8,1
4530,Exophytic Polypoid Lesion,papillary adenoma of extrahepatic bile duct,1
4531,Childhood Lesion,Stage III Childhood Hodgkin Lymphoma,1
4532,Malignant Cellular Infiltrate,Stage I Differentiated Thyroid Gland Carcinoma AJCC v7,1
4533,Cutaneous Involvement,Harlequin Fetus,1
4534,Malignant Cellular Infiltrate,"Neuroectodermal Tumor, Melanotic",1
4535,Carcinomatous Component Present,Stage IIIC Ovarian Cancer,1
4536,Carcinomatous Component Present,Stage 0 Rectal Cancer AJCC v6 and v7,1
4537,Recurrent disease,Recurrent Ovarian Endometrioid Adenocarcinoma,1
4538,Multifocal Lesion,Gardner Syndrome,1
4539,Malignant Cellular Infiltrate,Stage II Childhood Hepatocellular Carcinoma AJCC v6 and v7,1
4540,Malignant Cellular Infiltrate,Anal Lymphoma,1
4541,Epithelial Component Present,Resectable Intrahepatic Cholangiocarcinoma,1
4542,Dysplasia,Penile intraepithelial neoplasia,1
4543,Biphasic Pattern,Fibroadenoma of breast,1
4544,Malignant Cellular Infiltrate,Gallbladder Melanoma,1
4545,Malignant Cellular Infiltrate,Hepatoblastoma recurrent,1
4546,Thin-Walled Branching Vascular Pattern,"Meningeal Solitary Fibrous Tumor/Hemangiopericytoma, Grade 3",1
4547,Malignant Cellular Infiltrate,Stage IV Indolent Adult Non-Hodgkin Lymphoma,1
4548,Lymphadenopathy,Nodal Marginal Zone Lymphoma by Ann Arbor Stage,1
4549,Carcinomatous Component Present,Stage I Bladder Cancer AJCC v8,1
4550,Malignant Cellular Infiltrate,Class 1 Uveal Melanoma,1
4551,Low Mitotic Activity,Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
4552,Metastatic Lesion,Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents,1
4553,Tubular Pattern,Appendix Tubular Carcinoid,1
4554,Secondary Lesion,Secondary Prostate Urothelial Carcinoma,1
4555,Dysplasia,"Vulvar Intraepithelial Neoplasia, Differentiated Type",1
4556,In Situ Lesion,Stage 0 Vulvar Cancer,1
4557,High Grade Lesion,Leiomyosarcoma NCI Grade 3,1
4558,Childhood Lesion,Mixed Congenital Mesoblastic Nephroma,1
4559,Malignant Cellular Infiltrate,Localized Resectable Neuroblastoma,1
4560,Recurrent disease,Recurrent Childhood Gliosarcoma,1
4561,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v6 and v7,1
4562,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity recurrent,1
4563,Metastatic Lesion,Metastatic Urethral Urothelial Carcinoma,1
4564,Recurrent disease,Recurrent Extensive Stage Lung Small Cell Carcinoma,1
4565,Malignant Cellular Infiltrate,Recurrent Parotid Gland Squamous Cell Carcinoma,1
4566,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,Refractory High Risk Myelodysplastic Syndrome,1
4567,Pseudopapillary Pattern,Cerebellar Papillary Meningioma,1
4568,Malignant Cellular Infiltrate,Malignant neoplasm of nipple of female breast,1
4569,Intermediate Grade Lesion,Intermediate Grade Lung Neuroendocrine Neoplasm,1
4570,Erythroid Precursors 50 Percent or More of Bone Marrow Nucleated Cells,Recurrent Acute Erythroid Leukemia,1
4571,CD1a-Positive Neoplastic Cells Present,Adult Langerhans Cell Histiocytosis,1
4572,Mixture of Germ Cell Neoplastic Components Present,Ovarian germ cell tumor mixed,1
4573,Carcinomatous Component Present,Stage II Prostate Cancer AJCC v8,1
4574,Carcinomatous Component Present,Vaginal Warty Carcinoma,1
4575,Malignant Cellular Infiltrate,Stage 0 Lung Cancer AJCC v8,1
4576,Benign Cellular Infiltrate,Benign Ovarian Clear Cell Tumor,1
4577,Carcinomatous Component Present,Labia Minora Carcinoma,1
4578,Papillary Pattern,Papillary fibroelastoma,1
4579,Cutaneous Involvement,Germinative Follicular Epithelium Neoplasm,1
4580,Epithelial Component Present,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
4581,Mitotic Activity,Temporal Lobe Anaplastic Astrocytoma,1
4582,Squamous metaplasia of bladder,Bladder squamous cell carcinoma stage II,1
4583,Malignant Cellular Infiltrate,Metastatic Oral Cavity Squamous Cell Carcinoma,1
4584,Cutaneous Involvement,Skin Clear Cell Basal Cell Carcinoma,1
4585,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Aleukemic Monocytic Leukemia Cutis,1
4586,Epithelial Component Present,Stage IIIB Rectal Cancer AJCC v7,1
4587,Tissue Differentiation Uncertain,Soft Tissue Tumor of Uncertain Differentiation,1
4588,Childhood Lesion,Juvenile Pilocytic Astrocytoma,1
4589,Multinodular Mass,Colorectal Angiosarcoma,1
4590,Carcinomatous Component Present,Small Intestinal Mucinous Adenocarcinoma,1
4591,Adulthood Lesion,Advanced Adult Hepatocellular Carcinoma,1
4592,Epithelial Component Present,Stage I Colorectal Neuroendocrine Tumor AJCC v8,1
4593,Malignant Cellular Infiltrate,Childhood Anaplastic Large Cell Lymphoma,1
4594,Malignant Cellular Infiltrate,Stage IA Ovarian Cancer,1
4595,Painless Mass,Desmoplastic fibroblastoma,1
4596,Benign Cellular Infiltrate,Benign Dermal Schwannoma,1
4597,Encapsulated Mass,minimally invasive follicular carcinoma of the thyroid gland,1
4598,Immature Granulocytes in Peripheral Blood Under 10 Percent,Chronic Myelomonocytic Leukemia with Eosinophilia,1
4599,Metastatic Lesion,Metastatic Fibrolamellar Carcinoma,1
4600,Absence of Invasion,Lobular carcinoma in situ of breast,1
4601,Anaplasia,Pulmonary Blastoma,1
4602,Malignant Cellular Infiltrate,Differentiating Neuroblastoma,1
4603,Cutaneous Involvement,Sarcoma of skin,1
4604,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma,1
4605,Indolent Clinical Course,Congenital hemangioma,1
4606,Epithelial Component Present,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
4607,Absence of Invasion,Gastric Cardia Carcinoma In Situ AJCC v6 and v7,1
4608,Malignant Cellular Infiltrate,Stage II Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8,1
4609,Malignant Cellular Infiltrate,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
4610,Diffuse Lesion,"Retinoblastoma, diffuse",1
4611,Carcinomatous Component Present,Basal cell carcinoma - adamantinoid,1
4612,Childhood Lesion,Childhood Acute Monocytic Leukemia,1
4613,Severe cytologic atypia,Undifferentiated Stromal Sarcoma,1
4614,Malignant Cellular Infiltrate,Stage IA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8,1
4615,Fibromyxoid Stroma Formation,Fibromyxolipoma,1
4616,Epithelial Component Present,Low Grade Salivary Gland Mucoepidermoid Carcinoma,1
4617,Epithelial Component Present,Multiple endocrine neoplasia type 4,1
4618,Birbeck Granules Present,"Histiocytosis, Langerhans-Cell",1
4619,Childhood Lesion,Stage II Childhood Anaplastic Large Cell Lymphoma,1
4620,Pseudoencapsulated Mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
4621,Carcinomatous Component Present,Stage III Lung Cancer AJCC v7,1
4622,Benign Cellular Infiltrate,"Adenoma, Sweat Gland",1
4623,Carcinomatous Component Present,Carcinoma in situ of trachea,1
4624,Epithelial Component Present,Colon Neuroendocrine Tumor by AJCC v8 Stage,1
4625,Secondary Lesion,Urothelial carcinoma ureter metastatic,1
4626,Tissues Derived from Two or Three Embryonic Layers Present,Ovarian Solid Teratoma,1
4627,Papillary Pattern,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
4628,Benign Cellular Infiltrate,Intermediate Rhabdomyoma,1
4629,Well-Circumscribed Lesion,Gastric hyperplastic polyp,1
4630,Geographic Necrosis,embryonal carcinoma of mediastinum,1
4631,Epithelial Component Present,Recurrent Low Grade Fallopian Tube Serous Adenocarcinoma,1
4632,Epithelial Component Present,Hepatitis Virus-Related Hepatocellular Carcinoma,1
4633,Epithelial Component Present,Vulvar Adenocarcinoma of Sweat Gland Type,1
4634,Mass of body structure,Small Intestinal Myeloid Sarcoma,1
4635,Hyalinized Stroma Formation,Bone Epithelioid Hemangioendothelioma,1
4636,Dysplasia,Pancreatic Intraepithelial Neoplasia-1B,1
4637,Recurrent disease,Lung squamous cell carcinoma recurrent,1
4638,Bead-Like Arrangement of Elastic Fibers,Elastofibroma,1
4639,Trabecular Pattern,Pancreatic Somatostatinoma,1
4640,Antoni A Pattern,Sympathetic Schwannoma,1
4641,Malignant Cellular Infiltrate,Cutaneous Precursor Lymphoid Neoplasm,1
4642,Malignant Cellular Infiltrate,Mucoepidermoid carcinoma of the oral cavity,1
4643,Malignant Cellular Infiltrate,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Nested Variant",1
4644,Carcinomatous Component Present,Stage I Colorectal Cancer AJCC v6 and v7,1
4645,Nodular Pattern,Recurrent Grade 1 Follicular Lymphoma,1
4646,Malignant Cellular Infiltrate,Nonestrogen-Dependent Malignant Neoplasm,1
4647,Acanthosis,inverted follicular keratosis,1
4648,Non-Hereditary Lesion,Gastric Intramucosal Adenocarcinoma,1
4649,Necrotic changes (finding),Cerebral Glioblastoma,1
4650,Malignant Cellular Infiltrate,Malignant Ovarian Granulosa Cell Tumor,1
4651,Malignant Cellular Infiltrate,Stage II Appendix Carcinoma AJCC v8,1
4652,Poorly Differentiated Lesion,Sarcomatoid carcinoma of the lung,1
4653,Mitotic Activity,teratocarcinoma of mediastinum,1
4654,Malignant Cellular Infiltrate,Clinical Stage IA Cutaneous Melanoma AJCC v8,1
4655,Below the Diaphragm Disease,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
4656,Malignant Cellular Infiltrate,Penile Cancer by AJCC v7 Stage,1
4657,Indolent Clinical Course,"Fibro-odontoma, Ameloblastic",1
4658,Secondary Lesion,Metastatic Sarcomatoid Renal Cell Carcinoma,1
4659,Malignant Cellular Infiltrate,leiomyosarcoma of bone,1
4660,Epithelial Component Present,small cell carcinoma of breast,1
4661,High Grade Lesion,Stage III Lung Small Cell Carcinoma AJCC v7,1
4662,Absence of Invasion,"Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8",1
4663,Primary Lesion,Primary peritoneal carcinoma,1
4664,Secondary Lesion,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
4665,Diffuse Pattern,Refractory High Grade B-Cell Lymphoma with MYC and BCL2 or BCL6 Rearrangements,1
4666,High Mitotic Activity,Choroid Plexus Carcinoma,1
4667,Epithelial Component Present,Growth Hormone-Secreting Pituitary Adenoma,1
4668,Epithelioid Component Present,Lung Biphasic Synovial Sarcoma,1
4669,Malignant Cellular Infiltrate,Solar Radiation-Related Skin Squamous Cell Carcinoma,1
4670,Carcinomatous Component Present,Borderline Resectable Carcinoma,1
4671,Nested Pattern,Paraganglioma-Like Dermal Melanocytic Tumor,1
4672,Malignant Cellular Infiltrate,Thymic Carcinoma,1
4673,Cutaneous Involvement,Cutaneous Melanoma of the Extremity,1
4674,Invasive Lesion,Metastatic Prostate Small Cell Carcinoma,1
4675,Solitary mass,Epithelioid hemangioendothelioma,1
4676,Malignant Cellular Infiltrate,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Stage,1
4677,Benign Cellular Infiltrate,Mature Teratoma,1
4678,Capillary Sized Vascular Channel Formation,Solid Glomus Tumor,1
4679,Carcinomatous Component Present,Stage IIIC Rectal Cancer AJCC v7,1
4680,Hereditary Lesion,"Optic Atrophy, Hereditary, Leber",1
4681,CD30-Positive Neoplastic Cells Present,"Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative",1
4682,High Grade Lesion,Pleural Biphasic Synovial Sarcoma,1
4683,Necrotic changes (finding),Small cell carcinoma of esophagus,1
4684,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v8,1
4685,Epithelial Component Present,Stage 0 Merkel Cell Carcinoma AJCC v7,1
4686,Hyperkeratosis,Cervical Squamotransitional Carcinoma,1
4687,Well Differentiated Lesion,mucinous adenocarcinoma of lung,1
4688,Malignant Cellular Infiltrate,Apocrine Breast Carcinoma In Situ,1
4689,Malignant Cellular Infiltrate,Precursor T cell lymphoblastic leukemia/lymphoblastic lymphoma,1
4690,Hereditary Lesion,"Elliptocytosis, Hereditary",1
4691,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity stage II,1
4692,Multinodular Pattern,Sporadic Cylindroma,1
4693,Epithelial Component Present,Squamous cell carcinoma,1
4694,Carcinomatous Component Present,Recurrent Oral Cavity Carcinoma,1
4695,Primary Lesion,"Leukemia, Mast-Cell",1
4696,Epithelial Component Present,Pancreatic Intraepithelial Neoplasia-1A,1
4697,Hyperplastic Tissue Present,Reactive C-Cell Hyperplasia,1
4698,Non-Invasive Lesion,Bladder Non-Invasive Papillary Urothelial Carcinoma,1
4699,Tissue Differentiation Uncertain,Mediastinal Synovial Sarcoma,1
4700,Benign Cellular Infiltrate,Subcutaneous Nodular Fasciitis,1
4701,Well-Circumscribed Lesion,Intermediate Rhabdomyoma,1
4702,Mesenchymal Component Present,Lung Pleomorphic Adenoma,1
4703,Recurrent disease,Recurrent Nasal Cavity and Paranasal Sinus Carcinoma,1
4704,Nuclear pleomorphism,Localized Childhood Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
4705,Malignant Cellular Infiltrate,Neural Glioblastoma,1
4706,Malignant Cellular Infiltrate,Borrelia Burgdoferi-Associated Cutaneous Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,1
4707,Metastatic Lesion,"Squamous cell carcinoma, metastatic",1
4708,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Secondary Tumor,1
4709,Epithelial Component Present,Endometrial Carcinoma,1
4710,Benign Cellular Infiltrate,Thyroid Gland Hemangioma,1
4711,Epithelial Component Present,Refractory Endometrial Mixed Cell Adenocarcinoma,1
4712,Exophytic Polypoid Lesion,Filiform Serrated Adenoma,1
4713,Secondary Lesion,Metastatic Malignant Neoplasm in the Viscera,1
4714,Non-Hereditary Lesion,"Papillary renal cell carcinoma, sporadic",1
4715,Malignant Cellular Infiltrate,Stage IIB Uterine Sarcoma AJCC v7,1
4716,Malignant Cellular Infiltrate,Hodgkin's disease mixed cellularity stage II subdiaphragmatic,1
4717,Organoid Pattern,Alveolar Soft Part Sarcoma,1
4718,Childhood Lesion,Childhood Central Nervous System Germ Cell Tumor,1
4719,Malignant Cellular Infiltrate,Malignant Ovarian Germ Cell Neoplasm,1
4720,Malignant Cellular Infiltrate,Malignant tumor of iris,1
4721,Carcinomatous Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7,1
4722,Malignant Cellular Infiltrate,Childhood Immunoblastic Lymphoma,1
4723,Carcinomatous Component Present,Stage IVB Lung Cancer AJCC v8,1
4724,Recurrent disease,Recurrent Non-Cutaneous Melanoma,1
4725,Metaplasia,Lung Enteric Adenocarcinoma,1
4726,Fibrotic Stroma Formation,Borderline Ovarian Mucinous Adenofibroma,1
4727,Chromogranin A Positive Neoplastic Cells Present,"Cervical Low Grade Neuroendocrine Tumor, Grade 1",1
4728,Malignant Cellular Infiltrate,Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
4729,Absence of Invasion,Carcinoma in Situ,1
4730,Poorly Differentiated Lesion,Thymic Sarcomatoid Carcinoma,1
4731,Nerve palsy,Congenital facial nerve palsy,1
4732,Carcinomatous Component Present,Pancreatic Intraductal Tubulopapillary Neoplasm with an Associated Invasive Carcinoma,1
4733,Epithelial Component Present,Adenocarcinoma of the prostate stage I,1
4734,Malignant Cellular Infiltrate,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
4735,Refractory Disease,Refractory Mediastinal Lymphoma,1
4736,Epithelial Component Present,Collecting Duct Carcinoma of the Kidney,1
4737,Malignant Cellular Infiltrate,cystadenocarcinoma of salivary gland,1
4738,Epithelial Component Present,Biliary Tract Carcinoma,1
4739,Carcinomatous Component Present,Oropharyngeal squamous cell carcinoma stage I,1
4740,Vascular Channel Formation,Angiosarcoma NCI Grade 2,1
4741,Epithelial Component Present,Recurrent Ovarian Transitional Cell Carcinoma,1
4742,Absence of Basal Cell Layer,Recurrent Prostate Acinar Adenocarcinoma,1
4743,Histiocytoid Differentiation,Lymphohistiocytoid Mesothelioma,1
4744,Malignant Cellular Infiltrate,Metastatic Sarcomatoid Renal Cell Carcinoma,1
4745,Epithelial Component Present,Refractory Head and Neck Carcinoma,1
4746,Carcinomatous Component Present,Stomach Carcinoma,1
4747,Spontaneous Regression,keratoacanthoma,1
4748,Malignant Cellular Infiltrate,Precursor Lymphoid Neoplasm,1
4749,Lobulated Growth Pattern,Unresectable Chordoma,1
4750,Cystic Change,Pancreatic Intraductal Papillary Mucinous Neoplasm,1
4751,Proliferation of Follicular Dendritic Cells Present,Angioimmunoblastic T-cell lymphoma refractory,1
4752,Secondary Lesion,Metastatic Cervical Adenocarcinoma,1
4753,Mixture of Germ Cell Neoplastic Components Present,Mediastinal Mixed Germ Cell Tumor,1
4754,Carcinomatous Component Present,Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component,1
4755,Extensive Stage Lesion,Advanced Microsatellite Stable Colorectal Carcinoma,1
4756,Malignant Cellular Infiltrate,Metastatic Digestive System Neuroendocrine Tumor G1,1
4757,Malignant Cellular Infiltrate,Stage IIIA Breast Carcinoma,1
4758,Recurrent Lymphoma,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
4759,Bone Marrow and Blood Involvement,Childhood Burkitt Leukemia,1
4760,Crystal deposition,Alveolar Soft Part Sarcoma,1
4761,Epithelial Component Present,Stage I Vaginal Cancer AJCC v6 and v7,1
4762,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v7 Stage,1
4763,Malignant Cellular Infiltrate,Nodal Peripheral T-Cell Lymphoma of T Follicular Helper Cell Origin,1
4764,Epithelial Component Present,Recurrent Hepatocellular Carcinoma,1
4765,Myeloblasts Under 20 Percent of Peripheral Blood White Cells,High Risk Myelodysplastic Syndrome,1
4766,Malignant Cellular Infiltrate,Breast Carcinoma Metastatic in the Spine,1
4767,Hereditary Lesion,Hereditary Nonpolyposis Colorectal Cancer,1
4768,Carcinomatous Component Present,BAP1-Mutant Clear Cell Renal Cell Carcinoma,1
4769,Epithelial Component Present,Stage III Carcinoma of Penis,1
4770,Stromal Invasion,Stage IIIB Ovarian Cancer AJCC v8,1
4771,Capillary Sized Vascular Channel Formation,Breast Epithelioid Hemangioma,1
4772,Adnexal Differentiation,Sebaceous Gland Neoplasms,1
4773,Epithelial Component Present,"Infiltrating Bladder Urothelial Carcinoma, Microcystic Variant",1
4774,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
4775,Epithelial Component Present,Squamous cell carcinoma of vagina,1
4776,Carcinomatous Component Present,Adult Penile Carcinoma,1
4777,Epithelial Component Present,Gallbladder papillary adenocarcinoma,1
4778,High Grade Lesion,Small cell lung cancer recurrent,1
4779,Tissue Differentiation Uncertain,Lung Clear Cell Tumor,1
4780,Metaplasia,"Vulvar Adenocarcinoma, Intestinal-Type",1
4781,Neuroendocrine Differentiation,small cell carcinoma of kidney,1
4782,Epithelial Component Present,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v7,1
4783,Peripheral Nuclear Palisading,Basaloid carcinoma,1
4784,Nodular Pattern,Hodgkin's disease nodular sclerosis refractory,1
4785,Benign Cellular Infiltrate,Epicardial Lipoma,1
4786,Dysplasia,Conjunctival intraepithelial neoplasia,1
4787,Absence of Invasion,"Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8",1
4788,Epithelial Component Present,Bile Duct Biliary Intraepithelial Neoplasia,1
4789,Recurrent disease,Recurrent Extraskeletal Myxoid Chondrosarcoma,1
4790,Recurrent disease,Recurrent Abdominal Neuroendocrine Neoplasm,1
4791,Malignant Cellular Infiltrate,Mast-Cell Sarcoma,1
4792,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Small Cell Neuroendocrine Variant",1
4793,Malignant Cellular Infiltrate,Stage I Rectal Cancer AJCC v6 and v7,1
4794,atypia morphology,Malignant Testicular Leydig Cell Tumor,1
4795,Carcinomatous Component Present,Stage I Hepatocellular Carcinoma AJCC v6 and v7,1
4796,Malignant Cellular Infiltrate,Refractory Leukemia,1
4797,Carcinomatous Component Present,mucinous adenocarcinoma of anus,1
4798,Well-Circumscribed Lesion,Colorectal Adenoma with Moderate Dysplasia,1
4799,Epithelial Component Present,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
4800,Well Differentiated Neuroendocrine Lesion,Rectal Neuroendocrine Tumor by AJCC v8 Stage,1
4801,Neuroendocrine Differentiation,Gastric Small Cell Carcinoma,1
4802,Malignant Cellular Infiltrate,Clinical Stage II Retinoblastoma AJCC v8,1
4803,Carcinomatous Component Present,Cervical Endometrioid Adenocarcinoma,1
4804,Splenomegaly,Philadelphia chromosome positive chronic myelogenous leukemia,1
4805,Indolent Clinical Course,Myxoma,1
4806,Epithelial Component Present,Sporadic Diffuse Gastric Adenocarcinoma,1
4807,'Starry-sky' pattern,Ann Arbor Stage II Contiguous Adult Burkitt Lymphoma,1
4808,Storiform Growth Pattern,follicular dendritic cell sarcoma of thyroid gland,1
4809,Secondary Lesion,Locally Advanced Unresectable Prostate Adenocarcinoma,1
4810,Cutaneous Involvement,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
4811,Tissue of Mullerian Origin Present,carcinosarcoma of fallopian tube,1
4812,Dysplasia,Stage 0 Vulvar Cancer,1
4813,Monomorphic Cellular Infiltrate,Childhood Ependymoma,1
4814,Epithelial Component Present,"High Grade Prostatic Intraepithelial Neoplasia, Foamy Variant",1
4815,Dysplasia,Anal Intraepithelial Neoplasia 3,1
4816,Secondary Lesion,Locally Advanced Urothelial Carcinoma,1
4817,Epithelial Component Present,Stage IVA Hypopharyngeal Squamous Cell Carcinoma AJCC v7,1
4818,Epithelial Component Present,FIGO Stage IC2 Ovarian Cancer,1
4819,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
4820,Carcinomatous Component Present,Clinical Stage I Esophageal Adenocarcinoma AJCC v8,1
4821,Carcinomatous Component Present,Stage IV Lung Small Cell Carcinoma AJCC v7,1
4822,Secondary Lesion,Secondary malignant neoplasm of parathyroid gland,1
4823,Primary Lesion,Stage II Osteosarcoma AJCC v7,1
4824,Indolent Clinical Course,Uterine Corpus Hydropic Leiomyoma,1
4825,Malignant Cellular Infiltrate,Iris Spindle Cell Melanoma,1
4826,Malignant Cellular Infiltrate,Gallbladder Lymphoma,1
4827,Follicular Structures Present,Macrofollicular adenoma,1
4828,'Starry-sky' pattern,Burkitt's lymphoma of breast,1
4829,Epithelial Component Present,Thoracic Esophagus Adenocarcinoma,1
4830,Papillary Pattern,Skin Papilloma,1
4831,Epithelial Component Present,Stage II Vaginal Cancer AJCC v8,1
4832,Composite Lesion,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
4833,Malignant Cellular Infiltrate,Stage IA Uterine Corpus Adenosarcoma AJCC v8,1
4834,Vertical Growth Phase,Desmoplastic melanoma,1
4835,Epithelial Component Present,Breast Carcinoma with Osteoclastic Giant Cells,1
4836,Epithelial Component Present,Stage II Lung Small Cell Carcinoma AJCC v7,1
4837,Malignant Cellular Infiltrate,Malignant Bladder Paraganglioma,1
4838,Adulthood Lesion,Adult Mixed Cellularity Classical Hodgkin Lymphoma,1
4839,Epithelial Component Present,Stage I Ureter Cancer AJCC v8,1
4840,Neuroendocrine Differentiation,Anal Canal Neuroendocrine Tumor G1,1
4841,Childhood Lesion,Childhood Central Nervous System Embryonal Carcinoma,1
4842,Chromogranin A Positive Neoplastic Cells Present,Carcinoid tumor of intestine,1
4843,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Myelodysplastic Syndrome with Isolated del(5q),1
4844,Epithelial Component Present,Stage IIIA Appendix Carcinoma AJCC v8,1
4845,Recurrent disease,Recurrent Salivary Duct Carcinoma,1
4846,Carcinomatous Component Present,Small cell carcinoma of esophagus,1
4847,Bead-Like Arrangement of Elastic Fibers,Elastofibroma,1
4848,Carcinomatous Component Present,Stage III Laryngeal Cancer AJCC v8,1
4849,Severe dysplasia,Stage 0is Renal Pelvis and Ureter Cancer AJCC v7,1
4850,Epithelial Component Present,Clinical Stage III Merkel Cell Carcinoma AJCC v8,1
4851,Epithelial Component Present,Alcohol-Related Esophageal Squamous Cell Carcinoma,1
4852,Malignant Cellular Infiltrate,Malignant neoplasm of mouth,1
4853,Well-Circumscribed Lesion,"Papillary mucinous cystadenoma, borderline malignancy",1
4854,Hereditary Lesion,"Anemia, Hemolytic, Congenital",1
4855,Clinical TNM Finding,Clinical Stage IIA Cutaneous Melanoma AJCC v8,1
4856,Epithelial Component Present,Gallbladder Papillary Biliary Intraepithelial Neoplasia,1
4857,Neuroectodermal Differentiation,Childhood Central Nervous System Neuroblastoma,1
4858,Tobacco Toxicity,Tobacco Chewing-Related Carcinoma,1
4859,Malignant Cellular Infiltrate,Invasive Malignant Neoplasm,1
4860,Cutaneous Involvement,Superficial spreading malignant melanoma of skin,1
4861,Pathologic TNM Finding,Pathologic Stage IIB Gastric Cancer AJCC v8,1
4862,Carcinomatous Component Present,Unresectable Gallbladder Carcinoma,1
4863,Refractory Disease,Refractory Primary Lymphoma of Bone,1
4864,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7,1
4865,Fibrotic Stroma Formation,Ovarian Clear Cell Adenofibroma,1
4866,Carcinomatous Component Present,Clinical Stage IVA Esophageal Squamous Cell Carcinoma AJCC v8,1
4867,Recurrent disease,Recurrent Ovarian Cystadenocarcinoma,1
4868,Recurrent disease,Recurrent Hodgkin Lymphoma,1
4869,Stromal Invasion,squamous cell carcinoma of ovary,1
4870,Epithelial Component Present,Stage IIA Ovarian Cancer AJCC V6 and v7,1
4871,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
4872,Severe dysplasia,Noninfiltrating Intraductal Carcinoma,1
4873,Carcinomatous Component Present,Cervical Keratinizing Squamous Cell Carcinoma,1
4874,Malignant Cellular Infiltrate,Paget's Disease of the Nipple,1
4875,Well-Circumscribed Lesion,estrogen-producing adrenal cortical adenoma,1
4876,Benign Cellular Infiltrate,Borderline Ovarian Clear Cell Cystadenofibroma,1
4877,Epithelial Component Present,Stage IV Colon Cancer AJCC v8,1
4878,Cutaneous Involvement,Monilethrix,1
4879,Cutaneous Involvement,Scleromyxedema,1
4880,Malignant Cellular Infiltrate,Colon Small Cell Neuroendocrine Carcinoma,1
4881,Cellular Changes Resembling Foveolar Epithelium Cells,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
4882,Mitotic Activity,"Testicular Yolk Sac Tumor, Enteric Pattern",1
4883,Epithelial Component Present,tubular adenoma of stomach,1
4884,Multifocal Lesion,"Lipomatosis, Multiple Symmetrical",1
4885,Malignant Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma,1
4886,Chromogranin A Positive Neoplastic Cells Present,Transverse Colon Neuroendocrine Tumor G1,1
4887,Refractory Disease,Mantle cell lymphoma refractory,1
4888,Chronic Inflammatory Infiltrate,Cutaneous Fibrous Histiocytoma,1
4889,Carcinomatous Component Present,Stage IB Intrahepatic Cholangiocarcinoma AJCC v8,1
4890,Necrotic changes (finding),Recurrent Dedifferentiated Liposarcoma,1
4891,Well-Circumscribed Lesion,Stage I Thyroid Gland Medullary Carcinoma AJCC v7,1
4892,Papillary Pattern,Laryngeal verrucous carcinoma,1
4893,Indolent Clinical Course,Benign neoplasm of soft tissue,1
4894,Epithelial Component Present,Childhood Hepatocellular Carcinoma,1
4895,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma of the Vagina,1
4896,atypia morphology,Borderline Ovarian Serous Tumor-Micropapillary Variant/Non-Invasive Low Grade Ovarian Serous Carcinoma,1
4897,Solitary mass,Solitary Osseous Plasmacytoma,1
4898,Epithelial Component Present,Metaplastic thymoma,1
4899,Well Differentiated Neuroendocrine Lesion,Esophageal Neuroendocrine Tumor G1,1
4900,More than 5 Mitoses per 50HPF,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage",1
4901,Adnexal Differentiation,"Adenoma, Sweat Gland",1
4902,Cutaneous Involvement,Pilosebaceous Hamartoma,1
4903,Acanthosis,Melanoacanthoma,1
4904,Malignant Cellular Infiltrate,Stage IIIB Primary Peritoneal Cancer AJCC v8,1
4905,Absence of Invasion,"Ampullary Flat Intraepithelial Neoplasia, High Grade",1
4906,Carcinomatous Component Present,Stage IV Cervical Cancer AJCC v6 and v7,1
4907,Increased Cellularity Present,Recurrent Anaplastic Oligodendroglioma,1
4908,Secondary Lesion,Secondary malignant neoplasm of pituitary gland,1
4909,Epithelial Component Present,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,1
4910,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
4911,Carcinomatous Component Present,Recurrent Pancreatic Ductal Adenocarcinoma,1
4912,More than 5 Mitoses per 50HPF,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage",1
4913,Malignant Cellular Infiltrate,Clinical Stage IV Cutaneous Melanoma AJCC v8,1
4914,Non-Specific Glandular Pattern,"Salivary Gland Adenocarcinoma, Not Otherwise Specified",1
4915,Secondary Lesion,Locally Metastatic Malignant Neoplasm,1
4916,Vascular proliferation,Cellular angiofibroma,1
4917,Cystic Change,Papillary mucinous cystadenocarcinoma,1
4918,Neuroendocrine Differentiation,Stage II Duodenal Neuroendocrine Tumor AJCC v8,1
4919,Epithelial Component Present,Small Intestinal Intraepithelial Neoplasia,1
4920,Oligodendroglial Component Present,"Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted",1
4921,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Polystotic",1
4922,Epithelial Component Present,"Invasive Lobular Breast Carcinoma, Alveolar Variant",1
4923,Cutaneous Involvement,Acanthosis Nigricans,1
4924,Carcinomatous Component Present,Esophageal Spindle Cell Carcinoma,1
4925,Malignant Cellular Infiltrate,Stage I Childhood Lymphoblastic Lymphoma,1
4926,Immunosuppression-Related Post-Transplant Toxicity,New Onset Diabetes After Transplant,1
4927,Absence of Invasion,Stage 0 Esophageal Adenocarcinoma AJCC v7,1
4928,Benign Cellular Infiltrate,Ovarian Cellular Fibroma,1
4929,Refractory Disease,Refractory Bile Duct Carcinoma,1
4930,Malignant Cellular Infiltrate,Appendix Carcinoma by AJCC v8 Stage,1
4931,Polymorphic Cellular Infiltrate,Infectious mononucleosis-like post-transplant lymphoproliferative disorder,1
4932,Cutaneous Involvement,Blastic plasmacytoid dendritic cell neoplasm,1
4933,Angiodestructive Pattern,Lymphomatoid Granulomatosis,1
4934,Epithelial Component Present,Thyroid Gland Anaplastic Carcinoma by AJCC v8 Stage,1
4935,Epithelial Component Present,Ovarian mixed epithelial carcinoma,1
4936,Dysplasia,Vaginal high grade squamous intraepithelial lesion,1
4937,Malignant Cellular Infiltrate,Metastatic Adrenal Cortex Carcinoma,1
4938,Intracytoplasmic Eosinophilic Inclusion,Refractory Rhabdoid Tumor,1
4939,Argentaffin Positive Neoplastic Cells Present,Colorectal Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
4940,Carcinomatous Component Present,Bartholin Gland Adenoid Cystic Carcinoma,1
4941,Carcinomatous Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
4942,Malignant Cellular Infiltrate,Colorectal Carcinoma Metastatic in the Liver,1
4943,Cytoplasmic Membrane-Bound Granules Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
4944,Refractory Disease,Refractory Plasma Cell Neoplasm,1
4945,Nuclear Pseudoinclusion,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
4946,Diffuse Pattern,Diffuse Large B-Cell Lymphoma by Ann Arbor Stage,1
4947,Carcinomatous Component Present,Metastatic Carcinoma to the Uterine Cervix,1
4948,Epithelial Component Present,Ampulla of Vater Tubular Adenoma,1
4949,Metastatic Lesion,Colorectal Carcinoma Metastatic in the Lung,1
4950,Monocytosis,Chronic Myelomonocytic Leukemia-0,1
4951,Well-Circumscribed Lesion,"Papillary cystadenoma, borderline malignancy",1
4952,Nodular Pattern,Grade 2 Cutaneous Follicular Lymphoma,1
4953,Carcinomatous Component Present,Rectal Medullary Carcinoma,1
4954,Indolent Clinical Course,Giant cell angiofibroma,1
4955,Epithelial Component Present,Stage III Hilar Cholangiocarcinoma AJCC v8,1
4956,Myeloblasts Under 20 Percent of Bone Marrow Nucleated Cells,Refractory Thrombocytopenia,1
4957,Non-Invasive Lesion,Bladder Urothelial Papilloma,1
4958,Misplaced Exocytosis Present,Sparsely Granulated Lactotroph Adenoma,1
4959,Epithelial Component Present,Stage III Colorectal Cancer AJCC v7,1
4960,Adnexal Differentiation,Eyelid Sebaceous Gland Carcinoma,1
4961,Epithelial Component Present,Stage III Appendix Neuroendocrine Tumor AJCC v7,1
4962,Bilateral Disease,Bilateral Malignant Neoplasm,1
4963,Finding related to pregnancy,Non-Hodgkin Lymphoma During Pregnancy,1
4964,Secondary Lesion,Secondary malignant neoplasm of sternum,1
4965,Carcinomatous Component Present,Renal Cell Carcinoma,1
4966,Malignant Cellular Infiltrate,Stage I Merkel Cell Carcinoma AJCC v7,1
4967,Microvascular Proliferation,Glioblastoma by Gene Expression Profile,1
4968,Hyperplastic Tissue Present,Atypical Mesothelial Hyperplasia,1
4969,Fibrotic Stroma Formation,Mucinous adenofibroma,1
4970,Cutaneous Involvement,basal cell carcinoma of scrotum,1
4971,Childhood Lesion,Hepatoblastoma,1
4972,Carcinomatous Component Present,Carcinoma of Littre Glands,1
4973,Carcinomatous Component Present,Mucoepidermoid carcinoma of submandibular gland,1
4974,Osseous Differentiation,Osteosarcoma by AJCC v7 Stage,1
4975,Lipomatous Component Present,Ectopic hamartomatous thymoma,1
4976,Diffuse Pattern,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
4977,Cutaneous Involvement,furuncle,1
4978,Lipomatous Metaplasia,Uterine Corpus Lipoleiomyoma,1
4979,Epithelial Component Present,Hard Palate Mucoepidermoid Carcinoma,1
4980,Malignant Cellular Infiltrate,Colorectal Squamous Cell Carcinoma,1
4981,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Perihilar Variant,1
4982,Perivascular Arrangement of Tumor Cells,Malignant Pericytic Neoplasm,1
4983,Capillary Sized Vascular Channel Formation,Peripheral Hemangioblastoma,1
4984,Fibrous Septa Present,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
4985,Secondary Lesion,Locally Advanced Bone Sarcoma,1
4986,Cutaneous Involvement,Signet Ring Melanoma,1
4987,Well-Circumscribed Lesion,Polyp of esophagus,1
4988,Malignant Cellular Infiltrate,Metastatic Non-Cutaneous Melanoma,1
4989,Malignant Cellular Infiltrate,Stage IA Testicular Cancer AJCC v6 and v7,1
4990,Low Cellularity Present,Pilocytic Astrocytoma,1
4991,Perivascular Arrangement of Tumor Cells,Adult Papillary Meningioma,1
4992,Infiltrating Tumor Margins Present,Stage IA Uterine Corpus Endometrial Stromal Sarcoma AJCC v8,1
4993,Collagenous Stroma Formation,Breast Myofibroblastoma,1
4994,Epithelial Component Present,Recurrent Inverted Schneiderian Papilloma,1
4995,Epithelial Component Present,Recurrent Thyroid Carcinoma,1
4996,Carcinomatous Component Present,Stage 0 Renal Pelvis Cancer AJCC v7,1
4997,Tissue of Mullerian Origin Present,Adenosarcoma,1
4998,Immunologic Deficiency Syndromes,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
4999,Neuroendocrine Differentiation,Non functioning pancreatic endocrine tumor,1
5000,Malignant Cellular Infiltrate,Extraskeletal Osteosarcoma,1
5001,Cutaneous Involvement,Pseudoporphyria,1
5002,Epithelial Component Present,Adult Cholangiocarcinoma,1
5003,Epithelial Component Present,Stage IIA Prostate Cancer AJCC v7,1
5004,Malignant Cellular Infiltrate,Refractory T-Cell Prolymphocytic Leukemia,1
5005,Malignant Cellular Infiltrate,Epithelial Predominant Kidney Wilms Tumor,1
5006,Carcinomatous Component Present,Pharyngeal Carcinoma,1
5007,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Basophilic Leukemia,1
5008,Malignant Cellular Infiltrate,Nasopharyngeal lymphoepithelioma stage I,1
5009,Smooth Muscle Component Present,Kidney Epithelioid Type Angiomyolipoma,1
5010,High Mitotic Activity,Colorectal Large Cell Neuroendocrine Carcinoma,1
5011,Intramucosal Lesion,Intramucosal Adenocarcinoma,1
5012,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Diffuse Large B-Cell Lymphoma,1
5013,Well Differentiated Lesion,Warty Carcinoma of the Penis,1
5014,Indolent Clinical Course,Pelvic lipomatosis,1
5015,High Grade Lesion,Alveolar soft part sarcoma non-metastatic,1
5016,Carcinomatous Component Present,"Lung Squamous Cell Carcinoma, Small Cell Variant",1
5017,Epithelial Component Present,"Thymoma, type A, malignant",1
5018,Diffuse Pattern,Recurrent Anaplastic Astrocytoma,1
5019,Clusters and Cords of GFAP Positive Epithelioid Tumor Cells Present,Chordoid Glioma of the Third Ventricle,1
5020,Benign Cellular Infiltrate,Ectomesenchymal Chondromyxoid Tumor,1
5021,Epithelial Component Present,Metastatic Esophageal Carcinoma,1
5022,Malignant Cellular Infiltrate,Splenic Manifestation of Prolymphocytic Leukemia,1
5023,Dysplasia,Low Grade Squamous Intraepithelial Neoplasia,1
5024,Non-Invasive Lesion,Stage 0is Ureter Cancer AJCC v7,1
5025,Secondary Lesion,Metastatic Oral Cavity Carcinoma,1
5026,Malignant Cellular Infiltrate,Colon Cancer by AJCC v8 Stage,1
5027,Carcinomatous Component Present,Stage IIIC Colon Cancer AJCC v7,1
5028,Adnexal Differentiation,Mixed Epithelial and Mesenchymal Hair Follicle Neoplasm,1
5029,Exophytic Polypoid Lesion,Cervical Fibroepithelial Polyp,1
5030,Diffuse Lesion,Carcinomatosis,1
5031,Benign Cellular Infiltrate,Benign Osteogenic Neoplasm,1
5032,Invasive Lesion,Bladder transitional cell carcinoma stage II,1
5033,Cystic Change,Eccrine hidrocystoma,1
5034,Above the Diaphragm Disease,Hodgkin's disease mixed cellularity stage I supradiaphragmatic,1
5035,Benign Cellular Infiltrate,Benign neoplasm of adrenal gland,1
5036,Carcinomatous Component Present,Thymic Undifferentiated Carcinoma,1
5037,High Grade Lesion,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
5038,Epithelial Component Present,Seborrheic keratosis of eyelid,1
5039,Carcinomatous Component Present,Pancreatic Medullary Carcinoma,1
5040,Carcinomatous Component Present,"Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
5041,Malignant Cellular Infiltrate,Colon Liposarcoma,1
5042,Dysplasia,Anal Intraepithelial Neoplasia 3,1
5043,Epithelial Component Present,Carcinoma of extrahepatic bile duct,1
5044,Metaplasia,Schistosoma Hematobium-Related Bladder Verrucous Carcinoma,1
5045,Adnexal Differentiation,Primary Cutaneous Mucinous Carcinoma,1
5046,Vascular Channel Formation,Hemangioma acquired,1
5047,Diffuse Pattern,Grade 1 Diffuse Follicular Lymphoma,1
5048,Primary Lesion,"Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative",1
5049,Malignant Cellular Infiltrate,"Carcinoma, Basosquamous",1
5050,Exophytic Polypoid Lesion,Pyloric Gland Adenoma,1
5051,Prominent Keratin Formation,Esophageal Well Differentiated Squamous Cell Carcinoma,1
5052,Adnexal Differentiation,Pilar tumor,1
5053,Epithelial Component Present,Stage II Renal Pelvis Cancer AJCC v7,1
5054,Mild dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
5055,Osseous Differentiation,Osteosarcoma Arising in Paget Disease of Bone,1
5056,Secondary Lesion,Metastatic Triple-Negative Breast Carcinoma,1
5057,Carcinomatous Component Present,Thyroid Gland Medullary Carcinoma by AJCC v7 Stage,1
5058,Epithelial Component Present,Rectal Neuroendocrine Tumor,1
5059,Severe dysplasia,Stage 0 Esophageal Cancer AJCC v6,1
5060,Extensive Stage Lesion,Advanced Laryngeal Squamous Cell Carcinoma,1
5061,Immature Myeloid Cells Increased in Bone Marrow,Benzene-Related Acute Myeloid Leukemia,1
5062,Blasts 5-19 Percent of Peripheral Blood White Cells,Chronic Myelomonocytic Leukemia-2,1
5063,Anaplasia,Adult Systemic Anaplastic Large Cell Lymphoma,1
5064,Dysplasia,Stage 0 Renal Pelvis and Ureter Cancer AJCC v7,1
5065,VIP Positive Neoplastic Cells Present,Small Intestinal VIP-Producing Neuroendocrine Tumor,1
5066,Carcinomatous Component Present,Ureter Cancer by AJCC v7 Stage,1
5067,Epithelial Component Present,Stage III Distal Bile Duct Cancer AJCC v8,1
5068,Malignant Cellular Infiltrate,Conventional (Clear Cell) Renal Cell Carcinoma,1
5069,Benign Cellular Infiltrate,Benign Prostate Phyllodes Tumor,1
5070,Secondary Lesion,Recurrent Metastatic Malignant Neoplasm,1
5071,In Situ Lesion,Stage 0 Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
5072,Absence of Stromal Invasion,Borderline Ovarian Endometrioid Cystadenofibroma,1
5073,Malignant Cellular Infiltrate,Pancreatic carcinoma,1
5074,Cytoplasmic Membrane-Bound Granules Present,Clinical Stage II Merkel Cell Carcinoma AJCC v8,1
5075,Malignant Cellular Infiltrate,Ovarian Clear Cell Cystadenocarcinoma,1
5076,Malignant Cellular Infiltrate,Metastatic Esophageal Carcinoma,1
5077,Alternative Fascicle (Bundle) Pattern,Liver Leiomyoma,1
5078,Secondary Lesion,Secondary Supratentorial Anaplastic Astrocytoma,1
5079,Epithelial Component Present,Atypical Pituitary Gland Adenoma,1
5080,Malignant Cellular Infiltrate,Primary Cutaneous Anaplastic Large Cell Lymphoma,1
5081,Cutaneous Involvement,Mucoepidermoid carcinoma of skin,1
5082,Adulthood Lesion,Adult Anaplastic Astrocytoma,1
5083,Carcinomatous Component Present,Colon Carcinoma Metastatic in the Lung,1
5084,Lamellar Pattern,Metastatic Fibrolamellar Carcinoma,1
5085,Carcinomatous Component Present,Endometrial Carcinoma,1
5086,Malignant Cellular Infiltrate,Recurrent Lung Non-Squamous Non-Small Cell Carcinoma,1
5087,Follicular Cell Differentiation,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
5088,Epithelial Component Present,Broad Ligament Serous Cystadenofibroma,1
5089,Hyperkeratosis,Vaginal Warty Carcinoma,1
5090,Malignant Cellular Infiltrate,Stage II Colon Cancer AJCC v7,1
5091,Childhood Lesion,Benign Childhood Brain Neoplasm,1
5092,Neuroendocrine Differentiation,Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation,1
5093,Severe dysplasia,Stage 0 Colorectal Cancer AJCC v6 and v7,1
5094,Epithelial Component Present,Childhood Renal Cell Carcinoma,1
5095,Nodular Pattern,Grade 1 Cutaneous Follicular Lymphoma,1
5096,Primary Lesion,Recurrent Primary Lymphoma of Bone,1
5097,Epithelial Component Present,Squamous intraepithelial lesion,1
5098,Severe cytologic atypia,Esophageal Large Cell Neuroendocrine Carcinoma,1
5099,Breast Microcalcification,Childhood Oligodendroglioma,1
5100,Thin Bands of Collagen Present,benign fibroma of liver,1
5101,Epithelial Component Present,Adult Cholangiocarcinoma,1
5102,Cauliflower-Like Mass,Choroid Plexus Papilloma,1
5103,Epithelial Component Present,Stage IC Fallopian Tube Cancer AJCC v6 and v7,1
5104,Carcinomatous Component Present,Salivary Gland Myoepithelial Carcinoma,1
5105,Malignant Cellular Infiltrate,Stage IB Pleural Malignant Mesothelioma AJCC v7,1
5106,Biphasic Pattern,Anal Ectopic Fibroadenoma,1
5107,Carcinomatous Component Present,Cystadenocarcinoma of pancreas,1
5108,Malignant Cellular Infiltrate,Clear Cell Hepatocellular Carcinoma,1
5109,Malignant Cellular Infiltrate,"Follicular Variant Thyroid Gland Papillary Carcinoma, Encapsulated Subtype with Invasion",1
5110,Secondary Lesion,Metastatic Malignant Neoplasm to the Thyroid,1
5111,Malignant Cellular Infiltrate,Recurrent Submandibular Gland Acinic Cell Carcinoma,1
5112,Malignant Cellular Infiltrate,Childhood Leukemia,1
5113,HMB-45-Positive Neoplastic Cells Present,Lung Clear Cell Tumor,1
5114,Malignant Cellular Infiltrate,Carcinoma of the Floor of the Mouth,1
5115,Malignant Cellular Infiltrate,Lower Gingival Squamous Cell Carcinoma,1
5116,Malignant Cellular Infiltrate,Undifferentiated Fallopian Tube Carcinoma,1
5117,Malignant Cellular Infiltrate,Granulomatous slack skin disease,1
5118,Malignant Cellular Infiltrate,Childhood Thyroid Gland Carcinoma,1
5119,Well Differentiated Lesion,Vaginal Papillary Carcinoma,1
5120,Childhood Lesion,Childhood Giant Cell Glioblastoma,1
5121,High Mitotic Activity,Sellar Embryonal Carcinoma,1
5122,Vascular Channel Formation,Pyogenic granuloma of skin and subcutaneous tissue,1
5123,Malignant Cellular Infiltrate,Invasive Lobular Breast Carcinoma,1
5124,Malignant Cellular Infiltrate,Marginal Zone Lymphoma by Ann Arbor Stage,1
5125,Secondary Lesion,Advanced Gastric Neuroendocrine Carcinoma,1
5126,Malignant Cellular Infiltrate,Ureteric cancer regional,1
5127,Childhood Lesion,Lugano Classification Stage II Bulky Childhood Hodgkin Lymphoma AJCC v8,1
5128,Neuroendocrine Differentiation,Metastatic Lung Small Cell Carcinoma,1
5129,Malignant Cellular Infiltrate,Hypopharyngeal Carcinoma,1
5130,Heterologous Elements Present,"Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor, Variant with Heterologous Elements",1
5131,Epithelial Component Present,Renal Cell Carcinoma with t(6;11);(p21;q12); MALAT1-TFEB,1
5132,Tubular Pattern,Appendix Tubular Adenoma,1
5133,Benign Cellular Infiltrate,Chondroma,1
5134,Epithelial Component Present,Stage II Laryngeal Cancer AJCC v8,1
5135,Cutaneous Involvement,Small Congenital Melanocytic Nevus,1
5136,Malignant Cellular Infiltrate,Vaginal Small Cell Carcinoma,1
5137,Malignant Cellular Infiltrate,Anaplastic Sarcoma of the Kidney,1
5138,Junctional Proliferation,Vulvar Dysplastic Melanocytic Nevus,1
5139,Primary Lesion,Childhood Parosteal Osteosarcoma,1
5140,Resectable Mass,Localized Resectable Adult Liver Carcinoma,1
5141,Epithelial Component Present,Stage IV Gallbladder Cancer AJCC v7,1
5142,Therapy-Related Toxicity,Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder,1
5143,Epithelial Component Present,Paget's Disease of the Nipple,1
5144,Carcinomatous Component Present,Localized Gastric Carcinoma,1
5145,Intraocular Lesion,Lymphoma of retina,1
5146,Papillary Pattern,Borderline Ovarian Serous Adenofibroma,1
5147,Malignant Cellular Infiltrate,Well Differentiated Prostate Adenocarcinoma,1
5148,Rapidly Enlarging Mass,rhabdomyosarcoma of extrahepatic bile duct,1
5149,Diffuse Pattern,Diffuse large B-cell lymphoma associated with chronic inflammation,1
5150,Carcinomatous Component Present,Refractory Bile Duct Carcinoma,1
5151,Epithelial Component Present,Poorly Cohesive Gastric Carcinoma,1
5152,Epithelial Component Present,Refractory Extensive Stage Lung Small Cell Carcinoma,1
5153,Absence of Invasion,Anal Intraepithelial Neoplasia 3,1
5154,Vascular Channel Formation,Prostate Kaposi Sarcoma,1
5155,Epithelial Component Present,Intraductal Cribriform Breast Adenocarcinoma,1
5156,Malignant Cellular Infiltrate,Lymphadenopathic Kaposi Sarcoma,1
5157,Birbeck Granules Present,Adult Langerhans Cell Histiocytosis,1
5158,Metastatic Lesion,Secondary Central Nervous System Non-Hodgkin Lymphoma,1
5159,Cutaneous Involvement,Vulvar Seborrheic Keratosis,1
5160,Malignant Cellular Infiltrate,Recurrent BRCA-Mutated Ovarian Carcinoma,1
5161,Carcinomatous Component Present,Anatomic Stage IIB Breast Cancer AJCC v8,1
5162,Malignant Cellular Infiltrate,Mixed Germ Cell Tumor,1
5163,Dysplasia,Carcinoma in situ of prostate,1
5164,Recurrent disease,Metastasizing Chondroblastoma,1
5165,Malignant Cellular Infiltrate,Lung Mucinous Adenocarcinoma In Situ,1
5166,Dysplasia,Gallbladder Papillary Adenoma,1
5167,Epithelial Component Present,Stage IIIA Lung Cancer AJCC v8,1
5168,Malignant Cellular Infiltrate,Refractory Soft Tissue Sarcoma,1
5169,Diffuse Pattern,Metastatic Malignant Peripheral Nerve Sheath Tumor,1
5170,Fibrotic Stroma Formation,Pancreatic Foamy Gland Adenocarcinoma,1
5171,Cutaneous Involvement,Skin Mastocytoma,1
5172,Metastatic Lesion,Secondary malignant neoplasm of small intestine,1
5173,Malignant Cellular Infiltrate,High-Risk Neuroblastoma,1
5174,Metastatic Lesion,Metastatic Lip and Oral Cavity Carcinoma,1
5175,Epithelial Component Present,Recurrent ovarian cancer,1
5176,Neuroendocrine Differentiation,Sporadic Thyroid Gland Micromedullary Carcinoma,1
5177,Cutaneous Involvement,"Keratoderma, Palmoplantar, Epidermolytic",1
5178,Single Cell Necrosis,Stage IIIA Merkel Cell Carcinoma AJCC v7,1
5179,Mixed Cellular Population,Infiltrating duct and lobular carcinoma,1
5180,Cutaneous Involvement,Syringoma,1
5181,Carcinomatous Component Present,Stage II Intrahepatic Cholangiocarcinoma AJCC v8,1
5182,Bilateral Mass,bilateral breast cancer,1
5183,Malignant Cellular Infiltrate,Stage III Thyroid Gland Papillary Carcinoma AJCC v7,1
5184,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Grade 3 Endometrial Endometrioid Adenocarcinoma,1
5185,Epithelial Component Present,Low Grade Ovarian Serous Adenocarcinoma,1
5186,Malignant Cellular Infiltrate,Gastrointestinal carcinoma in situ,1
5187,Metastatic Lesion,"Sarcoma, metastatic",1
5188,Epithelial Component Present,Parotid Gland Warthin Tumor,1
5189,Adnexal Differentiation,Eccrine porocarcinoma,1
5190,Neuroendocrine Differentiation,Digestive System Neuroendocrine Tumor by AJCC v7 Stage,1
5191,Unfavorable Clinical Outcome,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
5192,Congenital Lesion,Congenital spondylolysis of lumbosacral region,1
5193,Clinical TNM Finding,Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5194,Cystic Change,Major Salivary Gland Mucoepidermoid Carcinoma,1
5195,Adulthood Lesion,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,1
5196,Primary Lesion,Childhood Brain Stem Astrocytoma,1
5197,Malignant Cellular Infiltrate,Stage IIIB Breast Carcinoma,1
5198,Malignant Cellular Infiltrate,Metastatic Lip Squamous Cell Carcinoma,1
5199,Rapidly Enlarging Mass,Unresectable Rhabdomyosarcoma,1
5200,Vascular Channel Formation,Spindle cell hemangioma,1
5201,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
5202,Malignant Cellular Infiltrate,Malignant Ovarian Granulosa Cell Tumor,1
5203,Epithelial Component Present,Adenosquamous cell lung cancer stage IIIB,1
5204,Papillary Pattern,Stage II Laryngeal Verrucous Carcinoma AJCC v6 and v7,1
5205,Malignant Cellular Infiltrate,Burkitt's lymphoma of breast,1
5206,Primary Lesion,Stage IVB Hepatocellular Carcinoma AJCC v8,1
5207,Carcinomatous Component Present,Major Salivary Gland Cancer by AJCC v8 Stage,1
5208,Carcinomatous Component Present,Stage IB Pancreatic Cancer AJCC v6 and v7,1
5209,Alternative Fascicle (Bundle) Pattern,Urethral Leiomyoma,1
5210,Pregnancy Complications,Gestational Trophoblastic Neoplasms,1
5211,Pathologic TNM Finding,Pathologic Stage I Cutaneous Melanoma AJCC v8,1
5212,Regional Disease,Locally Advanced Carcinoma,1
5213,Epithelial Component Present,"Urinary bladder carcinoma stage I, with cancer in situ",1
5214,Malignant Cellular Infiltrate,Pathologic Stage IIID Cutaneous Melanoma AJCC v8,1
5215,Malignant Cellular Infiltrate,Gallbladder Melanoma,1
5216,Malignant Cellular Infiltrate,Stage II Kidney Wilms Tumor,1
5217,Postneoadjuvant Therapy Pathologic TNM Finding,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5218,Dysplasia,Appendix Intraepithelial Neoplasia,1
5219,Diffuse Pattern,Anaplastic large B-cell lymphoma,1
5220,Carcinomatous Component Present,Stage IIB Prostate Cancer AJCC v7,1
5221,Epithelial Component Present,High Grade Lung Neuroendocrine Neoplasm,1
5222,Epithelial Component Present,Posterior Tongue Squamous Cell Carcinoma,1
5223,Mixed Cellular Population,Stage IC Uterine Corpus Adenosarcoma AJCC v8,1
5224,Carcinomatous Component Present,Stage IIB Lung Adenocarcinoma AJCC v7,1
5225,Osteoid formation,Aggressive osteoblastoma,1
5226,Carcinomatous Component Present,Unresectable Extrahepatic Bile Duct Carcinoma,1
5227,Malignant Cellular Infiltrate,Refractory Mature B-Cell Non-Hodgkin Lymphoma,1
5228,Extraosseous Lesion,Peripheral Odontogenic Fibroma,1
5229,Epithelial Component Present,Malignant Pancreatic Vipoma,1
5230,Carcinomatous Component Present,Renal cell carcinoma recurrent,1
5231,Non-Encapsulated Neoplasm,Hemosiderotic Fibrolipomatous Tumor,1
5232,Exophytic Papillary Lesion,Plantar Verrucous Skin Carcinoma,1
5233,Peripheral Nuclear Palisading,Refractory Lung Small Cell Carcinoma,1
5234,Recurrent disease,Recurrent Anaplastic Large Cell Lymphoma,1
5235,Recurrent disease,Recurrent Grade 3 Follicular Lymphoma,1
5236,Malignant Cellular Infiltrate,Stage IIIC Choroidal and Ciliary Body Melanoma AJCC v8,1
5237,Vascular Channel Formation,Anastomosing Hemangioma,1
5238,Carcinomatous Component Present,Prolactin-Producing Pituitary Gland Carcinoma,1
5239,Low Mitotic Activity,Small Intestinal Gangliocytic Paraganglioma,1
5240,Pathologic TNM Finding,Pathologic Stage IIIC Cutaneous Melanoma AJCC v8,1
5241,Monoclonal Cellular Population Present,Mast-Cell Sarcoma,1
5242,Dysplasia,Colorectal Adenoma with Severe Dysplasia,1
5243,Microvascular Proliferation,MGMT-Unmethylated Glioblastoma,1
5244,Carcinomatous Component Present,Metastatic Colon Carcinoma,1
5245,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
5246,Blasts Under 20 Percent of Bone Marrow Nucleated Cells,"Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative",1
5247,Malignant Cellular Infiltrate,Stage IVB Lip and Oral Cavity Cancer AJCC v6 and v7,1
5248,Adulthood Lesion,Adult B Acute Lymphoblastic Leukemia,1
5249,Malignant Cellular Infiltrate,Adenoid cystic carcinoma of submandibular gland,1
5250,Cutaneous Involvement,GIANT PIGMENTED HAIRY NEVUS,1
5251,Moderate dysplasia,Bile Duct Papillary Neoplasm with Intermediate Grade Intraepithelial Neoplasia,1
5252,Unresectable Mass,Unresectable Synovial Sarcoma,1
5253,Malignant Cellular Infiltrate,Adult Pleomorphic Rhabdomyosarcoma,1
5254,Hereditary Lesion,Adenomatous Polyposis Coli,1
5255,Vascular Channel Formation,Hobnail Hemangioma,1
5256,Epithelial Component Present,Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8,1
5257,Recurrent disease,Recurrent Prostate Acinar Adenocarcinoma,1
5258,Carcinomatous Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma,1
5259,Epithelial Component Present,FIGO Stage IIIA1(i) Ovarian Cancer,1
5260,Epithelial Component Present,Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7,1
5261,Malignant Cellular Infiltrate,Extrarenal Rhabdoid Tumor of the Liver,1
5262,Biphasic Pattern,Vaginal Adenosarcoma,1
5263,Benign Cellular Infiltrate,Proliferative fasciitis,1
5264,Malignant Cellular Infiltrate,Unresectable Thymic Carcinoma,1
5265,Malignant Cellular Infiltrate,Refractory Malignant Central Nervous System Neoplasm,1
5266,Osteoid formation,Ossifying Renal Tumor of Infancy,1
5267,Stromal Invasion,Ovarian Cancer by AJCC v6 and v7 Stage,1
5268,Malignant Cellular Infiltrate,Breast Carcinoma with Melanotic Features,1
5269,Carcinomatous Component Present,Stage I Lip Carcinoma,1
5270,Malignant Cellular Infiltrate,intestinal type adenocarcinoma of extrahepatic bile duct,1
5271,Malignant Cellular Infiltrate,Carcinoma,1
5272,Carcinomatous Component Present,Metastatic Oral Cavity Mucoepidermoid Carcinoma,1
5273,Malignant Cellular Infiltrate,Colon Hodgkin Lymphoma,1
5274,Metastatic Lesion,Peritoneal mesothelioma malignant advanced,1
5275,Malignant Cellular Infiltrate,Stage II Pancreatic Cancer AJCC v8,1
5276,Epithelial Component Present,Adenocarcinoma in situ in adenomatous polyp,1
5277,Nodular Pattern,Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma,1
5278,Epithelial Component Present,Renal Pelvis Urothelial Papilloma,1
5279,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Follicular Adenoma with Bizarre Nuclei,1
5280,Childhood Lesion,Stage IV Childhood Anaplastic Large Cell Lymphoma,1
5281,Intraluminal Tumor Growth,Intimal sarcoma,1
5282,Malignant Cellular Infiltrate,Stage 0 Oropharyngeal (p16-Negative) Carcinoma AJCC v8,1
5283,Carcinomatous Component Present,Squamous cell carcinoma of prostate,1
5284,High Mitotic Activity,Anaplastic Ependymoma,1
5285,Unclassifiable Lesion,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",1
5286,High Grade Lesion,Poorly Differentiated Fibrosarcoma,1
5287,Carcinomatous Component Present,Stage III Ampulla of Vater Cancer AJCC v8,1
5288,Carcinomatous Component Present,Tongue Carcinoma,1
5289,Diffuse Pattern,Childhood Glioblastoma,1
5290,Follicular Cell Differentiation,Thyroid Hurthle Cell Carcinoma,1
5291,Carcinomatous Component Present,Stage I Prostate Carcinoma,1
5292,Refractory Disease,Angioimmunoblastic T-cell lymphoma refractory,1
5293,Regional Disease,Locally Advanced Unresectable Renal Cell Carcinoma,1
5294,Cutaneous Involvement,Skin Cavernous Hemangioma,1
5295,Cutaneous Involvement,"Carcinoma, Skin Appendage",1
5296,Malignant Cellular Infiltrate,Stage IIIB Anal Cancer AJCC v8,1
5297,Carcinomatous Component Present,Noninfiltrating intraductal papillary adenocarcinoma,1
5298,Prominent Elastic Tissue Cores Present,Papillary fibroelastoma,1
5299,Infiltrative Growth Pattern,"Fibromatosis, Aggressive",1
5300,Epithelial Component Present,Cervical Cancer by AJCC v8 Stage,1
5301,Malignant Cellular Infiltrate,Precursor B-lymphoblastic lymphoma recurrent,1
5302,Nuclear Grooves,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
5303,Malignant Cellular Infiltrate,Acute Myeloid Leukemia with Biallelic Mutations of CEBPA,1
5304,Carcinomatous Component Present,Rectosigmoid Cancer by AJCC v7 Stage,1
5305,Epithelial Component Present,Intra-Abdominal Paraganglioma,1
5306,Carcinomatous Component Present,Laryngeal squamous cell carcinoma recurrent,1
5307,Epithelial Component Present,inverted ductal papilloma of salivary gland,1
5308,Malignant Cellular Infiltrate,Ann Arbor Stage II Follicular Lymphoma,1
5309,Locally Aggressive Lesion,Retiform hemangioendothelioma,1
5310,Epithelial Component Present,Clinical Stage 0 Merkel Cell Carcinoma AJCC v8,1
5311,Epithelial Component Present,"Cystadenocarcinoma, Mucinous",1
5312,atypia morphology,Stage IV Borderline Ovarian Surface Epithelial-Stromal Tumor,1
5313,Neuroendocrine Differentiation,Rectal Small Cell Neuroendocrine Carcinoma,1
5314,Below the Diaphragm Disease,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
5315,Malignant Cellular Infiltrate,Recurrent tumors of the Ewing's family,1
5316,Epithelial Component Present,Stage IIB Esophageal Adenocarcinoma AJCC v7,1
5317,Malignant Cellular Infiltrate,Stage IIIA Esophageal Cancer AJCC v7,1
5318,Childhood Lesion,Childhood Burkitt Lymphoma,1
5319,Malignant Cellular Infiltrate,Lugano Classification Stage IE Childhood Hodgkin Lymphoma AJCC v8,1
5320,Carcinomatous Component Present,Stage IVC Lip Cancer AJCC v6 and v7,1
5321,Anaplasia,Anaplastic Pleomorphic Xanthoastrocytoma,1
5322,Transformed Phase of Disease,Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma,1
5323,Cutaneous Involvement,Hidroacanthoma simplex,1
5324,Infiltrative Growth Pattern,Central Nervous System Desmoid-Type Fibromatosis,1
5325,Precise Histogenesis Unknown,Medullary Hemangioblastoma,1
5326,Unclassifiable Lesion,"Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified",1
5327,Malignant Cellular Infiltrate,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
5328,Indolent Clinical Course,Cavernous hemangioma of retina,1
5329,Refractory Disease,Non-Hodgkin's lymphoma refractory,1
5330,Carcinomatous Component Present,Breast Carcinoma with Chondroid Metaplasia,1
5331,Epithelial Component Present,Childhood Lung Non-Small Cell Carcinoma,1
5332,Malignant Cellular Infiltrate,Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8,1
5333,Childhood Lesion,Childhood Testicular Immature Teratoma,1
5334,Chronic lymphocytic inflammation,"Thymoma, type B2",1
5335,Malignant Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma recurrent,1
5336,Malignant Cellular Infiltrate,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
5337,Slow Growing Mass,Recurrent Childhood Pilocytic Astrocytoma,1
5338,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,adenosquamous carcinoma of ovary,1
5339,Carcinomatous Component Present,"Prostate Ductal Adenocarcinoma, Cribriform Pattern",1
5340,Malignant Cellular Infiltrate,Adult Acute Erythroid Leukemia,1
5341,Carcinomatous Component Present,Stage IVB Colon Cancer AJCC v7,1
5342,Malignant Cellular Infiltrate,Stage II Skin Cancer,1
5343,Benign Cellular Infiltrate,Benign Thalamic Neoplasm,1
5344,Carcinomatous Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5345,Malignant Cellular Infiltrate,Lip and Oral Cavity Cancer by AJCC v6 and v7 Stage,1
5346,Malignant Cellular Infiltrate,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8,1
5347,Mixed Cellular Population,Stromal Predominant Kidney Wilms Tumor,1
5348,Malignant Cellular Infiltrate,Thyroid Diffuse Large B-Cell Lymphoma,1
5349,Malignant Cellular Infiltrate,Prognostic Stage IIIC Breast Cancer AJCC v8,1
5350,Neuroectodermal Differentiation,Stage 4S neuroblastoma,1
5351,Chronic Inflammatory Infiltrate,Childhood Ovarian Dysgerminoma,1
5352,Carcinomatous Component Present,Stage II Thyroid Gland Papillary Carcinoma AJCC v7,1
5353,Malignant Cellular Infiltrate,signet ring cell carcinoma of gallbladder,1
5354,Cutaneous Involvement,GIANT PIGMENTED HAIRY NEVUS,1
5355,Fibrotic Stroma Formation,Central odontogenic fibroma,1
5356,Lipomatous Component Present,Thymus Lipofibroadenoma,1
5357,Epithelial Component Present,Stage IVC Major Salivary Gland Cancer AJCC v8,1
5358,Refractory Disease,Refractory Myelodysplastic Syndrome,1
5359,Malignant Cellular Infiltrate,Anaplastic Lymphoma Post-Transplant Lymphoproliferative Disorder,1
5360,Recurrent Lymphoma,Systemic EBV positive T-cell lymphoproliferative disease of childhood,1
5361,Childhood Lesion,Childhood Botryoid-Type Embryonal Rhabdomyosarcoma,1
5362,Biphasic Pattern,Anal Ectopic Fibroadenoma,1
5363,S-100-Positive Neoplastic Cells Present,Benign Lung PEComa,1
5364,atypia morphology,Atypical adenoma,1
5365,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v7,1
5366,Secondary Lesion,Secondary Myelodysplastic Syndrome,1
5367,Epithelial Component Present,Colorectal Micropapillary Adenocarcinoma,1
5368,Epithelial Component Present,Stage IIIA Fallopian Tube Cancer AJCC v7,1
5369,Malignant Cellular Infiltrate,Ocular Adnexal Lymphoma,1
5370,Multinodular Mass,Metastatic angiosarcoma,1
5371,Peripheral Nuclear Palisading,Nasopharyngeal Basaloid Squamous Cell Carcinoma,1
5372,Malignant Cellular Infiltrate,Mediastinal Neuroblastoma,1
5373,Solitary mass,Dedifferentiated chordoma,1
5374,Epithelial Component Present,Stage II Hilar Cholangiocarcinoma AJCC v7,1
5375,Carcinomatous Component Present,Anal Canal Small Cell Neuroendocrine Carcinoma,1
5376,Neuroendocrine Differentiation,Recurrent Paraganglioma,1
5377,Malignant Cellular Infiltrate,Invasive Cribriform Breast Carcinoma,1
5378,Recurrent disease,Oropharyngeal cancer recurrent,1
5379,CD30-Positive Neoplastic Cells Present,Borderline Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder,1
5380,Carcinomatous Component Present,Stage IIA Pancreatic Cancer AJCC v8,1
5381,Malignant Cellular Infiltrate,mucinous adenocarcinoma of lung,1
5382,Pseudoglandular Pattern,Stage III Ovarian Embryonal Carcinoma AJCC v6 and v7,1
5383,Neuroendocrine Differentiation,Stage IIIA Lung Small Cell Carcinoma AJCC v7,1
5384,Hemorrhagic Neuroblastic Nodules Present,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
5385,Indolent Clinical Course,Hemangioma,1
5386,Epithelial Component Present,Merkel Cell Carcinoma by AJCC v8 Pathologic Stage,1
5387,Epithelial Component Present,adenosquamous carcinoma of pancreas,1
5388,Malignant Cellular Infiltrate,Stage IIIA Breast Carcinoma,1
5389,Benign Cellular Infiltrate,Pleomorphic adenoma of lacrimal gland,1
5390,Pain,Aggressive osteoblastoma,1
5391,Malignant Cellular Infiltrate,Serous cystadenocarcinoma of pancreas,1
5392,Pregnancy Complications,Stage IIIB Gestational Trophoblastic Tumor AJCC v7,1
5393,Unmethylated MGMT Gene Promoter,MGMT-Unmethylated Glioblastoma,1
5394,HMB-45-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
5395,Apocrine Differentiation,apocrine adenocarcinoma of vulva,1
5396,Ineffective hematopoiesis,Recurrent Myelodysplastic Syndrome,1
5397,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11,1
5398,Exophytic Papillary Lesion,Subglottic Verrucous Carcinoma,1
5399,Epithelial Component Present,Carcinoma in situ of cecum,1
5400,Malignant Cellular Infiltrate,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
5401,Malignant Cellular Infiltrate,Stage 0 Penile Cancer AJCC v6,1
5402,Microinvasive tumor,Borderline Ovarian Serous Tumor with Microinvasion,1
5403,Carcinomatous Component Present,Eyelid Carcinoma by AJCC v8 Stage,1
5404,Nested Pattern,Childhood Clear Cell Sarcoma of Soft Parts,1
5405,Epithelial Component Present,Occult Lung Adenosquamous Carcinoma,1
5406,Cutaneous Involvement,Signet Ring Melanoma,1
5407,Biphasic Pattern,"Infiltrating Bladder Urothelial Carcinoma, Sarcomatoid Variant with Heterologous Elements",1
5408,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Adenocarcinoma,1
5409,Malignant Cellular Infiltrate,Lung Micropapillary Adenocarcinoma,1
5410,Primary Lesion,Body Cavity Primary Effusion Lymphoma,1
5411,Malignant Cellular Infiltrate,Stage IV Adult Burkitt Lymphoma,1
5412,Carcinomatous Component Present,Supraglottic Verrucous Carcinoma,1
5413,Malignant Cellular Infiltrate,Stage I Cutaneous Melanoma AJCC v6,1
5414,Epithelial Component Present,"Endometrial Endometrioid Adenocarcinoma, Secretory Variant",1
5415,Malignant Cellular Infiltrate,Refractory Anal Carcinoma,1
5416,Epithelial Component Present,Benign Ovarian Clear Cell Tumor,1
5417,Malignant Cellular Infiltrate,"Acinar Prostate Adenocarcinoma, Atrophic Variant",1
5418,Nodular Pattern,Recurrent Grade 2 Follicular Lymphoma,1
5419,Epithelial Component Present,Stage III Pancreatic Cancer AJCC v8,1
5420,Epithelial Component Present,Midgut Carcinoid Tumor,1
5421,Epithelial Component Present,Stage IB Eyelid Carcinoma AJCC v7,1
5422,Vascular Channel Formation,Pulmonary Artery Angiosarcoma,1
5423,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
5424,Tissue Differentiation Uncertain,Clear Cell Sarcoma of Soft Tissue,1
5425,Malignant Cellular Infiltrate,Epstein-Barr virus positive diffuse large B-cell lymphoma of elderly,1
5426,Metastatic Lesion,Metastatic basal cell carcinoma,1
5427,Malignant Cellular Infiltrate,Clinical Stage IVB Esophageal Squamous Cell Carcinoma AJCC v8,1
5428,Indolent Clinical Course,Rectal Lipoma,1
5429,Malignant Cellular Infiltrate,"Mesothelioma, biphasic, malignant",1
5430,Epidermotropic Lymphocytic Infiltrate,Mycosis fungoides stage III,1
5431,Low Mitotic Activity,Stage 0 Digestive System Neuroendocrine Tumor AJCC v7,1
5432,Follicular Cell Differentiation,Differentiated Thyroid Gland Carcinoma by AJCC v8 Stage,1
5433,High Mitotic Activity,Neuroendocrine carcinoma of appendix,1
5434,Epithelial Component Present,Recurrent Fibrolamellar Carcinoma,1
5435,Cutaneous Involvement,Granulomatous dermatitis,1
5436,Epithelial Component Present,intestinal type adenocarcinoma of gallbladder,1
5437,Epithelial Component Present,Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7,1
5438,Malignant Cellular Infiltrate,Stage I Ovarian Cancer AJCC v6 and v7,1
5439,Intraductal Lesion,Intraductal papillomatosis,1
5440,Childhood Lesion,Childhood Brain Germ Cell Tumor,1
5441,Pseudorosette Formation,Small Intestinal Gastrin-Producing Neuroendocrine Tumor,1
5442,Cutaneous Involvement,Breast Nevus,1
5443,Hyaline Cartilage Differentiation,Metastatic Extraskeletal Myxoid Chondrosarcoma,1
5444,Metastatic Lesion,Locally Advanced Unresectable Gastric Adenocarcinoma,1
5445,Carcinomatous Component Present,Stage 0 Rectal Cancer AJCC v8,1
5446,Malignant Cellular Infiltrate,Burkitt Leukemia,1
5447,Indolent Clinical Course,"Odontogenic tumor, benign",1
5448,Cystic Change,Proliferating Brenner Tumor,1
5449,Tumor Vascular Invasion,Malignant Vipoma,1
5450,Hemorrhagic,Adult Angiosarcoma,1
5451,Negative Bone Marrow and Peripheral Blood,B-cell small lymphocytic lymphoma stage II,1
5452,Carcinomatous Component Present,Stage IVA Bladder Cancer AJCC v8,1
5453,Non-Invasive Lesion,"Bladder Non-Invasive Papillary Urothelial Carcinoma, High Grade",1
5454,Monomorphic Cellular Infiltrate,Ependymoma of brain stem,1
5455,Adulthood Lesion,Adult Spinal Cord Neoplasm,1
5456,Papillary Pattern,Multicentric Thyroid Gland Papillary Carcinoma,1
5457,Malignant Cellular Infiltrate,Calcifying Nested Epithelial Stromal Tumor of the Liver,1
5458,Perineural spread,Adenoid cystic carcinoma of oropharynx,1
5459,Malignant Cellular Infiltrate,Childhood Lung Small Cell Carcinoma,1
5460,Vascular Channel Formation,Scrotal Hemangioma,1
5461,Carcinomatous Component Present,Stage IV Major Salivary Gland Carcinoma without Metastasis,1
5462,Secondary Lesion,Rectal Carcinoma Metastatic in the Liver,1
5463,Malignant Cellular Infiltrate,Metastatic Signet Ring Cell Breast Carcinoma,1
5464,Metastatic Lesion,Secondary malignant neoplasm of thymus,1
5465,Epithelial Component Present,Fallopian Tube Endometrioid Adenocarcinoma,1
5466,Clinical TNM Finding,Clinical Stage IIC Cutaneous Melanoma AJCC v8,1
5467,Carcinomatous Component Present,Stage II Major Salivary Gland Cancer AJCC v7,1
5468,Benign Cellular Infiltrate,Vulvar Congenital Melanocytic Nevus,1
5469,Mixed Cellular Population,Malignant Submandibular Gland Mixed Tumor,1
5470,Malignant Cellular Infiltrate,Adenocarcinoma of duodenum,1
5471,Primary Lesion,Childhood Spindle Cell Rhabdomyosarcoma,1
5472,Recurrent disease,Mycosis fungoides recurrent,1
5473,Carcinomatous Component Present,Stage IVA Oral Cavity Cancer AJCC v6 and v7,1
5474,Papillary Pattern,"Papilloma, Squamous Cell",1
5475,Malignant Cellular Infiltrate,Stage IB2 Cervical Cancer,1
5476,Nuclear Atypia,Glioblastoma multiforme of spinal cord,1
5477,Malignant Cellular Infiltrate,Nasal Cavity and Paranasal Sinus Carcinoma,1
5478,Cutaneous Involvement,Pathologic Stage IIA Cutaneous Melanoma AJCC v8,1
5479,Chromogranin A Positive Neoplastic Cells Present,Jejunal Neuroendocrine Tumor G1,1
5480,Well-Circumscribed Lesion,Adult Cardiac Cellular Rhabdomyoma,1
5481,Hyaline Cartilage Differentiation,Central Nervous System Chondroma,1
5482,Malignant Cellular Infiltrate,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
5483,Metastatic/Recurrent Disease,Liver Synovial Sarcoma,1
5484,Carcinomatous Component Present,Gastric Cancer by AJCC v8 Stage,1
5485,Extensive Stage Lesion,Advanced Cervical Carcinoma,1
5486,Epidermal Involvement,Classical Poroma,1
5487,Local disease,Infiltrating angiolipoma,1
5488,Primary Lesion,Meningeal melanocytoma,1
5489,Anaplasia,Childhood Systemic Anaplastic Large Cell Lymphoma,1
5490,Pathologic TNM Finding,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
5491,Carcinomatous Component Present,Hobnail Variant Thyroid Gland Papillary Carcinoma,1
5492,Malignant Cellular Infiltrate,Adenocarcinoma of anus,1
5493,Perivascular Arrangement of Tumor Cells,Hereditary Glomangioma,1
5494,Immunologic Deficiency Syndromes,Stage IV AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
5495,Carcinomatous Component Present,Metastatic Bile Duct Carcinoma,1
5496,Malignant Cellular Infiltrate,"Stage 0 Laryngeal Cancer AJCC v6, v7, and V8",1
5497,High Mitotic Activity,Frontal Lobe Anaplastic Oligodendroglioma,1
5498,Dysplasia,Appendix Tubular Adenoma,1
5499,Malignant Cellular Infiltrate,Malignant Cardiac Paraganglioma,1
5500,Carcinomatous Component Present,Inflammatory Breast Carcinoma,1
5501,Intraosseous Lesion,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
5502,Pathologic TNM Finding,Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8,1
5503,Benign Cellular Infiltrate,Deep Penetrating Nevus,1
5504,Malignant Germinomatous Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
5505,Single Cell Necrosis,Stage II Merkel Cell Carcinoma AJCC v7,1
5506,Well-Circumscribed Lesion,Clear cell sarcoma of kidney,1
5507,Metastatic Lesion,Locally Advanced Malignant Neoplasm,1
5508,Epithelial Component Present,Gastroesophageal Junction Neuroendocrine Carcinoma,1
5509,Malignant Cellular Infiltrate,Stage IVA Cervical Cancer AJCC v6 and v7,1
5510,Malignant Cellular Infiltrate,Stage I Anal Canal Cancer AJCC v6 and v7,1
5511,Collagenous Stroma Formation,Desmoplastic fibroma,1
5512,Malignant Cellular Infiltrate,Precursor T-lymphoblastic lymphoma/leukemia stage IV,1
5513,Hereditary Lesion,BRCA2 Syndrome,1
5514,Hyaline Cartilage Differentiation,chondroma of lung,1
5515,Cutaneous Involvement,Merkel cell carcinoma,1
5516,Malignant Cellular Infiltrate,Renal Pelvis and Ureter Cancer by AJCC v8 Stage,1
5517,Carcinomatous Component Present,Stage IIB Eyelid Carcinoma AJCC v8,1
5518,Epithelial Component Present,Stage III Esophageal Cancer AJCC v7,1
5519,Absence of Invasion,Stage 0 Appendix Carcinoma AJCC v7,1
5520,Malignant Cellular Infiltrate,Refractory Lymphoblastic Lymphoma,1
5521,Recurrent disease,Lymphoplasmacytoid lymphoma/immunocytoma recurrent,1
5522,Lobulated Growth Pattern,Vertebral chordoma,1
5523,Necrotic changes (finding),Necrotic intraocular melanoma,1
5524,Low Cellularity Present,Desmoplastic fibroblastoma,1
5525,Malignant Cellular Infiltrate,Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5526,Epithelial Component Present,Recurrent Endometrial Endometrioid Adenocarcinoma,1
5527,Epithelial Component Present,Thyroid Gland Oncocytic Adenoma,1
5528,Mitotic Activity,Anaplastic astrocytoma,1
5529,Prolymphocytes Exceed 55 Percent of Lymphoid Cells in the Peripheral Blood,Recurrent B-Cell Prolymphocytic Leukemia,1
5530,Cystic Change,Borderline cystadenoma,1
5531,Tissue Differentiation Uncertain,Benign Uterine Corpus PEComa,1
5532,Carcinomatous Component Present,Pathologic Stage IA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5533,Cartilaginous Differentiation,Solitary Osteochondroma,1
5534,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia,1
5535,Mixed Cellular Population,Lung Mixed Squamous Cell and Glandular Papilloma,1
5536,Malignant Cellular Infiltrate,Laryngeal Lymphoepithelial Carcinoma,1
5537,Carcinomatous Component Present,Metastatic Squamous Cell Carcinoma of the Oropharynx,1
5538,Nodular lesions,Nodular amyloidosis,1
5539,Hyaline Cartilage Differentiation,Myxoid chondrosarcoma,1
5540,Malignant Cellular Infiltrate,Recurrent Parotid Gland Carcinoma,1
5541,Secondary Lesion,Metastatic Unresectable Carcinoma,1
5542,Low Mitotic Activity,Jejunal Neuroendocrine Tumor G1,1
5543,Thyroglobulin Positive Neoplastic Cells Present,Differentiated Thyroid Gland Carcinoma,1
5544,Tissue of Mullerian Origin Present,Broad Ligament Serous Adenofibroma,1
5545,Carcinomatous Component Present,Refractory Endometrial Endometrioid Adenocarcinoma,1
5546,Epithelial Component Present,Stage IV Renal Cell Cancer,1
5547,Benign Cellular Infiltrate,Large cell acanthoma,1
5548,Neuroendocrine Differentiation,Cardiac Paraganglioma,1
5549,Recurrent disease,Recurrent Oropharyngeal Undifferentiated Carcinoma,1
5550,Cutaneous Involvement,Stage II Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8,1
5551,Malignant Cellular Infiltrate,Recurrent Myxoid Liposarcoma,1
5552,Stromal Invasion,Malignant Ovarian Endometrioid Tumor,1
5553,High Mitotic Activity,Stage II Ovarian Embryonal Carcinoma AJCC v6 and v7,1
5554,Papillary Pattern,Thymic Papillary Adenocarcinoma,1
5555,Hereditary Lesion,Familial Retinoblastoma,1
5556,Malignant Cellular Infiltrate,Recurrent Lung Carcinoma Cell Type Unspecified,1
5557,Malignant Cellular Infiltrate,Stage IB Ampulla of Vater Cancer AJCC v7,1
5558,Epithelial Component Present,Oropharyngeal squamous cell carcinoma stage I,1
5559,Malignant Cellular Infiltrate,Pituitary Gland Diffuse Large B-Cell Lymphoma,1
5560,Malignant Cellular Infiltrate,Hodgkin's disease nodular sclerosis stage IV,1
5561,Epithelial Component Present,adenosquamous carcinoma of pancreas,1
5562,Malignant Cellular Infiltrate,Tonsillar Lymphoma,1
5563,Malignant Cellular Infiltrate,M5b Acute differentiated monocytic leukemia,1
5564,Carcinomatous Component Present,Renal Cell Cancer by AJCC v8 Stage,1
5565,Malignant Cellular Infiltrate,Metastatic Kidney Carcinoma,1
5566,Malignant Cellular Infiltrate,Grade 3b Follicular Lymphoma,1
5567,Malignant Cellular Infiltrate,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
5568,Synchronous Lesion,Synchronous Multifocal Osteosarcoma,1
5569,Vascular Channel Formation,Metastatic angiosarcoma,1
5570,Malignant Cellular Infiltrate,clear cell adenocarcinoma of urethra,1
5571,Myeloblasts 20 Percent or More of Bone Marrow Nucleated Cells,Childhood Acute Myeloid Leukemia with Maturation,1
5572,Malignant Cellular Infiltrate,Blast Phase,1
5573,Polymorphic Cellular Infiltrate,Angioimmunoblastic T-cell lymphoma stage II,1
5574,Complete Spontaneous Regression,Type D Lymphomatoid Papulosis,1
5575,Carcinomatous Component Present,Stage IIA Cervical Cancer AJCC v6,1
5576,Metaplasia,Squamous Lung Dysplasia,1
5577,Carcinomatous Component Present,Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7,1
5578,Bilateral Disease,Bilateral Optic Nerve Meningioma,1
5579,Epithelial Component Present,Stage III Lung Cancer AJCC v8,1
5580,Carcinomatous Component Present,Stage I Ovarian Cancer AJCC v6 and v7,1
5581,Encapsulated Mass,Tumor contained within organ capsule,1
5582,Mucoid Stroma Formation,Mucinous cystadenocarcinoma appendix,1
5583,Malignant Cellular Infiltrate,Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8,1
5584,Immunosuppression-Related Post-Transplant Toxicity,Florid Follicular Hyperplasia Post-Transplant Lymphoproliferative Disorder,1
5585,Low Grade Lesion,Low-grade fibromyxoid sarcoma,1
5586,Malignant Cellular Infiltrate,Resectable Pancreatic Acinar Cell Carcinoma,1
5587,Perivascular Pseudorosette Formation,Adult Anaplastic Ependymoma,1
5588,Recurrent disease,Recurrent Primary Lymphoma of Bone,1
5589,Indolent Clinical Course,Osteoma of skull,1
5590,Benign Cellular Infiltrate,Trichoadenoma,1
5591,Nuclear pleomorphism,Primary Cutaneous CD4-Positive Small/Medium T-Cell Lymphoproliferative Disorder,1
5592,Epithelial Component Present,Unresectable Pancreatic Neuroendocrine Carcinoma,1
5593,Epithelial Component Present,Appendix Neuroendocrine Tumor by AJCC v8 Stage,1
5594,Benign Cellular Infiltrate,Benign neoplasm of testis,1
5595,Epithelial Component Present,"Ovarian Leydig Cell Tumor, Not Otherwise Specified",1
5596,Diffuse Pattern,N1 Diffuse Large B-Cell Lymphoma,1
5597,Epithelial Component Present,"Uterine Carcinosarcoma, Heterologous Type",1
5598,Cutaneous Involvement,Nevus comedonicus,1
5599,Malignant Cellular Infiltrate,Stage IVC Hypopharyngeal Carcinoma AJCC v7,1
5600,Non-Invasive Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia,1
5601,Intraductal Lesion,Invasive intraductal papillary-mucinous carcinoma of pancreas,1
5602,Moderate dysplasia,Colorectal Adenoma with Moderate Dysplasia,1
5603,Metastatic Lesion,Transitional cell cancer of renal pelvis and ureter metastatic,1
5604,Eosinophilic inflammation,Breast Inflammatory Myofibroblastic Tumor,1
5605,Epithelial Component Present,Non-Functioning Pituitary Gland Neoplasm,1
5606,Anaplasia,"Anaplastic Large Cell Lymphoma, Signet Ring-Like Subtype",1
5607,Mixed Cellular Population,Adenocarcinofibroma,1
5608,CD56-Positive Neoplastic Cells Present,Recurrent Aggressive NK-Cell Leukemia,1
5609,Vascular Channel Formation,Lymphangioma of skin,1
5610,Epithelial Component Present,Oropharyngeal lymphoepithelioma stage I,1
5611,Carcinomatous Component Present,Mucoepidermoid Breast Carcinoma,1
5612,Mitotic Activity,Recurrent Gliosarcoma,1
5613,Metastatic Lesion,Meningeal Carcinomatosis,1
5614,Gastric dysplasia,villous adenoma of stomach,1
5615,Refractory Disease,Refractory Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma,1
5616,Microvascular Proliferation,Glioblastoma,1
5617,Tissue Differentiation Uncertain,Benign Lung PEComa,1
5618,Malignant Cellular Infiltrate,Non-Hodgkin Lymphoma by Clinical Course,1
5619,Nuclear pleomorphism,undifferentiated carcinoma of pancreas,1
5620,Epithelial Component Present,Recurrent Parotid Gland Carcinoma ex Pleomorphic Adenoma,1
5621,Blasts Under 10 Percent of Bone Marrow Nucleated Cells,Chronic Myelomonocytic Leukemia-1,1
5622,Carcinomatous Component Present,"Malignant Mixed Tumor, Not Otherwise Specified",1
5623,Refractory Disease,Precursor B-lymphoblastic lymphoma refractory,1
5624,Recurrent disease,Mycosis fungoides recurrent,1
5625,Indolent Clinical Course,Benign Fibroblastic Neoplasm,1
5626,Malignant Primitive Cellular Infiltrate,Stage II Ovarian Dysgerminoma AJCC v6 and v7,1
5627,Vascular Channel Formation,"Neoplasms, Vascular Tissue",1
5628,Secondary Lesion,Alveolar soft part sarcoma metastatic,1
5629,Metastatic Lesion,Peripheral neuroepithelioma of bone metastatic,1
5630,Malignant Cellular Infiltrate,Liver and Intrahepatic Bile Duct Malignant Non-Epithelial Neoplasm,1
5631,Adulthood Lesion,Lugano Classification Stage I Adult Non-Hodgkin Lymphoma AJCC v8,1
5632,Malignant Component Present,Sellar Teratoma with Malignant Transformation,1
5633,Malignant Cellular Infiltrate,Recurrent Childhood Malignant Germ Cell Tumor,1
5634,Anaplasia,High grade surface osteosarcoma,1
5635,Malignant Cellular Infiltrate,Localized Bone Ewing Sarcoma,1
5636,Nuclear Molding,Childhood Lung Small Cell Carcinoma,1
5637,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage II,1
5638,Carcinomatous Component Present,Endometrial adenocarcinoma metastatic,1
5639,Neuroendocrine Differentiation,Stage I Adrenal Gland Pheochromocytoma and Sympathetic Paraganglioma AJCC v8,1
5640,Vascular Channel Formation,Intermediate Vascular Neoplasm,1
5641,Dysplasia,Stage 0a Renal Pelvis Cancer AJCC v7,1
5642,Malignant Cellular Infiltrate,non-Hodgkin's lymphoma of small intestine,1
5643,Submucosal Tumor Growth,"Carcinoid, Goblet Cell",1
5644,Malignant Cellular Infiltrate,"Gallbladder Adenocarcinoma, Gastric Foveolar Type",1
5645,Regional Disease,Locally Advanced Unresectable Sarcoma,1
5646,Malignant Cellular Infiltrate,Intermediate Cell Type Iris Melanoma,1
5647,Hyperplastic Tissue Present,Adrenal Medullary Hyperplasia,1
5648,Dysplasia,Villous adenoma of colon,1
5649,Epithelial Component Present,Posterior Tongue Adenoid Cystic Carcinoma,1
5650,Regional Disease,Locally Advanced Adrenal Gland Pheochromocytoma,1
5651,Diffuse Pattern,Grade 1 Diffuse Follicular Lymphoma,1
5652,Malignant Cellular Infiltrate,Pleural mesothelioma malignant recurrent,1
5653,Malignant Cellular Infiltrate,Ann Arbor Stage II Subdiaphragmatic Nodular Lymphocyte Predominant Hodgkin Lymphoma,1
5654,Tissue Differentiation Uncertain,Hepatic Angiomyolipoma,1
5655,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma with Trophoblastic Differentiation,1
5656,Nuclear Pseudoinclusion,Stage IV Thyroid Gland Papillary Carcinoma AJCC v7,1
5657,Cutaneous Involvement,Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7,1
5658,Well-Circumscribed Lesion,Colorectal Perineurioma,1
5659,Locally Aggressive Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
5660,Cutaneous Involvement,Lentigo maligna melanoma,1
5661,Mitotic Activity,Glioblastoma,1
5662,High Mitotic Activity,Merkel Cell Carcinoma by AJCC v7 Stage,1
5663,Extraosseous Lesion,Breast Extraskeletal Osteosarcoma,1
5664,Epithelial Component Present,Mucinous Tubular and Spindle Cell Carcinoma of the Kidney,1
5665,Malignant Cellular Infiltrate,Stage IIIA Prostate Cancer AJCC v8,1
5666,In Situ Lesion,Gastric Antrum Carcinoma In Situ AJCC v6 and v7,1
5667,Follicular Cell Differentiation,Papillary thyroid carcinoma,1
5668,Malignant Cellular Infiltrate,Localized Peripheral Primitive Neuroectodermal Tumor,1
5669,Epithelial Component Present,Endometrial intraepithelial neoplasia,1
5670,Carcinomatous Component Present,Recurrent Ureter Carcinoma,1
5671,Epithelial Component Present,Nasopharyngeal Nonkeratinizing Carcinoma,1
5672,Benign Cellular Infiltrate,Cellular neurothekeoma,1
5673,Malignant Cellular Infiltrate,Cerebellar Glioblastoma,1
5674,Well-Circumscribed Lesion,Intramuscular Myxoma,1
5675,Encapsulated Mass,Stage III Thyroid Gland Follicular Carcinoma AJCC v7,1
5676,Adulthood Lesion,Adult Central Nervous System Teratoma,1
5677,Breast Microcalcification,Oligodendroglioma of spinal cord,1
5678,Malignant Cellular Infiltrate,Resectable Malignant Neoplasm,1
5679,Moderately Differentiated Lesion,Grade 2 Colorectal Adenocarcinoma,1
5680,Mesenchymal Component Present,Phyllodes Tumor,1
5681,Malignant Cellular Infiltrate,Recurrent Acute Leukemia,1
5682,Malignant Cellular Infiltrate,Malignant neoplasm of pharynx,1
5683,Well Differentiated Neuroendocrine Lesion,Ampulla of Vater Enterochromaffin Cell Serotonin-Producing Neuroendocrine Tumor,1
5684,Vascular Channel Formation,Kaposi Sarcoma NCI Grade 2,1
5685,Well-Circumscribed Lesion,Colorectal Adenoma with Mild Dysplasia,1
5686,Absence of a Hormonal Syndrome,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
5687,Indolent Clinical Course,"Hemangioma, Cavernous, Central Nervous System",1
5688,Epithelial Component Present,Stage II Pancreatic Neuroendocrine Tumor AJCC v8,1
5689,Recurrent disease,Recurrent Aggressive Adult Non-Hodgkin Lymphoma,1
5690,Carcinomatous Component Present,Anal margin basal cell carcinoma,1
5691,Secondary Lesion,Meningeal Carcinomatosis,1
5692,Carcinomatous Component Present,Stage IIB Lung Cancer AJCC v7,1
5693,Fibrotic Stroma Formation,Cholangiolocellular Carcinoma,1
5694,Benign Cellular Infiltrate,benign fibrous histiocytoma of bone,1
5695,Thick-Walled Hyalinized Vessels Present,Ureter Schwannoma,1
5696,Malignant Cellular Infiltrate,Stage IB Testicular Cancer AJCC v6 and v7,1
5697,Malignant Cellular Infiltrate,Renal Pelvis Cancer by AJCC v8 Stage,1
5698,Epithelial Component Present,"Recurrent Cervical Squamous Cell Carcinoma, Not Otherwise Specified",1
5699,Metastatic Lesion,Metastatic Lip and Oral Cavity Carcinoma,1
5700,Monoclonal Cellular Population Present,"Leukemia, Mast-Cell",1
5701,Benign Cellular Infiltrate,Halo nevus,1
5702,Malignant Cellular Infiltrate,Malignant lymphoma - lymphoplasmacytic,1
5703,Primary Lesion,Poorly Differentiated Hepatocellular Carcinoma,1
5704,Epithelial Component Present,Unresectable Intrahepatic Cholangiocarcinoma,1
5705,Metastatic Lesion,Locally Advanced Unresectable Sarcoma,1
5706,Malignant Cellular Infiltrate,Cervical Adenocarcinoma,1
5707,Epithelial Component Present,Eccrine dermal cylindroma,1
5708,Adulthood Lesion,Adult Acute Myeloid Leukemia with t(9;11)(p21.3;q23.3); MLLT3-KMT2A,1
5709,Angiodestructive Pattern,Grade III Lymphomatoid Granulomatosis,1
5710,Benign Cellular Infiltrate,"Benign Central Nervous System Mesenchymal, Non-Meningothelial Neoplasm",1
5711,Carcinomatous Component Present,Metastatic Ureter Carcinoma,1
5712,Indolent Clinical Course,Rhabdomyoma,1
5713,Dysplasia,Colorectal Adenoma with Severe Dysplasia,1
5714,Papillary Pattern,Intracystic papillary adenoma,1
5715,Gastrin Positive Neoplastic Cells Present,Gastric Gastrin-Producing Neuroendocrine Tumor,1
5716,Adulthood Lesion,Adult Pure Erythroid Leukemia,1
5717,Borderline Lesion,T-Cell Proliferation of Uncertain Malignant Potential,1
5718,Malignant Cellular Infiltrate,Poorly Differentiated Fibrosarcoma,1
5719,In Situ Lesion,Stage 0 Anal Canal Cancer AJCC v6 and v7,1
5720,Recurrent disease,Recurrent Metastatic Digestive System Carcinoma,1
5721,Stromal Invasion,Small cell carcinoma of ovary,1
5722,Malignant Cellular Infiltrate,Stage IA1 Lung Cancer AJCC v8,1
5723,Pathologic TNM Finding,Pathologic Stage 0 Cutaneous Melanoma AJCC v8,1
5724,Epithelial Component Present,Clinical Stage IVB Gastric Cancer AJCC v8,1
5725,Well Differentiated Neuroendocrine Lesion,Pancreatic Neuroendocrine Tumor G1,1
5726,Carcinomatous Component Present,Squamous Cell Bile Duct Carcinoma,1
5727,Metastatic/Recurrent Disease,Epithelioid sarcoma metastatic,1
5728,Primary Lesion,Localized Resectable Adult Hepatocellular Carcinoma,1
5729,Malignant Cellular Infiltrate,BCLC Stage D Adult Hepatocellular Carcinoma,1
5730,Recurrent disease,Recurrent Submandibular Gland Squamous Cell Carcinoma,1
5731,Malignant Cellular Infiltrate,Stage III Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
5732,Acanthosis,Condylomata Acuminata,1
5733,Epithelial Component Present,squamous cell carcinoma of lacrimal gland,1
5734,Malignant Cellular Infiltrate,Stage IVA Nasopharyngeal Carcinoma AJCC v8,1
5735,Lesion with Diameter of 4mm or More,Vulvar Dysplastic Melanocytic Nevus,1
5736,Hereditary Lesion,Neurofibromatosis aggravated,1
5737,Borderline Lesion,Pancreatic Intraepithelial Neoplasia-1A,1
5738,Diffuse Pattern,Centroblastic lymphoma refractory,1
5739,Well-Circumscribed Lesion,Vaginal Angiomyofibroblastoma,1
5740,Malignant Cellular Infiltrate,Fallopian Tube Cancer by AJCC v7 Stage,1
5741,Epithelial Component Present,Recurrent Submandibular Gland Adenoid Cystic Carcinoma,1
5742,Malignant Cellular Infiltrate,Recurrent Primary Vitreoretinal Lymphoma,1
5743,Cutaneous Involvement,Recurrent Nevus,1
5744,Epithelial Component Present,"Transitional cell papilloma, inverted",1
5745,Malignant Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type",1
5746,Carcinomatous Component Present,Cystadenocarcinoma of pancreas,1
5747,Biphasic Pattern,Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
5748,Anaplasia,Adult Primary Cutaneous Anaplastic Large Cell Lymphoma,1
5749,Malignant Cellular Infiltrate,Childhood Salivary Gland Carcinoma,1
5750,Secondary Lesion,Metastatic Digestive System Neuroendocrine Neoplasm,1
5751,atypia morphology,Atypical hyperplasia of breast,1
5752,Epithelial Component Present,Pancreatic adenocarcinoma resectable,1
5753,Carcinomatous Component Present,Plantar Verrucous Skin Carcinoma,1
5754,Monophasic Pattern,Lung Monophasic Synovial Sarcoma,1
5755,Cystic Change,inverted follicular keratosis,1
5756,Adulthood Lesion,Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities,1
5757,Bone Marrow Dysplasia Present,Refractory Neutropenia,1
5758,Malignant Cellular Infiltrate,Teratocarcinoma,1
5759,Hormonal resistance,Hormone-Resistant Prostate Carcinoma,1
5760,Malignant Cellular Infiltrate,Recurrent Acute Myelomonocytic Leukemia,1
5761,Severe dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
5762,Benign Cellular Infiltrate,Benign neoplasm of thorax,1
5763,Carcinomatous Component Present,Recurrent Female Reproductive System Carcinoma,1
5764,Cystic Change,inverted follicular keratosis,1
5765,Diffuse Pattern,Anaplastic Oligoastrocytoma,1
5766,Endophytic Tumor Growth,Laryngeal verrucous carcinoma recurrent,1
5767,Metastatic Lesion,Metastatic Hypopharyngeal Carcinoma,1
5768,Carcinomatous Component Present,Adenocarcinoma of the prostate stage I,1
5769,Invasive Lesion,Ductal Breast Carcinoma with Squamous Metaplasia,1
5770,Myeloblasts Under 5 Percent of Bone Marrow Nucleated Cells,Refractory anemia with ringed sideroblasts,1
5771,Primary Lesion,Posterior Cranial Fossa Ependymal Tumor,1
5772,Slow Growing Mass,Childhood Ependymoma,1
5773,Myxoid Stroma Formation,Adult Botryoid-Type Embryonal Rhabdomyosarcoma,1
5774,Localized Lesion,Nodular amyloidosis,1
5775,Malignant Cellular Infiltrate,Pancreatic carcinoma recurrent,1
5776,Indolent Clinical Course,Angiomyoma,1
5777,Stromal Invasion,Malignant Ovarian Surface Epithelial-Stromal Tumor,1
5778,Recurrent disease,Recurrent T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
5779,Malignant Cellular Infiltrate,Stage IIA Choroidal and Ciliary Body Melanoma AJCC v8,1
5780,Carcinomatous Component Present,Stage 0 Gallbladder Cancer AJCC v8,1
5781,Malignant Cellular Infiltrate,Stage I Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
5782,Microvascular Proliferation,Glioblastoma by Gene Expression Profile,1
5783,Carcinomatous Component Present,Nonencapsulated sclerosing tumor,1
5784,Borderline Lesion,Primary Peritoneal Serous Borderline Tumor/ Primary Peritoneal Atypical Proliferative Serous Tumor,1
5785,Pathologic TNM Finding,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5786,Malignant Cellular Infiltrate,Stage III Breast Cancer AJCC v7,1
5787,Malignant Cellular Infiltrate,Resectable Liposarcoma,1
5788,Metastatic Lesion,Advanced Melanoma,1
5789,Thyroglobulin Positive Neoplastic Cells Present,Tall Cell Variant Thyroid Gland Papillary Carcinoma,1
5790,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma AJCC v7,1
5791,Carcinomatous Component Present,Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5792,Malignant Cellular Infiltrate,Pathologic Stage III Cutaneous Melanoma AJCC v8,1
5793,Malignant Cellular Infiltrate,anaplastic large cell lymphoma of central nervous system,1
5794,Carcinomatous Component Present,Squamous cell carcinoma of tongue,1
5795,Malignant Cellular Infiltrate,Intracranial Germinoma,1
5796,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
5797,Epithelial Component Present,Pyriform Fossa Carcinoma,1
5798,Malignant Cellular Infiltrate,Malignant Accessory Urethral Gland Neoplasm,1
5799,Refractory Disease,Refractory Primary Lymphoma of Bone,1
5800,Tissue of Mullerian Origin Present,Ovarian Seromucinous Adenofibroma,1
5801,"Fully Differentiated ""Adult-Type"" Tissues Present",Childhood Mature Teratoma,1
5802,Carcinomatous Component Present,Prostate cancer stage B,1
5803,Pseudoencapsulated Mass,Intraocular Malignant Peripheral Nerve Sheath Tumor,1
5804,Primary Lesion,Central Nervous System Intravascular Large B-Cell Lymphoma,1
5805,Malignant Cellular Infiltrate,Peripheral primitive neuroectodermal bone tumor,1
5806,Epithelial Component Present,Appendix Tubulovillous Adenoma,1
5807,Cutaneous Involvement,"Adenoma, Sweat Gland",1
5808,Low Mitotic Activity,Non-Functioning Pancreatic Delta Cell Neuroendocrine Tumor,1
5809,Primary Lesion,Stage IIIC Primary Peritoneal Cancer AJCC v8,1
5810,Tumor Vascular Invasion,Malignant Pancreatic Insulinoma,1
5811,Malignant Cellular Infiltrate,Pathologic Stage IB Gastric Cancer AJCC v8,1
5812,Immunologic Deficiency Syndromes,AIDS-Related Cervical Kaposi Sarcoma,1
5813,Tissue of Mullerian Origin Present,Stage I Uterine Corpus Adenosarcoma AJCC v8,1
5814,Carcinomatous Component Present,Stage IV Cervical Cancer AJCC v6 and v7,1
5815,Follicular Cell Differentiation,Stage III Differentiated Thyroid Gland Carcinoma AJCC v8,1
5816,Carcinomatous Component Present,Stage I Thyroid Gland Follicular Carcinoma Under 55 Years AJCC v8,1
5817,Lobular Pattern,Pilar tumor,1
5818,Carcinomatous Component Present,Carcinoma of bladder,1
5819,Carcinomatous Component Present,Stage IIA1 Cervical Cancer AJCC v8,1
5820,Diffuse Lesion,Refractory Diffuse Intrinsic Pontine Glioma,1
5821,Hereditary Lesion,TUBEROUS SCLEROSIS 1 (disorder),1
5822,Well-Circumscribed Lesion,Angiomyofibroblastoma,1
5823,Necrotic changes (finding),Mesenchymal Glioblastoma,1
5824,Malignant Glandular Epithelium Resembling the Endocervical Epithelium Present,"Mucinous adenocarcinoma, endocervical type",1
5825,Benign Cellular Infiltrate,Lung Mucinous Cystadenoma,1
5826,Multinodular Mass,Adult Angiosarcoma,1
5827,Well-Circumscribed Lesion,Cystadenocarcinoma of kidney,1
5828,Malignant Cellular Infiltrate,Prognostic Stage III Breast Cancer AJCC v8,1
5829,Immunologic Deficiency Syndromes,AIDS-Related Vulvovaginal Candidiasis,1
5830,Recurrent disease,Recurrent Sarcoma of the Extremity,1
5831,Well-Circumscribed Lesion,Colon adenoma,1
5832,Rapidly Enlarging Mass,Thyroid Gland Anaplastic Carcinoma by AJCC v7 Stage,1
5833,Borderline Lesion,Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor,1
5834,Tissues Derived from Two or Three Embryonic Layers Present,Immature Ovarian Teratoma,1
5835,"Fully Differentiated ""Adult-Type"" Tissues Present",Ovarian Solid Teratoma,1
5836,Radiation Sickness,Radiation-Induced Dermatitis,1
5837,Epithelial Component Present,Stage IVA Cervical Cancer AJCC v8,1
5838,Malignant Cellular Infiltrate,Metastatic Kidney Medullary Carcinoma,1
5839,Epithelial Component Present,keratinizing squamous cell carcinoma of lung,1
5840,Malignant Cellular Infiltrate,"Cervical Mucinous Adenocarcinoma, Endocervical Type",1
5841,Epithelial Component Present,Intrahepatic Bile Duct Papillary Neoplasm with an Associated Invasive Carcinoma,1
5842,Recurrent disease,Pericardial mesothelioma malignant recurrent,1
5843,Epithelial Component Present,Clear cell papillary renal cell carcinoma,1
5844,Malignant Cellular Infiltrate,Squamous cell carcinoma of the hypopharynx stage II,1
5845,Epithelial Component Present,Ovarian Stromal-Leydig Cell Tumor,1
5846,Recurrent disease,Recurrent Primary Effusion Lymphoma,1
5847,Cutaneous Involvement,Scrotal Carcinoma,1
5848,Recurrent disease,Pharyngeal cancer recurrent,1
5849,Malignant Cellular Infiltrate,Hepatocellular Carcinoma by AJCC v8 Stage,1
5850,Fibrotic Stroma Formation,Pancreatic Moderately Differentiated Ductal Adenocarcinoma,1
5851,Nuclear Pseudoinclusion,Warthin-Like Variant Thyroid Gland Papillary Carcinoma,1
5852,Skin nodule,Proliferative dermal lesion in congenital nevus,1
5853,Cutaneous Involvement,Congenital melanocytic nevus,1
5854,Refractory Disease,Refractory Neuroendocrine Neoplasm,1
5855,Childhood Lesion,Childhood Liver and Intrahepatic Bile Duct Neoplasm,1
5856,Malignant Cellular Infiltrate,Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8,1
5857,Mixed Cellular Population,Ovarian Adenosarcoma,1
5858,Refractory Disease,Refractory Indolent Adult Non-Hodgkin Lymphoma,1
5859,Cutaneous Involvement,Stage 0 Cutaneous Melanoma AJCC v6 and v7,1
5860,Carcinomatous Component Present,Occult Lung Large Cell Carcinoma,1
5861,Carcinomatous Component Present,Recurrent Submandibular Gland Carcinoma,1
5862,Malignant Cellular Infiltrate,Breast Extraskeletal Osteosarcoma,1
5863,Well-Circumscribed Lesion,Rectal Adenoma with Severe Dysplasia,1
5864,Malignant Cellular Infiltrate,Metastatic Lung Small Cell Carcinoma,1
5865,Mitotic Activity,"Testicular Yolk Sac Tumor, Myxomatous Pattern",1
5866,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma,1
5867,Malignant Cellular Infiltrate,Stage IVA Pharyngeal Carcinoma,1
5868,Stromal Invasion,Ovarian Clear Cell Cystadenocarcinoma,1
5869,Neuroectodermal Differentiation,"Composite Ganglioneuroblastoma, Schwannian Stroma-Rich and Stroma-Poor",1
5870,Epithelial Component Present,Borderline Ovarian Clear Cell Tumor/Atypical Proliferative Ovarian Clear Cell Tumor,1
5871,Epithelial Component Present,Basaloid squamous cell carcinoma,1
5872,Multihormonal Immunoreactivity Present,Plurimorphous Plurihormonal Pituitary Gland Adenoma,1
5873,Locally Aggressive Lesion,Inflammatory Myofibroblastic Tumor,1
5874,Carcinomatous Component Present,Stage III Renal Pelvis Cancer AJCC v8,1
5875,Adnexal Differentiation,External Auditory Canal Ceruminous Adenoma,1
5876,Well Differentiated Neuroendocrine Lesion,Appendix Neuroendocrine Tumor by AJCC v7 Stage,1
5877,Exophytic Polypoid Lesion,Cecum Villous Adenoma,1
5878,Malignant Cellular Infiltrate,Secondary malignant neoplasm of vagina,1
5879,Locally Aggressive Lesion,Intermediate Cutaneous Fibrohistiocytic Neoplasm,1
5880,Malignant Cellular Infiltrate,Extranodal marginal zone B-cell lymphoma (MALT type) stage II,1
5881,Malignant Glandular Epithelium Resembling the Normal Endometrium Present,Advanced Uterine Corpus Carcinosarcoma,1
5882,Stromal Invasion,FIGO Stage IC2 Ovarian Cancer,1
5883,Immunosuppression-Related Post-Transplant Toxicity,Transplant-Related Disorder,1
5884,Epithelial Component Present,Anal Intraepithelial Neoplasia 2,1
5885,Well Developed Rough Endoplasmic Reticulum Present,Sparsely Granulated Lactotroph Adenoma,1
5886,Carcinomatous Component Present,Stage IIIC Vulvar Cancer AJCC v8,1
5887,Malignant Cellular Infiltrate,Vaginal Undifferentiated Sarcoma,1
5888,Mucoid Stroma Formation,Pseudomyxoma Peritonei,1
5889,Epithelial Component Present,Pharyngeal Carcinoma by AJCC v8 Stage,1
5890,Carcinomatous Component Present,Squamous cell carcinoma of trachea,1
5891,Malignant Cellular Infiltrate,Childhood Epithelioid Hemangioendothelioma,1
5892,Carcinomatous Component Present,Stage I Lip and Oral Cavity Squamous Cell Carcinoma AJCC v6 and v7,1
5893,Malignant Cellular Infiltrate,Stage III Uterine Corpus Cancer AJCC v8,1
5894,Benign Cellular Infiltrate,Tumorlet,1
5895,Hyperplastic Tissue Present,Intraepithelial Melanocytic Hyperplasia,1
5896,Nodular Pattern,Follicular T-cell lymphoma,1
5897,In Situ Lesion,Gastric Body Carcinoma In Situ AJCC v6 and v7,1
5898,Malignant Cellular Infiltrate,Stage IVA Hepatocellular Carcinoma AJCC v7,1
5899,Carcinomatous Component Present,"Adenocarcinoma, Clear Cell",1
5900,Carcinomatous Component Present,Adenocarcinoma of anus,1
5901,Indolent Clinical Course,Breast Epithelioid Hemangioma,1
5902,Edema,Inflammatory carcinoma of breast stage III,1
5903,Epithelial Component Present,Stage IV Cervical Cancer AJCC v6 and v7,1
5904,Malignant Cellular Infiltrate,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
5905,Malignant Cellular Infiltrate,Stage IV Major Salivary Gland Cancer AJCC v7,1
5906,Malignant Cellular Infiltrate,Locally Advanced Carcinoma,1
5907,Epithelial Component Present,Adenocarcinoma of small intestine,1
5908,Papillary Pattern,Invasive micropapillary carcinoma of breast,1
5909,Indolent Clinical Course,Inner Ear Lipoma,1
5910,Malignant Cellular Infiltrate,Recurrent Malignant Peripheral Nerve Sheath Tumor,1
5911,Malignant Cellular Infiltrate,Stage IV Osteosarcoma AJCC v7,1
5912,Nests of Nevus Cells Resembling Nerve Bundles Present,Neuronevus,1
5913,Carcinomatous Component Present,Stage 0 AIDS-Related Anal Canal Cancer AJCC v6 and v7,1
5914,Carcinomatous Component Present,ACTH-Producing Pituitary Gland Carcinoma,1
5915,Diffuse Pattern,Recurrent Gliosarcoma,1
5916,Malignant Cellular Infiltrate,Polycythemia Vera,1
5917,Malignant Cellular Infiltrate,Hereditary Non-Polyposis Colon Cancer Type 2,1
5918,Epithelial Component Present,Metastatic Renal Cell Carcinoma,1
5919,Malignant Cellular Infiltrate,Colorectal Neuroendocrine Carcinoma,1
5920,Nuclear Molding,Refractory Lung Small Cell Carcinoma,1
5921,Epithelial Component Present,Ileal Neuroendocrine Tumor,1
5922,Thick-Walled Vessels Present,Epithelioid Type Angiomyolipoma,1
5923,Adulthood Lesion,Adult Brain Medulloblastoma,1
5924,Malignant Cellular Infiltrate,"Carcinoma, Lobular",1
5925,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v8,1
5926,High Grade Lesion,Pleomorphic Rhabdomyosarcoma,1
5927,"Fully Differentiated ""Adult-Type"" Tissues Present",Central Nervous System Dermoid Cyst,1
5928,Carcinomatous Component Present,Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
5929,Secondary Lesion,Advanced Sarcoma of the Extremity,1
5930,Trabecular Pattern,Thyroid Hyalinizing Trabecular Adenoma,1
5931,Metastatic Lesion,"Sarcoma, metastatic",1
5932,Precise Histogenesis Unknown,Medullary Hemangioblastoma,1
5933,Adulthood Lesion,Recurrent Adult Liver Carcinoma,1
5934,Carcinomatous Component Present,Stage IV Anal Canal Cancer AJCC v6 and v7,1
5935,Chronic Inflammatory Infiltrate,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
5936,Storiform Growth Pattern,"Histiocytoma, Benign Fibrous",1
5937,Epithelial Component Present,Non-Small Cell Adenocarcinoma,1
5938,Neuroendocrine Differentiation,Atypical carcinoid tumor,1
5939,Epithelial Component Present,Macrofollicular adenoma,1
5940,Serotonin Positive Neoplastic Cells Present,"Carcinoid, Goblet Cell",1
5941,Malignant Cellular Infiltrate,Parietal cell carcinoma,1
5942,Carcinomatous Component Present,eccrine adenocarcinoma of vulva,1
5943,Low Mitotic Activity,Localized Digestive System Neuroendocrine Tumor G1,1
5944,Malignant Cellular Infiltrate,Stage IIA Anal Cancer AJCC v8,1
5945,Diffuse Pattern,Fibrin-Associated Diffuse Large B-Cell Lymphoma,1
5946,In Situ Lesion,Carcinoma in situ of vagina,1
5947,Carcinomatous Component Present,Stage II Renal Cell Cancer,1
5948,Epithelial Component Present,Fallopian Tube Gestational Choriocarcinoma,1
5949,Malignant Cellular Infiltrate,Stage IIC Colorectal Cancer AJCC v7,1
5950,Childhood Lesion,Mixed Congenital Mesoblastic Nephroma,1
5951,Recurrent disease,Recurrent Urinary System Carcinoma,1
5952,Follicular Cell Differentiation,Childhood Thyroid Gland Papillary Carcinoma,1
5953,High Mitotic Activity,small cell carcinoma of kidney,1
5954,Indolent Clinical Course,Leiomyomatosis,1
5955,Adulthood Lesion,Adult Cardiac Cellular Rhabdomyoma,1
5956,Invasive Lesion,Invasive Cutaneous Melanoma,1
5957,Mild cytologic atypia,Stage IVC Laryngeal Verrucous Carcinoma AJCC v7,1
5958,Malignant Cellular Infiltrate,Scirrhous carcinoma of breast,1
5959,Thick-Walled Hyalinized Vessels Present,Benign Mediastinal Psammomatous Schwannoma,1
5960,Polymorphic Cellular Infiltrate,Cutaneous Angioimmunoblastic T-Cell Lymphoma,1
5961,Infantile Lesion,Desmoplastic infantile astrocytoma,1
5962,Carcinomatous Component Present,Papillary serous cystadenocarcinoma,1
5963,Epithelial Component Present,Renal Pelvis and Ureter Cancer by AJCC v7 Stage,1
5964,Malignant Cellular Infiltrate,Resectable Intrahepatic Cholangiocarcinoma,1
5965,Epithelial Component Present,Metastatic Breast Carcinoma,1
5966,Increased Cellularity Present,pineoblastoma,1
5967,Malignant Cellular Infiltrate,Unresectable Digestive System Carcinoma,1
5968,Epithelial Component Present,Adenoma of Minor Vestibular Glands,1
5969,Mixed Cellular Population,Adenosarcoma,1
5970,CD30-Positive Neoplastic Cells Present,Stage II Childhood Anaplastic Large Cell Lymphoma,1
5971,Nuclear Atypia,Recurrent Anaplastic Astrocytoma,1
5972,Neuroendocrine Differentiation,Paraganglioma of head and neck,1
5973,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v8 Stage,1
5974,Malignant Cellular Infiltrate,Well Differentiated Prostate Adenocarcinoma,1
5975,Epithelial Component Present,Anatomic Stage I Breast Cancer AJCC v8,1
5976,Hereditary Lesion,MUTYH-Associate Polyposis,1
5977,Malignant Cellular Infiltrate,Duodenal Cancer,1
5978,Biphasic Pattern,Stage IIIC Uterine Corpus Adenosarcoma AJCC v8,1
5979,Malignant Cellular Infiltrate,Small cell carcinoma of prostate,1
5980,Metaplasia,Metaplastic carcinoma,1
5981,Absence of a Hormonal Syndrome,Advanced Non-Functioning Well Differentiated Neuroendocrine Neoplasm,1
5982,Ulcer,Esophageal Neuroendocrine Tumor G2,1
5983,Diffuse Lesion,Recurrent respiratory papillomatosis,1
5984,Well-Circumscribed Lesion,Cortisol-Producing Adrenal Cortex Adenoma,1
5985,Secondary Lesion,Alkylating Agent-Related Myelodysplastic Syndrome,1
5986,Refractory Disease,Mycosis fungoides refractory,1
5987,Epithelial Component Present,Gastric Adenosquamous Carcinoma,1
5988,Epithelial Component Present,Metastatic Kidney Carcinoma,1
5989,Epithelial Component Present,Lung Non-Keratinizing Squamous Cell Carcinoma,1
5990,Epithelial Component Present,Stage IV Colon Carcinoma,1
5991,Malignant Cellular Infiltrate,Plasmacytoma,1
5992,Malignant Cellular Infiltrate,Stage IIB Anal Cancer AJCC v8,1
5993,Mitotic Activity,Stage III Ovarian Yolk Sac Tumor AJCC v6 and v7,1
5994,Focal dysplasia,Sessile Serrated Adenoma/Polyp,1
5995,Malignant Cellular Infiltrate,Radiation-Related Sarcoma,1
5996,Epithelial Component Present,Metanephric stromal tumor,1
5997,Malignant Cellular Infiltrate,intraductal micropapillary carcinoma of breast,1
5998,Epithelial Component Present,Stage IIIB Appendix Carcinoma AJCC v7,1
5999,Papillary Pattern,Childhood Choroid Plexus Papilloma,1
6000,Hereditary Lesion,BRCA1 Syndrome,1
6001,Malignant Cellular Infiltrate,Advanced Prostate Carcinoma,1
6002,Schwannian Stroma More than 50 Percent of the Tumor Volume,"Adrenal Gland Ganglioneuroblastoma, Intermixed",1
6003,Cystic Change,Vulvar Seborrheic Keratosis,1
6004,Epithelial Component Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7,1
6005,Exophytic Papillary Lesion,Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia,1
6006,Epithelial Component Present,Papillary adenoma,1
6007,Moderate dysplasia,Grade II Glandular Intraepithelial Neoplasia,1
6008,Malignant Cellular Infiltrate,Pelvic Undifferentiated High Grade Pleomorphic Sarcoma,1
6009,Malignant Cellular Infiltrate,Childhood Central Nervous System Yolk Sac Tumor,1
6010,Cutaneous Involvement,Clinical Stage II Cutaneous Melanoma AJCC v8,1
6011,Cutaneous Involvement,Skin Basal Cell Carcinoma with Adnexal Differentiation,1
6012,Carcinomatous Component Present,Stage IV Small Intestinal Adenocarcinoma AJCC v8,1
6013,Malignant Cellular Infiltrate,Choriocarcinoma of the Testis,1
6014,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Small Cell Neuroendocrine Carcinoma,1
6015,Malignant Cellular Infiltrate,Prostate Adenosquamous Carcinoma,1
6016,Epithelial Component Present,Squamous cell carcinoma of head and neck metastatic,1
6017,Carcinomatous Component Present,Stage I Rectal Cancer AJCC v6 and v7,1
6018,Malignant Cellular Infiltrate,Stage III Renal Pelvis and Ureter Cancer AJCC v7,1
6019,Carcinomatous Component Present,Stage 0 Eyelid Carcinoma AJCC v8,1
6020,Serrated Glandular Architecture,Traditional Serrated Adenoma,1
6021,Epithelial Component Present,Distal Bile Duct Carcinoma,1
6022,Carcinomatous Component Present,Keratinizing Head and Neck Squamous Cell Carcinoma,1
6023,Epithelial Component Present,Carcinoma in situ of trachea,1
6024,Epithelial Component Present,Adult Craniopharyngioma,1
6025,Tissue of Mullerian Origin Present,Cystadenofibroma,1
6026,Benign Cellular Infiltrate,Skin Cavernous Hemangioma,1
6027,Eosinophilic inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
6028,Diffuse Pattern,Diffuse malignant mesothelioma,1
6029,Neuroendocrine Differentiation,Stage IIIB Colon Neuroendocrine Tumor AJCC v8,1
6030,Epithelial Component Present,Condylomata Acuminata,1
6031,Exophytic Polypoid Lesion,tubular adenoma of extrahepatic bile duct,1
6032,Metastatic Lesion,Secondary Central Nervous System Hodgkin Lymphoma,1
6033,Carcinomatous Component Present,Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE3 Gene Fusions,1
6034,Carcinomatous Component Present,Esophageal Cancer by AJCC v6 Stage,1
6035,Malignant Cellular Infiltrate,Recurrent Anaplastic Oligoastrocytoma,1
6036,Nuclear Atypia,Anaplastic Hemispheric Astrocytoma,1
6037,Pregnancy Complications,Leuteoma of Pregnancy,1
6038,Polymorphic Cellular Infiltrate,"Langerhans cell histiocytosis, unifocal",1
6039,Epithelial Component Present,Stage IV Nasal Cavity and Paranasal Sinus Cancer AJCC v7,1
6040,Malignant Cellular Infiltrate,Childhood Clear Cell Sarcoma of Soft Parts,1
6041,Rapidly Enlarging Mass,Alveolar rhabdomyosarcoma,1
6042,Malignant Cellular Infiltrate,Childhood Lymphocyte-Depleted Classic Hodgkin Lymphoma,1
6043,Recurrent disease,Recurrent Childhood Cerebellar Astrocytoma,1
6044,Malignant Cellular Infiltrate,Vaginal Yolk Sac Tumor,1
6045,Precise Histogenesis Unknown,Retinal hemangioblastoma,1
6046,Malignant Cellular Infiltrate,Stage IV Cutaneous Melanoma AJCC v6 and v7,1
6047,Chronic lymphocytic inflammation,Eccrine spiradenoma,1
6048,Malignant Cellular Infiltrate,Refractory Lymphoblastic Lymphoma,1
6049,Malignant Cellular Infiltrate,Mucosal lentiginous melanoma,1
6050,Epithelial Component Present,Stage IB2 Cervical Cancer,1
6051,Epithelial Component Present,Stage IIB Distal Bile Duct Cancer AJCC v8,1
6052,Low Mitotic Activity,Ampulla of Vater Neuroendocrine Tumor G1,1
6053,Malignant Cellular Infiltrate,Pituitary carcinoma,1
6054,Benign Cellular Infiltrate,Thyroid Gland Cavernous Hemangioma,1
6055,Single Cell Necrosis,Stage IIB Merkel Cell Carcinoma AJCC v7,1
6056,Anaplasia,"Glioblastoma, IDH-Wildtype",1
6057,Epithelial Component Present,Stage III Esophageal Cancer,1
6058,Firm mass,Cervical Malignant Peripheral Nerve Sheath Tumor,1
6059,Localized Hydropic Villous Change,"Hydatidiform Mole, Partial",1
6060,In Situ Lesion,Stage 0 Vulvar Carcinoma,1
6061,Cutaneous Involvement,Local infection skin/subcut tissue NOS,1
6062,Well-Circumscribed Lesion,Spinal hemangioblastoma,1
6063,Epithelial Component Present,Gastrointestinal carcinoma,1
6064,Tissue Differentiation Uncertain,"Synovial sarcoma, epithelioid cell",1
6065,Carcinomatous Component Present,Stage IVB Oropharyngeal Squamous Cell Carcinoma AJCC v7,1
6066,Indolent Clinical Course,Benign neoplasm of tongue,1
6067,Capillary Sized Vascular Channel Formation,Kaposiform Hemangioendothelioma,1
6068,Primary Lesion,Stage IV Primary Peritoneal Cancer AJCC v7,1
6069,Infiltrative Growth Pattern,Classical Glioblastoma,1
6070,Multinodular Mass,Dedifferentiated Dermatofibrosarcoma Protuberans,1
6071,Malignant Cellular Infiltrate,Stage II Uterine Corpus Leiomyosarcoma AJCC v8,1
6072,Adulthood Lesion,Adult Pilocytic Astrocytoma,1
6073,Carcinomatous Component Present,Stage III Esophageal Squamous Cell Carcinoma AJCC v7,1
6074,Adulthood Lesion,Adult Epithelioid Hemangioendothelioma,1
6075,Recurrent disease,Recurrent Childhood Anaplastic Large Cell Lymphoma,1
6076,Epithelial Component Present,Invasive Lobular Breast Carcinoma,1
6077,Epithelial Component Present,Eyelid Sebaceous Gland Carcinoma,1
6078,Malignant Cellular Infiltrate,Stage I Thyroid Gland Papillary Carcinoma AJCC v7,1
6079,Malignant Cellular Infiltrate,Choriocarcinoma of the Testis,1
6080,Malignant Cellular Infiltrate,Early Invasive Cervical Adenocarcinoma,1
6081,Recurrent disease,Recurrent Ph-Like Acute Lymphoblastic Leukemia,1
6082,Epithelial Component Present,Refractory Neuroendocrine Neoplasm,1
6083,Malignant Cellular Infiltrate,Localized Gastroesophageal Junction Adenocarcinoma,1
6084,Thyroglobulin Positive Neoplastic Cells Present,minimally invasive follicular carcinoma of the thyroid gland,1
6085,Malignant Cellular Infiltrate,Thyroid Gland Sclerosing Mucoepidermoid Carcinoma with Eosinophilia,1
6086,Neuroendocrine Differentiation,Metastatic Breast Neuroendocrine Neoplasm,1
6087,High Mitotic Activity,undifferentiated sarcoma of ovary,1
6088,Malignant Cellular Infiltrate,Unresectable Carcinoma,1
6089,Neuroendocrine Differentiation,Carcinoid tumor of ileum,1
6090,Mixed Cellular Population,Mixed Neoplasm,1
6091,Eosinophilic inflammation,Gastric Inflammatory Myofibroblastic Tumor,1
6092,Lesion with Diameter of 5cm or Less,"Gastrointestinal stromal tumor, benign",1
6093,Epithelial Component Present,Colon Micropapillary Adenocarcinoma,1
6094,Fibrotic Stroma Formation,Pancreatic Medullary Carcinoma,1
6095,Nuclear Molding,Stage IB Lung Small Cell Carcinoma AJCC v7,1
6096,Epithelial Component Present,Thyroid Gland Papillary Carcinoma by AJCC v7 Stage,1
6097,Epithelial Component Present,Maxillary Sinus Inverted Papilloma,1
6098,Papillary Pattern,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
6099,Cutaneous Involvement,"Lymphoma, T-Cell, Cutaneous",1
6100,Secondary Lesion,Colorectal Adenocarcinoma Metastatic in the Liver,1
6101,Mixed Cellular Population,Ovarian Adenosarcoma,1
6102,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma,1
6103,Carcinomatous Component Present,epithelial-myoepithelial carcinoma of lung,1
6104,Anaplasia,Temporal Lobe Anaplastic Astrocytoma,1
6105,Malignant Cellular Infiltrate,Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,1
6106,Myxoid Stroma Formation,Dedifferentiated chordoma,1
6107,Borderline Lesion,Uterine Corpus Smooth Muscle Tumor of Uncertain Malignant Potential,1
6108,Epithelial Component Present,squamous cell carcinoma of middle ear,1
6109,Malignant Cellular Infiltrate,Squamous cell breast carcinoma,1
6110,Carcinomatous Component Present,Small intestine carcinoma stage III,1
6111,Epithelial Component Present,Stage I Prostate Cancer AJCC v7,1
6112,Carcinomatous Component Present,Bladder squamous cell carcinoma stage IV,1
6113,Carcinomatous Component Present,Endometrial Clear Cell Adenocarcinoma,1
6114,Malignant Cellular Infiltrate,"Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
6115,Infiltrative Growth Pattern,Proneural Glioblastoma,1
6116,Carcinomatous Component Present,Stage IA Eyelid Carcinoma AJCC v8,1
6117,Malignant Cellular Infiltrate,Stage I Non-Hodgkin Lymphoma,1
6118,Necrotic changes (finding),Small cell lung cancer recurrent,1
6119,Acantholysis,"Squamous Cell Breast Carcinoma, Acantholytic Variant",1
6120,Malignant Cellular Infiltrate,Grade 1 Colon Adenocarcinoma,1
6121,Myxoid Stroma Formation,Clivus Chondroid Chordoma,1
6122,Solitary mass,Unresectable Chordoma,1
6123,Malignant Cellular Infiltrate,Colorectal Leiomyosarcoma,1
6124,Epithelial Component Present,Refractory Neuroendocrine Neoplasm,1
6125,Vascular Channel Formation,Congenital hemangioma,1
6126,Monoclonal Cellular Population Present,"Systemic mastocytosis with associated clonal, hematologic non-mast-cell lineage disease",1
6127,Low Mitotic Activity,Stage IV Ileal Neuroendocrine Tumor AJCC v8,1
6128,Malignant Cellular Infiltrate,Primary Intraosseous Squamous Cell Carcinoma Derived From Keratocystic Odontogenic Tumor,1
6129,Congenital Lesion,Congenital ptosis,1
6130,Malignant Cellular Infiltrate,"Neoplasm, malignant, uncertain whether primary or metastatic",1
6131,Carcinomatous Component Present,Uterine Ligament Serous Adenocarcinoma,1
6132,Malignant Cellular Infiltrate,Prostate Cancer by AJCC v6 Stage,1
6133,Metastatic Lesion,Locally Advanced Bile Duct Carcinoma,1
6134,Neuroendocrine Differentiation,Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8,1
6135,Poorly Differentiated Lesion,Thymic Sarcomatoid Carcinoma,1
6136,Single Type of Tissue Derived from One Embryonic Layer Present,Ovarian Dermoid Cyst with Melanocytic Nevus,1
6137,Well-Circumscribed Lesion,polyps,1
6138,Malignant Cellular Infiltrate,Rectosigmoid Cancer by AJCC v6 Stage,1
6139,Malignant Cellular Infiltrate,Recurrent Adult Undifferentiated High Grade Pleomorphic Sarcoma of Bone,1
6140,Malignant Cellular Infiltrate,Stage I Renal Cell Carcinoma,1
6141,Cells of Monocytic Lineage 80 Percent or More of Bone Marrow Leukemic Cells,Childhood Acute Monocytic Leukemia,1
6142,Anaplasia,Neural Glioblastoma,1
6143,Epithelial Component Present,Stage IIB Lung Adenosquamous Carcinoma AJCC v7,1
6144,Epithelial Component Present,Benign Prostate Phyllodes Tumor,1
6145,Hyaline Cartilage Differentiation,Grade II Chondrosarcoma,1
6146,Squamous Metaplasia of Malignant Cells Present,Adenocarcinoma with squamous metaplasia,1
6147,Epithelial Component Present,Carcinoma in situ of trachea,1
6148,Epithelial Component Present,Castration-Sensitive Prostate Carcinoma,1
6149,Epithelial Component Present,Lung Large Cell Carcinoma by AJCC v7 Stage,1
6150,Eccrine Differentiation,Eccrine Neoplasm,1
6151,Refractory Disease,Refractory Nasopharyngeal Carcinoma,1
6152,Nerve palsy,Acquired Facial Nerve Palsy,1
6153,Carcinomatous Component Present,Stage IIIA Distal Bile Duct Cancer AJCC v8,1
6154,Epithelial Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant",1
6155,Carcinomatous Component Present,Malignant myoepithelioma,1
6156,Well Differentiated Neuroendocrine Lesion,Metastatic Breast Carcinoid Tumor,1
6157,Malignant Cellular Infiltrate,Alveolar soft part sarcoma recurrent,1
6158,Carcinomatous Component Present,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
6159,Carcinomatous Component Present,Metastatic Breast Carcinoma,1
6160,Fibrotic Stroma Formation,mucoepidermoid carcinoma of accessory sinus,1
6161,Epithelial Component Present,Rectal Signet Ring Cell Adenocarcinoma,1
6162,Epithelial Component Present,High Grade Fallopian Tube Serous Adenocarcinoma,1
6163,Benign Cellular Infiltrate,"Nevus, Intradermal",1
6164,Monocytosis,Juvenile Myelomonocytic Leukemia,1
6165,Exophytic Papillary Lesion,papillary carcinoma of penis,1
6166,Malignant Cellular Infiltrate,follicular lymphoma of spleen,1
6167,Neutral Epithelial Mucin Present,Adult Combined Hepatocellular Carcinoma and Cholangiocarcinoma,1
6168,Histiocytosis,Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma,1
6169,Cartilaginous Component Present,Subungual exostoses,1
6170,Immunosuppression-Related Post-Transplant Toxicity,Chronic Allograft Arteriopathy,1
6171,Chronic Clinical Course,"Thrombocythemia, Essential",1
6172,Tumor Mass,Extracavitary Primary Effusion Lymphoma,1
6173,Malignant Cellular Infiltrate,Bladder adenocarcinoma stage 0,1
6174,Multinodular Pattern,Plexiform fibrohistiocytic tumor,1
6175,Cutaneous Involvement,Stage I Cutaneous Melanoma AJCC v7,1
6176,Benign Cellular Infiltrate,Hemolymphangioma,1
6177,Epithelial Component Present,Recurrent Parotid Gland Squamous Cell Carcinoma,1
6178,Malignant Cellular Infiltrate,Fallopian Tube Mucinous Adenocarcinoma,1
6179,Tissue Differentiation Uncertain,"Synovial sarcoma, epithelioid cell",1
6180,Encapsulated Mass,Thyroid Gland Follicular Carcinoma by AJCC v8 Stage,1
6181,Indolent Clinical Course,Ovarian Fibromata,1
6182,Cutaneous Involvement,Stage I Mycosis Fungoides and Sezary Syndrome AJCC v8,1
6183,Hyperkeratosis,Plantar wart,1
6184,Myxoid Stroma Formation,Myxoid liposarcoma metastatic,1
6185,Neuroendocrine Differentiation,Stage II Lung Small Cell Carcinoma AJCC v7,1
6186,Exophytic Papillary Lesion,Papillary squamous cell carcinoma,1
6187,Indolent Clinical Course,"Myositis, Proliferative",1
6188,Hyperplastic Tissue Present,Focal Epithelial Hyperplasia,1
6189,Severe dysplasia,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
6190,Neuroendocrine Differentiation,Pathologic Stage II Merkel Cell Carcinoma AJCC v8,1
6191,Low Mitotic Activity,Colorectal Neuroendocrine Tumor G1,1
6192,Carcinomatous Component Present,Unresectable Gastric Adenocarcinoma,1
6193,Benign Cellular Infiltrate,Venous hemangioma,1
6194,Dysplasia,Pathologic Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6195,Cutaneous Involvement,Malignant vascular tumor of skin,1
6196,Epithelial Component Present,Primary Peritoneal Cancer by AJCC v8 Stage,1
6197,Malignant Cellular Infiltrate,Secondary malignant neoplasm of esophagus,1
6198,Lobulated Growth Pattern,Vertebral chordoma,1
6199,Malignant Cellular Infiltrate,Malignant Peripheral Nerve Sheath Tumor,1
6200,Invasive Lesion,"Thyroid Gland Follicular Carcinoma, Widely Invasive",1
6201,Anaplasia,Adult Giant Cell Glioblastoma,1
6202,Carcinomatous Component Present,Pathologic Stage III Esophageal Squamous Cell Carcinoma AJCC v8,1
6203,Epithelial Component Present,Clear Cell Papillary Cystadenoma,1
6204,Malignant Cellular Infiltrate,Secondary malignant neoplasm of ciliary body,1
6205,Epithelial Component Present,Prostate carcinoma,1
6206,Carcinomatous Component Present,Locally Advanced Unresectable Gastric Adenocarcinoma,1
6207,Severe dysplasia,Stage 0 Lung Cancer AJCC v6 and v7,1
6208,Keratin pearl formation,Keratinizing Primary Intraosseous Squamous Cell Carcinoma -Solid Type,1
6209,Resectable Mass,Hepatoma resectable,1
6210,Malignant Cellular Infiltrate,adenoid cystic carcinoma of pharynx,1
6211,Epithelial Component Present,Stage 0is Ureter Cancer AJCC v7,1
6212,Local disease,Epidural Spinal Canal Angiolipoma,1
6213,Mixed Cellular Population,Stage I Kidney Wilms Tumor,1
6214,Metastatic Lesion,"Squamous cell carcinoma, metastatic",1
6215,Tissue Differentiation Uncertain,Alveolar soft part sarcoma metastatic,1
6216,Malignant Cellular Infiltrate,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
6217,Childhood Lesion,Recurrent Childhood Anaplastic Astrocytoma,1
6218,Indolent Clinical Course,Venous Angioleiomyoma,1
6219,Malignant Cellular Infiltrate,Lung Adenocarcinoma by AJCC v7 Stage,1
6220,Metastatic Lesion,Lymphangitis carcinomatosa,1
6221,Carcinomatous Component Present,Childhood Lung Non-Small Cell Carcinoma,1
6222,Adulthood Lesion,Adult Malignant Peripheral Nerve Sheath Tumor,1
6223,Pathologic TNM Finding,Pathologic Stage IA Esophageal Squamous Cell Carcinoma AJCC v8,1
6224,Papillary Pattern,Papillary carcinoma of the breast,1
6225,Chronic Inflammatory Infiltrate,"Cutaneous Fibrous Histiocytoma, Histiocytic Variant",1
6226,Epithelial Component Present,Gastric Cancer by AJCC v8 Postneoadjuvant Therapy Stage,1
6227,Malignant Cellular Infiltrate,Malignant Parotid Gland Mixed Tumor,1
6228,Carcinomatous Component Present,Stage IA Lung Non-Small Cell Carcinoma AJCC v7,1
6229,Epithelial Component Present,Breast Phyllodes Tumor,1
6230,Delicate Vascular Network Formation,Non-Hereditary Clear Cell Renal Cell Carcinoma,1
6231,Carcinomatous Component Present,Gallbladder Neuroendocrine Carcinoma,1
6232,Malignant Cellular Infiltrate,Cerebral Glioblastoma,1
6233,Absence of Invasion,Stage 0 Non-Small Cell Lung Cancer AJCC v6 and v7,1
6234,Malignant Cellular Infiltrate,Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1
6235,Acanthosis,Buccal Mucosa Verrucous Carcinoma,1
6236,Clinical TNM Finding,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
6237,Polymorphic Cellular Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
6238,Lymphoplasmacytic Infiltrate,Recurrent Grade I Lymphomatoid Granulomatosis,1
6239,Dysplasia,Appendix High Grade Intraepithelial Neoplasia,1
6240,Encapsulated Mass,Stage I Thyroid Gland Follicular Carcinoma AJCC v8,1
6241,Immunologic Deficiency Syndromes,Transplant-Related Lung Carcinoma,1
6242,Malignant Cellular Infiltrate,Malignant Splenic Soft Tissue Neoplasm,1
6243,Adulthood Lesion,Adult T-cell lymphoma/leukemia stage IV,1
6244,Malignant Cellular Infiltrate,"Retinoblastoma, diffuse",1
6245,Increased Cellularity Present,"Childhood Cerebral Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
6246,Metastatic Lesion,Metastatic Rectal Carcinoma,1
6247,Cutaneous Involvement,Primary Cutaneous Follicle Center Lymphoma,1
6248,Low Mitotic Activity,Gastric Neuroendocrine Tumor by AJCC v8 Stage,1
6249,Malignant Cellular Infiltrate,Cecum Non-Hodgkin Lymphoma,1
6250,Malignant Cellular Infiltrate,Signet-ring cell adenocarcinoma gastric,1
6251,Absence of Invasion,"Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8",1
6252,Secondary Lesion,Synovial sarcoma metastatic,1
6253,Epithelial Component Present,Squamous Cell Neoplasms,1
6254,Malignant Cellular Infiltrate,Low Grade Mucoepidermoid Breast Carcinoma,1
6255,Well-Circumscribed Lesion,Breast adenoma,1
6256,Invasive Lesion,Infiltrating angiolipoma,1
6257,Benign Cellular Infiltrate,Benign Intracranial Meningioma,1
6258,Invasive Lesion,Bladder transitional cell carcinoma stage I,1
6259,Recurrent Lymphoma,Classic Hodgkin Lymphoma Type Post-Transplant Lymphoproliferative Disorder,1
6260,Hypercellular bone marrow,Prefibrotic/Early Primary Myelofibrosis,1
6261,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Borderline Fallopian Tube Endometrioid Tumor,1
6262,Malignant Cellular Infiltrate,Recurrent Endometrial Undifferentiated Carcinoma,1
6263,Granuloma,Granulomatous slack skin disease,1
6264,Epithelial Component Present,Mixed Acinar-Ductal Carcinoma of the Pancreas,1
6265,Metastatic Lesion,Locally Advanced Unresectable Soft Tissue Sarcoma,1
6266,Secondary Lesion,Disseminated carcinoma,1
6267,Malignant Cellular Infiltrate,Unresectable Ewing Sarcoma,1
6268,Alternative Fascicle (Bundle) Pattern,Leiomyoma of lung,1
6269,Malignant Cellular Infiltrate,Schneiderian carcinoma,1
6270,Epithelial Component Present,Stage IB Non-Small Cell Lung Carcinoma AJCC v7,1
6271,Malignant Cellular Infiltrate,Neuroblastoma,1
6272,Epithelial Component Present,Rectal Small Cell Neuroendocrine Carcinoma,1
6273,Epithelial Component Present,Recurrent Thyroid Gland Follicular Carcinoma,1
6274,Benign Cellular Infiltrate,Vulvar Leiomyoma,1
6275,Malignant Cellular Infiltrate,Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7,1
6276,Malignant Cellular Infiltrate,Poorly Differentiated Ovarian Sertoli-Leydig Cell Tumor,1
6277,Indolent Clinical Course,Senile hemangioma of lip,1
6278,Malignant Cellular Infiltrate,Undifferentiated carcinoma of stomach,1
6279,Epithelial Component Present,Anal margin Paget's disease,1
6280,Malignant Cellular Infiltrate,Biochemically Recurrent Prostate Carcinoma,1
6281,Epithelial Component Present,Comedocarcinoma,1
6282,Recurrent disease,Recurrent Ampulla of Vater Adenocarcinoma,1
6283,Malignant Cellular Infiltrate,Stage IVA Vulvar Cancer AJCC v8,1
6284,Borderline Lesion,Borderline Ovarian Mucinous Tumor/Atypical Proliferative Ovarian Mucinous Tumor,1
6285,Malignant Cellular Infiltrate,Ann Arbor Stage IIIB Hodgkin Lymphoma,1
6286,Low Mitotic Activity,Stage III Pancreatic Neuroendocrine Tumor AJCC v8,1
6287,Carcinomatous Component Present,Stage II Nasopharyngeal Carcinoma AJCC v6,1
6288,Malignant Cellular Infiltrate,Stage IVC Laryngeal Cancer AJCC v8,1
6289,Carcinomatous Component Present,Recurrent Thymic Carcinoma,1
6290,Cutaneous Involvement,Benign Cutaneous Fibroblastic Neoplasm,1
6291,Epithelial Component Present,Endocrine Gland Neoplasms,1
6292,Thyroglobulin Positive Neoplastic Cells Present,Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7,1
6293,Increased Cellularity Present,Frontal Lobe Anaplastic Oligodendroglioma,1
6294,Malignant Cellular Infiltrate,Pelvic Cancer,1
6295,Epithelial Component Present,Cervical Adenocarcinoma In Situ,1
6296,Carcinomatous Component Present,Cecum Carcinoma,1
6297,Malignant Cellular Infiltrate,Metastatic Neuroblastoma,1
6298,Collagenous Stroma Formation,Alveolar adenoma,1
6299,atypia morphology,Atypical Endometrial Hyperplasia,1
6300,Cystic Change,Ovarian Clear Cell Cystadenofibroma,1
6301,Benign Cellular Infiltrate,Colon Ganglioneuroma,1
6302,Epithelial Component Present,Stage I Laryngeal Squamous Cell Carcinoma AJCC v6 and v7,1
6303,Perineural spread,Stage IVB Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7,1
6304,Epithelial Component Present,Colon Serrated Adenocarcinoma,1
6305,Primary Lesion,Central Nervous System Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma,1
6306,Epithelial Component Present,Adenocarcinoma in adenomatous polyp,1
6307,Carcinomatous Component Present,Stage IIB Breast Carcinoma,1
6308,Epithelial Component Present,Peripheral Intrahepatic Cholangiocarcinoma,1
6309,Birbeck Granules Present,Childhood Langerhans Cell Histiocytosis,1
6310,Malignant Cellular Infiltrate,Stage IB Vulvar Carcinoma AJCC v6,1
6311,Recurrent disease,Recurrent Adult Immunoblastic Lymphoma,1
6312,Recurrent disease,Pharyngeal cancer recurrent,1
6313,Swelling,Subungual exostoses,1
6314,Refractory Disease,Refractory Erdheim-Chester Disease,1
6315,Malignant Cellular Infiltrate,"Composite Ganglioneuroblastoma, Stroma-Dominant and Stroma-Poor",1
6316,Malignant Cellular Infiltrate,Stage IVB Oral Cavity Mucoepidermoid Carcinoma AJCC v6 and v7,1
6317,Malignant Cellular Infiltrate,Adrenal Cortex Carcinoma by ENSAT Stage,1
6318,Carcinomatous Component Present,Stage I Intrahepatic Cholangiocarcinoma AJCC v8,1
6319,Epithelial Component Present,Hypopharyngeal Carcinoma by AJCC v6 Stage,1
6320,Adnexal Differentiation,Superficial Epithelioma with Sebaceous Differentiation,1
6321,Well Differentiated Neuroendocrine Lesion,Gastrinoma,1
6322,Carcinomatous Component Present,Stage IIIB Colon Cancer AJCC v8,1
6323,Hyaline Cartilage Differentiation,Mesenchymal Chondrosarcoma,1
6324,Glandular Pattern,Pancreatic Somatostatinoma,1
6325,Epithelial Component Present,Stage IIIC Primary Peritoneal Cancer AJCC v7,1
6326,Carcinomatous Component Present,Recurrent Primary Peritoneal Serous Adenocarcinoma,1
6327,Radiation Sickness,Radiation Pneumonitis,1
6328,Carcinomatous Component Present,Stage IIIB Gallbladder Cancer AJCC v8,1
6329,Hyaline Cartilage Differentiation,mesenchymal chondrosarcoma of bone,1
6330,Benign Cellular Infiltrate,Inner Ear Lipoma,1
6331,Carcinomatous Component Present,Stage IVA Hypopharyngeal Carcinoma AJCC v8,1
6332,Cutaneous Involvement,Clinical Stage IIB Merkel Cell Carcinoma AJCC v8,1
6333,Indolent Clinical Course,benign neoplasm of lower jaw bone,1
6334,Well Differentiated Neuroendocrine Lesion,Stage II Appendix Neuroendocrine Tumor AJCC v8,1
6335,Increased Cellularity Present,Adult Anaplastic Oligodendroglioma,1
6336,Necrotic changes (finding),Classical Glioblastoma,1
6337,Carcinomatous Component Present,"Metastatic Infiltrating Bladder Urothelial Carcinoma, Lipid-Rich Variant",1
6338,Keratin pearl formation,"Squamous cell carcinoma, keratinizing",1
6339,Indolent Clinical Course,Infantile hemangioma,1
6340,Epithelial Component Present,Stage IVA Laryngeal Verrucous Carcinoma AJCC v7,1
6341,Benign Cellular Infiltrate,Benign neoplasm of spleen,1
6342,Poorly Differentiated Neuroendocrine Lesion,Advanced Small Intestinal Neuroendocrine Carcinoma,1
6343,Malignant Cellular Infiltrate,Malignant tumor of gum,1
6344,Malignant Cellular Infiltrate,Stage III Small Intestinal Adenocarcinoma AJCC v8,1
6345,Adulthood Lesion,Adult Myelodysplastic Syndrome,1
6346,Well-Circumscribed Lesion,Conventional Cardiac Rhabdomyoma,1
6347,Thyroglobulin Positive Neoplastic Cells Present,Stage II Differentiated Thyroid Gland Carcinoma Under 55 Years AJCC v8,1
6348,Tissue of Mullerian Origin Present,Stage II Uterine Corpus Adenosarcoma AJCC v8,1
6349,Malignant Cellular Infiltrate,Tracheal Carcinoma,1
6350,Malignant Cellular Infiltrate,adenocarcinoma of epididymis,1
6351,Extensive Stage Lesion,Advanced Adult Hepatocellular Carcinoma,1
6352,Birbeck Granules Present,"Langerhans Cell Histiocytosis, Polystotic",1
6353,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Uterine Corpus Carcinosarcoma,1
6354,Childhood Lesion,Childhood Acute Erythroid Leukemia,1
6355,Epithelial Component Present,Common wart,1
6356,Indolent Clinical Course,Verrucous keratotic hemangioma,1
6357,Benign Cellular Infiltrate,sialadenoma papilliferum of salivary gland,1
6358,Osteoid formation,Osteosarcoma Arising in Paget Disease of Bone,1
6359,Immunosuppression-Related Post-Transplant Toxicity,Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder,1
6360,Malignant Cellular Infiltrate,Lugano Classification Stage I Childhood Hodgkin Lymphoma AJCC v8,1
6361,Well-Circumscribed Lesion,Esophageal squamous papilloma,1
6362,Malignant Cellular Infiltrate,Stage 0 Testicular Cancer AJCC v6 and v7,1
6363,Calcitonin serum level increased,Stage III Thyroid Gland Medullary Carcinoma AJCC v7,1
6364,Secondary Lesion,Advanced Adult Hepatocellular Carcinoma,1
6365,Invasive Lesion,"Acinar Prostate Adenocarcinoma, Foamy Gland Variant",1
6366,No Evidence of Metastatic Disease,Benign Adrenal Gland Composite Pheochromocytoma,1
6367,Epithelial Component Present,Intrahepatic Bile Duct Microcystic Adenoma,1
6368,Junctional Proliferation,Vulvar Dysplastic Melanocytic Nevus,1
6369,Biphasic Pattern,Benign Cervical Mixed Epithelial and Mesenchymal Neoplasm,1
6370,Indolent Clinical Course,Endobronchial Leiomyoma,1
6371,Carcinomatous Component Present,Primary intraosseous squamous cell carcinoma derived from odontogenic cyst,1
6372,Childhood Lesion,Childhood Central Nervous System Germinoma,1
6373,Fibrotic Stroma Formation,Malignant Brenner Tumor,1
6374,Benign Cellular Infiltrate,Cellular Neurofibroma,1
6375,Malignant Cellular Infiltrate,Buccal Mucosa Verrucous Carcinoma,1
6376,Carcinomatous Component Present,Thymic Undifferentiated Carcinoma,1
6377,Epithelial Component Present,Gallbladder Well Differentiated Endocrine Tumor/Carcinoma,1
6378,Epithelial Component Present,Small cell lung cancer extensive stage,1
6379,Malignant Cellular Infiltrate,Stage IV Cervical Cancer AJCC v6 and v7,1
6380,Malignant Cellular Infiltrate,Neonatal leukemia,1
6381,Malignant Cellular Infiltrate,Virus-Related Sarcoma,1
6382,Epithelial Component Present,Recurrent Paranasal Sinus Squamous Cell Carcinoma,1
6383,Malignant Cellular Infiltrate,Stage 0 Colon Cancer AJCC v8,1
6384,Localized Lesion,Plasmacytoma,1
6385,Absence of Invasion,Carcinoma in Situ,1
6386,Perivascular Arrangement of Tumor Cells,Benign Pericytic Neoplasm,1
6387,Lobulated Growth Pattern,Multiple Lobular Capillary Hemangiomas,1
6388,Benign Cellular Infiltrate,Hemangioma of choroid,1
6389,Metastatic Lesion,Disseminated Malignant Neoplasm,1
6390,Carcinomatous Component Present,Squamous cell carcinoma of trachea,1
6391,Well-Circumscribed Lesion,Rectal Sessile Serrated Adenoma/Polyp,1
6392,Malignant Cellular Infiltrate,Extra-osseous Ewing's sarcoma metastatic,1
6393,Benign Cellular Infiltrate,Hemangioma of orbit,1
6394,Epithelial Component Present,Ureter Inverted Papilloma,1
6395,Malignant Cellular Infiltrate,Pathologic Stage IB Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6396,Neuroendocrine Differentiation,Sympathetic paraganglioma,1
6397,Tartrate Resistant Acid Phosphatase Positive Cells Present,Progressive Hairy Cell Leukemia Initial Treatment,1
6398,Low Mitotic Activity,Stage III Appendix Neuroendocrine Tumor AJCC v8,1
6399,Primary Lesion,Recurrent Primary Peritoneal Low Grade Serous Adenocarcinoma,1
6400,Carcinomatous Component Present,Stage IB Esophageal Cancer AJCC v7,1
6401,Epithelial Component Present,Stage IB Pancreatic Cancer AJCC v6 and v7,1
6402,Epithelial Component Present,Laryngeal Cancer by AJCC v6 Stage,1
6403,Malignant Cellular Infiltrate,Paget Disease of the Scrotum,1
6404,High Grade Lesion,Rhabdomyosarcoma of cervix uteri,1
6405,Adulthood Lesion,Stage III Adult Liver Cancer AJCC v7,1
6406,Malignant Cellular Infiltrate,Parotid Gland Undifferentiated Carcinoma,1
6407,Carcinomatous Component Present,Locally Advanced Lung Non-Small Cell Squamous Carcinoma,1
6408,Epithelial Component Present,"Cystadenoma, Papillary",1
6409,Epithelial Component Present,Anal Canal Squamous Papilloma,1
6410,Carcinomatous Component Present,Bladder Squamous Cell Carcinoma,1
6411,Malignant Cellular Infiltrate,Stage B Chronic Lymphocytic Leukemia,1
6412,Malignant Cellular Infiltrate,Malignant Uveal Neoplasm,1
6413,Carcinomatous Component Present,Adenocarcinoma of pancreas,1
6414,Malignant Cellular Infiltrate,Malignant tumor of cervix,1
6415,Epithelial Component Present,Pancreatic Vipoma,1
6416,Malignant Cellular Infiltrate,Gastric and Omental Gastrointestinal Stromal Tumor by AJCC v8 Stage,1
6417,Neuroendocrine Differentiation,"Carcinoma, Small Cell",1
6418,Cutaneous Involvement,Eccrine hidrocystoma,1
6419,Epithelial Component Present,Adenocarcinoma with apocrine metaplasia,1
6420,Malignant Cellular Infiltrate,Ampulla of Vater Hepatoid Adenocarcinoma,1
6421,Epithelial Component Present,Verrucous carcinoma,1
6422,Malignant Cellular Infiltrate,Ovarian germ cell choriocarcinoma stage IV,1
6423,Epithelial Component Present,Digital papillary eccrine carcinoma of skin,1
6424,Malignant Cellular Infiltrate,"Malignant neoplasm of kidney, except pelvis",1
6425,Postneoadjuvant Therapy Pathologic TNM Finding,Gastroesophageal Junction Adenocarcinoma by AJCC v8 Postneoadjuvant Therapy Stage,1
6426,Malignant Cellular Infiltrate,Lung Pleomorphic Carcinoma,1
6427,Benign Cellular Infiltrate,Nodular tenosynovitis,1
6428,Neuronal Differentiation,Childhood Ganglioglioma,1
6429,Carcinomatous Component Present,Colon Cribriform Comedo-Type Adenocarcinoma,1
6430,Epithelial Component Present,Stage II Adrenal Cortex Carcinoma AJCC v8,1
6431,Fibrotic Stroma Formation,Mucinous adenofibroma,1
6432,Hydropic degeneration,Uterine Corpus Hydropic Leiomyoma,1
6433,Malignant Cellular Infiltrate,Squamous cell carcinoma of trachea,1
6434,Recurrent disease,Urothelial carcinoma recurrent,1
6435,Carcinomatous Component Present,"Pancreatic carcinoma, familial",1
6436,Dysplasia,Cervical intraepithelial neoplasia grade 1,1
6437,Malignant Cellular Infiltrate,Recurrent B-Cell Prolymphocytic Leukemia,1
6438,High Mitotic Activity,Vaginal Undifferentiated Sarcoma,1
6439,Malignant Cellular Infiltrate,Stage II Urethral Cancer AJCC v8,1
6440,Benign Cellular Infiltrate,Cardiac Cavernous Hemangioma,1
6441,Childhood Lesion,Acute Myeloid Leukemia with t(5;11)(q35;p15); NUP98-NSD1,1
6442,Malignant Cellular Infiltrate,Bone Sarcoma,1
6443,Cutaneous Involvement,Vulvar Syringoma,1
6444,Epithelial Component Present,Adenocarcinoma Of Esophagus,1
6445,Malignant Cellular Infiltrate,Metastatic Infiltrating Bladder Urothelial Carcinoma with Giant Cells,1
6446,Malignant Cellular Infiltrate,Combined Lung Small Cell and Squamous Cell Carcinoma,1
6447,Recurrent disease,Recurrent Childhood T Acute Lymphoblastic Leukemia,1
6448,Sinusoidal Infiltration,Recurrent Hepatosplenic T-Cell Lymphoma,1
6449,Synchronous Lesion,Bilateral Synchronous Sporadic Renal Cell Carcinoma,1
6450,Glomerular Hypertrophy,Focal Segmental Glomerulosclerosis Collapsing Variant,1
6451,Bone Marrow Dysplasia Present,Refractory anemia with excess blasts I,1
6452,Multifocal Lesion,Refractory Erdheim-Chester Disease,1
6453,High Mitotic Activity,undifferentiated sarcoma of ovary,1
6454,Bone Marrow Dysplasia Present,Epipodophyllotoxin-Related Myelodysplastic Syndrome,1
6455,Epithelial Component Present,BCLC Stage D Hepatocellular Carcinoma,1
6456,Epithelial Component Present,Digestive System Large Cell Neuroendocrine Carcinoma,1
6457,Malignant Cellular Infiltrate,Stage 0 Esophageal Cancer AJCC v6,1
6458,Malignant Cellular Infiltrate,Diffuse Large B-Cell Lymphoma,1
6459,Malignant Cellular Infiltrate,Peripheral Ganglioneuroblastoma,1
6460,High Mitotic Activity,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
6461,Recurrent Lymphoma,EBV-Related Clonal Post-Transplant Lymphoproliferative Disorder,1
6462,Increased Cellularity Present,Recurrent Anaplastic Oligodendroglioma,1
6463,Severe dysplasia,Stage 0 Lung Large Cell Carcinoma AJCC v6 and v7,1
6464,Epithelial Component Present,Thyroid Gland Medullary Carcinoma with Amyloid Stroma,1
6465,Dilated Terminal Duct Lobular Units Present,Columnar Cell Change of the Breast with Atypia,1
6466,Cutaneous Involvement,Pemphigus Vulgaris,1
6467,Epithelial Component Present,Stage IIIB Gallbladder Cancer AJCC v7,1
6468,Malignant Cellular Infiltrate,Stage I Gallbladder Cancer AJCC v6,1
6469,CD30-Positive Neoplastic Cells Present,Anaplastic small cell lymphoma,1
6470,Locally Aggressive Lesion,Inflammatory pseudotumor of liver,1
6471,Non-Invasive Lesion,Bladder Urothelial Proliferation of Uncertain Malignant Potential,1
6472,Epithelial Component Present,Stage III Ureter Cancer AJCC v8,1
6473,Cervical Glandular Dysplasia,Low grade cervical glandular intraepithelial neoplasia,1
6474,Hyperplastic Tissue Present,Urothelial Hyperplasia,1
6475,Pregnancy Complications,Placenta Disorders,1
6476,Mucoid Stroma Formation,Mucinous adenocarcinoma of appendix,1
6477,Well-Circumscribed Lesion,Cellular angiofibroma,1
6478,Carcinomatous Component Present,Stage I Lip Basal Cell Carcinoma,1
6479,Neoplastic Glandular Epithelium Resembling the Normal Endometrium Present,Endometrioid tumor,1
6480,Carcinomatous Component Present,Acinic Cell Breast Carcinoma,1
6481,Mild dysplasia,Intracystic papillary neoplasm with low grade intraepithelial neoplasia,1
6482,Recurrent disease,Recurrent Aggressive NK-Cell Leukemia,1
6483,Epithelial Component Present,Anatomic Stage IB Breast Cancer AJCC v8,1
6484,Malignant Cellular Infiltrate,Stage II Nasopharyngeal Carcinoma AJCC v7,1
6485,Cutaneous Involvement,External Auditory Canal Ceruminous Adenoma,1
6486,Cystic Lesion,Papillary craniopharyngioma,1
6487,Presence of a Hormonal Syndrome,Functioning Pancreatic Neuroendocrine Tumor G2,1
6488,Carcinomatous Component Present,Carcinoma of the Floor of the Mouth,1
6489,Benign Cellular Infiltrate,Benign neoplasm of accessory sinus,1
6490,Clinical TNM Finding,Clinical Stage IIA Merkel Cell Carcinoma AJCC v8,1
6491,Secondary Lesion,Advanced Digestive System Carcinoma,1
6492,Alternative Fascicle (Bundle) Pattern,"Uterine Corpus Leiomyoma, Mitotically Active Variant",1
6493,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia,1
6494,Malignant Cellular Infiltrate,Refractory Thrombocytopenia,1
6495,Malignant Cellular Infiltrate,Stage III Testicular Non-Seminomatous Germ Cell Tumor AJCC v6 and v7,1
6496,Epithelial Component Present,Thymic epithelial tumor,1
6497,Unclassifiable Lesion,"Intestinal T-Cell Lymphoma, Not Otherwise Specified",1
6498,Epithelial Component Present,Postneoadjuvant Therapy Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8,1
6499,Malignant Cellular Infiltrate,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1,1
6500,Monomorphic Cellular Infiltrate,Tanycytic ependymoma,1
6501,Fibrotic Stroma Formation,Pigmented villonodular synovitis,1
6502,Biphasic Pattern,Childhood Brain Stem Gliosarcoma,1
6503,Malignant Cellular Infiltrate,Stage IVA Thyroid Gland Undifferentiated (Anaplastic) Carcinoma AJCC v8,1
6504,Polymorphic Cellular Infiltrate,"Histiocytosis, Langerhans-Cell",1
6505,Hyaline Cartilage Differentiation,Enchondroma,1
6506,Endophytic Tumor Growth,Laryngeal verrucous carcinoma recurrent,1
6507,Malignant Cellular Infiltrate,"Vulvar Adenocarcinoma, Intestinal-Type",1
6508,Cutaneous Involvement,Benign Dermal Schwannoma,1
6509,Malignant Cellular Infiltrate,Stage IVB Nasopharyngeal Carcinoma AJCC v8,1
6510,Epithelial Component Present,Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7,1
6511,Rapidly Enlarging Mass,"Vulvar Squamous Cell Carcinoma, Keratoacanthoma Type",1
6512,Neuroendocrine Differentiation,Jejunal Neuroendocrine Tumor G1,1
6513,Adulthood Lesion,"Adult Embryonal Tumor with Multilayered Rosettes, C19MC-Altered",1
6514,Secondary Lesion,Metastatic Oropharyngeal Carcinoma,1
6515,Well-Circumscribed Lesion,Stage V Kidney Wilms Tumor,1
6516,Malignant Cellular Infiltrate,Small Intestinal Enteropathy-Associated T-Cell Lymphoma,1
6517,Carcinomatous Component Present,Vaginal Neuroendocrine Carcinoma,1
6518,Increased Cellularity Present,neuroblastoma of spinal cord,1
6519,Malignant Cellular Infiltrate,Recurrent Non-Hodgkin Lymphoma,1
6520,Benign Cellular Infiltrate,Giant Hemangioma,1
6521,Nuclear Atypia,Anaplastic Diencephalic Astrocytoma,1
6522,Carcinomatous Component Present,Carcinoma of supraglottis,1
6523,Exophytic Papillary Lesion,Urethral Verrucous Carcinoma,1
6524,Epithelial Component Present,Stage IIIC Esophageal Adenocarcinoma AJCC v7,1
6525,Malignant Cellular Infiltrate,Bone Sarcoma by AJCC v7 Stage,1
6526,Malignant Cellular Infiltrate,Low grade myofibroblastic sarcoma,1
6527,Childhood Lesion,Recurrent Childhood Kidney Neoplasm,1
6528,Well Differentiated Neuroendocrine Lesion,Gastric Neuroendocrine Tumor,1
6529,Diffuse Pattern,Frontal Lobe Anaplastic Astrocytoma,1
6530,Secondary Lesion,Secondary Central Chondrosarcoma,1
6531,Malignant Cellular Infiltrate,Stage IIIB Vulvar Cancer AJCC v8,1
6532,Epithelial Component Present,Adenosquamous cell lung cancer stage IV,1
6533,Malignant Cellular Infiltrate,Stage IVC Lip Cancer AJCC v6 and v7,1
6534,Epithelial Component Present,BCLC Stage A Adult Hepatocellular Carcinoma,1
6535,Indolent Clinical Course,Endobronchial Leiomyoma,1
6536,Papillary Pattern,ductal papilloma of salivary gland,1
6537,Childhood Lesion,Childhood Myxoid Chondrosarcoma,1
6538,Carcinomatous Component Present,Esophageal adenocarcinoma recurrent,1
6539,Exophytic Papillary Lesion,Verrucous carcinoma of the oral cavity recurrent,1
6540,Carcinomatous Component Present,Adenoid cystic carcinoma of the oral cavity,1
6541,Primary Lesion,Primary Effusion Lymphoma,1
6542,Carcinomatous Component Present,Stage IA Vulvar Cancer AJCC v8,1
6543,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm,1
6544,Secondary Lesion,Metastatic Nasopharyngeal Keratinizing Squamous Cell Carcinoma,1
6545,Carcinomatous Component Present,Carcinoma of the Appendix,1
6546,Malignant Cellular Infiltrate,Anaplastic (Malignant) Intracranial Meningioma,1
6547,Mixed Cellular Population,carcinosarcoma of lung,1
6548,Mucoid Stroma Formation,mucinous adenocarcinoma of gallbladder,1
6549,Epithelial Component Present,Extrahepatic Bile Duct Neuroendocrine Neoplasm,1
6550,Childhood Lesion,Childhood Favorable Prognosis Hodgkin Lymphoma,1
6551,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Gland Black Follicular Adenoma,1
6552,Unclassifiable Lesion,"Childhood Central Nervous System Embryonal Tumor, Not Otherwise Specified",1
6553,Epithelial Component Present,"Adenocarcinoma, metastatic",1
6554,Malignant Cellular Infiltrate,Transitional cell carcinoma urethra,1
6555,Skin Papule,Desmoplastic trichoepithelioma,1
6556,Necrotic changes (finding),Stage III Lung Small Cell Carcinoma AJCC v7,1
6557,Malignant Cellular Infiltrate,Stage IIIB Adult Liver Cancer AJCC v7,1
6558,Malignant Cellular Infiltrate,Adult Acute Basophilic Leukemia,1
6559,Myxoid Stroma Formation,Myxoid liposarcoma metastatic,1
6560,Epithelial Component Present,undifferentiated carcinoma of pancreas,1
6561,Epithelial Component Present,Stage 0 Eyelid Carcinoma AJCC v7,1
6562,S-100-Positive Neoplastic Cells Present,Kidney Epithelioid Type Angiomyolipoma,1
6563,Follicular Cell Differentiation,Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7,1
6564,Hyperplastic Tissue Present,Drug-induced gingival hyperplasia,1
6565,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma,1
6566,Lymphadenopathy,Nodal marginal zone B-cell lymphoma stage II,1
6567,Benign Cellular Infiltrate,Borderline Ovarian Mucinous Adenofibroma,1
6568,More than 10 Mitoses per 10HPF,Stage IIIB Lung Small Cell Carcinoma with Pleural Effusion AJCC v7,1
6569,Invasive Lesion,Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant,1
6570,Epithelial Component Present,Acinar Cell Carcinoma,1
6571,Slow Growing Mass,Childhood Ependymoma,1
6572,Epithelial Component Present,Unresectable Adrenal Cortex Carcinoma,1
6573,Malignant Cellular Infiltrate,Endometrial Endometrioid Adenocarcinoma with Clear Cell Change,1
6574,Metastatic Lesion,Pancreatic neuroendocrine tumor metastatic,1
6575,Epithelial Component Present,Stage II Anal Cancer AJCC v8,1
6576,Dermal Involvement,Vaginal Blue Nevus,1
6577,Cystic Change,Thyroid Gland Mucoepidermoid Carcinoma,1
6578,Mild cytologic atypia,verrucous carcinoma of bladder,1
6579,Carcinomatous Component Present,Stage IVA Vaginal Cancer AJCC v8,1
6580,Malignant Cellular Infiltrate,Sarcoma of soft tissue,1
6581,Secondary Lesion,Metachronous Osteosarcoma,1
6582,Monoblasts 80 Percent or More of Bone Marrow Monocytic Cells,Childhood Acute Monoblastic Leukemia,1
6583,Epithelial Component Present,Ampulla of Vater Neuroendocrine Neoplasm,1
6584,Malignant Cellular Infiltrate,Large Cell/Anaplastic Medulloblastoma,1
6585,Malignant Cellular Infiltrate,"Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor by AJCC v8 Stage",1
6586,Malignant Cellular Infiltrate,adenocarcinoma of epididymis,1
6587,Malignant Cellular Infiltrate,Sclerosing Epithelioid Fibrosarcoma,1
6588,Epithelial Component Present,Lung Carcinoma Metastatic in the Bone,1
6589,Malignant Cellular Infiltrate,Recurrent Olfactory Neuroblastoma,1
6590,Childhood Lesion,Childhood Central Nervous System Ganglioneuroblastoma,1
6591,Syncytial Pattern,Stage IVA Oropharyngeal Undifferentiated Carcinoma AJCC v7,1
6592,Mesenchymal Component Present,Recurrent Submandibular Gland Carcinoma ex Pleomorphic Adenoma,1
6593,Malignant Primitive Cellular Infiltrate,Stage IV Ovarian Embryonal Carcinoma AJCC v6 and v7,1
6594,Cystic Change,Testicular Dermoid Cyst,1
6595,Epithelial Component Present,Adenoid cystic carcinoma of lacrimal gland,1
6596,Low Mitotic Activity,Gastric Neuroendocrine Tumor,1
6597,Extraosseous Lesion,Liver Extraskeletal Osteosarcoma,1
6598,Malignant Cellular Infiltrate,Refractory Metastatic Digestive System Carcinoma,1
6599,Indolent Clinical Course,Myxoma,1
6600,Epithelial Component Present,Stage II Ovarian Cancer AJCC v8,1
6601,Metastatic Lesion,Metastatic Squamous Cell Breast Carcinoma,1
6602,Cutaneous Involvement,Epithelial neoplasm of skin,1
6603,Carcinomatous Component Present,Pathologic Stage IIA Esophageal Squamous Cell Carcinoma AJCC v8,1
6604,Pseudopapillary Pattern,Stage I Ovarian Embryonal Carcinoma AJCC v6 and v7,1
6605,Malignant Cellular Infiltrate,Lymphoplasmacytoid lymphoma/immunocytoma stage IV,1
6606,Epithelial Component Present,Carcinoma in Situ,1
6607,Cutaneous Involvement,Sebaceous Gland Neoplasms,1
6608,Malignant Cellular Infiltrate,Stage III Penile Cancer AJCC v6,1
6609,Vascular Channel Formation,Deep Hemangioma,1
6610,Epithelial Component Present,Laryngeal verrucous carcinoma,1
6611,Malignant Cellular Infiltrate,Malignant sex-cord stromal tumor,1
6612,Malignant Cellular Infiltrate,Malignant Anterior Tongue Neoplasm,1
6613,Malignant Cellular Infiltrate,"Testicular Yolk Sac Tumor, Enteric Pattern",1
6614,Epithelial Component Present,Stage III Hilar Cholangiocarcinoma AJCC v8,1
6615,Epithelial Component Present,Stage III Carcinoma of Stomach,1
6616,Malignant Cellular Infiltrate,Laryngeal verrucous carcinoma,1
6617,Duct-Like Structures Present,epithelial-myoepithelial carcinoma of lung,1
6618,Immunologic Deficiency Syndromes,Bone Marrow Transplantation Nephropathy,1
6619,Malignant Cellular Infiltrate,Desmoplastic Neurotropic Melanoma,1
6620,Epithelial Component Present,Stage I Differentiated Thyroid Gland Carcinoma Under 45 Years AJCC v7,1
6621,Thyroglobulin Positive Neoplastic Cells Present,Thyroid Hurthle Cell Carcinoma,1
6622,Malignant Cellular Infiltrate,Proneural Glioblastoma,1
6623,Crystal deposition,Childhood Alveolar Soft Part Sarcoma,1
6624,Malignant Cellular Infiltrate,Primary bone lymphoma,1
6625,Malignant Cellular Infiltrate,Malignant neoplasm of cheek mucosa,1
6626,Mixed Cellular Population,Uterine Corpus Carcinofibroma,1
6627,Malignant Cellular Infiltrate,Bladder Urachal Urothelial Carcinoma,1
6628,Carcinomatous Component Present,Stage IB Lung Squamous Cell Carcinoma AJCC v7,1
